data_6c00_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6c00 _Structure_validation_residue.Date_analyzed 2019-01-11 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.636 0.255 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.1 mm -107.69 101.9 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.285 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -81.59 115.29 20.8 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.155 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' VAL . 20.2 mt -132.5 164.15 27.24 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.591 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.72 146.14 25.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.12 154.77 25.76 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.002 -1.571 . . . . 0.0 109.662 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -104.98 124.72 50.01 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.407 ' H ' HG21 ' A' ' 13' ' ' VAL . 5.2 t -61.13 113.84 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.16 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -88.12 -31.05 19.39 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.648 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -154.4 158.1 39.51 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.463 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.61 ' H ' ' CD ' ' A' ' 15' ' ' GLU . . . -124.48 124.36 42.13 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.733 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.43 162.59 33.38 Favored Pre-proline 0 N--CA 1.487 1.381 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.28 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 5.9 Cg_exo -55.98 179.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.67 1.58 . . . . 0.0 111.508 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.1 t-20 74.93 17.2 2.8 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.081 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.0 50.86 9.58 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.798 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.8 mtt -142.77 171.64 13.77 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.715 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.726 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.44 166.32 29.45 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.479 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -100.04 143.56 30.1 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.25 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.524 ' CG2' ' SG ' ' A' ' 34' ' ' CYS . 19.1 t -132.62 137.42 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.326 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 25' ' ' LYS . 8.0 ptmm? -111.42 126.93 55.47 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.393 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.491 HD13 ' H ' ' A' ' 26' ' ' LEU . 4.5 mp -87.45 153.21 21.61 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.799 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -57.67 -17.55 15.51 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.772 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.456 ' HB2' ' HD1' ' A' ' 30' ' ' HIS . 28.9 m-20 -69.23 -14.73 63.13 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.693 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.68 -11.67 53.55 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.677 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.456 ' HD1' ' HB2' ' A' ' 28' ' ' ASN . 20.8 m80 -87.78 175.48 7.83 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.015 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -137.43 149.29 46.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.316 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 33' ' ' LEU . 50.7 mt -142.86 154.06 17.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.463 ' N ' HG22 ' A' ' 32' ' ' ILE . 10.0 mt -86.25 147.47 26.07 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.211 -0.995 . . . . 0.0 109.231 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -139.34 147.71 41.91 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.854 -1.139 . . . . 0.0 111.393 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 22.4 t-80 -119.04 155.55 31.26 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.286 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.503 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 46.8 mt -84.01 145.93 7.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.445 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.9 m -96.57 169.61 9.77 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.03 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.34 -14.09 80.79 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.335 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -75.58 -62.76 1.47 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.582 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.05 -19.69 33.48 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.616 -1.234 . . . . 0.0 109.086 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -42.92 70.45 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.034 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.483 ' SD ' ' O ' ' A' ' 42' ' ' MET . 4.4 tmm? -60.42 -33.68 72.85 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.696 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.422 ' CB ' ' CD1' ' A' ' 45' ' ' ILE . 36.5 m-20 -64.42 -17.7 64.03 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 118.769 -1.172 . . . . 0.0 109.873 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.4 t80 67.7 73.67 0.31 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.067 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.635 ' CG2' ' N ' ' A' ' 46' ' ' ARG . 2.0 mp -117.85 165.86 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.337 0.589 . . . . 0.0 111.781 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.635 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 24.1 ttt180 -144.85 74.52 1.41 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.069 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 tt -77.19 149.6 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.119 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 49' ' ' GLU . 12.1 mt -120.4 139.57 52.61 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.072 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' LEU . 1.8 pm0 -38.21 148.07 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.007 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.16 -4.57 58.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -98.37 139.58 33.92 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.088 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -75.5 144.09 42.18 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.773 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.5 m -149.9 167.35 2.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.686 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.582 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -93.42 127.52 39.09 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 9' ' ' LEU . 2.9 t -104.15 129.56 56.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.438 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -106.11 110.47 22.74 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.359 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.1 mt -88.01 143.17 27.24 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.065 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 60' ' ' TYR . 25.4 p -98.79 132.98 22.8 Favored Pre-proline 0 N--CA 1.492 1.658 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.118 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.4 -1.3 1.34 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.445 1.43 . . . . 0.0 111.442 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.481 ' H ' ' C ' ' A' ' 58' ' ' SER . 5.6 t80 -81.13 -21.68 39.63 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.705 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.0 p30 179.88 105.78 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.908 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt -66.6 20.7 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.608 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.705 ' H ' ' C ' ' A' ' 61' ' ' ASP . 76.1 m -98.19 -14.4 20.38 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.044 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.423 ' NH2' ' OD1' ' A' ' 61' ' ' ASP . 17.2 mtp180 -138.83 146.61 41.47 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.197 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.57 -151.75 5.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.67 143.28 4.74 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.175 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.3 mm -93.15 119.05 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.059 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.597 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 7.2 p -126.62 7.38 6.88 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.685 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.85 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.16 111.87 0.73 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.378 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.468 ' NE ' HG22 ' A' ' 45' ' ' ILE . 28.5 ptt85 -111.36 146.28 37.4 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.255 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? . . . . . 0 C--N 1.302 -1.483 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.92 -179.959 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.5 mt -97.73 101.38 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.222 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -94.55 108.38 20.34 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 mt -132.64 148.94 52.36 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.067 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.84 144.1 27.17 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.66 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.47 179.82 25.94 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 119.069 -1.539 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.4 m -124.16 131.05 53.5 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.445 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.73 119.08 3.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 118.576 -1.249 . . . . 0.0 110.591 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' LYS . 5.7 t -88.88 -32.24 17.85 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.165 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -151.1 156.32 40.78 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.694 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.84 107.38 18.1 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.627 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.3 mt -99.79 144.52 28.5 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.099 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.9 Cg_endo -61.01 166.68 10.15 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.255 1.304 . . . . 0.0 111.037 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER 76.96 29.76 0.59 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.652 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.82 57.77 4.5 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.531 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.766 ' SD ' ' NE2' ' A' ' 35' ' ' HIS . 15.8 mtm -152.6 159.42 43.24 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.897 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.696 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -159.45 165.34 33.31 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.668 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 14' ' ' SER . 27.4 ttpt -103.29 114.3 28.47 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.657 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.425 HG23 ' SG ' ' A' ' 34' ' ' CYS . 47.6 t -98.51 146.98 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.303 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -124.2 114.4 19.57 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.746 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.576 ' C ' ' H ' ' A' ' 28' ' ' ASN . 10.6 mt -69.58 147.07 51.22 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.659 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.643 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -49.31 -11.36 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.959 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.643 ' N ' ' CD ' ' A' ' 27' ' ' GLU . 36.6 t30 -78.84 -17.79 55.08 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.7 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.69 -2.18 42.13 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.804 -1.189 . . . . 0.0 112.294 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.465 ' HD1' ' HB3' ' A' ' 28' ' ' ASN . 51.9 m80 -94.29 137.56 33.31 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.069 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -91.53 141.26 28.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.491 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.5 mm -137.93 144.53 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.248 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.688 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 5.2 mp -85.85 134.41 33.91 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.14 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.425 ' SG ' HG23 ' A' ' 24' ' ' VAL . 3.0 m -139.57 151.35 45.99 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.399 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.766 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 18.3 m80 -115.55 161.82 18.09 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.654 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.502 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 27.9 mt -92.59 146.06 6.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.66 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.46 ' N ' HG23 ' A' ' 36' ' ' ILE . 3.2 m -92.47 -178.34 4.88 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.21 -8.61 87.44 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.854 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -75.12 -62.18 1.64 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.48 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.69 -20.68 5.74 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.188 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -73.52 -39.19 64.97 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.308 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.61 -28.62 67.08 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.397 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -77.55 -16.28 58.75 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.618 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.2 t80 47.66 80.94 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.551 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.5 mt -144.86 113.21 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.019 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -60.27 126.1 26.18 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.688 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 mm -95.12 148.28 5.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.551 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.3 tp -125.08 135.45 52.71 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.083 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.21 152.34 0.59 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.932 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.02 -16.4 59.62 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.247 -1.454 . . . . 0.0 109.667 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.91 162.21 29.79 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.425 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.73 141.4 36.54 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.377 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.412 ' CG2' HG13 ' A' ' 67' ' ' ILE . 5.3 m -148.57 162.49 5.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.583 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 2.0 m-20 -92.46 124.09 36.25 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.23 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.57 142.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.644 -0.823 . . . . 0.0 112.254 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -122.84 108.64 13.23 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.405 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.1 mt -84.42 132.29 34.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.391 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.454 ' H ' ' HG ' ' A' ' 58' ' ' SER . 13.7 p -91.01 139.33 25.81 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 119.024 -1.07 . . . . 0.0 112.152 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.32 -4.9 8.73 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.518 1.479 . . . . 0.0 111.403 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -89.15 -22.82 22.64 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.724 -0.79 . . . . 0.0 108.98 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.661 ' C ' ' H ' ' A' ' 63' ' ' THR . 4.1 m-20 -151.34 89.31 1.49 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mt -69.89 23.06 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.417 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.661 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.1 m -119.53 -8.59 9.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.169 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.25 150.43 39.28 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.236 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.8 -152.57 6.42 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -166.36 143.76 5.2 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.146 -1.422 . . . . 0.0 112.166 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.607 ' CD1' ' N ' ' A' ' 67' ' ' ILE . 1.3 mp -92.34 121.7 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.22 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.57 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 70.2 p -124.7 7.08 8.16 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.076 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.863 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.67 111.02 0.65 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.646 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.36 162.91 28.4 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.114 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.928 0.394 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 mt -94.46 102.44 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.575 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 1.9 mm-40 -80.38 117.04 20.79 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.156 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.2 mt -128.95 150.73 50.26 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.222 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -88.18 142.64 27.6 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.393 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.7 165.61 31.59 Favored Glycine 0 N--CA 1.485 1.941 0 C-N-CA 119.172 -1.489 . . . . 0.0 110.221 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.484 ' HG1' ' HG2' ' A' ' 52' ' ' LYS . 33.7 m -113.7 125.79 54.51 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.739 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.417 ' H ' HG21 ' A' ' 13' ' ' VAL . 5.3 t -60.99 112.06 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 118.624 -1.23 . . . . 0.0 110.546 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.469 ' HG ' ' CB ' ' A' ' 25' ' ' LYS . 1.2 m -90.36 -32.75 16.33 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.429 -0.908 . . . . 0.0 112.141 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -152.56 137.85 17.51 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.389 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.37 117.12 32.07 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.376 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -106.86 155.22 39.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.618 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.54 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 3.7 Cg_exo -56.54 -164.3 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.879 0 C-N-CA 121.334 1.356 . . . . 0.0 112.126 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 18' ' ' PRO . 8.0 p30 46.63 31.34 1.35 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.062 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' HB3' ' NE2' ' A' ' 35' ' ' HIS . . . 52.07 58.08 5.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.981 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.51 ' SD ' ' OD1' ' A' ' 19' ' ' ASN . 37.0 mtp -149.85 137.59 20.11 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.714 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.71 163.22 27.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.424 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -103.84 108.88 20.39 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.521 ' CG2' ' SG ' ' A' ' 34' ' ' CYS . 36.6 t -94.93 152.48 3.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.375 -0.93 . . . . 0.0 112.01 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' N ' HG13 ' A' ' 24' ' ' VAL . 2.7 ttmp? -120.74 110.91 16.94 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.825 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.1 mp -65.45 178.6 0.92 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.545 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -77.23 -23.69 51.32 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.649 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.784 ' ND2' ' HD1' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -66.12 -15.82 63.43 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.494 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.36 -8.23 35.13 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.068 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.784 ' HD1' ' ND2' ' A' ' 28' ' ' ASN . 22.3 m80 -95.76 176.8 6.0 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.676 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -138.34 160.46 39.43 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.82 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 33' ' ' LEU . 76.7 mt -143.53 161.67 16.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.1 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.679 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 3.9 mp -86.37 131.51 34.19 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.549 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 8.2 m -132.99 135.28 45.38 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.631 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 2.4 t60 -102.31 173.68 6.26 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.509 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.644 ' CG2' ' N ' ' A' ' 37' ' ' SER . 10.7 mt -91.3 165.91 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.998 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.644 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -128.2 160.77 31.04 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.946 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.97 -20.01 66.18 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.341 -1.409 . . . . 0.0 111.594 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.42 ' C ' ' N ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -67.81 -62.27 1.49 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.342 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -52.83 -20.25 3.12 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.808 -1.157 . . . . 0.0 109.643 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.427 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.35 -42.81 68.03 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.406 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.511 ' C ' ' H ' ' A' ' 44' ' ' PHE . 1.4 ptm -72.4 -22.32 61.14 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.298 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.453 ' N ' ' HG3' ' A' ' 42' ' ' MET . 7.2 m120 -67.09 6.51 0.52 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.801 -1.16 . . . . 0.0 110.646 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.511 ' H ' ' C ' ' A' ' 42' ' ' MET . 0.8 OUTLIER 48.19 82.32 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.876 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 mm -142.46 147.06 21.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.088 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.78 75.13 1.51 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.572 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.442 HG21 ' CB ' ' A' ' 51' ' ' ASP . 42.8 mt -105.79 149.59 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.771 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.3 mt -110.72 165.8 11.54 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.517 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -40.41 153.26 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.47 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.26 -12.18 65.25 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.588 -1.292 . . . . 0.0 109.873 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.442 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -92.6 152.63 19.48 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.74 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.484 ' HG2' ' HG1' ' A' ' 12' ' ' THR . 66.1 mttt -78.41 147.43 34.04 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.629 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -149.58 162.44 4.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.643 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.516 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -95.2 123.04 38.49 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.453 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 34' ' ' CYS . 61.1 t -104.35 127.5 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.625 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.65 113.69 26.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.946 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 23.8 mt -88.48 147.26 24.75 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.752 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.05 135.2 33.65 Favored Pre-proline 0 N--CA 1.492 1.648 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.18 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -65.1 -4.93 9.92 Favored 'Trans proline' 0 C--O 1.217 -0.548 0 C-N-CA 121.625 1.55 . . . . 0.0 112.068 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.78 -22.05 14.98 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.083 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.664 ' C ' ' H ' ' A' ' 63' ' ' THR . 33.0 t0 -155.23 91.64 1.36 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.55 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.33 19.83 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.464 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.664 ' H ' ' C ' ' A' ' 61' ' ' ASP . 53.2 m -99.92 -13.33 19.19 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.011 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -137.67 147.31 44.76 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.13 -159.33 7.89 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.426 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 5.8 ptp180 -154.71 143.88 21.12 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.842 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.2 mm -93.26 122.05 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.296 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.635 ' OG1' ' NE1' ' A' ' 69' ' ' TRP . 5.0 p -126.47 6.4 6.93 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.012 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.859 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -158.4 157.72 32.84 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.315 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -154.32 88.72 1.24 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.063 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.309 -1.175 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.655 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.926 0.393 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 mm -95.61 106.72 18.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.415 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.53 112.55 13.18 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.194 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' VAL . 25.0 mt -134.0 164.95 26.17 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.611 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -90.01 143.84 26.43 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.8 148.32 18.8 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.437 ' HG1' ' HG2' ' A' ' 52' ' ' LYS . 20.1 m -104.27 132.13 50.85 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.439 ' H ' HG22 ' A' ' 13' ' ' VAL . 4.2 t -63.36 117.66 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.619 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.09 -29.46 13.61 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.319 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -150.09 121.9 8.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.122 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.46 105.34 17.69 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.034 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.42 149.03 36.61 Favored Pre-proline 0 C--N 1.307 -1.259 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.799 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 2.3 Cg_endo -58.72 167.21 5.51 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.308 1.339 . . . . 0.0 111.229 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 75.79 29.94 0.8 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.573 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.546 ' O ' ' CD2' ' A' ' 35' ' ' HIS . . . 54.16 61.37 3.07 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.822 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 ttm -155.23 136.51 13.99 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.28 165.69 25.19 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.809 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -105.08 109.01 20.83 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.365 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.46 HG23 ' SG ' ' A' ' 34' ' ' CYS . 69.8 t -96.35 143.96 11.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.201 -1.0 . . . . 0.0 112.079 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' N ' HG13 ' A' ' 24' ' ' VAL . 14.8 pttm -110.95 126.87 55.21 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.968 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.8 mp -83.77 175.46 9.64 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.183 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -73.91 -26.93 60.78 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.775 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.477 ' HB3' ' HD1' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -65.85 -16.86 64.22 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.904 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.81 -11.77 35.0 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.365 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.477 ' HD1' ' HB3' ' A' ' 28' ' ' ASN . 45.6 m80 -83.72 174.98 10.01 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.284 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -133.3 151.78 51.9 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.651 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.481 HG23 ' N ' ' A' ' 33' ' ' LEU . 65.8 mt -141.28 155.33 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.914 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 2.2 mp -88.04 134.41 33.75 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.522 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.508 ' HG ' HG11 ' A' ' 55' ' ' VAL . 61.6 m -132.96 139.1 47.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.957 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -107.96 172.35 6.88 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.815 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.646 ' CG2' ' N ' ' A' ' 37' ' ' SER . 25.0 mt -98.61 167.42 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.818 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.646 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 35.1 m -130.93 117.74 19.67 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.817 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.49 -15.34 0.05 OUTLIER Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.82 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 37' ' ' SER . 30.7 mtmt -72.42 -61.54 1.76 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.196 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.461 ' HA ' HD21 ' A' ' 43' ' ' ASN . 1.1 pp -53.15 -21.36 4.88 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.96 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.45 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 1.9 ttt-85 -72.78 -39.72 66.52 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.52 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 42' ' ' MET . 6.9 tpp -63.72 -27.4 69.18 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.725 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 40' ' ' LEU . 83.2 m-20 -78.93 5.39 11.7 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.877 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 54.23 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.223 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.57 114.07 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -59.34 137.15 58.09 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.607 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 mm -102.52 149.78 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.39 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -164.26 134.95 4.26 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.501 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 51' ' ' ASP . 2.2 pp20? -63.42 152.24 38.79 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.223 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.59 -8.31 28.1 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 118.873 -1.632 . . . . 0.0 109.695 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 49' ' ' GLU . 56.5 t0 -72.53 133.1 44.61 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.284 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.437 ' HG2' ' HG1' ' A' ' 12' ' ' THR . 77.8 mttt -76.1 141.76 41.89 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.332 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.6 m -148.48 168.79 3.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.681 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.597 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -91.42 120.26 32.11 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.538 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.508 HG11 ' HG ' ' A' ' 34' ' ' CYS . 26.3 t -104.76 116.66 48.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.634 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.17 120.13 33.98 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.7 mt -92.8 159.43 15.4 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.406 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.0 m -94.85 141.08 22.83 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.599 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -69.68 -21.88 33.25 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.825 1.683 . . . . 0.0 112.055 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -88.24 -26.39 22.37 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.403 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.653 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -148.04 88.21 1.65 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.12 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mt -71.76 20.61 0.06 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.278 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.653 ' H ' ' C ' ' A' ' 61' ' ' ASP . 7.1 p -98.43 -12.32 21.49 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -138.02 150.68 47.18 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.678 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.36 -153.28 5.85 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 4.8 ptt180 -165.48 147.13 7.41 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.664 -1.215 . . . . 0.0 111.595 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.417 ' CD1' HG21 ' A' ' 55' ' ' VAL . 25.2 mm -92.72 117.3 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.969 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.63 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 32.6 p -127.95 7.97 6.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.963 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.824 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -169.98 127.72 0.88 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.28 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 71' ' ' LYS . 8.7 tmm_? -72.3 162.08 29.97 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.515 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 9.2 tttt . . . . . 0 N--CA 1.488 1.45 0 C-N-CA 119.416 -0.913 . . . . 0.0 111.334 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.448 HG22 ' H ' ' A' ' 7' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.41 0.148 . . . . 0.0 110.602 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.448 ' H ' HG22 ' A' ' 6' ' ' VAL . 1.8 mp -116.76 110.19 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.246 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -100.52 127.12 46.98 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.092 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' VAL . 35.2 mt -144.44 160.24 41.4 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.646 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -88.0 143.73 26.93 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.19 168.77 30.2 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.117 -1.516 . . . . 0.0 109.804 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.5 m -123.87 130.03 51.95 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.72 133.07 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.734 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 t -113.24 -26.92 8.18 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.326 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -153.15 158.2 41.45 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.108 -1.437 . . . . 0.0 112.223 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.558 ' H ' ' CD ' ' A' ' 15' ' ' GLU . . . -99.15 113.99 26.51 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.577 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.4 mt -104.66 146.94 33.6 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 119.739 -0.785 . . . . 0.0 111.008 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.517 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 3.1 Cg_endo -65.0 170.49 10.27 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 121.296 1.331 . . . . 0.0 111.433 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.517 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER 75.07 28.62 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.154 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.483 ' O ' ' CE1' ' A' ' 35' ' ' HIS . . . 58.89 61.99 2.01 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.347 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.454 ' SD ' ' HB2' ' A' ' 19' ' ' ASN . 8.6 ptm -165.29 170.38 14.8 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.607 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -155.41 165.34 36.92 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.837 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -88.88 132.46 34.67 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.768 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.473 HG21 ' SG ' ' A' ' 34' ' ' CYS . 2.3 t -125.93 143.39 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.575 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.433 ' N ' HG12 ' A' ' 24' ' ' VAL . 18.6 mttp -122.81 124.75 44.02 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.97 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.71 172.73 10.92 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.93 -41.64 62.19 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.823 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.503 ' HB3' ' CE1' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -71.63 -14.82 62.17 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.411 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.02 -0.78 44.47 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.969 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.503 ' CE1' ' HB3' ' A' ' 28' ' ' ASN . 71.7 m80 -55.34 104.88 0.14 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.835 -1.146 . . . . 0.0 111.224 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -76.19 124.28 27.21 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.431 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.3 mt -137.42 152.6 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.318 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.656 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 6.3 mp -90.45 132.79 35.44 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.356 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.473 ' SG ' HG21 ' A' ' 24' ' ' VAL . 8.8 p -132.03 134.64 45.78 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.889 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.587 ' ND1' ' N ' ' A' ' 36' ' ' ILE . 54.3 t-80 -103.68 176.23 5.22 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.941 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.587 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 22.1 mt -99.74 161.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.005 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.559 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 4.0 p -121.72 -169.49 1.88 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.389 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.32 -5.32 89.81 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.418 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -71.95 -63.41 1.14 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.769 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 mp -54.81 -21.42 11.16 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.874 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -35.16 66.91 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.601 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.8 ttp -74.66 -31.98 62.1 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.783 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.645 ' C ' ' CD1' ' A' ' 44' ' ' PHE . 2.7 t-20 -93.96 0.76 56.25 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.819 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.645 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 18.6 p90 31.01 72.55 0.06 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.1 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 46' ' ' ARG . 43.7 mt -102.69 166.5 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.823 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' N ' HG22 ' A' ' 45' ' ' ILE . 6.1 ptt180 -144.31 79.63 1.62 Allowed 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.634 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.2 mm -104.22 150.7 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.61 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 mp -99.04 156.78 16.75 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.556 -0.858 . . . . 0.0 112.359 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.605 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 6.4 mp0 -41.38 153.71 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.685 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.25 -4.62 60.54 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.004 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -90.82 142.27 27.94 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.591 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.475 ' HZ1' ' HB3' ' A' ' 52' ' ' LYS . 6.5 mtpm? -81.93 145.57 30.24 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.543 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.5 m -148.64 166.56 4.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.42 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.595 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 1.9 m-20 -92.17 123.83 35.81 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.835 -1.146 . . . . 0.0 108.124 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 9' ' ' LEU . 56.8 t -104.32 126.49 59.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.783 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -99.83 114.54 27.79 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.637 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.73 145.27 24.72 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.134 -1.027 . . . . 0.0 111.024 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 60' ' ' TYR . 4.5 p -86.93 128.1 57.26 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.079 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.88 -1.64 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.348 1.365 . . . . 0.0 111.378 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.473 ' H ' ' C ' ' A' ' 58' ' ' SER . 78.6 m-85 -109.05 -16.84 14.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.881 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.656 ' C ' ' H ' ' A' ' 63' ' ' THR . 13.0 m-20 -145.11 84.0 1.7 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt -71.7 23.25 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.656 ' H ' ' C ' ' A' ' 61' ' ' ASP . 6.7 m -116.37 -5.73 11.78 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.622 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.481 ' HG2' ' N ' ' A' ' 65' ' ' GLY . 1.7 tmt_? -148.68 144.88 27.42 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.728 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.481 ' N ' ' HG2' ' A' ' 64' ' ' ARG . . . -138.28 -150.75 5.69 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.462 HH11 ' HG2' ' A' ' 66' ' ' ARG . 10.5 ptt-85 -165.59 141.45 5.19 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.855 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.2 mm -87.44 117.87 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 119.846 -0.741 . . . . 0.0 109.802 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.633 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 25.6 p -125.44 6.88 7.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.863 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -169.92 110.74 0.43 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.231 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.538 ' CG ' ' N ' ' A' ' 71' ' ' LYS . 22.6 ttp85 -68.5 161.56 27.54 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.654 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.538 ' N ' ' CG ' ' A' ' 70' ' ' ARG . 23.2 tttp . . . . . 0 C--N 1.307 -1.252 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.892 0.377 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.7 mt -127.12 103.06 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.787 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.38 115.14 11.27 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.446 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 mt -141.88 143.18 33.2 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -86.25 141.49 29.25 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.476 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.08 149.65 21.68 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.228 -1.463 . . . . 0.0 109.873 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -93.91 130.01 40.14 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.459 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.8 t -59.99 127.12 18.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.277 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.469 ' HG ' ' HE2' ' A' ' 25' ' ' LYS . 46.3 m -99.47 -32.45 11.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.943 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -160.38 157.78 28.42 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.614 -1.234 . . . . 0.0 111.818 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.63 118.7 35.94 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.785 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.8 mt -106.2 147.73 35.37 Favored Pre-proline 0 N--CA 1.491 1.582 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.399 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.74 171.18 4.9 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.611 1.54 . . . . 0.0 111.929 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.58 28.95 7.32 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.805 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.59 60.55 2.22 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.168 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.774 ' SD ' ' CD2' ' A' ' 35' ' ' HIS . 46.7 mtm -152.4 164.51 37.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.334 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.54 165.18 31.29 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.722 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -99.04 137.18 37.93 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.224 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 25' ' ' LYS . 46.9 t -130.93 145.13 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.64 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HE2' ' HG ' ' A' ' 14' ' ' SER . 9.0 mtmm -111.49 120.76 43.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.563 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.513 ' H ' ' CD1' ' A' ' 26' ' ' LEU . 3.9 mp -74.41 168.31 19.95 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.03 -29.59 70.39 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.41 ' CB ' ' HD1' ' A' ' 30' ' ' HIS . 16.4 m120 -63.0 -11.05 16.31 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.641 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.29 -11.52 65.36 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.735 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.41 ' HD1' ' CB ' ' A' ' 28' ' ' ASN . 59.3 m80 -78.38 167.69 20.95 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.524 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -127.42 142.69 51.35 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.155 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 33' ' ' LEU . 77.0 mt -143.69 160.91 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.246 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 6.1 mp -90.35 141.8 28.36 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.151 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' A' ' 55' ' ' VAL . 4.7 m -138.7 139.81 38.54 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.384 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.774 ' CD2' ' SD ' ' A' ' 21' ' ' MET . 4.3 m80 -104.15 168.81 8.87 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.321 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.496 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 57.8 mt -92.78 152.09 3.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.772 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.472 ' N ' HG22 ' A' ' 36' ' ' ILE . 3.5 m -104.08 -166.69 1.28 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.63 -16.82 74.67 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.468 -1.348 . . . . 0.0 111.252 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.486 ' C ' ' N ' ' A' ' 41' ' ' ARG . 30.0 mttp -70.89 -63.22 1.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.658 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.473 HD11 ' H ' ' A' ' 40' ' ' LEU . 4.5 mp -52.84 -20.27 3.14 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.679 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.486 ' N ' ' C ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.91 -36.95 62.18 Favored 'General case' 0 C--N 1.271 -2.848 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.898 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 39' ' ' LYS . 92.3 mtp -90.32 -21.53 21.99 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.637 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.484 ' ND2' HG13 ' A' ' 45' ' ' ILE . 12.9 t30 -83.5 -37.76 22.67 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.316 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.9 t80 42.76 54.72 4.54 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.687 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.484 HG13 ' ND2' ' A' ' 43' ' ' ASN . 5.6 mm -96.35 159.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.216 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.4 ' N ' ' HD2' ' A' ' 46' ' ' ARG . 18.2 mmm180 -62.15 137.58 58.28 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.258 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.429 ' HA ' ' NH2' ' A' ' 70' ' ' ARG . 3.3 mt -133.19 140.27 47.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.889 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.8 mt -143.77 135.33 26.11 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.289 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -43.93 152.09 0.18 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.92 -15.11 63.56 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.731 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -76.11 146.8 39.05 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.356 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -88.23 143.55 26.97 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.702 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.5 m -146.03 169.15 6.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.671 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.498 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.4 OUTLIER -96.57 117.93 32.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.107 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.401 HG12 ' SG ' ' A' ' 34' ' ' CYS . 10.4 t -105.25 117.3 50.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.197 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -94.07 118.61 31.77 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.008 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.3 mt -88.49 139.81 30.11 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.913 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.0 m -95.01 132.56 27.89 Favored Pre-proline 0 N--CA 1.49 1.538 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.356 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.96 -2.81 8.51 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.297 1.332 . . . . 0.0 110.967 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -92.11 -22.83 19.67 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.677 ' C ' ' H ' ' A' ' 63' ' ' THR . 5.5 m-20 -150.83 87.26 1.41 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.199 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mt -66.87 18.81 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.677 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.677 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.3 p -113.33 -8.88 13.45 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.43 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.434 ' NH1' ' NE2' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -140.71 151.59 44.64 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.467 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.71 -153.17 6.1 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -163.72 135.88 5.02 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.195 -1.402 . . . . 0.0 112.474 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.8 mm -92.82 123.09 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.429 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.603 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -125.1 7.09 7.89 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.544 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.817 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -168.89 166.1 11.42 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.785 -1.166 . . . . 0.0 111.483 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' A' ' 47' ' ' ILE . 2.4 ttm180 -144.04 125.87 15.22 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.171 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt . . . . . 0 N--CA 1.488 1.452 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.509 -179.912 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.709 0.29 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.5 mt -114.6 100.93 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.109 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -78.87 114.59 17.93 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.398 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 55' ' ' VAL . 12.2 mt -134.32 153.37 51.92 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.383 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.49 142.1 28.61 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.704 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.03 -178.4 18.08 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.414 ' N ' HG13 ' A' ' 24' ' ' VAL . 13.7 m -137.86 125.8 22.68 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.476 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 13' ' ' VAL . 6.1 t -59.79 123.94 13.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.527 -1.269 . . . . 0.0 110.534 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -105.51 -29.3 10.27 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.984 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -156.99 149.11 22.91 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.879 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.28 131.67 35.96 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -122.29 152.74 61.24 Favored Pre-proline 0 N--CA 1.492 1.626 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.571 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.29 -176.44 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.031 1.154 . . . . 0.0 110.888 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 3.2 m-20 55.52 40.93 31.23 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.51 49.65 13.3 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.848 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.482 ' HG3' ' CE1' ' A' ' 35' ' ' HIS . 28.9 mtp -140.82 168.41 19.85 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.819 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.0 165.94 29.05 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.917 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -95.3 128.58 42.25 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.109 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 12' ' ' THR . 39.0 t -117.65 140.23 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.647 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -105.72 122.69 46.59 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.141 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.48 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.1 mp -76.79 171.99 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.26 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -71.25 -14.5 62.25 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.444 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -75.52 -16.79 60.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.067 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.29 -15.25 33.0 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 119.767 -1.206 . . . . 0.0 111.419 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -89.5 179.24 6.1 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.115 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -137.68 149.9 46.9 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.268 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.57 ' CG2' ' H ' ' A' ' 33' ' ' LEU . 11.2 mm -136.99 174.73 11.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.231 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.57 ' H ' ' CG2' ' A' ' 32' ' ' ILE . 6.8 mp -97.01 136.5 37.49 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.577 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.1 m -132.73 152.96 51.62 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.654 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.482 ' CE1' ' HG3' ' A' ' 21' ' ' MET . 1.9 t60 -118.92 152.7 35.83 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.257 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.533 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 28.0 mt -93.99 146.68 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.995 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.46 ' N ' HG22 ' A' ' 36' ' ' ILE . 4.5 m -97.22 136.28 37.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.469 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.37 -11.28 39.77 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.185 -1.483 . . . . 0.0 110.496 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.446 ' C ' ' N ' ' A' ' 41' ' ' ARG . 6.8 tttm -70.88 -62.22 1.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.26 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -52.72 -20.21 2.99 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.55 -1.26 . . . . 0.0 108.893 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.446 ' N ' ' C ' ' A' ' 39' ' ' LYS . 3.7 ttt180 -63.99 -53.21 53.66 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.635 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 tpp -65.5 -25.35 67.43 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.895 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -65.14 -4.48 5.03 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.739 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 t80 52.28 87.81 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.571 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.6 mt -140.29 141.88 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.722 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -74.53 134.55 42.2 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.797 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 48' ' ' LEU . 37.9 mt -131.18 147.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.342 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.628 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 1.8 pt? -159.59 148.91 18.14 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.657 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -63.34 152.07 39.0 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.416 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.97 -13.15 60.05 Favored Glycine 0 N--CA 1.485 1.9 0 C-N-CA 119.445 -1.36 . . . . 0.0 110.198 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.607 ' CG ' ' HE ' ' A' ' 70' ' ' ARG . 9.5 t70 -80.12 162.16 24.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.655 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -91.06 152.14 20.75 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.751 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.428 ' CG2' HG12 ' A' ' 67' ' ' ILE . 22.3 m -154.62 167.73 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.455 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.532 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -93.72 122.41 36.15 Favored 'General case' 0 C--O 1.203 -1.351 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.27 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 9' ' ' LEU . 4.1 t -104.59 121.14 56.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.419 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.85 121.2 41.65 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.606 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 mt -95.14 141.87 28.26 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.212 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.5 m -86.03 128.81 56.48 Favored Pre-proline 0 N--CA 1.493 1.677 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.592 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.32 -13.38 39.65 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 121.306 1.337 . . . . 0.0 110.898 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -101.32 -10.41 20.31 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.668 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -147.1 72.45 1.26 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.771 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -70.59 23.35 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.641 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.668 ' H ' ' C ' ' A' ' 61' ' ' ASP . 9.1 m -105.5 -21.16 13.27 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.458 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -140.66 159.6 41.84 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.776 -0.77 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.18 -159.96 8.44 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 6.8 ptt180 -166.91 139.36 3.51 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 117.957 -1.497 . . . . 0.0 112.164 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 67' ' ' ILE . 1.8 mp -93.29 126.34 45.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.563 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.469 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 4.8 p -126.77 7.04 6.74 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.888 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.843 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -166.45 142.69 4.77 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.589 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.607 ' HE ' ' CG ' ' A' ' 51' ' ' ASP . 11.0 ttt-85 -124.11 128.15 48.87 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.947 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' ARG . 16.3 mmtt . . . . . 0 N--CA 1.488 1.459 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.847 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.561 0.219 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.4 mm -100.0 107.83 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -76.09 118.41 18.81 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.431 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.6 138.17 37.64 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 12.3 mp0 -88.47 140.65 29.25 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.66 172.24 28.88 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.089 -1.529 . . . . 0.0 110.201 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 m -115.67 129.68 56.58 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.791 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 t -59.67 127.72 19.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.749 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 23' ' ' LYS . 37.1 t -93.98 -40.11 10.29 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.664 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -156.65 158.24 36.64 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.634 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.56 123.75 44.12 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.5 mt -119.29 149.51 47.54 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.461 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 2.3 Cg_endo -59.01 -179.89 0.18 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.289 1.326 . . . . 0.0 111.104 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 6.0 t30 73.58 18.62 3.5 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.61 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.66 42.95 10.33 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.575 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.8 mtp -142.3 174.75 10.33 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.827 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.651 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.52 166.19 27.44 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.372 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' SER . 46.2 tttm -99.14 130.68 45.47 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.55 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG11 ' N ' ' A' ' 25' ' ' LYS . 95.2 t -119.85 150.46 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.336 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.42 ' N ' HG11 ' A' ' 24' ' ' VAL . 26.6 tttt -124.18 112.14 16.73 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.412 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 28' ' ' ASN . 4.7 mp -70.11 138.27 51.83 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.053 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.89 -15.5 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.276 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.551 ' H ' ' C ' ' A' ' 26' ' ' LEU . 18.0 m120 -65.09 -16.27 63.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.243 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.92 -11.21 52.58 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.906 -1.14 . . . . 0.0 111.354 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -98.04 172.02 7.88 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.524 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -125.49 157.94 35.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.59 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 33' ' ' LEU . 34.0 mt -152.01 156.89 5.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.171 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.539 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 7.4 mp -93.45 136.94 33.23 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.228 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' ' CG1' ' A' ' 55' ' ' VAL . 82.8 m -132.78 151.22 52.05 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.289 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -118.65 160.18 22.28 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.0 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.7 mt -91.49 140.67 15.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.324 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 m -85.72 -171.56 3.66 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.011 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.13 -6.85 89.11 Favored Glycine 0 N--CA 1.487 2.039 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.208 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' HB2' ' HZ2' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -75.68 -62.04 1.72 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.246 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mp -56.29 -20.76 20.2 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.021 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -74.88 -38.16 61.97 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.327 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.6 tpp -71.6 -29.32 64.56 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.11 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.456 ' N ' HD21 ' A' ' 43' ' ' ASN . 1.0 OUTLIER -77.04 -38.74 52.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.345 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.26 77.79 0.32 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.223 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.533 ' CG2' ' H ' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -124.68 -150.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.768 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.533 ' H ' ' CG2' ' A' ' 45' ' ' ILE . 0.5 OUTLIER -149.57 98.23 2.74 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.638 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.44 HD13 ' H ' ' A' ' 47' ' ' ILE . 4.2 mp -92.69 121.89 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.832 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 7.2 mp -96.19 136.89 36.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.942 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -42.46 152.66 0.09 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.248 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.24 -14.41 64.48 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -81.38 143.56 32.08 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.483 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -80.41 149.99 29.95 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.732 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.06 168.4 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.798 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.552 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -101.97 117.86 35.71 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.506 ' CG1' ' SG ' ' A' ' 34' ' ' CYS . 24.3 t -104.39 123.98 58.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.436 -0.906 . . . . 0.0 113.182 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -95.55 114.31 26.06 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.99 147.63 24.19 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.577 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 m -91.97 132.51 32.52 Favored Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.056 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.94 -18.56 64.25 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 121.426 1.417 . . . . 0.0 111.712 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.09 -11.45 24.38 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.397 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.646 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.0 t70 -142.32 78.53 1.63 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.096 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -71.7 23.93 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.413 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.646 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -115.54 -23.82 8.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.08 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.01 151.73 48.19 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.622 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 35' ' ' HIS . . . -144.05 -159.36 7.98 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -166.65 146.16 5.67 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.12 -1.432 . . . . 0.0 112.584 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 67' ' ' ILE . 1.8 mp -93.44 126.19 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.796 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.635 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 7.7 p -126.49 6.71 6.93 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.478 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.796 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -171.73 110.47 0.29 Allowed 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.102 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 162.22 28.77 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.379 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 120.74 0.305 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 7' ' ' ILE . 4.5 mp -103.94 146.66 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.27 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -122.46 127.85 50.13 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 55' ' ' VAL . 6.4 mt -144.56 156.02 43.94 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.262 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.544 ' OE2' ' NZ ' ' A' ' 71' ' ' LYS . 39.4 mt-10 -90.56 141.87 28.33 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.609 -0.836 . . . . 0.0 111.25 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.11 158.88 27.91 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.1 m -102.49 132.84 48.28 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.482 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.9 t -68.51 127.13 29.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 118.727 -1.189 . . . . 0.0 110.656 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -98.04 -39.0 9.14 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.588 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -153.56 145.15 23.29 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.092 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.74 110.58 22.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mt -100.14 145.7 30.67 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.15 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.3 Cg_endo -61.92 172.42 3.9 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.242 1.295 . . . . 0.0 111.459 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 76.0 13.79 2.67 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.767 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 19' ' ' ASN . . . 72.49 50.15 0.19 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.032 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.457 ' HE2' ' NE2' ' A' ' 35' ' ' HIS . 9.5 mtp -144.18 140.62 29.44 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.114 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.475 ' CZ ' ' CD1' ' A' ' 36' ' ' ILE . 3.5 m-85 -133.19 166.0 23.47 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.224 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 14' ' ' SER . 78.1 tttt -112.63 111.93 23.09 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.564 ' CG2' ' SG ' ' A' ' 34' ' ' CYS . 16.7 t -107.38 152.11 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 119.472 -0.891 . . . . 0.0 112.774 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' N ' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -126.78 117.24 22.26 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.592 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.464 ' C ' ' N ' ' A' ' 28' ' ' ASN . 2.9 mp -77.0 136.48 38.71 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.855 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -45.91 -19.01 0.05 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.578 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.464 ' N ' ' C ' ' A' ' 26' ' ' LEU . 12.6 m-20 -69.32 -15.9 63.43 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.865 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.04 -12.57 34.31 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.022 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -84.17 163.81 19.53 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.505 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -131.76 144.49 50.99 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.16 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.472 HG21 ' N ' ' A' ' 33' ' ' LEU . 68.0 mt -145.59 148.87 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.575 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 6.1 mp -84.88 125.15 32.4 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.159 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.564 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 59.4 m -116.53 134.24 55.08 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.39 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.466 ' N ' ' HA ' ' A' ' 66' ' ' ARG . 23.3 m170 -97.79 173.54 7.05 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.451 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.475 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 12.9 mt -100.64 147.15 8.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.796 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.491 ' H ' HD21 ' A' ' 40' ' ' LEU . 1.3 t -94.46 161.51 14.19 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.34 -34.67 25.39 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.267 -1.445 . . . . 0.0 111.28 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -65.07 -53.21 49.15 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.056 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.491 HD21 ' H ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -51.88 -22.4 3.76 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.447 -1.301 . . . . 0.0 110.502 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.498 ' CA ' ' HE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.06 -42.1 63.43 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 118.043 -1.463 . . . . 0.0 107.739 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.5 tpp -54.17 -29.25 44.9 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.389 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.65 ' C ' ' CD2' ' A' ' 44' ' ' PHE . 60.3 m-80 -93.25 2.84 56.45 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.65 ' CD2' ' C ' ' A' ' 43' ' ' ASN . 2.8 p90 40.8 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.0 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mm -119.9 102.59 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.578 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -70.09 115.8 9.72 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.2 mt -108.55 110.25 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.589 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mt -97.11 135.57 38.89 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.04 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 1.4 pm0 -46.27 152.38 0.43 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.941 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.61 60.58 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.147 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -91.96 156.37 17.49 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.321 -0.951 . . . . 0.0 110.769 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.51 143.66 27.62 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.547 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.57 161.27 9.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.826 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.571 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.9 OUTLIER -91.75 120.89 32.89 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.915 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 9' ' ' LEU . 93.5 t -104.11 121.11 55.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.211 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -90.57 123.02 33.89 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.466 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.1 mt -97.3 140.12 32.24 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.771 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 60' ' ' TYR . 4.7 p -92.84 129.69 39.12 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.538 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -57.85 -2.46 0.78 Allowed 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 121.271 1.314 . . . . 0.0 111.668 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.5 ' H ' ' C ' ' A' ' 58' ' ' SER . 27.3 t80 -100.32 -13.07 18.96 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.657 ' C ' ' H ' ' A' ' 63' ' ' THR . 26.6 m-20 -149.59 87.28 1.49 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.544 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 mp -70.66 23.69 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.46 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.657 ' H ' ' C ' ' A' ' 61' ' ' ASP . 39.5 m -135.77 3.49 2.98 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.282 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -141.31 135.08 30.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.082 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.13 -147.78 4.97 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.465 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.466 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 11.9 ptp180 -165.89 151.46 8.91 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.302 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.421 ' CD1' HG23 ' A' ' 55' ' ' VAL . 17.3 mm -93.37 122.36 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.94 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.62 ' C ' ' CG ' ' A' ' 69' ' ' TRP . 0.2 OUTLIER -127.6 7.59 6.31 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.944 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.913 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -176.55 111.45 0.09 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.432 -1.307 . . . . 0.0 111.844 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -76.28 126.82 31.68 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.604 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.544 ' NZ ' ' OE2' ' A' ' 10' ' ' GLU . 12.5 tptt . . . . . 0 C--N 1.303 -1.434 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.962 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.885 0.374 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.2 mm -101.78 101.81 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.892 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -83.2 119.36 24.45 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.566 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 mt -133.87 157.29 46.34 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.454 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -92.87 144.24 25.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.23 162.9 30.82 Favored Glycine 0 N--CA 1.483 1.813 0 C-N-CA 118.943 -1.599 . . . . 0.0 109.939 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 m -113.49 130.73 56.27 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.074 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.0 t -65.14 116.65 4.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 118.533 -1.267 . . . . 0.0 111.096 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.0 m -97.81 -33.45 11.26 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.752 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -141.73 157.87 44.51 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.67 117.02 24.8 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.083 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' MET . 22.7 mt -98.12 147.77 33.55 Favored Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.036 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.7 Cg_endo -60.38 152.23 68.7 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.417 1.411 . . . . 0.0 111.517 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER 79.56 46.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.137 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.43 58.07 5.81 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.596 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 17' ' ' LEU . 21.1 mtm -144.46 142.4 30.25 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.335 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.655 ' N ' ' CD2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -153.02 166.02 33.75 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.612 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -106.7 142.06 36.95 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.286 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 t -133.31 132.62 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.831 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 2.0 pttm -99.84 129.47 45.94 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.038 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mp -86.13 177.1 7.65 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.043 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.405 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 3.9 mm-40 -73.34 -31.2 63.83 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.501 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -62.78 -10.79 14.22 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.486 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.41 -10.2 63.08 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.05 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.455 ' HD1' ' HB3' ' A' ' 28' ' ' ASN . 64.1 m80 -84.98 156.77 21.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.471 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -116.17 148.55 40.25 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.599 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 33' ' ' LEU . 78.5 mt -141.09 149.68 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.67 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 5.3 mp -81.53 154.74 26.1 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.667 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.413 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . 39.9 m -145.54 154.31 42.05 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.449 -1.301 . . . . 0.0 111.546 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.419 ' H ' ' HA ' ' A' ' 66' ' ' ARG . 1.9 t60 -127.76 143.88 51.11 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.386 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.467 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 5.5 mt -70.5 135.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.085 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.91 165.43 12.67 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.923 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.88 -7.26 88.77 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -74.69 -62.71 1.44 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -55.25 -20.62 11.52 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.708 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.43 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -71.57 -41.66 68.74 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.12 -1.032 . . . . 0.0 108.861 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.7 mmt -61.54 -27.08 68.36 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.181 -1.007 . . . . 0.0 109.337 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.444 ' ND2' ' N ' ' A' ' 43' ' ' ASN . 3.3 m120 -69.33 -1.63 8.72 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.318 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.569 ' O ' ' CG ' ' A' ' 44' ' ' PHE . 11.3 t80 57.63 54.62 6.21 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.095 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.606 ' CG2' ' N ' ' A' ' 46' ' ' ARG . 62.1 mt -152.88 172.3 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.162 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.606 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 5.5 ptp85 -139.85 163.56 32.32 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.906 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 mp -109.41 148.95 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.058 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.2 mt -127.78 136.94 52.18 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.977 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -40.18 152.47 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.855 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.61 -9.38 59.16 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.432 -1.365 . . . . 0.0 110.36 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -93.03 135.66 33.99 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.581 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.565 ' CD ' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -75.51 149.01 38.52 Favored 'General case' 0 CA--C 1.486 -1.511 0 C-N-CA 118.764 -1.174 . . . . 0.0 110.577 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.4 m -151.93 165.86 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.738 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.542 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -98.22 125.18 43.17 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.0 t -102.88 128.13 56.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.86 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.612 ' OE2' ' NH1' ' A' ' 66' ' ' ARG . 6.1 tt0 -100.33 110.28 22.5 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.395 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.0 mt -89.55 148.92 23.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.599 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.2 p -99.61 142.04 23.89 Favored Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 119.364 -0.934 . . . . 0.0 112.087 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.21 -3.68 6.57 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.732 1.621 . . . . 0.0 111.559 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -87.96 -23.36 23.88 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.051 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.681 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.4 OUTLIER -166.65 96.09 0.54 Allowed 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.309 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -67.69 18.51 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.563 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.681 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -103.63 -9.77 18.93 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.215 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -137.78 144.73 41.73 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.786 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.31 -152.27 5.67 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.308 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.612 ' NH1' ' OE2' ' A' ' 56' ' ' GLU . 4.1 ptt180 -162.42 152.03 15.94 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.925 -1.11 . . . . 0.0 111.469 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.643 ' CG1' ' CZ ' ' A' ' 22' ' ' PHE . 33.5 mm -92.75 121.21 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.626 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 1.4 p -126.98 6.95 6.6 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.701 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.866 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.19 111.7 0.72 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.068 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.515 ' C ' ' CD ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -102.57 159.9 15.04 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.972 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 3.2 tptt . . . . . 0 N--CA 1.484 1.231 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.396 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.737 0.304 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mm -98.08 104.22 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.46 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -73.35 112.64 9.6 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.988 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mt -137.13 136.15 38.02 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.352 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -91.47 140.96 29.25 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.515 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.52 -166.98 11.02 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.038 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.41 ' H ' HG11 ' A' ' 24' ' ' VAL . 51.2 m -137.44 128.77 28.02 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.517 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.71 130.44 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.485 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.1 t -120.89 -32.42 3.98 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.13 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.433 ' HB3' ' HZ1' ' A' ' 23' ' ' LYS . 36.1 tt0 -141.22 155.5 46.03 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.573 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.13 126.68 39.51 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.958 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.59 144.26 31.5 Favored Pre-proline 0 N--CA 1.494 1.749 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.354 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 3.3 Cg_endo -64.92 164.41 24.79 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 121.539 1.492 . . . . 0.0 111.57 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER 76.2 34.12 0.53 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.257 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.82 61.1 2.51 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.289 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.596 ' SD ' ' CE1' ' A' ' 35' ' ' HIS . 5.2 ptm -162.52 174.78 12.2 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.597 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.764 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.25 161.5 30.79 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.696 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HZ1' ' HB3' ' A' ' 15' ' ' GLU . 1.3 ttmp? -84.6 138.55 32.65 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.551 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.441 ' CG2' ' SG ' ' A' ' 34' ' ' CYS . 2.0 t -127.34 131.65 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.186 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -97.13 123.65 40.95 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.95 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' GLY . 42.0 mt -74.25 155.93 37.75 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.402 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 28' ' ' ASN . 12.3 pt-20 -47.26 -40.25 16.21 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.944 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.504 ' HB3' ' ND1' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -67.53 -16.62 64.29 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.456 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 26' ' ' LEU . . . 108.89 -1.77 31.78 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.333 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.504 ' ND1' ' HB3' ' A' ' 28' ' ' ASN . 60.5 m80 -75.58 138.28 41.35 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.564 -1.254 . . . . 0.0 111.567 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.44 138.0 38.1 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.313 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.453 HG21 ' N ' ' A' ' 33' ' ' LEU . 22.0 mt -146.65 154.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.963 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 7.1 mp -90.9 133.69 35.05 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.352 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.441 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 1.1 p -133.77 144.71 49.21 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.013 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.596 ' CE1' ' SD ' ' A' ' 21' ' ' MET . 13.6 m-70 -108.56 178.23 4.55 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 37' ' ' SER . 49.5 mt -112.25 156.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.782 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.491 ' N ' HG23 ' A' ' 36' ' ' ILE . 4.6 m -107.03 155.72 19.52 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.519 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.26 -6.45 87.75 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.751 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -74.35 -59.12 2.87 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.068 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 pp -54.24 -20.55 7.16 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.539 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.424 ' HG3' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -70.98 -49.2 47.9 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.409 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.507 ' C ' ' H ' ' A' ' 44' ' ' PHE . 8.8 ttm -55.58 -34.99 65.29 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.585 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.1 13.12 0.33 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 42' ' ' MET . 0.1 OUTLIER 56.69 34.78 25.14 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.614 -0.835 . . . . 0.0 111.296 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.424 HG23 ' H ' ' A' ' 46' ' ' ARG . 28.8 mm -98.21 170.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.251 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.424 ' H ' HG23 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -149.18 154.07 38.6 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.594 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' N ' ' A' ' 48' ' ' LEU . 29.4 mt -132.21 144.37 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.712 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.411 ' N ' HG21 ' A' ' 47' ' ' ILE . 13.2 mt -132.48 171.46 13.74 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.495 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 152.36 44.31 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.224 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.17 -13.96 30.09 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.229 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 0.9 OUTLIER -80.57 135.61 36.11 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.576 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -75.24 150.19 38.66 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.029 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.454 ' CG2' HD12 ' A' ' 67' ' ' ILE . 29.1 m -151.93 166.29 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.94 -1.104 . . . . 0.0 112.429 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -96.6 121.11 38.07 Favored 'General case' 0 C--O 1.203 -1.382 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.714 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -104.63 123.31 58.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.345 -0.942 . . . . 0.0 113.07 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -101.1 106.4 17.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.747 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.0 mt -81.14 147.31 30.12 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.675 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 p -98.16 138.08 20.87 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.485 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.4 -9.71 21.2 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.735 1.623 . . . . 0.0 112.074 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -90.53 -22.44 21.31 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.405 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.674 ' C ' ' H ' ' A' ' 63' ' ' THR . 15.5 m-20 -153.53 89.29 1.33 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.375 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mt -69.12 20.42 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.474 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.674 ' H ' ' C ' ' A' ' 61' ' ' ASP . 59.0 m -108.7 -9.84 15.22 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.513 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -138.46 148.26 44.18 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.58 -161.92 8.97 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.489 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 8.3 ptt180 -156.48 131.35 9.02 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.61 -1.236 . . . . 0.0 111.93 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.454 HD12 ' CG2' ' A' ' 53' ' ' VAL . 66.3 mt -95.44 129.21 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.59 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -127.97 7.32 6.09 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.49 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.781 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -168.2 111.87 0.61 Allowed 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.75 -1.18 . . . . 0.0 112.209 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' HE ' HG22 ' A' ' 45' ' ' ILE . 5.7 ptt180 -73.45 151.93 40.93 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.483 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 tttt . . . . . 0 N--CA 1.488 1.435 0 C-N-CA 118.916 -1.113 . . . . 0.0 110.927 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.585 0.231 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.7 mt -95.95 101.94 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.258 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.7 114.12 9.46 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 55' ' ' VAL . 7.4 mt -131.0 150.99 51.88 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.456 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -97.75 144.26 27.55 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.908 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.54 -175.48 23.36 Favored Glycine 0 N--CA 1.483 1.767 0 C-N-CA 118.885 -1.626 . . . . 0.0 110.335 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.23 131.21 45.42 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.205 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.415 ' CG1' ' HA ' ' A' ' 49' ' ' GLU . 87.4 t -63.52 116.18 3.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 118.434 -1.306 . . . . 0.0 110.187 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 p -95.46 -37.52 10.88 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.749 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -146.19 151.88 38.33 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 118.558 -1.257 . . . . 0.0 111.792 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.92 130.57 46.94 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.494 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.6 mt -121.91 151.07 57.35 Favored Pre-proline 0 N--CA 1.488 1.469 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 20' ' ' ALA . 1.9 Cg_endo -61.13 -156.5 0.02 OUTLIER 'Trans proline' 0 C--O 1.204 -1.182 0 C-N-CA 121.452 1.435 . . . . 0.0 111.007 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 25.4 m120 46.8 12.72 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.87 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 18' ' ' PRO . . . 71.09 42.94 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.914 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.4 170.48 15.94 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.252 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.677 ' N ' ' CD2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.73 165.84 29.75 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.443 -0.903 . . . . 0.0 112.216 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -97.06 136.89 36.97 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.887 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.429 HG22 ' SG ' ' A' ' 34' ' ' CYS . 77.1 t -129.68 143.56 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.163 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -102.88 118.87 37.77 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.197 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.559 ' H ' ' CD1' ' A' ' 26' ' ' LEU . 4.2 mp -74.19 168.88 18.72 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.793 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.62 -19.42 65.22 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.022 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -68.44 -16.24 63.83 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.445 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.44 -10.85 50.51 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -91.31 177.55 6.21 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.168 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -132.8 140.19 47.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.904 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.599 ' CG2' ' N ' ' A' ' 33' ' ' LEU . 8.4 mm -134.58 173.27 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.386 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.599 ' N ' ' CG2' ' A' ' 32' ' ' ILE . 20.2 mt -90.59 145.35 24.93 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.568 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.455 ' HG ' HG12 ' A' ' 55' ' ' VAL . 90.8 m -134.91 152.26 51.59 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.188 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.52 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 33.2 t-80 -128.0 147.51 50.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.156 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.603 ' CG2' ' N ' ' A' ' 37' ' ' SER . 28.3 mt -86.83 166.84 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.492 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.603 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 6.4 p -154.07 159.12 41.39 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.354 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.31 -4.9 0.09 OUTLIER Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.489 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.59 ' H ' ' C ' ' A' ' 37' ' ' SER . 0.7 OUTLIER -62.46 -61.17 2.62 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.472 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 mt -51.56 -21.51 2.57 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.441 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.405 ' N ' ' C ' ' A' ' 39' ' ' LYS . 2.3 mmm180 -83.44 -25.79 30.9 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.333 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' LYS . 13.7 ttp -89.79 -21.39 22.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.262 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -93.23 3.87 54.94 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.788 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 52.06 66.49 1.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.725 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.621 ' CG2' ' N ' ' A' ' 46' ' ' ARG . 26.5 mt -146.22 165.58 8.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.105 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.621 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 50.3 ttm-85 -133.21 140.85 47.76 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.398 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 48' ' ' LEU . 58.9 mt -132.44 149.04 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.263 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 1.9 pt? -142.97 -176.82 5.05 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.72 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.415 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 23.3 mt-10 -75.42 152.24 38.01 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.259 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.51 -14.07 37.55 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.074 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.15 143.37 26.75 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.859 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -75.63 154.33 36.69 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.711 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.583 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 31.6 m -154.8 171.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.482 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.555 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -103.36 123.92 47.72 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG12 ' HG ' ' A' ' 34' ' ' CYS . 3.1 t -103.36 134.21 45.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.648 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.81 111.63 22.92 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.118 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.8 mt -77.8 121.58 24.27 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.672 -1.211 . . . . 0.0 108.981 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 60' ' ' TYR . 1.5 m -80.49 130.04 66.55 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.941 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.05 -1.25 1.59 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.339 1.359 . . . . 0.0 110.646 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.507 ' H ' ' C ' ' A' ' 58' ' ' SER . 5.7 m-30 -84.6 -21.56 30.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.644 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.4 t0 -169.82 100.64 0.31 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.046 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mt -69.25 19.31 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.876 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.644 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.1 p -102.71 -12.19 17.84 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.264 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.483 ' HG2' ' N ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -148.93 144.57 26.92 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.923 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.483 ' N ' ' HG2' ' A' ' 64' ' ' ARG . . . -120.7 -156.57 9.89 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.44 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 9.1 ptm180 -157.41 147.03 20.28 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.502 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.583 ' CD1' ' CG2' ' A' ' 53' ' ' VAL . 1.9 mm -94.04 118.02 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.212 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.624 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 72.2 p -127.17 7.79 6.57 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.24 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.846 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -173.66 118.49 0.28 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 118.621 -1.232 . . . . 0.0 112.403 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -68.68 161.77 27.49 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.881 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.2 tttp . . . . . 0 C--N 1.302 -1.474 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.581 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.507 HG23 ' H ' ' A' ' 7' ' ' ILE . 4.7 p . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.507 ' H ' HG23 ' A' ' 6' ' ' VAL . 24.5 mm -104.02 101.78 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.561 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 4.9 pt-20 -103.71 118.83 37.63 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.9 mt -132.25 161.25 33.92 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.431 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -87.96 135.37 33.44 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.798 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.83 154.6 26.04 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -104.9 127.87 52.9 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.856 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.4 t -59.01 127.03 17.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 118.67 -1.212 . . . . 0.0 110.552 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.35 -39.48 8.38 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.526 -0.87 . . . . 0.0 113.013 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.09 136.27 17.57 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.231 -1.388 . . . . 0.0 112.17 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.89 113.55 21.04 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.58 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 21' ' ' MET . 64.4 mt -100.11 150.07 36.57 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.107 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 3.3 Cg_exo -56.78 160.23 12.52 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.219 1.28 . . . . 0.0 111.478 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.9 t-20 76.85 28.04 0.7 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.641 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.484 ' O ' ' CD2' ' A' ' 35' ' ' HIS . . . 55.42 61.94 2.66 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.544 -0.863 . . . . 0.0 111.928 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.489 ' HG3' ' N ' ' A' ' 22' ' ' PHE . 4.6 ttt -153.59 150.81 29.04 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.489 ' N ' ' HG3' ' A' ' 21' ' ' MET . 0.0 OUTLIER -145.38 164.85 30.21 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.298 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -99.84 113.98 26.87 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.389 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.44 ' CG2' ' SG ' ' A' ' 34' ' ' CYS . 70.8 t -94.2 150.35 4.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.125 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -121.47 111.15 16.92 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.428 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.656 ' H ' ' CD1' ' A' ' 26' ' ' LEU . 3.6 mp -71.25 162.88 28.71 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.139 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.65 -18.07 64.61 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.588 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.721 HD21 ' H ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -65.05 -16.44 63.46 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.807 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.93 -5.86 43.07 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.405 ' HD1' ' HB2' ' A' ' 28' ' ' ASN . 5.4 m80 -102.99 178.71 4.48 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.929 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 5.4 pm0 -138.71 158.72 43.71 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.994 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.583 ' CG2' ' N ' ' A' ' 33' ' ' LEU . 81.8 mt -141.76 167.6 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.732 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.671 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 3.6 mp -91.51 138.14 31.81 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.238 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.44 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 4.8 m -141.84 133.16 26.5 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.647 ' CG ' ' N ' ' A' ' 36' ' ' ILE . 51.9 t-80 -107.49 176.85 5.02 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.713 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.651 ' CG2' ' N ' ' A' ' 37' ' ' SER . 26.0 mt -103.92 167.1 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.256 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.651 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -123.32 110.13 14.79 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.96 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.63 -26.02 0.12 Allowed Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.821 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -69.74 -56.35 7.41 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.942 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.415 ' CD1' ' C ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -51.32 -21.78 2.42 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.779 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.419 ' N ' ' C ' ' A' ' 39' ' ' LYS . 5.1 ttm-85 -68.46 -47.36 67.34 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.195 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.454 ' C ' ' H ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -52.78 -31.85 40.66 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.489 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.642 ' C ' ' CD2' ' A' ' 44' ' ' PHE . 32.3 t30 -79.33 19.48 0.59 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.474 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.642 ' CD2' ' C ' ' A' ' 43' ' ' ASN . 6.6 p90 38.88 87.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.714 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.451 HD13 HD21 ' A' ' 43' ' ' ASN . 6.4 mt -140.92 88.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.77 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.33 128.25 33.33 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.175 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -132.63 128.57 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.669 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' GLU . 83.1 mt -108.26 150.82 26.79 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.823 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 48' ' ' LEU . 1.7 tm-20 -38.48 151.44 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.771 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.74 -11.95 50.28 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.241 -1.457 . . . . 0.0 109.861 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -82.09 133.9 35.3 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.696 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -77.83 143.68 37.66 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.078 -1.049 . . . . 0.0 111.221 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -149.87 169.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.745 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 41.2 m-20 -91.74 124.66 36.04 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.65 119.17 51.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.679 -0.808 . . . . 0.0 112.529 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -91.78 113.28 25.5 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.963 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.2 mt -101.65 148.77 24.86 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.238 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 m -83.12 121.21 77.03 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.688 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -59.95 -16.45 38.76 Favored 'Trans proline' 0 C--O 1.217 -0.563 0 C-N-CA 121.254 1.302 . . . . 0.0 111.846 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -106.2 -10.88 16.25 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.485 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.626 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -138.75 77.44 1.62 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.884 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.0 mt -74.29 27.77 0.08 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.091 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.626 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.9 OUTLIER -102.4 -29.69 11.48 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.976 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -139.29 160.51 39.65 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.047 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.17 -157.41 7.18 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.41 140.06 5.95 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.249 -1.38 . . . . 0.0 112.357 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.0 mm -92.32 108.62 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.727 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.632 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 21.5 p -128.84 8.1 5.7 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.837 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.827 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -164.47 120.39 1.52 Allowed 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 118.087 -1.445 . . . . 0.0 112.782 -179.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.36 152.18 36.4 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.66 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.3 tptt . . . . . 0 C--N 1.303 -1.454 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.419 -179.857 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mt -113.85 100.62 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.842 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.24 125.01 41.52 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.735 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.3 mt -142.34 151.89 42.38 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.555 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.441 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 25.5 mp0 -86.33 138.95 31.42 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.159 -1.017 . . . . 0.0 109.971 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.12 -177.07 15.96 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 119.127 -1.511 . . . . 0.0 109.564 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.81 124.33 35.13 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 50' ' ' GLY . 11.3 t -59.97 132.99 25.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.0 p -110.46 -29.69 7.98 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.864 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -149.14 157.45 43.39 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.738 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.74 126.09 54.85 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.7 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.3 mt -119.74 150.33 50.18 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.22 171.7 2.99 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.293 1.329 . . . . 0.0 111.276 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 68.99 31.15 4.26 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.668 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.451 ' HB2' ' NH2' ' A' ' 41' ' ' ARG . . . 55.3 52.44 11.46 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.585 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 mmm -141.02 142.24 34.25 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.874 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -143.58 157.69 44.23 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.245 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -96.66 129.2 44.1 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.219 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.449 HG13 ' N ' ' A' ' 25' ' ' LYS . 14.1 t -121.42 150.47 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.528 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.449 ' N ' HG13 ' A' ' 24' ' ' VAL . 15.4 mtpp -126.57 128.58 47.05 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.4 mt -85.41 142.75 29.04 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -49.7 -26.75 4.03 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.943 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.495 ' HB2' ' HD1' ' A' ' 30' ' ' HIS . 24.8 m120 -63.8 -17.05 62.7 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.291 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.92 -0.59 38.72 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.526 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.495 ' HD1' ' HB2' ' A' ' 28' ' ' ASN . 36.4 m80 -93.23 145.2 24.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.187 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.86 141.53 37.94 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.179 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.5 ' CD1' ' N ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -139.85 146.78 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.943 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 6.3 mp -93.09 125.26 37.59 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.499 ' SG ' ' CG1' ' A' ' 55' ' ' VAL . 73.2 m -118.52 155.62 30.54 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.149 -1.02 . . . . 0.0 112.451 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -118.26 155.79 29.96 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.733 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.544 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 37.7 mt -95.04 149.84 4.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.789 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.492 ' N ' HG22 ' A' ' 36' ' ' ILE . 73.1 m -88.32 -172.76 3.91 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.007 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.88 -21.4 63.48 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.578 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.615 ' CG ' ' N ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -72.26 -55.91 6.4 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.489 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.615 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 2.4 mp -54.82 -21.69 12.05 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.445 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.451 ' NH2' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -72.2 -40.2 68.02 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.534 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.1 mmm -72.15 -31.46 65.98 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.759 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -74.0 -34.07 64.05 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.294 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.0 t80 40.12 61.63 1.47 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.818 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -86.78 -165.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.158 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' H ' HG22 ' A' ' 45' ' ' ILE . 12.7 ptt85 -119.46 74.36 1.0 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mm -98.08 144.24 11.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.402 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 49' ' ' GLU . 4.4 mp -126.78 152.55 46.76 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.726 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 48' ' ' LEU . 2.9 pp20? -40.27 152.44 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.194 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 97.63 -15.05 62.54 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.26 131.91 39.55 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.262 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.62 146.46 36.15 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.296 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.8 m -152.45 171.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.972 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.591 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 2.0 m-80 -97.99 117.8 33.14 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.499 ' CG1' ' SG ' ' A' ' 34' ' ' CYS . 13.9 t -104.68 126.74 59.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.665 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.91 117.14 34.37 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.648 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.424 ' CD2' HG22 ' A' ' 32' ' ' ILE . 3.9 mt -99.27 149.16 23.4 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.907 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.36 136.13 30.35 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -59.54 -10.87 12.32 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.556 1.504 . . . . 0.0 111.715 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CD2' ' OD2' ' A' ' 61' ' ' ASP . 8.5 t80 -101.95 -14.45 17.19 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.608 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.658 ' C ' ' H ' ' A' ' 63' ' ' THR . 57.2 m-20 -144.19 79.8 1.63 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.564 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mt -71.06 20.28 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.292 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.658 ' H ' ' C ' ' A' ' 61' ' ' ASP . 10.6 p -118.63 -9.68 10.19 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.298 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.462 HH21 ' HB2' ' A' ' 64' ' ' ARG . 37.3 mtp-105 -133.7 143.95 48.83 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.075 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.85 -153.48 6.25 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.597 -1.287 . . . . 0.0 109.897 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -162.68 147.5 11.95 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.504 -1.279 . . . . 0.0 112.134 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.46 ' CG1' ' CZ ' ' A' ' 22' ' ' PHE . 20.5 mm -93.55 110.35 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.027 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.63 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 3.3 p -118.17 6.83 12.03 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.84 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -166.9 110.41 0.72 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 118.673 -1.211 . . . . 0.0 111.331 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.8 ptt-85 -76.27 136.89 39.64 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.435 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.904 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.6 0.238 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.1 100.26 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 119.167 -1.013 . . . . 0.0 109.556 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.02 112.31 20.5 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.654 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 mt -137.58 149.69 46.88 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.467 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.78 144.39 25.76 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.894 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.46 -155.0 6.31 Favored Glycine 0 N--CA 1.481 1.681 0 C-N-CA 119.149 -1.501 . . . . 0.0 109.766 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 50' ' ' GLY . 31.1 m -145.24 130.62 18.68 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.026 -1.07 . . . . 0.0 111.138 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 t -59.6 123.12 11.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.145 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -100.4 -30.31 11.91 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.73 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -150.3 155.03 38.91 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.821 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.98 123.57 48.86 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.501 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.2 mt -121.98 151.16 57.73 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.179 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.92 -178.8 0.34 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.269 1.313 . . . . 0.0 111.544 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER 69.41 14.94 8.44 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.134 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 19' ' ' ASN . . . 68.28 43.82 1.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.072 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtm -144.73 152.47 40.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.774 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -144.85 165.88 26.86 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.876 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -95.58 124.3 39.54 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.387 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -118.52 141.25 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.956 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HZ2' ' HA2' ' A' ' 29' ' ' GLY . 18.3 tttp -118.76 113.59 21.38 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.793 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.585 ' C ' ' H ' ' A' ' 28' ' ' ASN . 26.1 mt -67.38 137.75 56.2 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.494 -0.883 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.45 -12.29 0.06 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.522 -1.271 . . . . 0.0 109.179 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.585 ' H ' ' C ' ' A' ' 26' ' ' LEU . 39.1 m-80 -72.5 -17.23 61.77 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.41 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.405 ' HA2' ' HZ2' ' A' ' 25' ' ' LYS . . . 107.42 0.39 35.01 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.96 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -101.22 136.3 41.29 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.969 -1.093 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -109.27 132.09 54.45 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.301 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.455 HG21 ' N ' ' A' ' 33' ' ' LEU . 4.7 mp -141.37 165.55 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.043 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 7.0 mp -89.28 134.32 34.1 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.329 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.402 ' CB ' HD13 ' A' ' 67' ' ' ILE . 80.0 m -128.55 148.33 50.76 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.276 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.469 ' ND1' ' O ' ' A' ' 36' ' ' ILE . 48.9 t-80 -114.81 154.97 27.62 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.273 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.517 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 51.5 mt -90.75 153.32 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.087 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 6.0 m -82.6 126.51 32.39 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.931 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.4 -12.19 0.89 Allowed Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.453 -1.356 . . . . 0.0 111.315 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -80.7 -63.01 1.5 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.257 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.03 -18.61 36.15 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.38 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -71.64 -40.51 69.67 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.89 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.561 ' C ' ' H ' ' A' ' 44' ' ' PHE . 7.6 mmt -61.72 -35.82 79.17 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -58.92 -0.3 0.11 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.247 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.561 ' H ' ' C ' ' A' ' 42' ' ' MET . 4.8 t80 55.21 45.11 26.53 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.309 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 mm -98.55 157.49 3.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.096 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -150.03 99.14 2.79 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.818 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.1 tt -87.42 149.13 4.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.576 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.621 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 3.5 mp -83.75 135.35 34.58 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.25 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 49' ' ' GLU . 4.8 mm-40 -44.66 153.26 0.17 Allowed 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.891 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . 92.4 -15.19 62.86 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.253 -1.451 . . . . 0.0 109.628 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.79 152.95 41.32 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.046 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -83.98 146.65 27.88 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.745 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 m -150.34 164.62 3.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.386 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.578 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -91.83 121.52 33.52 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.08 123.84 59.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.517 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.13 113.32 26.47 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.31 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.43 132.75 33.89 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.956 -1.098 . . . . 0.0 110.741 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 t -85.64 121.49 73.35 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.393 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -61.98 -9.66 15.17 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 121.074 1.183 . . . . 0.0 110.942 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -94.27 -16.94 23.14 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.633 ' C ' ' H ' ' A' ' 63' ' ' THR . 13.8 m-20 -142.99 82.33 1.76 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.942 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.9 mt -71.21 24.09 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.768 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.633 ' H ' ' C ' ' A' ' 61' ' ' ASP . 42.0 m -122.91 -7.33 8.42 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.439 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -140.17 152.05 45.73 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.449 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 66' ' ' ARG . . . -137.56 -167.44 11.06 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.676 -1.77 . . . . 0.0 108.676 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.414 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 18.1 mtt85 -155.98 131.32 9.47 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.709 -1.597 . . . . 0.0 112.899 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.49 HD11 ' N ' ' A' ' 67' ' ' ILE . 1.4 mp -93.32 111.89 25.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.519 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.473 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 14.3 p -126.75 7.28 6.78 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.487 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.811 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -159.57 112.11 2.15 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.665 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -74.15 141.75 45.53 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.625 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.308 -1.197 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.067 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -178.31 71.0 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -97.95 116.23 29.75 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.644 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -172.56 129.44 0.54 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.104 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.29 -165.88 1.03 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.603 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.92 175.18 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.018 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.1 mm -107.69 101.9 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.285 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -81.59 115.29 20.8 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.155 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' VAL . 20.2 mt -132.5 164.15 27.24 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.591 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.72 146.14 25.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.12 154.77 25.76 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.002 -1.571 . . . . 0.0 109.662 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -104.98 124.72 50.01 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.407 ' H ' HG21 ' A' ' 13' ' ' VAL . 5.2 t -61.13 113.84 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.16 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -88.12 -31.05 19.39 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.648 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -154.4 158.1 39.51 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.463 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.61 ' H ' ' CD ' ' A' ' 15' ' ' GLU . . . -124.48 124.36 42.13 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.733 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.43 162.59 33.38 Favored Pre-proline 0 N--CA 1.487 1.381 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.28 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 5.9 Cg_exo -55.98 179.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.67 1.58 . . . . 0.0 111.508 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.1 t-20 74.93 17.2 2.8 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.081 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.0 50.86 9.58 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.798 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.8 mtt -142.77 171.64 13.77 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.715 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.726 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.44 166.32 29.45 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.479 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -100.04 143.56 30.1 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.25 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.524 ' CG2' ' SG ' ' A' ' 34' ' ' CYS . 19.1 t -132.62 137.42 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.326 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 25' ' ' LYS . 8.0 ptmm? -111.42 126.93 55.47 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.393 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.491 HD13 ' H ' ' A' ' 26' ' ' LEU . 4.5 mp -87.45 153.21 21.61 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.799 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -57.67 -17.55 15.51 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.772 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.456 ' HB2' ' HD1' ' A' ' 30' ' ' HIS . 28.9 m-20 -69.23 -14.73 63.13 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.693 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.68 -11.67 53.55 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.677 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.456 ' HD1' ' HB2' ' A' ' 28' ' ' ASN . 20.8 m80 -87.78 175.48 7.83 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.015 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -137.43 149.29 46.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.316 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 33' ' ' LEU . 50.7 mt -142.86 154.06 17.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.463 ' N ' HG22 ' A' ' 32' ' ' ILE . 10.0 mt -86.25 147.47 26.07 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.211 -0.995 . . . . 0.0 109.231 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -139.34 147.71 41.91 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.854 -1.139 . . . . 0.0 111.393 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 22.4 t-80 -119.04 155.55 31.26 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.286 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.503 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 46.8 mt -84.01 145.93 7.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.445 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.9 m -96.57 169.61 9.77 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.03 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.34 -14.09 80.79 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.335 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -75.58 -62.76 1.47 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.582 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.05 -19.69 33.48 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.616 -1.234 . . . . 0.0 109.086 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -42.92 70.45 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.034 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.483 ' SD ' ' O ' ' A' ' 42' ' ' MET . 4.4 tmm? -60.42 -33.68 72.85 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.696 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.422 ' CB ' ' CD1' ' A' ' 45' ' ' ILE . 36.5 m-20 -64.42 -17.7 64.03 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 118.769 -1.172 . . . . 0.0 109.873 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.4 t80 67.7 73.67 0.31 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.067 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.635 ' CG2' ' N ' ' A' ' 46' ' ' ARG . 2.0 mp -117.85 165.86 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.337 0.589 . . . . 0.0 111.781 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.635 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 24.1 ttt180 -144.85 74.52 1.41 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.069 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 tt -77.19 149.6 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.119 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 49' ' ' GLU . 12.1 mt -120.4 139.57 52.61 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.072 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' LEU . 1.8 pm0 -38.21 148.07 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.007 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.16 -4.57 58.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -98.37 139.58 33.92 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.088 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -75.5 144.09 42.18 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.773 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.5 m -149.9 167.35 2.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.686 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.582 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -93.42 127.52 39.09 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 9' ' ' LEU . 2.9 t -104.15 129.56 56.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.438 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -106.11 110.47 22.74 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.359 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.1 mt -88.01 143.17 27.24 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.065 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 60' ' ' TYR . 25.4 p -98.79 132.98 22.8 Favored Pre-proline 0 N--CA 1.492 1.658 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.118 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.4 -1.3 1.34 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.445 1.43 . . . . 0.0 111.442 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.481 ' H ' ' C ' ' A' ' 58' ' ' SER . 5.6 t80 -81.13 -21.68 39.63 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.705 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.0 p30 179.88 105.78 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.908 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt -66.6 20.7 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.608 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.705 ' H ' ' C ' ' A' ' 61' ' ' ASP . 76.1 m -98.19 -14.4 20.38 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.044 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.423 ' NH2' ' OD1' ' A' ' 61' ' ' ASP . 17.2 mtp180 -138.83 146.61 41.47 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.197 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.57 -151.75 5.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.67 143.28 4.74 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.175 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.3 mm -93.15 119.05 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.059 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.597 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 7.2 p -126.62 7.38 6.88 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.685 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.85 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.16 111.87 0.73 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.378 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.468 ' NE ' HG22 ' A' ' 45' ' ' ILE . 28.5 ptt85 -111.36 146.28 37.4 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.255 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -44.01 154.39 0.11 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.92 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 116.347 -1.787 . . . . 0.0 110.978 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mmm . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.932 0.396 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.24 -27.02 61.68 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.948 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -42.57 -34.92 0.95 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.955 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -149.34 50.36 0.96 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.672 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.501 ' OD2' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -40.19 140.0 0.65 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.672 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 p -173.15 164.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.669 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.5 mt -97.73 101.38 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.222 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -94.55 108.38 20.34 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 mt -132.64 148.94 52.36 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.067 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.84 144.1 27.17 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.66 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.47 179.82 25.94 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 119.069 -1.539 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.4 m -124.16 131.05 53.5 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.445 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.73 119.08 3.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 118.576 -1.249 . . . . 0.0 110.591 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' LYS . 5.7 t -88.88 -32.24 17.85 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.165 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -151.1 156.32 40.78 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.694 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.84 107.38 18.1 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.627 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.3 mt -99.79 144.52 28.5 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.099 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.9 Cg_endo -61.01 166.68 10.15 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.255 1.304 . . . . 0.0 111.037 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER 76.96 29.76 0.59 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.652 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.82 57.77 4.5 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.531 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.766 ' SD ' ' NE2' ' A' ' 35' ' ' HIS . 15.8 mtm -152.6 159.42 43.24 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.897 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.696 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -159.45 165.34 33.31 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.668 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 14' ' ' SER . 27.4 ttpt -103.29 114.3 28.47 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.657 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.425 HG23 ' SG ' ' A' ' 34' ' ' CYS . 47.6 t -98.51 146.98 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.303 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -124.2 114.4 19.57 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.746 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.576 ' C ' ' H ' ' A' ' 28' ' ' ASN . 10.6 mt -69.58 147.07 51.22 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.659 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.643 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -49.31 -11.36 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.959 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.643 ' N ' ' CD ' ' A' ' 27' ' ' GLU . 36.6 t30 -78.84 -17.79 55.08 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.7 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.69 -2.18 42.13 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.804 -1.189 . . . . 0.0 112.294 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.465 ' HD1' ' HB3' ' A' ' 28' ' ' ASN . 51.9 m80 -94.29 137.56 33.31 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.069 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -91.53 141.26 28.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.491 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.5 mm -137.93 144.53 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.248 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.688 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 5.2 mp -85.85 134.41 33.91 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.14 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.425 ' SG ' HG23 ' A' ' 24' ' ' VAL . 3.0 m -139.57 151.35 45.99 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.399 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.766 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 18.3 m80 -115.55 161.82 18.09 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.654 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.502 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 27.9 mt -92.59 146.06 6.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.66 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.46 ' N ' HG23 ' A' ' 36' ' ' ILE . 3.2 m -92.47 -178.34 4.88 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.21 -8.61 87.44 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.854 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -75.12 -62.18 1.64 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.48 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.69 -20.68 5.74 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.188 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -73.52 -39.19 64.97 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.308 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.61 -28.62 67.08 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.397 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -77.55 -16.28 58.75 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.618 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.2 t80 47.66 80.94 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.551 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.5 mt -144.86 113.21 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.019 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -60.27 126.1 26.18 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.688 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 mm -95.12 148.28 5.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.551 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.3 tp -125.08 135.45 52.71 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.083 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.21 152.34 0.59 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.932 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.02 -16.4 59.62 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.247 -1.454 . . . . 0.0 109.667 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.91 162.21 29.79 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.425 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.73 141.4 36.54 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.377 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.412 ' CG2' HG13 ' A' ' 67' ' ' ILE . 5.3 m -148.57 162.49 5.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.583 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 2.0 m-20 -92.46 124.09 36.25 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.23 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.57 142.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.644 -0.823 . . . . 0.0 112.254 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -122.84 108.64 13.23 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.405 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.1 mt -84.42 132.29 34.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.391 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.454 ' H ' ' HG ' ' A' ' 58' ' ' SER . 13.7 p -91.01 139.33 25.81 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 119.024 -1.07 . . . . 0.0 112.152 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.32 -4.9 8.73 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.518 1.479 . . . . 0.0 111.403 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -89.15 -22.82 22.64 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.724 -0.79 . . . . 0.0 108.98 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.661 ' C ' ' H ' ' A' ' 63' ' ' THR . 4.1 m-20 -151.34 89.31 1.49 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mt -69.89 23.06 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.417 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.661 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.1 m -119.53 -8.59 9.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.169 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.25 150.43 39.28 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.236 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.8 -152.57 6.42 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -166.36 143.76 5.2 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.146 -1.422 . . . . 0.0 112.166 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.607 ' CD1' ' N ' ' A' ' 67' ' ' ILE . 1.3 mp -92.34 121.7 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.22 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.57 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 70.2 p -124.7 7.08 8.16 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.076 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.863 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.67 111.02 0.65 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.646 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.36 162.91 28.4 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.52 133.2 1.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.114 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.8 pttp . . . . . 0 C--N 1.307 -1.269 0 CA-C-O 116.268 -1.825 . . . . 0.0 110.76 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.448 ' HG3' ' N ' ' A' ' 2' ' ' ALA . 8.0 ptp . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.902 0.382 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.448 ' N ' ' HG3' ' A' ' 1' ' ' MET . . . -79.03 106.22 10.92 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.381 -0.927 . . . . 0.0 111.202 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 5' ' ' ASP . 35.1 tttp 54.22 -93.93 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.72 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' H ' ' HB3' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -44.94 95.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.985 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 3' ' ' LYS . 6.2 m-20 -98.43 90.61 4.84 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.853 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.49 164.21 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.866 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 mt -94.46 102.44 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.575 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 1.9 mm-40 -80.38 117.04 20.79 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.156 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.2 mt -128.95 150.73 50.26 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.222 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -88.18 142.64 27.6 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.393 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.7 165.61 31.59 Favored Glycine 0 N--CA 1.485 1.941 0 C-N-CA 119.172 -1.489 . . . . 0.0 110.221 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.484 ' HG1' ' HG2' ' A' ' 52' ' ' LYS . 33.7 m -113.7 125.79 54.51 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.739 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.417 ' H ' HG21 ' A' ' 13' ' ' VAL . 5.3 t -60.99 112.06 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 118.624 -1.23 . . . . 0.0 110.546 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.469 ' HG ' ' CB ' ' A' ' 25' ' ' LYS . 1.2 m -90.36 -32.75 16.33 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.429 -0.908 . . . . 0.0 112.141 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -152.56 137.85 17.51 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.389 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.37 117.12 32.07 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.376 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -106.86 155.22 39.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.618 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.54 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 3.7 Cg_exo -56.54 -164.3 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.879 0 C-N-CA 121.334 1.356 . . . . 0.0 112.126 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 18' ' ' PRO . 8.0 p30 46.63 31.34 1.35 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.062 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' HB3' ' NE2' ' A' ' 35' ' ' HIS . . . 52.07 58.08 5.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.981 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.51 ' SD ' ' OD1' ' A' ' 19' ' ' ASN . 37.0 mtp -149.85 137.59 20.11 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.714 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.71 163.22 27.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.424 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -103.84 108.88 20.39 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.521 ' CG2' ' SG ' ' A' ' 34' ' ' CYS . 36.6 t -94.93 152.48 3.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.375 -0.93 . . . . 0.0 112.01 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' N ' HG13 ' A' ' 24' ' ' VAL . 2.7 ttmp? -120.74 110.91 16.94 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.825 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.1 mp -65.45 178.6 0.92 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.545 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -77.23 -23.69 51.32 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.649 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.784 ' ND2' ' HD1' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -66.12 -15.82 63.43 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.494 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.36 -8.23 35.13 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.068 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.784 ' HD1' ' ND2' ' A' ' 28' ' ' ASN . 22.3 m80 -95.76 176.8 6.0 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.676 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -138.34 160.46 39.43 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.82 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 33' ' ' LEU . 76.7 mt -143.53 161.67 16.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.1 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.679 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 3.9 mp -86.37 131.51 34.19 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.549 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 8.2 m -132.99 135.28 45.38 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.631 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 2.4 t60 -102.31 173.68 6.26 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.509 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.644 ' CG2' ' N ' ' A' ' 37' ' ' SER . 10.7 mt -91.3 165.91 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.998 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.644 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -128.2 160.77 31.04 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.946 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.97 -20.01 66.18 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.341 -1.409 . . . . 0.0 111.594 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.42 ' C ' ' N ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -67.81 -62.27 1.49 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.342 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -52.83 -20.25 3.12 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.808 -1.157 . . . . 0.0 109.643 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.427 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.35 -42.81 68.03 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.406 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.511 ' C ' ' H ' ' A' ' 44' ' ' PHE . 1.4 ptm -72.4 -22.32 61.14 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.298 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.453 ' N ' ' HG3' ' A' ' 42' ' ' MET . 7.2 m120 -67.09 6.51 0.52 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.801 -1.16 . . . . 0.0 110.646 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.511 ' H ' ' C ' ' A' ' 42' ' ' MET . 0.8 OUTLIER 48.19 82.32 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.876 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 mm -142.46 147.06 21.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.088 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.78 75.13 1.51 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.572 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.442 HG21 ' CB ' ' A' ' 51' ' ' ASP . 42.8 mt -105.79 149.59 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.771 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.3 mt -110.72 165.8 11.54 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.517 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -40.41 153.26 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.47 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.26 -12.18 65.25 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.588 -1.292 . . . . 0.0 109.873 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.442 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -92.6 152.63 19.48 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.74 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.484 ' HG2' ' HG1' ' A' ' 12' ' ' THR . 66.1 mttt -78.41 147.43 34.04 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.629 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -149.58 162.44 4.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.643 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.516 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -95.2 123.04 38.49 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.453 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 34' ' ' CYS . 61.1 t -104.35 127.5 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.625 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.65 113.69 26.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.946 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 23.8 mt -88.48 147.26 24.75 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.752 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.05 135.2 33.65 Favored Pre-proline 0 N--CA 1.492 1.648 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.18 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -65.1 -4.93 9.92 Favored 'Trans proline' 0 C--O 1.217 -0.548 0 C-N-CA 121.625 1.55 . . . . 0.0 112.068 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.78 -22.05 14.98 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.083 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.664 ' C ' ' H ' ' A' ' 63' ' ' THR . 33.0 t0 -155.23 91.64 1.36 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.55 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.33 19.83 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.464 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.664 ' H ' ' C ' ' A' ' 61' ' ' ASP . 53.2 m -99.92 -13.33 19.19 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.011 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -137.67 147.31 44.76 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.13 -159.33 7.89 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.426 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 5.8 ptp180 -154.71 143.88 21.12 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.842 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.2 mm -93.26 122.05 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.296 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.635 ' OG1' ' NE1' ' A' ' 69' ' ' TRP . 5.0 p -126.47 6.4 6.93 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.012 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.859 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -158.4 157.72 32.84 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.315 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -154.32 88.72 1.24 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.063 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.23 131.66 9.46 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.655 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.4 tttt . . . . . 0 C--N 1.305 -1.336 0 CA-C-O 116.397 -1.763 . . . . 0.0 110.877 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.562 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.4 mpp? . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.78 170.32 0.09 Allowed 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.757 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.76 22.19 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.714 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 16.6 pttp -161.94 -155.84 0.4 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.651 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 2.1 t0 72.13 -179.07 0.21 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.201 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.9 m -82.66 151.65 4.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.214 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 mm -95.61 106.72 18.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.415 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.53 112.55 13.18 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.194 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' VAL . 25.0 mt -134.0 164.95 26.17 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.611 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -90.01 143.84 26.43 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.8 148.32 18.8 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.437 ' HG1' ' HG2' ' A' ' 52' ' ' LYS . 20.1 m -104.27 132.13 50.85 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.439 ' H ' HG22 ' A' ' 13' ' ' VAL . 4.2 t -63.36 117.66 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.619 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.09 -29.46 13.61 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.319 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -150.09 121.9 8.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.122 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.46 105.34 17.69 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.034 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.42 149.03 36.61 Favored Pre-proline 0 C--N 1.307 -1.259 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.799 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 2.3 Cg_endo -58.72 167.21 5.51 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.308 1.339 . . . . 0.0 111.229 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 75.79 29.94 0.8 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.573 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.546 ' O ' ' CD2' ' A' ' 35' ' ' HIS . . . 54.16 61.37 3.07 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.822 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 ttm -155.23 136.51 13.99 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.28 165.69 25.19 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.809 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -105.08 109.01 20.83 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.365 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.46 HG23 ' SG ' ' A' ' 34' ' ' CYS . 69.8 t -96.35 143.96 11.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.201 -1.0 . . . . 0.0 112.079 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' N ' HG13 ' A' ' 24' ' ' VAL . 14.8 pttm -110.95 126.87 55.21 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.968 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.8 mp -83.77 175.46 9.64 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.183 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -73.91 -26.93 60.78 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.775 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.477 ' HB3' ' HD1' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -65.85 -16.86 64.22 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.904 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.81 -11.77 35.0 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.365 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.477 ' HD1' ' HB3' ' A' ' 28' ' ' ASN . 45.6 m80 -83.72 174.98 10.01 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.284 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -133.3 151.78 51.9 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.651 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.481 HG23 ' N ' ' A' ' 33' ' ' LEU . 65.8 mt -141.28 155.33 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.914 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 2.2 mp -88.04 134.41 33.75 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.522 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.508 ' HG ' HG11 ' A' ' 55' ' ' VAL . 61.6 m -132.96 139.1 47.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.957 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -107.96 172.35 6.88 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.815 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.646 ' CG2' ' N ' ' A' ' 37' ' ' SER . 25.0 mt -98.61 167.42 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.818 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.646 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 35.1 m -130.93 117.74 19.67 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.817 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.49 -15.34 0.05 OUTLIER Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.82 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 37' ' ' SER . 30.7 mtmt -72.42 -61.54 1.76 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.196 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.461 ' HA ' HD21 ' A' ' 43' ' ' ASN . 1.1 pp -53.15 -21.36 4.88 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.96 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.45 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 1.9 ttt-85 -72.78 -39.72 66.52 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.52 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 42' ' ' MET . 6.9 tpp -63.72 -27.4 69.18 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.725 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 40' ' ' LEU . 83.2 m-20 -78.93 5.39 11.7 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.877 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 54.23 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.223 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.57 114.07 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -59.34 137.15 58.09 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.607 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 mm -102.52 149.78 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.39 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -164.26 134.95 4.26 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.501 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 51' ' ' ASP . 2.2 pp20? -63.42 152.24 38.79 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.223 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.59 -8.31 28.1 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 118.873 -1.632 . . . . 0.0 109.695 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 49' ' ' GLU . 56.5 t0 -72.53 133.1 44.61 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.284 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.437 ' HG2' ' HG1' ' A' ' 12' ' ' THR . 77.8 mttt -76.1 141.76 41.89 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.332 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.6 m -148.48 168.79 3.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.681 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.597 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -91.42 120.26 32.11 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.538 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.508 HG11 ' HG ' ' A' ' 34' ' ' CYS . 26.3 t -104.76 116.66 48.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.634 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.17 120.13 33.98 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.7 mt -92.8 159.43 15.4 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.406 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.0 m -94.85 141.08 22.83 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.599 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -69.68 -21.88 33.25 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.825 1.683 . . . . 0.0 112.055 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -88.24 -26.39 22.37 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.403 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.653 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -148.04 88.21 1.65 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.12 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mt -71.76 20.61 0.06 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.278 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.653 ' H ' ' C ' ' A' ' 61' ' ' ASP . 7.1 p -98.43 -12.32 21.49 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -138.02 150.68 47.18 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.678 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.36 -153.28 5.85 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 4.8 ptt180 -165.48 147.13 7.41 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.664 -1.215 . . . . 0.0 111.595 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.417 ' CD1' HG21 ' A' ' 55' ' ' VAL . 25.2 mm -92.72 117.3 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.969 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.63 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 32.6 p -127.95 7.97 6.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.963 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.824 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -169.98 127.72 0.88 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.28 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 71' ' ' LYS . 8.7 tmm_? -72.3 162.08 29.97 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.515 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 9.2 tttt -43.28 135.2 3.49 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.416 -0.913 . . . . 0.0 111.334 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.3 tptm . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 116.304 -1.807 . . . . 0.0 110.634 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.896 0.379 . . . . 0.0 110.05 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.06 83.02 0.11 Allowed 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.859 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -165.91 94.78 0.58 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.76 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.555 ' C ' ' H ' ' A' ' 6' ' ' VAL . 8.1 tttt -148.62 -140.31 0.1 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.014 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.461 ' H ' ' HG2' ' A' ' 4' ' ' LYS . 31.2 t70 -48.52 -10.97 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.309 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -176.36 176.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.602 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.448 ' H ' HG22 ' A' ' 6' ' ' VAL . 1.8 mp -116.76 110.19 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.246 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -100.52 127.12 46.98 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.092 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' VAL . 35.2 mt -144.44 160.24 41.4 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.646 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -88.0 143.73 26.93 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.19 168.77 30.2 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.117 -1.516 . . . . 0.0 109.804 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.5 m -123.87 130.03 51.95 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.72 133.07 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.734 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 t -113.24 -26.92 8.18 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.326 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -153.15 158.2 41.45 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.108 -1.437 . . . . 0.0 112.223 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.558 ' H ' ' CD ' ' A' ' 15' ' ' GLU . . . -99.15 113.99 26.51 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.577 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.4 mt -104.66 146.94 33.6 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 119.739 -0.785 . . . . 0.0 111.008 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.517 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 3.1 Cg_endo -65.0 170.49 10.27 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 121.296 1.331 . . . . 0.0 111.433 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.517 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER 75.07 28.62 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.154 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.483 ' O ' ' CE1' ' A' ' 35' ' ' HIS . . . 58.89 61.99 2.01 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.347 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.454 ' SD ' ' HB2' ' A' ' 19' ' ' ASN . 8.6 ptm -165.29 170.38 14.8 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.607 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -155.41 165.34 36.92 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.837 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -88.88 132.46 34.67 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.768 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.473 HG21 ' SG ' ' A' ' 34' ' ' CYS . 2.3 t -125.93 143.39 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.575 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.433 ' N ' HG12 ' A' ' 24' ' ' VAL . 18.6 mttp -122.81 124.75 44.02 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.97 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.71 172.73 10.92 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.93 -41.64 62.19 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.823 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.503 ' HB3' ' CE1' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -71.63 -14.82 62.17 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.411 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.02 -0.78 44.47 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.969 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.503 ' CE1' ' HB3' ' A' ' 28' ' ' ASN . 71.7 m80 -55.34 104.88 0.14 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.835 -1.146 . . . . 0.0 111.224 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -76.19 124.28 27.21 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.431 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.3 mt -137.42 152.6 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.318 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.656 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 6.3 mp -90.45 132.79 35.44 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.356 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.473 ' SG ' HG21 ' A' ' 24' ' ' VAL . 8.8 p -132.03 134.64 45.78 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.889 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.587 ' ND1' ' N ' ' A' ' 36' ' ' ILE . 54.3 t-80 -103.68 176.23 5.22 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.941 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.587 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 22.1 mt -99.74 161.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.005 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.559 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 4.0 p -121.72 -169.49 1.88 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.389 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.32 -5.32 89.81 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.418 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -71.95 -63.41 1.14 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.769 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 mp -54.81 -21.42 11.16 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.874 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -35.16 66.91 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.601 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.8 ttp -74.66 -31.98 62.1 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.783 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.645 ' C ' ' CD1' ' A' ' 44' ' ' PHE . 2.7 t-20 -93.96 0.76 56.25 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.819 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.645 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 18.6 p90 31.01 72.55 0.06 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.1 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 46' ' ' ARG . 43.7 mt -102.69 166.5 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.823 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' N ' HG22 ' A' ' 45' ' ' ILE . 6.1 ptt180 -144.31 79.63 1.62 Allowed 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.634 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.2 mm -104.22 150.7 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.61 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 mp -99.04 156.78 16.75 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.556 -0.858 . . . . 0.0 112.359 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.605 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 6.4 mp0 -41.38 153.71 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.685 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.25 -4.62 60.54 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.004 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -90.82 142.27 27.94 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.591 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.475 ' HZ1' ' HB3' ' A' ' 52' ' ' LYS . 6.5 mtpm? -81.93 145.57 30.24 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.543 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.5 m -148.64 166.56 4.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.42 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.595 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 1.9 m-20 -92.17 123.83 35.81 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.835 -1.146 . . . . 0.0 108.124 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 9' ' ' LEU . 56.8 t -104.32 126.49 59.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.783 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -99.83 114.54 27.79 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.637 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.73 145.27 24.72 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.134 -1.027 . . . . 0.0 111.024 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 60' ' ' TYR . 4.5 p -86.93 128.1 57.26 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.079 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.88 -1.64 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.348 1.365 . . . . 0.0 111.378 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.473 ' H ' ' C ' ' A' ' 58' ' ' SER . 78.6 m-85 -109.05 -16.84 14.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.881 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.656 ' C ' ' H ' ' A' ' 63' ' ' THR . 13.0 m-20 -145.11 84.0 1.7 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt -71.7 23.25 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.656 ' H ' ' C ' ' A' ' 61' ' ' ASP . 6.7 m -116.37 -5.73 11.78 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.622 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.481 ' HG2' ' N ' ' A' ' 65' ' ' GLY . 1.7 tmt_? -148.68 144.88 27.42 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.728 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.481 ' N ' ' HG2' ' A' ' 64' ' ' ARG . . . -138.28 -150.75 5.69 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.462 HH11 ' HG2' ' A' ' 66' ' ' ARG . 10.5 ptt-85 -165.59 141.45 5.19 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.855 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.2 mm -87.44 117.87 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 119.846 -0.741 . . . . 0.0 109.802 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.633 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 25.6 p -125.44 6.88 7.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.863 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -169.92 110.74 0.43 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.231 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.538 ' CG ' ' N ' ' A' ' 71' ' ' LYS . 22.6 ttp85 -68.5 161.56 27.54 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.654 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.538 ' N ' ' CG ' ' A' ' 70' ' ' ARG . 23.2 tttp -87.41 134.23 33.62 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 116.336 -1.792 . . . . 0.0 110.825 -179.924 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mtp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.78 -16.89 15.82 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.127 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 4' ' ' LYS . 1.2 tppt? -167.49 142.37 3.84 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.767 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 3' ' ' LYS . 22.2 tttt -154.77 111.06 3.22 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.897 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.561 ' OD2' ' N ' ' A' ' 5' ' ' ASP . 6.8 p-10 -94.83 172.88 7.89 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.112 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 m -82.03 -180.0 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.117 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.7 mt -127.12 103.06 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.787 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.38 115.14 11.27 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.446 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 mt -141.88 143.18 33.2 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -86.25 141.49 29.25 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.476 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.08 149.65 21.68 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.228 -1.463 . . . . 0.0 109.873 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -93.91 130.01 40.14 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.459 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.8 t -59.99 127.12 18.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.277 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.469 ' HG ' ' HE2' ' A' ' 25' ' ' LYS . 46.3 m -99.47 -32.45 11.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.943 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -160.38 157.78 28.42 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.614 -1.234 . . . . 0.0 111.818 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.63 118.7 35.94 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.785 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.8 mt -106.2 147.73 35.37 Favored Pre-proline 0 N--CA 1.491 1.582 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.399 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.74 171.18 4.9 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.611 1.54 . . . . 0.0 111.929 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.58 28.95 7.32 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.805 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.59 60.55 2.22 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.168 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.774 ' SD ' ' CD2' ' A' ' 35' ' ' HIS . 46.7 mtm -152.4 164.51 37.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.334 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.54 165.18 31.29 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.722 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -99.04 137.18 37.93 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.224 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 25' ' ' LYS . 46.9 t -130.93 145.13 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.64 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HE2' ' HG ' ' A' ' 14' ' ' SER . 9.0 mtmm -111.49 120.76 43.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.563 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.513 ' H ' ' CD1' ' A' ' 26' ' ' LEU . 3.9 mp -74.41 168.31 19.95 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.03 -29.59 70.39 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.41 ' CB ' ' HD1' ' A' ' 30' ' ' HIS . 16.4 m120 -63.0 -11.05 16.31 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.641 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.29 -11.52 65.36 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.735 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.41 ' HD1' ' CB ' ' A' ' 28' ' ' ASN . 59.3 m80 -78.38 167.69 20.95 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.524 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -127.42 142.69 51.35 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.155 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 33' ' ' LEU . 77.0 mt -143.69 160.91 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.246 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 6.1 mp -90.35 141.8 28.36 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.151 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' A' ' 55' ' ' VAL . 4.7 m -138.7 139.81 38.54 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.384 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.774 ' CD2' ' SD ' ' A' ' 21' ' ' MET . 4.3 m80 -104.15 168.81 8.87 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.321 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.496 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 57.8 mt -92.78 152.09 3.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.772 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.472 ' N ' HG22 ' A' ' 36' ' ' ILE . 3.5 m -104.08 -166.69 1.28 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.63 -16.82 74.67 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.468 -1.348 . . . . 0.0 111.252 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.486 ' C ' ' N ' ' A' ' 41' ' ' ARG . 30.0 mttp -70.89 -63.22 1.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.658 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.473 HD11 ' H ' ' A' ' 40' ' ' LEU . 4.5 mp -52.84 -20.27 3.14 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.679 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.486 ' N ' ' C ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.91 -36.95 62.18 Favored 'General case' 0 C--N 1.271 -2.848 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.898 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 39' ' ' LYS . 92.3 mtp -90.32 -21.53 21.99 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.637 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.484 ' ND2' HG13 ' A' ' 45' ' ' ILE . 12.9 t30 -83.5 -37.76 22.67 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.316 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.9 t80 42.76 54.72 4.54 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.687 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.484 HG13 ' ND2' ' A' ' 43' ' ' ASN . 5.6 mm -96.35 159.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.216 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.4 ' N ' ' HD2' ' A' ' 46' ' ' ARG . 18.2 mmm180 -62.15 137.58 58.28 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.258 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.429 ' HA ' ' NH2' ' A' ' 70' ' ' ARG . 3.3 mt -133.19 140.27 47.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.889 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.8 mt -143.77 135.33 26.11 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.289 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -43.93 152.09 0.18 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.92 -15.11 63.56 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.731 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -76.11 146.8 39.05 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.356 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -88.23 143.55 26.97 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.702 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.5 m -146.03 169.15 6.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.671 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.498 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.4 OUTLIER -96.57 117.93 32.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.107 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.401 HG12 ' SG ' ' A' ' 34' ' ' CYS . 10.4 t -105.25 117.3 50.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.197 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -94.07 118.61 31.77 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.008 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.3 mt -88.49 139.81 30.11 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.913 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.0 m -95.01 132.56 27.89 Favored Pre-proline 0 N--CA 1.49 1.538 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.356 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.96 -2.81 8.51 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.297 1.332 . . . . 0.0 110.967 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -92.11 -22.83 19.67 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.677 ' C ' ' H ' ' A' ' 63' ' ' THR . 5.5 m-20 -150.83 87.26 1.41 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.199 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mt -66.87 18.81 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.677 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.677 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.3 p -113.33 -8.88 13.45 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.43 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.434 ' NH1' ' NE2' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -140.71 151.59 44.64 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.467 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.71 -153.17 6.1 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -163.72 135.88 5.02 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.195 -1.402 . . . . 0.0 112.474 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.8 mm -92.82 123.09 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.429 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.603 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -125.1 7.09 7.89 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.544 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.817 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -168.89 166.1 11.42 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.785 -1.166 . . . . 0.0 111.483 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' A' ' 47' ' ' ILE . 2.4 ttm180 -144.04 125.87 15.22 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.171 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -44.25 158.2 0.05 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.509 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 116.348 -1.787 . . . . 0.0 110.916 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.4 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.914 0.388 . . . . 0.0 109.995 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.01 150.99 29.76 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.722 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -73.64 151.54 40.78 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.891 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 4' ' ' LYS . 10.2 mmtm -90.33 105.63 17.95 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.824 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -134.54 -134.89 0.16 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.024 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 m -73.09 165.73 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.083 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.5 mt -114.6 100.93 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.109 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -78.87 114.59 17.93 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.398 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 55' ' ' VAL . 12.2 mt -134.32 153.37 51.92 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.383 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.49 142.1 28.61 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.704 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.03 -178.4 18.08 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.414 ' N ' HG13 ' A' ' 24' ' ' VAL . 13.7 m -137.86 125.8 22.68 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.476 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 13' ' ' VAL . 6.1 t -59.79 123.94 13.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.527 -1.269 . . . . 0.0 110.534 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -105.51 -29.3 10.27 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.984 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -156.99 149.11 22.91 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.879 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.28 131.67 35.96 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -122.29 152.74 61.24 Favored Pre-proline 0 N--CA 1.492 1.626 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.571 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.29 -176.44 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.031 1.154 . . . . 0.0 110.888 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 3.2 m-20 55.52 40.93 31.23 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.51 49.65 13.3 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.848 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.482 ' HG3' ' CE1' ' A' ' 35' ' ' HIS . 28.9 mtp -140.82 168.41 19.85 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.819 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.0 165.94 29.05 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.917 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -95.3 128.58 42.25 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.109 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 12' ' ' THR . 39.0 t -117.65 140.23 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.647 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -105.72 122.69 46.59 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.141 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.48 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.1 mp -76.79 171.99 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.26 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -71.25 -14.5 62.25 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.444 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -75.52 -16.79 60.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.067 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.29 -15.25 33.0 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 119.767 -1.206 . . . . 0.0 111.419 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -89.5 179.24 6.1 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.115 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -137.68 149.9 46.9 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.268 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.57 ' CG2' ' H ' ' A' ' 33' ' ' LEU . 11.2 mm -136.99 174.73 11.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.231 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.57 ' H ' ' CG2' ' A' ' 32' ' ' ILE . 6.8 mp -97.01 136.5 37.49 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.577 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.1 m -132.73 152.96 51.62 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.654 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.482 ' CE1' ' HG3' ' A' ' 21' ' ' MET . 1.9 t60 -118.92 152.7 35.83 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.257 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.533 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 28.0 mt -93.99 146.68 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.995 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.46 ' N ' HG22 ' A' ' 36' ' ' ILE . 4.5 m -97.22 136.28 37.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.469 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.37 -11.28 39.77 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.185 -1.483 . . . . 0.0 110.496 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.446 ' C ' ' N ' ' A' ' 41' ' ' ARG . 6.8 tttm -70.88 -62.22 1.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.26 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -52.72 -20.21 2.99 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.55 -1.26 . . . . 0.0 108.893 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.446 ' N ' ' C ' ' A' ' 39' ' ' LYS . 3.7 ttt180 -63.99 -53.21 53.66 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.635 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 tpp -65.5 -25.35 67.43 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.895 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -65.14 -4.48 5.03 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.739 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 t80 52.28 87.81 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.571 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.6 mt -140.29 141.88 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.722 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -74.53 134.55 42.2 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.797 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 48' ' ' LEU . 37.9 mt -131.18 147.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.342 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.628 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 1.8 pt? -159.59 148.91 18.14 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.657 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -63.34 152.07 39.0 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.416 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.97 -13.15 60.05 Favored Glycine 0 N--CA 1.485 1.9 0 C-N-CA 119.445 -1.36 . . . . 0.0 110.198 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.607 ' CG ' ' HE ' ' A' ' 70' ' ' ARG . 9.5 t70 -80.12 162.16 24.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.655 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -91.06 152.14 20.75 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.751 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.428 ' CG2' HG12 ' A' ' 67' ' ' ILE . 22.3 m -154.62 167.73 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.455 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.532 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -93.72 122.41 36.15 Favored 'General case' 0 C--O 1.203 -1.351 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.27 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 9' ' ' LEU . 4.1 t -104.59 121.14 56.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.419 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.85 121.2 41.65 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.606 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 mt -95.14 141.87 28.26 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.212 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.5 m -86.03 128.81 56.48 Favored Pre-proline 0 N--CA 1.493 1.677 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.592 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.32 -13.38 39.65 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 121.306 1.337 . . . . 0.0 110.898 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -101.32 -10.41 20.31 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.668 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -147.1 72.45 1.26 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.771 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -70.59 23.35 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.641 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.668 ' H ' ' C ' ' A' ' 61' ' ' ASP . 9.1 m -105.5 -21.16 13.27 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.458 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -140.66 159.6 41.84 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.776 -0.77 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.18 -159.96 8.44 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 6.8 ptt180 -166.91 139.36 3.51 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 117.957 -1.497 . . . . 0.0 112.164 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 67' ' ' ILE . 1.8 mp -93.29 126.34 45.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.563 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.469 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 4.8 p -126.77 7.04 6.74 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.888 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.843 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -166.45 142.69 4.77 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.589 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.607 ' HE ' ' CG ' ' A' ' 51' ' ' ASP . 11.0 ttt-85 -124.11 128.15 48.87 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.947 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' ARG . 16.3 mmtt -41.57 111.83 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.847 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 116.426 -1.75 . . . . 0.0 110.832 179.927 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.577 ' C ' ' H ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.897 0.38 . . . . 0.0 110.102 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 1' ' ' MET . . . 71.68 -22.98 0.19 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 1' ' ' MET . 8.4 mmtp 51.92 87.44 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.885 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.565 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 12.5 tptm -77.59 -144.2 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.049 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.565 ' H ' ' CG ' ' A' ' 4' ' ' LYS . 12.3 t70 -102.58 116.68 33.1 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.07 164.5 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.669 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.4 mm -100.0 107.83 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -76.09 118.41 18.81 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.431 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.6 138.17 37.64 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 12.3 mp0 -88.47 140.65 29.25 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.66 172.24 28.88 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.089 -1.529 . . . . 0.0 110.201 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 m -115.67 129.68 56.58 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.791 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 t -59.67 127.72 19.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.749 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 23' ' ' LYS . 37.1 t -93.98 -40.11 10.29 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.664 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -156.65 158.24 36.64 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.634 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.56 123.75 44.12 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.5 mt -119.29 149.51 47.54 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.461 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 2.3 Cg_endo -59.01 -179.89 0.18 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.289 1.326 . . . . 0.0 111.104 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 6.0 t30 73.58 18.62 3.5 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.61 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.66 42.95 10.33 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.575 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.8 mtp -142.3 174.75 10.33 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.827 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.651 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.52 166.19 27.44 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.372 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' SER . 46.2 tttm -99.14 130.68 45.47 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.55 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG11 ' N ' ' A' ' 25' ' ' LYS . 95.2 t -119.85 150.46 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.336 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.42 ' N ' HG11 ' A' ' 24' ' ' VAL . 26.6 tttt -124.18 112.14 16.73 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.412 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 28' ' ' ASN . 4.7 mp -70.11 138.27 51.83 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.053 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.89 -15.5 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.276 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.551 ' H ' ' C ' ' A' ' 26' ' ' LEU . 18.0 m120 -65.09 -16.27 63.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.243 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.92 -11.21 52.58 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.906 -1.14 . . . . 0.0 111.354 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -98.04 172.02 7.88 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.524 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -125.49 157.94 35.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.59 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 33' ' ' LEU . 34.0 mt -152.01 156.89 5.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.171 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.539 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 7.4 mp -93.45 136.94 33.23 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.228 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' ' CG1' ' A' ' 55' ' ' VAL . 82.8 m -132.78 151.22 52.05 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.289 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -118.65 160.18 22.28 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.0 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.7 mt -91.49 140.67 15.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.324 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 m -85.72 -171.56 3.66 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.011 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.13 -6.85 89.11 Favored Glycine 0 N--CA 1.487 2.039 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.208 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.468 ' HB2' ' HZ2' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -75.68 -62.04 1.72 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.246 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mp -56.29 -20.76 20.2 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.021 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -74.88 -38.16 61.97 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.327 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.6 tpp -71.6 -29.32 64.56 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.11 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.456 ' N ' HD21 ' A' ' 43' ' ' ASN . 1.0 OUTLIER -77.04 -38.74 52.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.345 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.26 77.79 0.32 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.223 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.533 ' CG2' ' H ' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -124.68 -150.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.768 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.533 ' H ' ' CG2' ' A' ' 45' ' ' ILE . 0.5 OUTLIER -149.57 98.23 2.74 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.638 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.44 HD13 ' H ' ' A' ' 47' ' ' ILE . 4.2 mp -92.69 121.89 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.832 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 7.2 mp -96.19 136.89 36.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.942 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -42.46 152.66 0.09 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.248 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.24 -14.41 64.48 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -81.38 143.56 32.08 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.483 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -80.41 149.99 29.95 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.732 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.06 168.4 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.798 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.552 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -101.97 117.86 35.71 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.506 ' CG1' ' SG ' ' A' ' 34' ' ' CYS . 24.3 t -104.39 123.98 58.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.436 -0.906 . . . . 0.0 113.182 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -95.55 114.31 26.06 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.99 147.63 24.19 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.577 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 m -91.97 132.51 32.52 Favored Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.056 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.94 -18.56 64.25 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 121.426 1.417 . . . . 0.0 111.712 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.09 -11.45 24.38 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.397 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.646 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.0 t70 -142.32 78.53 1.63 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.096 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -71.7 23.93 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.413 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.646 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -115.54 -23.82 8.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.08 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.01 151.73 48.19 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.622 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 35' ' ' HIS . . . -144.05 -159.36 7.98 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -166.65 146.16 5.67 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.12 -1.432 . . . . 0.0 112.584 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 67' ' ' ILE . 1.8 mp -93.44 126.19 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.796 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.635 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 7.7 p -126.49 6.71 6.93 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.478 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.796 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -171.73 110.47 0.29 Allowed 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.102 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 162.22 28.77 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.379 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.477 ' HG3' ' H ' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -130.16 158.31 40.05 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.14 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 46.6 tttm . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 116.332 -1.794 . . . . 0.0 110.73 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 mmt . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.849 0.357 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.19 24.33 0.73 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 mttm 46.5 67.72 0.73 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.788 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.524 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -148.94 172.91 13.95 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.975 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.524 ' H ' ' CG ' ' A' ' 4' ' ' LYS . 7.8 p-10 38.5 -147.8 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.516 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 p -113.14 174.58 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.06 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 7' ' ' ILE . 4.5 mp -103.94 146.66 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.27 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -122.46 127.85 50.13 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 55' ' ' VAL . 6.4 mt -144.56 156.02 43.94 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.262 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.544 ' OE2' ' NZ ' ' A' ' 71' ' ' LYS . 39.4 mt-10 -90.56 141.87 28.33 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.609 -0.836 . . . . 0.0 111.25 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.11 158.88 27.91 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.1 m -102.49 132.84 48.28 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.482 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.9 t -68.51 127.13 29.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 118.727 -1.189 . . . . 0.0 110.656 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -98.04 -39.0 9.14 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.588 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -153.56 145.15 23.29 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.092 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.74 110.58 22.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mt -100.14 145.7 30.67 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.15 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.3 Cg_endo -61.92 172.42 3.9 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.242 1.295 . . . . 0.0 111.459 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 76.0 13.79 2.67 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.767 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 19' ' ' ASN . . . 72.49 50.15 0.19 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.032 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.457 ' HE2' ' NE2' ' A' ' 35' ' ' HIS . 9.5 mtp -144.18 140.62 29.44 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.114 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.475 ' CZ ' ' CD1' ' A' ' 36' ' ' ILE . 3.5 m-85 -133.19 166.0 23.47 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.224 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 14' ' ' SER . 78.1 tttt -112.63 111.93 23.09 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.564 ' CG2' ' SG ' ' A' ' 34' ' ' CYS . 16.7 t -107.38 152.11 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 119.472 -0.891 . . . . 0.0 112.774 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' N ' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -126.78 117.24 22.26 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.592 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.464 ' C ' ' N ' ' A' ' 28' ' ' ASN . 2.9 mp -77.0 136.48 38.71 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.855 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -45.91 -19.01 0.05 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.578 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.464 ' N ' ' C ' ' A' ' 26' ' ' LEU . 12.6 m-20 -69.32 -15.9 63.43 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.865 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.04 -12.57 34.31 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.022 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -84.17 163.81 19.53 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.505 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -131.76 144.49 50.99 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.16 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.472 HG21 ' N ' ' A' ' 33' ' ' LEU . 68.0 mt -145.59 148.87 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.575 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 6.1 mp -84.88 125.15 32.4 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.159 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.564 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 59.4 m -116.53 134.24 55.08 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.39 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.466 ' N ' ' HA ' ' A' ' 66' ' ' ARG . 23.3 m170 -97.79 173.54 7.05 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.451 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.475 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 12.9 mt -100.64 147.15 8.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.796 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.491 ' H ' HD21 ' A' ' 40' ' ' LEU . 1.3 t -94.46 161.51 14.19 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.34 -34.67 25.39 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.267 -1.445 . . . . 0.0 111.28 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -65.07 -53.21 49.15 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.056 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.491 HD21 ' H ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -51.88 -22.4 3.76 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.447 -1.301 . . . . 0.0 110.502 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.498 ' CA ' ' HE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.06 -42.1 63.43 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 118.043 -1.463 . . . . 0.0 107.739 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.5 tpp -54.17 -29.25 44.9 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.389 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.65 ' C ' ' CD2' ' A' ' 44' ' ' PHE . 60.3 m-80 -93.25 2.84 56.45 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.65 ' CD2' ' C ' ' A' ' 43' ' ' ASN . 2.8 p90 40.8 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.0 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mm -119.9 102.59 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.578 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -70.09 115.8 9.72 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.2 mt -108.55 110.25 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.589 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mt -97.11 135.57 38.89 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.04 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 1.4 pm0 -46.27 152.38 0.43 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.941 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.61 60.58 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.147 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -91.96 156.37 17.49 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.321 -0.951 . . . . 0.0 110.769 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.51 143.66 27.62 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.547 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 m -146.57 161.27 9.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.826 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.571 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.9 OUTLIER -91.75 120.89 32.89 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.915 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 9' ' ' LEU . 93.5 t -104.11 121.11 55.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.211 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -90.57 123.02 33.89 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.466 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.1 mt -97.3 140.12 32.24 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.771 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 60' ' ' TYR . 4.7 p -92.84 129.69 39.12 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.538 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -57.85 -2.46 0.78 Allowed 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 121.271 1.314 . . . . 0.0 111.668 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.5 ' H ' ' C ' ' A' ' 58' ' ' SER . 27.3 t80 -100.32 -13.07 18.96 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.657 ' C ' ' H ' ' A' ' 63' ' ' THR . 26.6 m-20 -149.59 87.28 1.49 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.544 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 mp -70.66 23.69 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.46 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.657 ' H ' ' C ' ' A' ' 61' ' ' ASP . 39.5 m -135.77 3.49 2.98 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.282 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -141.31 135.08 30.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.082 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.13 -147.78 4.97 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.465 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.466 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 11.9 ptp180 -165.89 151.46 8.91 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.302 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.421 ' CD1' HG23 ' A' ' 55' ' ' VAL . 17.3 mm -93.37 122.36 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.94 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.62 ' C ' ' CG ' ' A' ' 69' ' ' TRP . 0.2 OUTLIER -127.6 7.59 6.31 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.944 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.913 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -176.55 111.45 0.09 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.432 -1.307 . . . . 0.0 111.844 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -76.28 126.82 31.68 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.604 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.544 ' NZ ' ' OE2' ' A' ' 10' ' ' GLU . 12.5 tptt -45.31 143.79 1.62 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.962 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.801 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 mmt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.58 91.45 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.198 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -172.06 -90.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HZ1' ' HE2' ' A' ' 39' ' ' LYS . 13.9 mtmt 61.42 101.54 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.013 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.41 114.98 28.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.142 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.74 173.64 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.38 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.2 mm -101.78 101.81 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.892 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -83.2 119.36 24.45 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.566 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 mt -133.87 157.29 46.34 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.454 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -92.87 144.24 25.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.23 162.9 30.82 Favored Glycine 0 N--CA 1.483 1.813 0 C-N-CA 118.943 -1.599 . . . . 0.0 109.939 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 m -113.49 130.73 56.27 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.074 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.0 t -65.14 116.65 4.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 118.533 -1.267 . . . . 0.0 111.096 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.0 m -97.81 -33.45 11.26 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.752 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -141.73 157.87 44.51 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.67 117.02 24.8 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.083 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' MET . 22.7 mt -98.12 147.77 33.55 Favored Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.036 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.7 Cg_endo -60.38 152.23 68.7 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.417 1.411 . . . . 0.0 111.517 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER 79.56 46.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.137 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.43 58.07 5.81 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.596 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 17' ' ' LEU . 21.1 mtm -144.46 142.4 30.25 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.335 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.655 ' N ' ' CD2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -153.02 166.02 33.75 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.612 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -106.7 142.06 36.95 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.286 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 t -133.31 132.62 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.831 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 2.0 pttm -99.84 129.47 45.94 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.038 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mp -86.13 177.1 7.65 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.043 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 3.9 mm-40 -73.34 -31.2 63.83 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.501 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -62.78 -10.79 14.22 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.486 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.41 -10.2 63.08 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.05 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.455 ' HD1' ' HB3' ' A' ' 28' ' ' ASN . 64.1 m80 -84.98 156.77 21.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.471 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -116.17 148.55 40.25 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.599 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 33' ' ' LEU . 78.5 mt -141.09 149.68 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.67 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 5.3 mp -81.53 154.74 26.1 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.667 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.413 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . 39.9 m -145.54 154.31 42.05 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.449 -1.301 . . . . 0.0 111.546 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.419 ' H ' ' HA ' ' A' ' 66' ' ' ARG . 1.9 t60 -127.76 143.88 51.11 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.386 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.467 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 5.5 mt -70.5 135.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.085 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.91 165.43 12.67 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.923 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.88 -7.26 88.77 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.437 ' HE2' ' HZ1' ' A' ' 4' ' ' LYS . 2.8 mttp -74.69 -62.71 1.44 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.979 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -55.25 -20.62 11.52 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.708 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.43 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -71.57 -41.66 68.74 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.12 -1.032 . . . . 0.0 108.861 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.7 mmt -61.54 -27.08 68.36 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.181 -1.007 . . . . 0.0 109.337 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.444 ' ND2' ' N ' ' A' ' 43' ' ' ASN . 3.3 m120 -69.33 -1.63 8.72 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.318 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.569 ' O ' ' CG ' ' A' ' 44' ' ' PHE . 11.3 t80 57.63 54.62 6.21 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.095 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.606 ' CG2' ' N ' ' A' ' 46' ' ' ARG . 62.1 mt -152.88 172.3 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.162 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.606 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 5.5 ptp85 -139.85 163.56 32.32 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.906 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 mp -109.41 148.95 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.058 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.2 mt -127.78 136.94 52.18 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.977 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -40.18 152.47 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.855 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.61 -9.38 59.16 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.432 -1.365 . . . . 0.0 110.36 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -93.03 135.66 33.99 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.581 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.565 ' CD ' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -75.51 149.01 38.52 Favored 'General case' 0 CA--C 1.486 -1.511 0 C-N-CA 118.764 -1.174 . . . . 0.0 110.577 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.4 m -151.93 165.86 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.738 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.542 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -98.22 125.18 43.17 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.0 t -102.88 128.13 56.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.86 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.612 ' OE2' ' NH1' ' A' ' 66' ' ' ARG . 6.1 tt0 -100.33 110.28 22.5 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.395 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.0 mt -89.55 148.92 23.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.599 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.2 p -99.61 142.04 23.89 Favored Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 119.364 -0.934 . . . . 0.0 112.087 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.21 -3.68 6.57 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.732 1.621 . . . . 0.0 111.559 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -87.96 -23.36 23.88 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.051 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.681 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.4 OUTLIER -166.65 96.09 0.54 Allowed 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.309 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -67.69 18.51 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.563 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.681 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -103.63 -9.77 18.93 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.215 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -137.78 144.73 41.73 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.786 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.31 -152.27 5.67 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.308 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.612 ' NH1' ' OE2' ' A' ' 56' ' ' GLU . 4.1 ptt180 -162.42 152.03 15.94 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.925 -1.11 . . . . 0.0 111.469 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.643 ' CG1' ' CZ ' ' A' ' 22' ' ' PHE . 33.5 mm -92.75 121.21 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.626 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 1.4 p -126.98 6.95 6.6 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.701 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.866 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.19 111.7 0.72 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.068 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.515 ' C ' ' CD ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -102.57 159.9 15.04 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.972 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 3.2 tptt -135.77 142.35 44.93 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.396 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 116.28 -1.819 . . . . 0.0 110.874 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mmm . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.869 0.366 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.42 -36.08 17.93 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.576 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -89.57 -78.72 0.35 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.632 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' HZ2' ' HB2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -146.75 -176.05 5.04 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.572 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.02 109.7 17.87 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.612 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.85 163.61 3.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mm -98.08 104.22 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.46 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -73.35 112.64 9.6 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.988 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mt -137.13 136.15 38.02 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.352 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -91.47 140.96 29.25 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.515 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.52 -166.98 11.02 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.038 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.41 ' H ' HG11 ' A' ' 24' ' ' VAL . 51.2 m -137.44 128.77 28.02 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.517 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.71 130.44 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.485 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.1 t -120.89 -32.42 3.98 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.13 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.433 ' HB3' ' HZ1' ' A' ' 23' ' ' LYS . 36.1 tt0 -141.22 155.5 46.03 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.573 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.13 126.68 39.51 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.958 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.59 144.26 31.5 Favored Pre-proline 0 N--CA 1.494 1.749 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.354 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 3.3 Cg_endo -64.92 164.41 24.79 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 121.539 1.492 . . . . 0.0 111.57 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER 76.2 34.12 0.53 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.257 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.82 61.1 2.51 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.289 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.596 ' SD ' ' CE1' ' A' ' 35' ' ' HIS . 5.2 ptm -162.52 174.78 12.2 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.597 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.764 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.25 161.5 30.79 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.696 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HZ1' ' HB3' ' A' ' 15' ' ' GLU . 1.3 ttmp? -84.6 138.55 32.65 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.551 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.441 ' CG2' ' SG ' ' A' ' 34' ' ' CYS . 2.0 t -127.34 131.65 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.186 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -97.13 123.65 40.95 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.95 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' GLY . 42.0 mt -74.25 155.93 37.75 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.402 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 28' ' ' ASN . 12.3 pt-20 -47.26 -40.25 16.21 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.944 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.504 ' HB3' ' ND1' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -67.53 -16.62 64.29 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.456 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 26' ' ' LEU . . . 108.89 -1.77 31.78 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.333 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.504 ' ND1' ' HB3' ' A' ' 28' ' ' ASN . 60.5 m80 -75.58 138.28 41.35 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.564 -1.254 . . . . 0.0 111.567 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.44 138.0 38.1 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.313 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.453 HG21 ' N ' ' A' ' 33' ' ' LEU . 22.0 mt -146.65 154.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.963 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 7.1 mp -90.9 133.69 35.05 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.352 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.441 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 1.1 p -133.77 144.71 49.21 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.013 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.596 ' CE1' ' SD ' ' A' ' 21' ' ' MET . 13.6 m-70 -108.56 178.23 4.55 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 37' ' ' SER . 49.5 mt -112.25 156.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.782 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.491 ' N ' HG23 ' A' ' 36' ' ' ILE . 4.6 m -107.03 155.72 19.52 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.519 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.26 -6.45 87.75 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.751 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -74.35 -59.12 2.87 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.068 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 pp -54.24 -20.55 7.16 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.539 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.424 ' HG3' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -70.98 -49.2 47.9 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.409 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.507 ' C ' ' H ' ' A' ' 44' ' ' PHE . 8.8 ttm -55.58 -34.99 65.29 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.585 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.1 13.12 0.33 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 42' ' ' MET . 0.1 OUTLIER 56.69 34.78 25.14 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.614 -0.835 . . . . 0.0 111.296 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.424 HG23 ' H ' ' A' ' 46' ' ' ARG . 28.8 mm -98.21 170.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.251 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' H ' HG23 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -149.18 154.07 38.6 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.594 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' N ' ' A' ' 48' ' ' LEU . 29.4 mt -132.21 144.37 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.712 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.411 ' N ' HG21 ' A' ' 47' ' ' ILE . 13.2 mt -132.48 171.46 13.74 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.495 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 152.36 44.31 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.224 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.17 -13.96 30.09 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.229 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 0.9 OUTLIER -80.57 135.61 36.11 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.576 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -75.24 150.19 38.66 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.029 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.454 ' CG2' HD12 ' A' ' 67' ' ' ILE . 29.1 m -151.93 166.29 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.94 -1.104 . . . . 0.0 112.429 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -96.6 121.11 38.07 Favored 'General case' 0 C--O 1.203 -1.382 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.714 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -104.63 123.31 58.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.345 -0.942 . . . . 0.0 113.07 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -101.1 106.4 17.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.747 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.0 mt -81.14 147.31 30.12 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.675 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 p -98.16 138.08 20.87 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.485 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.4 -9.71 21.2 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.735 1.623 . . . . 0.0 112.074 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -90.53 -22.44 21.31 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.405 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.674 ' C ' ' H ' ' A' ' 63' ' ' THR . 15.5 m-20 -153.53 89.29 1.33 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.375 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mt -69.12 20.42 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.474 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.674 ' H ' ' C ' ' A' ' 61' ' ' ASP . 59.0 m -108.7 -9.84 15.22 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.513 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -138.46 148.26 44.18 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.58 -161.92 8.97 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.489 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 8.3 ptt180 -156.48 131.35 9.02 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.61 -1.236 . . . . 0.0 111.93 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.454 HD12 ' CG2' ' A' ' 53' ' ' VAL . 66.3 mt -95.44 129.21 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.59 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -127.97 7.32 6.09 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.49 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.781 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -168.2 111.87 0.61 Allowed 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.75 -1.18 . . . . 0.0 112.209 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' HE ' HG22 ' A' ' 45' ' ' ILE . 5.7 ptt180 -73.45 151.93 40.93 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.483 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -44.1 111.61 0.31 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.916 -1.113 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.809 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 mmt . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.869 0.366 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.18 173.81 11.96 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -90.24 -179.36 5.62 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.835 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -136.86 71.92 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.507 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -111.57 18.04 19.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.518 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 m -92.77 141.31 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.583 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.7 mt -95.95 101.94 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.258 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.7 114.12 9.46 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 55' ' ' VAL . 7.4 mt -131.0 150.99 51.88 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.456 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -97.75 144.26 27.55 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.908 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.54 -175.48 23.36 Favored Glycine 0 N--CA 1.483 1.767 0 C-N-CA 118.885 -1.626 . . . . 0.0 110.335 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.23 131.21 45.42 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.205 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.415 ' CG1' ' HA ' ' A' ' 49' ' ' GLU . 87.4 t -63.52 116.18 3.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 118.434 -1.306 . . . . 0.0 110.187 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 p -95.46 -37.52 10.88 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.749 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -146.19 151.88 38.33 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 118.558 -1.257 . . . . 0.0 111.792 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.92 130.57 46.94 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.494 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.6 mt -121.91 151.07 57.35 Favored Pre-proline 0 N--CA 1.488 1.469 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 20' ' ' ALA . 1.9 Cg_endo -61.13 -156.5 0.02 OUTLIER 'Trans proline' 0 C--O 1.204 -1.182 0 C-N-CA 121.452 1.435 . . . . 0.0 111.007 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 25.4 m120 46.8 12.72 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.87 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 18' ' ' PRO . . . 71.09 42.94 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.914 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.4 170.48 15.94 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.252 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.677 ' N ' ' CD2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.73 165.84 29.75 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.443 -0.903 . . . . 0.0 112.216 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -97.06 136.89 36.97 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.887 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.429 HG22 ' SG ' ' A' ' 34' ' ' CYS . 77.1 t -129.68 143.56 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.163 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -102.88 118.87 37.77 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.197 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.559 ' H ' ' CD1' ' A' ' 26' ' ' LEU . 4.2 mp -74.19 168.88 18.72 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.793 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.62 -19.42 65.22 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.022 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -68.44 -16.24 63.83 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.445 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.44 -10.85 50.51 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -91.31 177.55 6.21 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.168 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -132.8 140.19 47.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.904 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.599 ' CG2' ' N ' ' A' ' 33' ' ' LEU . 8.4 mm -134.58 173.27 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.386 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.599 ' N ' ' CG2' ' A' ' 32' ' ' ILE . 20.2 mt -90.59 145.35 24.93 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.568 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.455 ' HG ' HG12 ' A' ' 55' ' ' VAL . 90.8 m -134.91 152.26 51.59 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.188 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.52 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 33.2 t-80 -128.0 147.51 50.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.156 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.603 ' CG2' ' N ' ' A' ' 37' ' ' SER . 28.3 mt -86.83 166.84 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.492 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.603 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 6.4 p -154.07 159.12 41.39 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.354 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.31 -4.9 0.09 OUTLIER Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.489 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.59 ' H ' ' C ' ' A' ' 37' ' ' SER . 0.7 OUTLIER -62.46 -61.17 2.62 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.472 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 mt -51.56 -21.51 2.57 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.441 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.405 ' N ' ' C ' ' A' ' 39' ' ' LYS . 2.3 mmm180 -83.44 -25.79 30.9 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.333 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' LYS . 13.7 ttp -89.79 -21.39 22.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.262 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -93.23 3.87 54.94 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.788 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 52.06 66.49 1.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.725 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.621 ' CG2' ' N ' ' A' ' 46' ' ' ARG . 26.5 mt -146.22 165.58 8.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.105 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.621 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 50.3 ttm-85 -133.21 140.85 47.76 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.398 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 48' ' ' LEU . 58.9 mt -132.44 149.04 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.263 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 1.9 pt? -142.97 -176.82 5.05 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.72 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.415 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 23.3 mt-10 -75.42 152.24 38.01 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.259 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.51 -14.07 37.55 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.074 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.15 143.37 26.75 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.859 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -75.63 154.33 36.69 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.711 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.583 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 31.6 m -154.8 171.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.482 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.555 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -103.36 123.92 47.72 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG12 ' HG ' ' A' ' 34' ' ' CYS . 3.1 t -103.36 134.21 45.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.648 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.81 111.63 22.92 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.118 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.8 mt -77.8 121.58 24.27 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.672 -1.211 . . . . 0.0 108.981 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 60' ' ' TYR . 1.5 m -80.49 130.04 66.55 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.941 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.05 -1.25 1.59 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.339 1.359 . . . . 0.0 110.646 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.507 ' H ' ' C ' ' A' ' 58' ' ' SER . 5.7 m-30 -84.6 -21.56 30.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.644 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.4 t0 -169.82 100.64 0.31 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.046 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mt -69.25 19.31 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.876 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.644 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.1 p -102.71 -12.19 17.84 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.264 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.483 ' HG2' ' N ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -148.93 144.57 26.92 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.923 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.483 ' N ' ' HG2' ' A' ' 64' ' ' ARG . . . -120.7 -156.57 9.89 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.44 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 9.1 ptm180 -157.41 147.03 20.28 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.502 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.583 ' CD1' ' CG2' ' A' ' 53' ' ' VAL . 1.9 mm -94.04 118.02 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.212 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.624 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 72.2 p -127.17 7.79 6.57 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.24 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.846 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -173.66 118.49 0.28 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 118.621 -1.232 . . . . 0.0 112.403 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -68.68 161.77 27.49 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.881 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.447 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 12.2 tttp -45.68 157.1 0.11 Allowed 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.581 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 71' ' ' LYS . 7.5 ttmt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.779 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.823 0.344 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.27 75.65 0.39 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 4' ' ' LYS . 2.4 tppp? -91.85 147.69 22.78 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.428 ' N ' ' HG3' ' A' ' 3' ' ' LYS . 10.7 mttp 51.08 85.99 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.857 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.71 145.72 0.42 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.428 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 HG23 ' H ' ' A' ' 7' ' ' ILE . 4.7 p -77.46 174.02 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.032 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.507 ' H ' HG23 ' A' ' 6' ' ' VAL . 24.5 mm -104.02 101.78 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.561 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 4.9 pt-20 -103.71 118.83 37.63 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.9 mt -132.25 161.25 33.92 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.431 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -87.96 135.37 33.44 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.798 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.83 154.6 26.04 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -104.9 127.87 52.9 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.856 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.4 t -59.01 127.03 17.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 118.67 -1.212 . . . . 0.0 110.552 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.35 -39.48 8.38 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.526 -0.87 . . . . 0.0 113.013 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.09 136.27 17.57 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.231 -1.388 . . . . 0.0 112.17 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.89 113.55 21.04 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.58 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 21' ' ' MET . 64.4 mt -100.11 150.07 36.57 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.107 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 3.3 Cg_exo -56.78 160.23 12.52 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.219 1.28 . . . . 0.0 111.478 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.9 t-20 76.85 28.04 0.7 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.641 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.484 ' O ' ' CD2' ' A' ' 35' ' ' HIS . . . 55.42 61.94 2.66 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.544 -0.863 . . . . 0.0 111.928 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.489 ' HG3' ' N ' ' A' ' 22' ' ' PHE . 4.6 ttt -153.59 150.81 29.04 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.489 ' N ' ' HG3' ' A' ' 21' ' ' MET . 0.0 OUTLIER -145.38 164.85 30.21 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.298 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -99.84 113.98 26.87 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.389 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.44 ' CG2' ' SG ' ' A' ' 34' ' ' CYS . 70.8 t -94.2 150.35 4.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.125 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -121.47 111.15 16.92 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.428 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.656 ' H ' ' CD1' ' A' ' 26' ' ' LEU . 3.6 mp -71.25 162.88 28.71 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.139 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.65 -18.07 64.61 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.588 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.721 HD21 ' H ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -65.05 -16.44 63.46 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.807 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.93 -5.86 43.07 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.405 ' HD1' ' HB2' ' A' ' 28' ' ' ASN . 5.4 m80 -102.99 178.71 4.48 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.929 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 5.4 pm0 -138.71 158.72 43.71 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.994 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.583 ' CG2' ' N ' ' A' ' 33' ' ' LEU . 81.8 mt -141.76 167.6 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.732 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.671 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 3.6 mp -91.51 138.14 31.81 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.238 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.44 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 4.8 m -141.84 133.16 26.5 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.647 ' CG ' ' N ' ' A' ' 36' ' ' ILE . 51.9 t-80 -107.49 176.85 5.02 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.713 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.651 ' CG2' ' N ' ' A' ' 37' ' ' SER . 26.0 mt -103.92 167.1 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.256 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.651 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -123.32 110.13 14.79 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.96 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.63 -26.02 0.12 Allowed Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.821 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -69.74 -56.35 7.41 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.942 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.415 ' CD1' ' C ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -51.32 -21.78 2.42 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.779 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.419 ' N ' ' C ' ' A' ' 39' ' ' LYS . 5.1 ttm-85 -68.46 -47.36 67.34 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.195 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.454 ' C ' ' H ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -52.78 -31.85 40.66 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.489 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.642 ' C ' ' CD2' ' A' ' 44' ' ' PHE . 32.3 t30 -79.33 19.48 0.59 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.474 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.642 ' CD2' ' C ' ' A' ' 43' ' ' ASN . 6.6 p90 38.88 87.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.714 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.451 HD13 HD21 ' A' ' 43' ' ' ASN . 6.4 mt -140.92 88.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.77 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.33 128.25 33.33 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.175 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -132.63 128.57 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.669 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' GLU . 83.1 mt -108.26 150.82 26.79 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.823 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 48' ' ' LEU . 1.7 tm-20 -38.48 151.44 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.771 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.74 -11.95 50.28 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.241 -1.457 . . . . 0.0 109.861 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -82.09 133.9 35.3 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.696 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -77.83 143.68 37.66 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.078 -1.049 . . . . 0.0 111.221 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -149.87 169.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.745 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 41.2 m-20 -91.74 124.66 36.04 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.65 119.17 51.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.679 -0.808 . . . . 0.0 112.529 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -91.78 113.28 25.5 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.963 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.2 mt -101.65 148.77 24.86 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.238 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 m -83.12 121.21 77.03 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.688 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -59.95 -16.45 38.76 Favored 'Trans proline' 0 C--O 1.217 -0.563 0 C-N-CA 121.254 1.302 . . . . 0.0 111.846 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -106.2 -10.88 16.25 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.485 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.626 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -138.75 77.44 1.62 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.884 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.0 mt -74.29 27.77 0.08 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.091 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.626 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.9 OUTLIER -102.4 -29.69 11.48 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.976 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -139.29 160.51 39.65 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.047 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.17 -157.41 7.18 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.41 140.06 5.95 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.249 -1.38 . . . . 0.0 112.357 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.0 mm -92.32 108.62 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.727 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.632 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 21.5 p -128.84 8.1 5.7 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.837 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.827 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -164.47 120.39 1.52 Allowed 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 118.087 -1.445 . . . . 0.0 112.782 -179.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.36 152.18 36.4 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.66 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -79.79 148.19 31.52 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.419 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tttp . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.098 179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 tmm? . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.7 -14.45 48.37 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.552 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -92.96 37.99 1.03 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.83 78.25 1.58 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.77 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 5' ' ' ASP . 6.0 p30 -153.4 21.94 0.55 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.281 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 p -173.14 168.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.136 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mt -113.85 100.62 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.842 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.24 125.01 41.52 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.735 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.3 mt -142.34 151.89 42.38 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.555 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.441 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 25.5 mp0 -86.33 138.95 31.42 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.159 -1.017 . . . . 0.0 109.971 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.12 -177.07 15.96 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 119.127 -1.511 . . . . 0.0 109.564 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.81 124.33 35.13 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 50' ' ' GLY . 11.3 t -59.97 132.99 25.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.0 p -110.46 -29.69 7.98 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.864 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -149.14 157.45 43.39 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.738 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.74 126.09 54.85 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.7 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.3 mt -119.74 150.33 50.18 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.22 171.7 2.99 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.293 1.329 . . . . 0.0 111.276 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 68.99 31.15 4.26 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.668 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.451 ' HB2' ' NH2' ' A' ' 41' ' ' ARG . . . 55.3 52.44 11.46 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.585 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 mmm -141.02 142.24 34.25 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.874 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -143.58 157.69 44.23 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.245 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -96.66 129.2 44.1 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.219 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.449 HG13 ' N ' ' A' ' 25' ' ' LYS . 14.1 t -121.42 150.47 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.528 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.449 ' N ' HG13 ' A' ' 24' ' ' VAL . 15.4 mtpp -126.57 128.58 47.05 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.4 mt -85.41 142.75 29.04 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -49.7 -26.75 4.03 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.943 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.495 ' HB2' ' HD1' ' A' ' 30' ' ' HIS . 24.8 m120 -63.8 -17.05 62.7 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.291 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.92 -0.59 38.72 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.526 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.495 ' HD1' ' HB2' ' A' ' 28' ' ' ASN . 36.4 m80 -93.23 145.2 24.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.187 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.86 141.53 37.94 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.179 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.5 ' CD1' ' N ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -139.85 146.78 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.943 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 6.3 mp -93.09 125.26 37.59 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.499 ' SG ' ' CG1' ' A' ' 55' ' ' VAL . 73.2 m -118.52 155.62 30.54 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.149 -1.02 . . . . 0.0 112.451 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -118.26 155.79 29.96 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.733 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.544 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 37.7 mt -95.04 149.84 4.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.789 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.492 ' N ' HG22 ' A' ' 36' ' ' ILE . 73.1 m -88.32 -172.76 3.91 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.007 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.88 -21.4 63.48 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.578 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.615 ' CG ' ' N ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -72.26 -55.91 6.4 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.489 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.615 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 2.4 mp -54.82 -21.69 12.05 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.445 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.451 ' NH2' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -72.2 -40.2 68.02 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.534 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.1 mmm -72.15 -31.46 65.98 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.759 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -74.0 -34.07 64.05 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.294 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.0 t80 40.12 61.63 1.47 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.818 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -86.78 -165.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.158 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' H ' HG22 ' A' ' 45' ' ' ILE . 12.7 ptt85 -119.46 74.36 1.0 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mm -98.08 144.24 11.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.402 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 49' ' ' GLU . 4.4 mp -126.78 152.55 46.76 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.726 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 48' ' ' LEU . 2.9 pp20? -40.27 152.44 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.194 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 97.63 -15.05 62.54 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.26 131.91 39.55 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.262 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.62 146.46 36.15 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.296 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.8 m -152.45 171.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.972 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.591 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 2.0 m-80 -97.99 117.8 33.14 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.499 ' CG1' ' SG ' ' A' ' 34' ' ' CYS . 13.9 t -104.68 126.74 59.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.665 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.91 117.14 34.37 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.648 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.424 ' CD2' HG22 ' A' ' 32' ' ' ILE . 3.9 mt -99.27 149.16 23.4 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.907 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.36 136.13 30.35 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -59.54 -10.87 12.32 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.556 1.504 . . . . 0.0 111.715 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CD2' ' OD2' ' A' ' 61' ' ' ASP . 8.5 t80 -101.95 -14.45 17.19 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.608 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.658 ' C ' ' H ' ' A' ' 63' ' ' THR . 57.2 m-20 -144.19 79.8 1.63 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.564 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mt -71.06 20.28 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.292 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.658 ' H ' ' C ' ' A' ' 61' ' ' ASP . 10.6 p -118.63 -9.68 10.19 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.298 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.462 HH21 ' HB2' ' A' ' 64' ' ' ARG . 37.3 mtp-105 -133.7 143.95 48.83 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.075 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.85 -153.48 6.25 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.597 -1.287 . . . . 0.0 109.897 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -162.68 147.5 11.95 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.504 -1.279 . . . . 0.0 112.134 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.46 ' CG1' ' CZ ' ' A' ' 22' ' ' PHE . 20.5 mm -93.55 110.35 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.027 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.63 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 3.3 p -118.17 6.83 12.03 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.84 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -166.9 110.41 0.72 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 118.673 -1.211 . . . . 0.0 111.331 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.8 ptt-85 -76.27 136.89 39.64 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.435 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.63 145.85 11.18 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.904 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.7 pttm . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.918 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.19 16.65 1.9 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.955 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp 57.32 174.8 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.646 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 6.8 mttp 47.16 -159.02 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.869 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 1.2 t0 73.01 -144.61 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.167 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -74.27 157.18 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.613 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.1 100.26 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 119.167 -1.013 . . . . 0.0 109.556 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.02 112.31 20.5 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.654 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 mt -137.58 149.69 46.88 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.467 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.78 144.39 25.76 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.894 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.46 -155.0 6.31 Favored Glycine 0 N--CA 1.481 1.681 0 C-N-CA 119.149 -1.501 . . . . 0.0 109.766 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 50' ' ' GLY . 31.1 m -145.24 130.62 18.68 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.026 -1.07 . . . . 0.0 111.138 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 t -59.6 123.12 11.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.145 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -100.4 -30.31 11.91 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.73 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -150.3 155.03 38.91 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.821 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.98 123.57 48.86 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.501 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.2 mt -121.98 151.16 57.73 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.179 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.92 -178.8 0.34 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.269 1.313 . . . . 0.0 111.544 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER 69.41 14.94 8.44 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.134 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 19' ' ' ASN . . . 68.28 43.82 1.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.072 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtm -144.73 152.47 40.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.774 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -144.85 165.88 26.86 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.876 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -95.58 124.3 39.54 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.387 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -118.52 141.25 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.956 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HZ2' ' HA2' ' A' ' 29' ' ' GLY . 18.3 tttp -118.76 113.59 21.38 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.793 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.585 ' C ' ' H ' ' A' ' 28' ' ' ASN . 26.1 mt -67.38 137.75 56.2 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.494 -0.883 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.45 -12.29 0.06 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.522 -1.271 . . . . 0.0 109.179 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.585 ' H ' ' C ' ' A' ' 26' ' ' LEU . 39.1 m-80 -72.5 -17.23 61.77 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.41 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' HA2' ' HZ2' ' A' ' 25' ' ' LYS . . . 107.42 0.39 35.01 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.96 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -101.22 136.3 41.29 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.969 -1.093 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -109.27 132.09 54.45 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.301 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.455 HG21 ' N ' ' A' ' 33' ' ' LEU . 4.7 mp -141.37 165.55 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.043 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 7.0 mp -89.28 134.32 34.1 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.329 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.402 ' CB ' HD13 ' A' ' 67' ' ' ILE . 80.0 m -128.55 148.33 50.76 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.276 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.469 ' ND1' ' O ' ' A' ' 36' ' ' ILE . 48.9 t-80 -114.81 154.97 27.62 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.273 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.517 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 51.5 mt -90.75 153.32 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.087 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 6.0 m -82.6 126.51 32.39 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.931 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.4 -12.19 0.89 Allowed Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.453 -1.356 . . . . 0.0 111.315 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -80.7 -63.01 1.5 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.257 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.03 -18.61 36.15 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.38 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -71.64 -40.51 69.67 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.89 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.561 ' C ' ' H ' ' A' ' 44' ' ' PHE . 7.6 mmt -61.72 -35.82 79.17 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -58.92 -0.3 0.11 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.247 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.561 ' H ' ' C ' ' A' ' 42' ' ' MET . 4.8 t80 55.21 45.11 26.53 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.309 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 mm -98.55 157.49 3.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.096 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -150.03 99.14 2.79 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.818 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.1 tt -87.42 149.13 4.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.576 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.621 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 3.5 mp -83.75 135.35 34.58 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.25 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 49' ' ' GLU . 4.8 mm-40 -44.66 153.26 0.17 Allowed 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.891 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . 92.4 -15.19 62.86 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.253 -1.451 . . . . 0.0 109.628 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.79 152.95 41.32 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.046 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -83.98 146.65 27.88 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.745 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 m -150.34 164.62 3.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.386 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.578 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -91.83 121.52 33.52 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.08 123.84 59.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.517 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.13 113.32 26.47 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.31 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.43 132.75 33.89 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.956 -1.098 . . . . 0.0 110.741 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 t -85.64 121.49 73.35 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.393 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -61.98 -9.66 15.17 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 121.074 1.183 . . . . 0.0 110.942 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -94.27 -16.94 23.14 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.633 ' C ' ' H ' ' A' ' 63' ' ' THR . 13.8 m-20 -142.99 82.33 1.76 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.942 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.9 mt -71.21 24.09 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.768 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.633 ' H ' ' C ' ' A' ' 61' ' ' ASP . 42.0 m -122.91 -7.33 8.42 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.439 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -140.17 152.05 45.73 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.449 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 66' ' ' ARG . . . -137.56 -167.44 11.06 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.676 -1.77 . . . . 0.0 108.676 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.414 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 18.1 mtt85 -155.98 131.32 9.47 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.709 -1.597 . . . . 0.0 112.899 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.49 HD11 ' N ' ' A' ' 67' ' ' ILE . 1.4 mp -93.32 111.89 25.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.519 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.473 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 14.3 p -126.75 7.28 6.78 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.487 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.811 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -159.57 112.11 2.15 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.665 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -74.15 141.75 45.53 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.625 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HG2' ' H ' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -87.38 164.35 16.27 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.067 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.425 ' H ' ' HG2' ' A' ' 71' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.248 0 CA-C-O 116.304 -1.807 . . . . 0.0 110.578 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.445 HG21 ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.636 0.255 . . . . 0.0 111.018 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.1 mm -107.69 101.9 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.285 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -81.59 115.29 20.8 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.155 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 55' ' ' VAL . 20.2 mt -132.5 164.15 27.24 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.591 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.72 146.14 25.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.12 154.77 25.76 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.002 -1.571 . . . . 0.0 109.662 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -104.98 124.72 50.01 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 51' ' ' ASP . 5.2 t -61.13 113.84 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.16 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -88.12 -31.05 19.39 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.648 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -154.4 158.1 39.51 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.463 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.595 ' H ' ' CD ' ' A' ' 15' ' ' GLU . . . -124.48 124.36 42.13 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.733 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -120.43 162.59 33.38 Favored Pre-proline 0 N--CA 1.487 1.381 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.28 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 5.9 Cg_exo -55.98 179.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.67 1.58 . . . . 0.0 111.508 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.1 t-20 74.93 17.2 2.8 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.081 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.0 50.86 9.58 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.798 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.416 ' C ' HD12 ' A' ' 17' ' ' LEU . 25.8 mtt -142.77 171.64 13.77 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.715 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.726 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.44 166.32 29.45 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.479 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -100.04 143.56 30.1 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.25 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.699 HG23 ' SG ' ' A' ' 34' ' ' CYS . 19.1 t -132.62 137.42 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.326 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 25' ' ' LYS . 8.0 ptmm? -111.42 126.93 55.47 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.393 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.694 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.5 mp -87.45 153.21 21.61 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.799 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.725 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -57.67 -17.55 15.51 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.772 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -69.23 -14.73 63.13 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.693 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.68 -11.67 53.55 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.677 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -87.78 175.48 7.83 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.015 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.612 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -137.43 149.29 46.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.316 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 33' ' ' LEU . 50.7 mt -142.86 154.06 17.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.453 ' N ' ' CG2' ' A' ' 32' ' ' ILE . 10.0 mt -86.25 147.47 26.07 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.211 -0.995 . . . . 0.0 109.231 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -139.34 147.71 41.91 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.854 -1.139 . . . . 0.0 111.393 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -119.04 155.55 31.26 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.286 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.754 HG23 HD21 ' A' ' 40' ' ' LEU . 46.8 mt -84.01 145.93 7.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.445 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 68' ' ' THR . 45.9 m -96.57 169.61 9.77 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.03 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.34 -14.09 80.79 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.335 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -75.58 -62.76 1.47 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.582 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.754 HD21 HG23 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -58.05 -19.69 33.48 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.616 -1.234 . . . . 0.0 109.086 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -42.92 70.45 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.034 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.483 ' SD ' ' O ' ' A' ' 42' ' ' MET . 4.4 tmm? -60.42 -33.68 72.85 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.696 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' HB3' HD11 ' A' ' 45' ' ' ILE . 36.5 m-20 -64.42 -17.7 64.03 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 118.769 -1.172 . . . . 0.0 109.873 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.419 ' C ' HD12 ' A' ' 45' ' ' ILE . 6.4 t80 67.7 73.67 0.31 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.067 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.635 ' CG2' ' N ' ' A' ' 46' ' ' ARG . 2.0 mp -117.85 165.86 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.337 0.589 . . . . 0.0 111.781 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.635 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 24.1 ttt180 -144.85 74.52 1.41 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.069 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 tt -77.19 149.6 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.119 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 49' ' ' GLU . 12.1 mt -120.4 139.57 52.61 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.072 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' LEU . 1.8 pm0 -38.21 148.07 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.007 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.16 -4.57 58.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.9 m-20 -98.37 139.58 33.92 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.088 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' C ' HG13 ' A' ' 53' ' ' VAL . 57.7 mttt -75.5 144.09 42.18 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.773 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.524 ' CG2' HD12 ' A' ' 67' ' ' ILE . 14.5 m -149.9 167.35 2.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.686 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.582 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -93.42 127.52 39.09 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 24' ' ' VAL . 2.9 t -104.15 129.56 56.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.438 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.445 ' OE1' HG21 ' A' ' 6' ' ' VAL . 36.5 tt0 -106.11 110.47 22.74 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.359 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.1 mt -88.01 143.17 27.24 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.065 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 60' ' ' TYR . 25.4 p -98.79 132.98 22.8 Favored Pre-proline 0 N--CA 1.492 1.658 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.118 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.4 -1.3 1.34 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.445 1.43 . . . . 0.0 111.442 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 58' ' ' SER . 5.6 t80 -81.13 -21.68 39.63 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.674 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.0 p30 179.88 105.78 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.908 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt -66.6 20.7 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.608 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.674 ' H ' ' C ' ' A' ' 61' ' ' ASP . 76.1 m -98.19 -14.4 20.38 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.044 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.423 ' NH2' ' OD1' ' A' ' 61' ' ' ASP . 17.2 mtp180 -138.83 146.61 41.47 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.197 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.57 -151.75 5.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.67 143.28 4.74 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.175 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.524 HD12 ' CG2' ' A' ' 53' ' ' VAL . 19.3 mm -93.15 119.05 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.592 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 7.2 p -126.62 7.38 6.88 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.685 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.85 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.16 111.87 0.73 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.378 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.5 ptt85 -111.36 146.28 37.4 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.255 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? . . . . . 0 C--N 1.302 -1.483 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.92 -179.959 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.5 mt -97.73 101.38 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.222 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -94.55 108.38 20.34 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 9' ' ' LEU . 10.8 mt -132.64 148.94 52.36 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.067 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.84 144.1 27.17 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.66 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.47 179.82 25.94 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 119.069 -1.539 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.4 m -124.16 131.05 53.5 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.445 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.457 HG23 ' H ' ' A' ' 13' ' ' VAL . 1.9 t -59.73 119.08 3.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 118.576 -1.249 . . . . 0.0 110.591 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' LYS . 5.7 t -88.88 -32.24 17.85 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.165 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -151.1 156.32 40.78 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.694 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.84 107.38 18.1 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.627 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.3 mt -99.79 144.52 28.5 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.099 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.9 Cg_endo -61.01 166.68 10.15 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.255 1.304 . . . . 0.0 111.037 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 6.4 t-20 76.96 29.76 0.59 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.652 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.82 57.77 4.5 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.531 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.766 ' SD ' ' NE2' ' A' ' 35' ' ' HIS . 15.8 mtm -152.6 159.42 43.24 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.897 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.696 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -159.45 165.34 33.31 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.668 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 14' ' ' SER . 27.4 ttpt -103.29 114.3 28.47 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.657 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -98.51 146.98 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.303 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -124.2 114.4 19.57 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.746 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.539 ' C ' ' N ' ' A' ' 28' ' ' ASN . 10.6 mt -69.58 147.07 51.22 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.659 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.643 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -49.31 -11.36 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.959 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.643 ' N ' ' CD ' ' A' ' 27' ' ' GLU . 36.6 t30 -78.84 -17.79 55.08 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.7 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.69 -2.18 42.13 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.804 -1.189 . . . . 0.0 112.294 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -94.29 137.56 33.31 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.069 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -91.53 141.26 28.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.491 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.415 ' C ' HD12 ' A' ' 33' ' ' LEU . 7.5 mm -137.93 144.53 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.248 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 33' ' ' LEU . 5.2 mp -85.85 134.41 33.91 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.14 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.0 m -139.57 151.35 45.99 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.399 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.766 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 18.3 m80 -115.55 161.82 18.09 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.654 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.532 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 27.9 mt -92.59 146.06 6.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.66 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.439 ' O ' HG22 ' A' ' 36' ' ' ILE . 3.2 m -92.47 -178.34 4.88 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.21 -8.61 87.44 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.854 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -75.12 -62.18 1.64 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.48 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.526 HD13 HG23 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -53.69 -20.68 5.74 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.188 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -73.52 -39.19 64.97 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.308 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.61 -28.62 67.08 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.397 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -77.55 -16.28 58.75 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.618 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.2 t80 47.66 80.94 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.551 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 45' ' ' ILE . 33.5 mt -144.86 113.21 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.019 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -60.27 126.1 26.18 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.688 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 mm -95.12 148.28 5.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.551 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 48' ' ' LEU . 14.3 tp -125.08 135.45 52.71 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.083 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.21 152.34 0.59 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.932 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.02 -16.4 59.62 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.247 -1.454 . . . . 0.0 109.667 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.91 162.21 29.79 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.425 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.73 141.4 36.54 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.377 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.436 ' CG2' HG13 ' A' ' 67' ' ' ILE . 5.3 m -148.57 162.49 5.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.583 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 2.0 m-20 -92.46 124.09 36.25 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.23 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.57 142.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.644 -0.823 . . . . 0.0 112.254 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -122.84 108.64 13.23 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.405 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.1 mt -84.42 132.29 34.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.391 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.7 p -91.01 139.33 25.81 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 119.024 -1.07 . . . . 0.0 112.152 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.32 -4.9 8.73 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.518 1.479 . . . . 0.0 111.403 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -89.15 -22.82 22.64 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.724 -0.79 . . . . 0.0 108.98 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.644 ' C ' ' H ' ' A' ' 63' ' ' THR . 4.1 m-20 -151.34 89.31 1.49 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mt -69.89 23.06 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.417 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.644 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.1 m -119.53 -8.59 9.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.169 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.25 150.43 39.28 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.236 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.8 -152.57 6.42 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -166.36 143.76 5.2 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.146 -1.422 . . . . 0.0 112.166 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 67' ' ' ILE . 1.3 mp -92.34 121.7 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.22 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.57 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 70.2 p -124.7 7.08 8.16 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.076 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.863 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.67 111.02 0.65 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.646 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.36 162.91 28.4 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.114 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.928 0.394 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 mt -94.46 102.44 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.575 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 1.9 mm-40 -80.38 117.04 20.79 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.156 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.2 mt -128.95 150.73 50.26 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.222 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -88.18 142.64 27.6 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.393 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.7 165.61 31.59 Favored Glycine 0 N--CA 1.485 1.941 0 C-N-CA 119.172 -1.489 . . . . 0.0 110.221 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.439 ' C ' HG13 ' A' ' 24' ' ' VAL . 33.7 m -113.7 125.79 54.51 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.739 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.99 112.06 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 118.624 -1.23 . . . . 0.0 110.546 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -90.36 -32.75 16.33 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.429 -0.908 . . . . 0.0 112.141 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -152.56 137.85 17.51 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.389 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.37 117.12 32.07 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.376 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -106.86 155.22 39.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.618 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.54 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 3.7 Cg_exo -56.54 -164.3 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.879 0 C-N-CA 121.334 1.356 . . . . 0.0 112.126 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 18' ' ' PRO . 8.0 p30 46.63 31.34 1.35 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.062 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' A' ' 36' ' ' ILE . . . 52.07 58.08 5.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.981 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.51 ' SD ' ' OD1' ' A' ' 19' ' ' ASN . 37.0 mtp -149.85 137.59 20.11 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.714 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -130.71 163.22 27.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.424 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -103.84 108.88 20.39 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.521 ' CG2' ' SG ' ' A' ' 34' ' ' CYS . 36.6 t -94.93 152.48 3.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.375 -0.93 . . . . 0.0 112.01 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -120.74 110.91 16.94 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.825 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.692 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.1 mp -65.45 178.6 0.92 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.545 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -77.23 -23.69 51.32 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.649 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.446 HD22 ' CB ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -66.12 -15.82 63.43 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.494 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.36 -8.23 35.13 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.068 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -95.76 176.8 6.0 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.676 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -138.34 160.46 39.43 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.82 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 33' ' ' LEU . 76.7 mt -143.53 161.67 16.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.1 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.679 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 3.9 mp -86.37 131.51 34.19 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.549 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 8.2 m -132.99 135.28 45.38 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.658 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 2.4 t60 -102.31 173.68 6.26 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.509 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.658 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 10.7 mt -91.3 165.91 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.998 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.644 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -128.2 160.77 31.04 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.946 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.97 -20.01 66.18 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.341 -1.409 . . . . 0.0 111.594 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.42 ' C ' ' N ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -67.81 -62.27 1.49 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.342 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -52.83 -20.25 3.12 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.808 -1.157 . . . . 0.0 109.643 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.437 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.35 -42.81 68.03 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.406 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.476 ' C ' ' H ' ' A' ' 44' ' ' PHE . 1.4 ptm -72.4 -22.32 61.14 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.298 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.472 ' N ' ' HG3' ' A' ' 42' ' ' MET . 7.2 m120 -67.09 6.51 0.52 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.801 -1.16 . . . . 0.0 110.646 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 42' ' ' MET . 0.8 OUTLIER 48.19 82.32 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.876 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 mm -142.46 147.06 21.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.088 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.78 75.13 1.51 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.572 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.452 HG21 ' CB ' ' A' ' 51' ' ' ASP . 42.8 mt -105.79 149.59 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.771 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.3 mt -110.72 165.8 11.54 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.517 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -40.41 153.26 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.47 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.26 -12.18 65.25 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.588 -1.292 . . . . 0.0 109.873 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.452 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -92.6 152.63 19.48 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.74 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 66.1 mttt -78.41 147.43 34.04 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.629 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.464 HG13 ' C ' ' A' ' 52' ' ' LYS . 33.9 m -149.58 162.44 4.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.643 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.516 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -95.2 123.04 38.49 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.453 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 9' ' ' LEU . 61.1 t -104.35 127.5 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.625 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.65 113.69 26.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.946 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.406 ' CD2' HD13 ' A' ' 32' ' ' ILE . 23.8 mt -88.48 147.26 24.75 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.752 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.05 135.2 33.65 Favored Pre-proline 0 N--CA 1.492 1.648 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.18 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -65.1 -4.93 9.92 Favored 'Trans proline' 0 C--O 1.217 -0.548 0 C-N-CA 121.625 1.55 . . . . 0.0 112.068 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.78 -22.05 14.98 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.083 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.617 ' C ' ' H ' ' A' ' 63' ' ' THR . 33.0 t0 -155.23 91.64 1.36 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.55 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.33 19.83 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.464 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.617 ' H ' ' C ' ' A' ' 61' ' ' ASP . 53.2 m -99.92 -13.33 19.19 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.011 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -137.67 147.31 44.76 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.13 -159.33 7.89 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.455 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 5.8 ptp180 -154.71 143.88 21.12 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.842 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.2 mm -93.26 122.05 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.296 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.635 ' OG1' ' NE1' ' A' ' 69' ' ' TRP . 5.0 p -126.47 6.4 6.93 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.012 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.859 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -158.4 157.72 32.84 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.315 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -154.32 88.72 1.24 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.063 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.309 -1.175 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.655 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 58' ' ' SER . 11.9 m . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.926 0.393 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 mm -95.61 106.72 18.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.415 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.53 112.55 13.18 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.194 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' A' ' 9' ' ' LEU . 25.0 mt -134.0 164.95 26.17 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.611 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -90.01 143.84 26.43 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.8 148.32 18.8 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.413 HG21 ' NZ ' ' A' ' 25' ' ' LYS . 20.1 m -104.27 132.13 50.85 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 51' ' ' ASP . 4.2 t -63.36 117.66 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.619 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.09 -29.46 13.61 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.319 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -150.09 121.9 8.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.122 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.46 105.34 17.69 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.034 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.42 149.03 36.61 Favored Pre-proline 0 C--N 1.307 -1.259 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.799 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 2.3 Cg_endo -58.72 167.21 5.51 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.308 1.339 . . . . 0.0 111.229 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 4.6 t-20 75.79 29.94 0.8 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.573 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.16 61.37 3.07 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.822 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 ttm -155.23 136.51 13.99 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.61 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -136.28 165.69 25.19 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.809 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -105.08 109.01 20.83 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.365 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.694 HG11 HG21 ' A' ' 55' ' ' VAL . 69.8 t -96.35 143.96 11.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.201 -1.0 . . . . 0.0 112.079 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 14.8 pttm -110.95 126.87 55.21 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.968 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.527 HD11 ' CD1' ' A' ' 32' ' ' ILE . 4.8 mp -83.77 175.46 9.64 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.183 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -73.91 -26.93 60.78 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.775 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.85 -16.86 64.22 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.81 -11.77 35.0 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.365 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -83.72 174.98 10.01 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.284 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -133.3 151.78 51.9 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.651 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.527 ' CD1' HD11 ' A' ' 26' ' ' LEU . 65.8 mt -141.28 155.33 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.914 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.872 ' H ' HD12 ' A' ' 33' ' ' LEU . 2.2 mp -88.04 134.41 33.75 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.522 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.57 ' SG ' HG13 ' A' ' 55' ' ' VAL . 61.6 m -132.96 139.1 47.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.957 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.435 ' H ' ' HA ' ' A' ' 66' ' ' ARG . 1.7 t-80 -107.96 172.35 6.88 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.815 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.651 HG22 ' N ' ' A' ' 37' ' ' SER . 25.0 mt -98.61 167.42 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.818 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.651 ' N ' HG22 ' A' ' 36' ' ' ILE . 35.1 m -130.93 117.74 19.67 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.817 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.49 -15.34 0.05 OUTLIER Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.82 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 37' ' ' SER . 30.7 mtmt -72.42 -61.54 1.76 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.196 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 36' ' ' ILE . 1.1 pp -53.15 -21.36 4.88 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.96 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.468 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 1.9 ttt-85 -72.78 -39.72 66.52 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.52 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 42' ' ' MET . 6.9 tpp -63.72 -27.4 69.18 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.725 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -78.93 5.39 11.7 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 54.23 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.223 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.57 114.07 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -59.34 137.15 58.09 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.607 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 mm -102.52 149.78 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.39 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -164.26 134.95 4.26 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.501 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.441 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 2.2 pp20? -63.42 152.24 38.79 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.223 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.59 -8.31 28.1 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 118.873 -1.632 . . . . 0.0 109.695 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 13' ' ' VAL . 56.5 t0 -72.53 133.1 44.61 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.284 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' C ' HG13 ' A' ' 53' ' ' VAL . 77.8 mttt -76.1 141.76 41.89 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.332 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.693 ' CG2' HD12 ' A' ' 67' ' ' ILE . 16.6 m -148.48 168.79 3.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.681 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.597 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -91.42 120.26 32.11 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.538 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.694 HG21 HG11 ' A' ' 24' ' ' VAL . 26.3 t -104.76 116.66 48.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.634 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.17 120.13 33.98 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.412 ' CD2' HD13 ' A' ' 32' ' ' ILE . 12.7 mt -92.8 159.43 15.4 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.406 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.454 ' HA ' HG12 ' A' ' 6' ' ' VAL . 67.0 m -94.85 141.08 22.83 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.599 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -69.68 -21.88 33.25 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.825 1.683 . . . . 0.0 112.055 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -88.24 -26.39 22.37 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.403 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.61 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -148.04 88.21 1.65 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.12 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mt -71.76 20.61 0.06 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.278 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.61 ' H ' ' C ' ' A' ' 61' ' ' ASP . 7.1 p -98.43 -12.32 21.49 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -138.02 150.68 47.18 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.678 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.36 -153.28 5.85 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.435 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 4.8 ptt180 -165.48 147.13 7.41 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.664 -1.215 . . . . 0.0 111.595 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.693 HD12 ' CG2' ' A' ' 53' ' ' VAL . 25.2 mm -92.72 117.3 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.969 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.63 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 32.6 p -127.95 7.97 6.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.963 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.824 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -169.98 127.72 0.88 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.28 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.474 ' HD2' ' N ' ' A' ' 71' ' ' LYS . 8.7 tmm_? -72.3 162.08 29.97 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.515 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.474 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 9.2 tttt . . . . . 0 N--CA 1.488 1.45 0 C-N-CA 119.416 -0.913 . . . . 0.0 111.334 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.713 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.41 0.148 . . . . 0.0 110.602 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.713 HD12 ' C ' ' A' ' 6' ' ' VAL . 1.8 mp -116.76 110.19 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.246 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -100.52 127.12 46.98 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.092 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' VAL . 35.2 mt -144.44 160.24 41.4 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.646 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -88.0 143.73 26.93 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.19 168.77 30.2 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.117 -1.516 . . . . 0.0 109.804 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.5 m -123.87 130.03 51.95 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.475 ' HA ' HG22 ' A' ' 24' ' ' VAL . 3.0 t -67.72 133.07 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.734 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 t -113.24 -26.92 8.18 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.326 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -153.15 158.2 41.45 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.108 -1.437 . . . . 0.0 112.223 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' H ' ' CD ' ' A' ' 15' ' ' GLU . . . -99.15 113.99 26.51 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.577 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.4 mt -104.66 146.94 33.6 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 119.739 -0.785 . . . . 0.0 111.008 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.517 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 3.1 Cg_endo -65.0 170.49 10.27 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 121.296 1.331 . . . . 0.0 111.433 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.517 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER 75.07 28.62 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.154 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.483 ' O ' ' CE1' ' A' ' 35' ' ' HIS . . . 58.89 61.99 2.01 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.347 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 19' ' ' ASN . 8.6 ptm -165.29 170.38 14.8 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.607 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -155.41 165.34 36.92 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.837 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -88.88 132.46 34.67 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.768 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.475 HG22 ' HA ' ' A' ' 13' ' ' VAL . 2.3 t -125.93 143.39 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.575 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -122.81 124.75 44.02 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.97 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.71 172.73 10.92 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.93 -41.64 62.19 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.823 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.521 ' HB3' ' CE1' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -71.63 -14.82 62.17 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.411 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.02 -0.78 44.47 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.969 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.521 ' CE1' ' HB3' ' A' ' 28' ' ' ASN . 71.7 m80 -55.34 104.88 0.14 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.835 -1.146 . . . . 0.0 111.224 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -76.19 124.28 27.21 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.431 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.486 ' C ' HD12 ' A' ' 33' ' ' LEU . 23.3 mt -137.42 152.6 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.318 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 33' ' ' LEU . 6.3 mp -90.45 132.79 35.44 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.356 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.428 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 8.8 p -132.03 134.64 45.78 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.889 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.587 ' ND1' ' N ' ' A' ' 36' ' ' ILE . 54.3 t-80 -103.68 176.23 5.22 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.941 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.587 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 22.1 mt -99.74 161.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.005 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.559 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 4.0 p -121.72 -169.49 1.88 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.389 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.32 -5.32 89.81 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.418 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -71.95 -63.41 1.14 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.769 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.586 HD13 HG23 ' A' ' 36' ' ' ILE . 1.7 mp -54.81 -21.42 11.16 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.874 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -35.16 66.91 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.601 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.8 ttp -74.66 -31.98 62.1 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.783 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.645 ' C ' ' CD1' ' A' ' 44' ' ' PHE . 2.7 t-20 -93.96 0.76 56.25 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.819 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.645 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 18.6 p90 31.01 72.55 0.06 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.1 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 46' ' ' ARG . 43.7 mt -102.69 166.5 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.823 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.611 ' N ' HG22 ' A' ' 45' ' ' ILE . 6.1 ptt180 -144.31 79.63 1.62 Allowed 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.634 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.431 HG21 ' CB ' ' A' ' 51' ' ' ASP . 5.2 mm -104.22 150.7 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.61 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 mp -99.04 156.78 16.75 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.556 -0.858 . . . . 0.0 112.359 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.686 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 6.4 mp0 -41.38 153.71 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.685 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.25 -4.62 60.54 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.004 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.431 ' CB ' HG21 ' A' ' 47' ' ' ILE . 23.8 t0 -90.82 142.27 27.94 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.591 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.438 ' C ' HG13 ' A' ' 53' ' ' VAL . 6.5 mtpm? -81.93 145.57 30.24 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.543 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.583 ' CG2' HD12 ' A' ' 67' ' ' ILE . 17.5 m -148.64 166.56 4.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.42 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.595 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 1.9 m-20 -92.17 123.83 35.81 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.835 -1.146 . . . . 0.0 108.124 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 9' ' ' LEU . 56.8 t -104.32 126.49 59.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.783 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -99.83 114.54 27.79 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.637 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.73 145.27 24.72 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.134 -1.027 . . . . 0.0 111.024 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 60' ' ' TYR . 4.5 p -86.93 128.1 57.26 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.079 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.88 -1.64 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.348 1.365 . . . . 0.0 111.378 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 58' ' ' SER . 78.6 m-85 -109.05 -16.84 14.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.881 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.61 ' C ' ' H ' ' A' ' 63' ' ' THR . 13.0 m-20 -145.11 84.0 1.7 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt -71.7 23.25 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.61 ' H ' ' C ' ' A' ' 61' ' ' ASP . 6.7 m -116.37 -5.73 11.78 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.622 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 65' ' ' GLY . 1.7 tmt_? -148.68 144.88 27.42 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.728 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.473 ' N ' ' HG2' ' A' ' 64' ' ' ARG . . . -138.28 -150.75 5.69 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.463 HH11 ' HG2' ' A' ' 66' ' ' ARG . 10.5 ptt-85 -165.59 141.45 5.19 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.855 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.583 HD12 ' CG2' ' A' ' 53' ' ' VAL . 20.2 mm -87.44 117.87 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 119.846 -0.741 . . . . 0.0 109.802 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.633 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 25.6 p -125.44 6.88 7.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.863 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -169.92 110.74 0.43 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.231 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.538 ' CG ' ' N ' ' A' ' 71' ' ' LYS . 22.6 ttp85 -68.5 161.56 27.54 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.654 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.538 ' N ' ' CG ' ' A' ' 70' ' ' ARG . 23.2 tttp . . . . . 0 C--N 1.307 -1.252 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.569 HG12 ' HD3' ' A' ' 59' ' ' PRO . 4.0 m . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.892 0.377 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 7' ' ' ILE . 11.7 mt -127.12 103.06 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.38 115.14 11.27 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.446 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 mt -141.88 143.18 33.2 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -86.25 141.49 29.25 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.476 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.08 149.65 21.68 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.228 -1.463 . . . . 0.0 109.873 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.46 ' C ' HG13 ' A' ' 24' ' ' VAL . 98.8 m -93.91 130.01 40.14 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.459 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 51' ' ' ASP . 3.8 t -59.99 127.12 18.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.277 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -99.47 -32.45 11.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.943 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -160.38 157.78 28.42 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.614 -1.234 . . . . 0.0 111.818 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.63 118.7 35.94 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.785 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.8 mt -106.2 147.73 35.37 Favored Pre-proline 0 N--CA 1.491 1.582 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.399 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.74 171.18 4.9 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.611 1.54 . . . . 0.0 111.929 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.6 OUTLIER 67.58 28.95 7.32 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.805 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 59.59 60.55 2.22 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.168 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.774 ' SD ' ' CD2' ' A' ' 35' ' ' HIS . 46.7 mtm -152.4 164.51 37.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.334 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.54 165.18 31.29 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.722 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' HG2' ' CG ' ' A' ' 31' ' ' GLU . 14.3 ttmt -99.04 137.18 37.93 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.224 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.46 HG13 ' C ' ' A' ' 12' ' ' THR . 46.9 t -130.93 145.13 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.64 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.459 ' HZ3' ' HG3' ' A' ' 25' ' ' LYS . 9.0 mtmm -111.49 120.76 43.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.563 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.919 ' H ' HD12 ' A' ' 26' ' ' LEU . 3.9 mp -74.41 168.31 19.95 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.03 -29.59 70.39 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.0 -11.05 16.31 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.641 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.29 -11.52 65.36 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.735 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -78.38 167.69 20.95 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.524 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.408 ' CG ' ' HG2' ' A' ' 23' ' ' LYS . 24.1 tt0 -127.42 142.69 51.35 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.155 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.558 HG22 ' N ' ' A' ' 33' ' ' LEU . 77.0 mt -143.69 160.91 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.246 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.558 ' N ' HG22 ' A' ' 32' ' ' ILE . 6.1 mp -90.35 141.8 28.36 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.151 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.4 ' SG ' HG13 ' A' ' 55' ' ' VAL . 4.7 m -138.7 139.81 38.54 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.384 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.774 ' CD2' ' SD ' ' A' ' 21' ' ' MET . 4.3 m80 -104.15 168.81 8.87 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.321 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.527 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 57.8 mt -92.78 152.09 3.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.772 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.42 ' O ' HG22 ' A' ' 36' ' ' ILE . 3.5 m -104.08 -166.69 1.28 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.63 -16.82 74.67 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.468 -1.348 . . . . 0.0 111.252 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.486 ' C ' ' N ' ' A' ' 41' ' ' ARG . 30.0 mttp -70.89 -63.22 1.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.658 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.653 ' H ' HD12 ' A' ' 40' ' ' LEU . 4.5 mp -52.84 -20.27 3.14 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.679 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.486 ' N ' ' C ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.91 -36.95 62.18 Favored 'General case' 0 C--N 1.271 -2.848 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.898 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 39' ' ' LYS . 92.3 mtp -90.32 -21.53 21.99 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.637 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.503 ' ND2' HG13 ' A' ' 45' ' ' ILE . 12.9 t30 -83.5 -37.76 22.67 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.316 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.9 t80 42.76 54.72 4.54 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.687 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.503 HG13 ' ND2' ' A' ' 43' ' ' ASN . 5.6 mm -96.35 159.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.216 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 46' ' ' ARG . 18.2 mmm180 -62.15 137.58 58.28 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.258 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.431 ' HA ' ' NH2' ' A' ' 70' ' ' ARG . 3.3 mt -133.19 140.27 47.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.889 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.8 mt -143.77 135.33 26.11 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.289 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -43.93 152.09 0.18 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.92 -15.11 63.56 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.731 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 13' ' ' VAL . 8.7 m-20 -76.11 146.8 39.05 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.356 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -88.23 143.55 26.97 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.702 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.503 ' CG2' HD12 ' A' ' 67' ' ' ILE . 18.5 m -146.03 169.15 6.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.671 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.527 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 0.4 OUTLIER -96.57 117.93 32.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.107 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.705 HG22 HD11 ' A' ' 67' ' ' ILE . 10.4 t -105.25 117.3 50.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.197 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -94.07 118.61 31.77 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.008 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.3 mt -88.49 139.81 30.11 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.913 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.0 m -95.01 132.56 27.89 Favored Pre-proline 0 N--CA 1.49 1.538 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.356 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.569 ' HD3' HG12 ' A' ' 6' ' ' VAL . 2.0 Cg_endo -66.96 -2.81 8.51 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.297 1.332 . . . . 0.0 110.967 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -92.11 -22.83 19.67 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.659 ' C ' ' H ' ' A' ' 63' ' ' THR . 5.5 m-20 -150.83 87.26 1.41 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.199 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mt -66.87 18.81 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.677 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.659 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.3 p -113.33 -8.88 13.45 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.43 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.434 ' NH1' ' NE2' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -140.71 151.59 44.64 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.467 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.71 -153.17 6.1 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -163.72 135.88 5.02 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.195 -1.402 . . . . 0.0 112.474 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 55' ' ' VAL . 47.8 mm -92.82 123.09 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.429 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.602 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -125.1 7.09 7.89 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.544 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.817 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -168.89 166.1 11.42 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.785 -1.166 . . . . 0.0 111.483 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 47' ' ' ILE . 2.4 ttm180 -144.04 125.87 15.22 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.171 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt . . . . . 0 N--CA 1.488 1.452 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.509 -179.912 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG12 ' HD3' ' A' ' 59' ' ' PRO . 2.0 m . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.709 0.29 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.5 mt -114.6 100.93 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.109 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -78.87 114.59 17.93 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.398 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 9' ' ' LEU . 12.2 mt -134.32 153.37 51.92 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.383 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.49 142.1 28.61 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.704 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.03 -178.4 18.08 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.416 ' N ' HG13 ' A' ' 24' ' ' VAL . 13.7 m -137.86 125.8 22.68 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.476 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.412 ' HA ' HG22 ' A' ' 24' ' ' VAL . 6.1 t -59.79 123.94 13.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.527 -1.269 . . . . 0.0 110.534 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -105.51 -29.3 10.27 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.984 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -156.99 149.11 22.91 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.879 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.28 131.67 35.96 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -122.29 152.74 61.24 Favored Pre-proline 0 N--CA 1.492 1.626 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.571 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.29 -176.44 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.031 1.154 . . . . 0.0 110.888 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 3.2 m-20 55.52 40.93 31.23 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.51 49.65 13.3 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.848 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.483 ' HG3' ' CE1' ' A' ' 35' ' ' HIS . 28.9 mtp -140.82 168.41 19.85 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.819 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.0 165.94 29.05 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.917 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -95.3 128.58 42.25 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.109 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.416 HG13 ' N ' ' A' ' 12' ' ' THR . 39.0 t -117.65 140.23 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.647 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -105.72 122.69 46.59 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.141 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.775 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.1 mp -76.79 171.99 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.26 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -71.25 -14.5 62.25 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.444 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -75.52 -16.79 60.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.067 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.29 -15.25 33.0 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 119.767 -1.206 . . . . 0.0 111.419 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -89.5 179.24 6.1 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.115 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -137.68 149.9 46.9 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.268 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.741 HG22 ' N ' ' A' ' 33' ' ' LEU . 11.2 mm -136.99 174.73 11.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.231 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.741 ' N ' HG22 ' A' ' 32' ' ' ILE . 6.8 mp -97.01 136.5 37.49 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.577 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.535 ' SG ' HG13 ' A' ' 55' ' ' VAL . 86.1 m -132.73 152.96 51.62 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.654 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.483 ' CE1' ' HG3' ' A' ' 21' ' ' MET . 1.9 t60 -118.92 152.7 35.83 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.257 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.608 HG23 HD21 ' A' ' 40' ' ' LEU . 28.0 mt -93.99 146.68 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.995 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.5 m -97.22 136.28 37.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.37 -11.28 39.77 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.185 -1.483 . . . . 0.0 110.496 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.446 ' C ' ' N ' ' A' ' 41' ' ' ARG . 6.8 tttm -70.88 -62.22 1.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.26 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -52.72 -20.21 2.99 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.55 -1.26 . . . . 0.0 108.893 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.446 ' N ' ' C ' ' A' ' 39' ' ' LYS . 3.7 ttt180 -63.99 -53.21 53.66 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.635 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 tpp -65.5 -25.35 67.43 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.895 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -65.14 -4.48 5.03 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.739 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 t80 52.28 87.81 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.571 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.6 mt -140.29 141.88 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.722 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.407 ' H ' ' HG2' ' A' ' 46' ' ' ARG . 15.1 ptt180 -74.53 134.55 42.2 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.797 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.432 HD11 HD11 ' A' ' 40' ' ' LEU . 37.9 mt -131.18 147.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.342 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.847 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.8 pt? -159.59 148.91 18.14 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.657 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 19.3 pt-20 -63.34 152.07 39.0 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.416 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.97 -13.15 60.05 Favored Glycine 0 N--CA 1.485 1.9 0 C-N-CA 119.445 -1.36 . . . . 0.0 110.198 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.641 ' CG ' ' HE ' ' A' ' 70' ' ' ARG . 9.5 t70 -80.12 162.16 24.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.655 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.492 ' C ' HG13 ' A' ' 53' ' ' VAL . 5.9 mtpm? -91.06 152.14 20.75 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.751 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.587 HG21 HG12 ' A' ' 67' ' ' ILE . 22.3 m -154.62 167.73 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.455 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.532 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -93.72 122.41 36.15 Favored 'General case' 0 C--O 1.203 -1.351 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.27 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.535 HG13 ' SG ' ' A' ' 34' ' ' CYS . 4.1 t -104.59 121.14 56.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.419 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.85 121.2 41.65 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.606 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 mt -95.14 141.87 28.26 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.212 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.5 m -86.03 128.81 56.48 Favored Pre-proline 0 N--CA 1.493 1.677 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.592 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.653 ' HD3' HG12 ' A' ' 6' ' ' VAL . 2.2 Cg_endo -66.32 -13.38 39.65 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 121.306 1.337 . . . . 0.0 110.898 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -101.32 -10.41 20.31 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.628 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -147.1 72.45 1.26 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.771 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -70.59 23.35 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.641 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.628 ' H ' ' C ' ' A' ' 61' ' ' ASP . 9.1 m -105.5 -21.16 13.27 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.458 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -140.66 159.6 41.84 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.776 -0.77 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.18 -159.96 8.44 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.45 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 6.8 ptt180 -166.91 139.36 3.51 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 117.957 -1.497 . . . . 0.0 112.164 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.587 HG12 HG21 ' A' ' 53' ' ' VAL . 1.8 mp -93.29 126.34 45.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.563 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.469 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 4.8 p -126.77 7.04 6.74 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.888 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.843 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -166.45 142.69 4.77 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.589 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.641 ' HE ' ' CG ' ' A' ' 51' ' ' ASP . 11.0 ttt-85 -124.11 128.15 48.87 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.947 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' ARG . 16.3 mmtt . . . . . 0 N--CA 1.488 1.459 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.847 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.561 0.219 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.4 mm -100.0 107.83 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -76.09 118.41 18.81 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.431 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.6 138.17 37.64 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 10' ' ' GLU . 12.3 mp0 -88.47 140.65 29.25 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.66 172.24 28.88 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.089 -1.529 . . . . 0.0 110.201 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 m -115.67 129.68 56.58 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.791 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 24' ' ' VAL . 14.9 t -59.67 127.72 19.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.749 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 23' ' ' LYS . 37.1 t -93.98 -40.11 10.29 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.664 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -156.65 158.24 36.64 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.634 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.56 123.75 44.12 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.5 mt -119.29 149.51 47.54 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.461 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 2.3 Cg_endo -59.01 -179.89 0.18 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.289 1.326 . . . . 0.0 111.104 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 6.0 t30 73.58 18.62 3.5 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.61 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 61.66 42.95 10.33 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.575 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.8 mtp -142.3 174.75 10.33 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.827 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.651 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.52 166.19 27.44 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.372 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' SER . 46.2 tttm -99.14 130.68 45.47 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.55 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 13' ' ' VAL . 95.2 t -119.85 150.46 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.336 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -124.18 112.14 16.73 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.412 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.683 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.7 mp -70.11 138.27 51.83 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.053 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.89 -15.5 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.276 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.543 ' N ' ' C ' ' A' ' 26' ' ' LEU . 18.0 m120 -65.09 -16.27 63.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.243 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.92 -11.21 52.58 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.906 -1.14 . . . . 0.0 111.354 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -98.04 172.02 7.88 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.524 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -125.49 157.94 35.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.59 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 33' ' ' LEU . 34.0 mt -152.01 156.89 5.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.171 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.539 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 7.4 mp -93.45 136.94 33.23 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.228 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' ' CG1' ' A' ' 55' ' ' VAL . 82.8 m -132.78 151.22 52.05 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.289 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -118.65 160.18 22.28 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.0 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.515 HG23 HD13 ' A' ' 40' ' ' LEU . 5.7 mt -91.49 140.67 15.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.324 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.44 ' O ' HG22 ' A' ' 36' ' ' ILE . 2.8 m -85.72 -171.56 3.66 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.011 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.13 -6.85 89.11 Favored Glycine 0 N--CA 1.487 2.039 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.208 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.68 -62.04 1.72 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.246 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.515 HD13 HG23 ' A' ' 36' ' ' ILE . 1.5 mp -56.29 -20.76 20.2 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.021 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -74.88 -38.16 61.97 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.327 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.6 tpp -71.6 -29.32 64.56 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.11 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.416 ' CB ' HD11 ' A' ' 45' ' ' ILE . 7.9 m-20 -77.04 -38.74 52.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.345 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.26 77.79 0.32 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.223 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.731 HG22 ' H ' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -124.68 -150.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.768 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.731 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -149.57 98.23 2.74 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.638 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.544 ' C ' HD12 ' A' ' 48' ' ' LEU . 4.2 mp -92.69 121.89 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.832 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.2 mp -96.19 136.89 36.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.942 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -42.46 152.66 0.09 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.248 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.24 -14.41 64.48 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -81.38 143.56 32.08 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.483 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.479 ' C ' HG13 ' A' ' 53' ' ' VAL . 37.3 mtmt -80.41 149.99 29.95 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.732 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.479 HG13 ' C ' ' A' ' 52' ' ' LYS . 26.9 m -152.06 168.4 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.798 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.552 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.9 OUTLIER -101.97 117.86 35.71 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.506 ' CG1' ' SG ' ' A' ' 34' ' ' CYS . 24.3 t -104.39 123.98 58.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.436 -0.906 . . . . 0.0 113.182 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -95.55 114.31 26.06 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.99 147.63 24.19 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.577 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 m -91.97 132.51 32.52 Favored Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.056 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.94 -18.56 64.25 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 121.426 1.417 . . . . 0.0 111.712 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.09 -11.45 24.38 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.397 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.0 t70 -142.32 78.53 1.63 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.096 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -71.7 23.93 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.413 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.614 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -115.54 -23.82 8.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.08 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.01 151.73 48.19 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.622 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 35' ' ' HIS . . . -144.05 -159.36 7.98 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -166.65 146.16 5.67 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.12 -1.432 . . . . 0.0 112.584 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.598 HD12 ' N ' ' A' ' 67' ' ' ILE . 1.8 mp -93.44 126.19 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.796 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.628 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 7.7 p -126.49 6.71 6.93 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.478 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.796 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -171.73 110.47 0.29 Allowed 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.102 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 162.22 28.77 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.379 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.631 HG22 ' H ' ' A' ' 7' ' ' ILE . 3.9 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 120.74 0.305 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.631 ' H ' HG22 ' A' ' 6' ' ' VAL . 4.5 mp -103.94 146.66 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.27 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -122.46 127.85 50.13 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.454 HD12 ' CD1' ' A' ' 57' ' ' LEU . 6.4 mt -144.56 156.02 43.94 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.262 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.519 ' OE2' ' NZ ' ' A' ' 71' ' ' LYS . 39.4 mt-10 -90.56 141.87 28.33 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.609 -0.836 . . . . 0.0 111.25 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.11 158.88 27.91 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.544 ' C ' HG13 ' A' ' 24' ' ' VAL . 29.1 m -102.49 132.84 48.28 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.482 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.9 t -68.51 127.13 29.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 118.727 -1.189 . . . . 0.0 110.656 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -98.04 -39.0 9.14 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.588 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -153.56 145.15 23.29 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.092 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.74 110.58 22.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mt -100.14 145.7 30.67 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.15 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.3 Cg_endo -61.92 172.42 3.9 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.242 1.295 . . . . 0.0 111.459 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER 76.0 13.79 2.67 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.767 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 72.49 50.15 0.19 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.032 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.466 ' HB3' ' HE2' ' A' ' 21' ' ' MET . 9.5 mtp -144.18 140.62 29.44 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.114 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.761 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 3.5 m-85 -133.19 166.0 23.47 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.224 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 14' ' ' SER . 78.1 tttt -112.63 111.93 23.09 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.7 HG21 ' SG ' ' A' ' 34' ' ' CYS . 16.7 t -107.38 152.11 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 119.472 -0.891 . . . . 0.0 112.774 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.78 117.24 22.26 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.592 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.464 ' C ' ' N ' ' A' ' 28' ' ' ASN . 2.9 mp -77.0 136.48 38.71 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.855 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -45.91 -19.01 0.05 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.578 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.464 ' N ' ' C ' ' A' ' 26' ' ' LEU . 12.6 m-20 -69.32 -15.9 63.43 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.865 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.04 -12.57 34.31 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.022 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -84.17 163.81 19.53 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.505 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -131.76 144.49 50.99 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.16 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.503 HD13 ' CD2' ' A' ' 57' ' ' LEU . 68.0 mt -145.59 148.87 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.575 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 6.1 mp -84.88 125.15 32.4 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.159 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.7 ' SG ' HG21 ' A' ' 24' ' ' VAL . 59.4 m -116.53 134.24 55.08 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.39 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.458 ' N ' ' HA ' ' A' ' 66' ' ' ARG . 23.3 m170 -97.79 173.54 7.05 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.451 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.761 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 12.9 mt -100.64 147.15 8.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.796 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -94.46 161.51 14.19 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.084 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.34 -34.67 25.39 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.267 -1.445 . . . . 0.0 111.28 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -65.07 -53.21 49.15 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.056 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -51.88 -22.4 3.76 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.447 -1.301 . . . . 0.0 110.502 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.52 ' HE ' ' HA ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.06 -42.1 63.43 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 118.043 -1.463 . . . . 0.0 107.739 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.5 tpp -54.17 -29.25 44.9 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.389 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.65 ' C ' ' CD2' ' A' ' 44' ' ' PHE . 60.3 m-80 -93.25 2.84 56.45 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.65 ' CD2' ' C ' ' A' ' 43' ' ' ASN . 2.8 p90 40.8 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.0 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mm -119.9 102.59 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.578 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -70.09 115.8 9.72 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.2 mt -108.55 110.25 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.589 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mt -97.11 135.57 38.89 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.04 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 1.4 pm0 -46.27 152.38 0.43 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.941 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.61 60.58 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.147 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -91.96 156.37 17.49 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.321 -0.951 . . . . 0.0 110.769 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.51 143.66 27.62 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.547 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.453 ' CG2' HD12 ' A' ' 67' ' ' ILE . 12.3 m -146.57 161.27 9.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.571 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.9 OUTLIER -91.75 120.89 32.89 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.915 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG13 ' SG ' ' A' ' 34' ' ' CYS . 93.5 t -104.11 121.11 55.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.211 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -90.57 123.02 33.89 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.466 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.503 ' CD2' HD13 ' A' ' 32' ' ' ILE . 6.1 mt -97.3 140.12 32.24 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.771 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 60' ' ' TYR . 4.7 p -92.84 129.69 39.12 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.538 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -57.85 -2.46 0.78 Allowed 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 121.271 1.314 . . . . 0.0 111.668 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 58' ' ' SER . 27.3 t80 -100.32 -13.07 18.96 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.637 ' C ' ' H ' ' A' ' 63' ' ' THR . 26.6 m-20 -149.59 87.28 1.49 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.544 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 62' ' ' LEU . 2.0 mp -70.66 23.69 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.46 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.637 ' H ' ' C ' ' A' ' 61' ' ' ASP . 39.5 m -135.77 3.49 2.98 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.282 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -141.31 135.08 30.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.082 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.13 -147.78 4.97 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.465 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.458 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 11.9 ptp180 -165.89 151.46 8.91 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.302 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.453 HD12 ' CG2' ' A' ' 53' ' ' VAL . 17.3 mm -93.37 122.36 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.94 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.62 ' C ' ' CG ' ' A' ' 69' ' ' TRP . 0.2 OUTLIER -127.6 7.59 6.31 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.944 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.913 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -176.55 111.45 0.09 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.432 -1.307 . . . . 0.0 111.844 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -76.28 126.82 31.68 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.604 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.519 ' NZ ' ' OE2' ' A' ' 10' ' ' GLU . 12.5 tptt . . . . . 0 C--N 1.303 -1.434 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.962 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.445 HG21 ' OE2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.885 0.374 . . . . 0.0 111.38 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.2 mm -101.78 101.81 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.892 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -83.2 119.36 24.45 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.566 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 9' ' ' LEU . 13.0 mt -133.87 157.29 46.34 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.454 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -92.87 144.24 25.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.23 162.9 30.82 Favored Glycine 0 N--CA 1.483 1.813 0 C-N-CA 118.943 -1.599 . . . . 0.0 109.939 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 m -113.49 130.73 56.27 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.074 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.483 ' HA ' HG22 ' A' ' 24' ' ' VAL . 25.0 t -65.14 116.65 4.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 118.533 -1.267 . . . . 0.0 111.096 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.0 m -97.81 -33.45 11.26 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.752 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -141.73 157.87 44.51 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.67 117.02 24.8 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.083 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' MET . 22.7 mt -98.12 147.77 33.55 Favored Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.036 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.7 Cg_endo -60.38 152.23 68.7 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.417 1.411 . . . . 0.0 111.517 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER 79.56 46.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.137 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.43 58.07 5.81 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.596 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 17' ' ' LEU . 21.1 mtm -144.46 142.4 30.25 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.335 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.655 ' N ' ' CD2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -153.02 166.02 33.75 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.612 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -106.7 142.06 36.95 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.286 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 13' ' ' VAL . 14.0 t -133.31 132.62 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.831 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 2.0 pttm -99.84 129.47 45.94 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.038 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.547 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.5 mp -86.13 177.1 7.65 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.043 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -73.34 -31.2 63.83 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.501 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -62.78 -10.79 14.22 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.486 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.41 -10.2 63.08 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.05 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.475 ' O ' HD12 ' A' ' 26' ' ' LEU . 64.1 m80 -84.98 156.77 21.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.471 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -116.17 148.55 40.25 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.599 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.697 HD13 HD21 ' A' ' 57' ' ' LEU . 78.5 mt -141.09 149.68 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 33' ' ' LEU . 5.3 mp -81.53 154.74 26.1 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.667 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.427 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . 39.9 m -145.54 154.31 42.05 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.449 -1.301 . . . . 0.0 111.546 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.441 ' H ' ' HA ' ' A' ' 66' ' ' ARG . 1.9 t60 -127.76 143.88 51.11 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.386 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.592 HG23 HD21 ' A' ' 40' ' ' LEU . 5.5 mt -70.5 135.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.085 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.91 165.43 12.67 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.923 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.88 -7.26 88.77 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -74.69 -62.71 1.44 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.592 HD21 HG23 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -55.25 -20.62 11.52 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.708 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.448 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -71.57 -41.66 68.74 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.12 -1.032 . . . . 0.0 108.861 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.7 mmt -61.54 -27.08 68.36 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.181 -1.007 . . . . 0.0 109.337 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -69.33 -1.63 8.72 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.318 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.569 ' O ' ' CG ' ' A' ' 44' ' ' PHE . 11.3 t80 57.63 54.62 6.21 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.095 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.786 HG22 ' N ' ' A' ' 46' ' ' ARG . 62.1 mt -152.88 172.3 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.162 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.786 ' N ' HG22 ' A' ' 45' ' ' ILE . 5.5 ptp85 -139.85 163.56 32.32 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.906 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 47' ' ' ILE . 2.3 mp -109.41 148.95 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.058 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.2 mt -127.78 136.94 52.18 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.977 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 15.6 mt-10 -40.18 152.47 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.855 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.61 -9.38 59.16 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.432 -1.365 . . . . 0.0 110.36 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -93.03 135.66 33.99 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.581 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.631 ' CD ' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -75.51 149.01 38.52 Favored 'General case' 0 CA--C 1.486 -1.511 0 C-N-CA 118.764 -1.174 . . . . 0.0 110.577 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.646 HG21 HD12 ' A' ' 67' ' ' ILE . 11.4 m -151.93 165.86 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.738 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.542 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -98.22 125.18 43.17 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.447 HG21 HG11 ' A' ' 24' ' ' VAL . 94.0 t -102.88 128.13 56.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.86 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.612 ' OE2' ' NH1' ' A' ' 66' ' ' ARG . 6.1 tt0 -100.33 110.28 22.5 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.395 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.697 HD21 HD13 ' A' ' 32' ' ' ILE . 17.0 mt -89.55 148.92 23.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.599 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.2 p -99.61 142.04 23.89 Favored Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 119.364 -0.934 . . . . 0.0 112.087 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.21 -3.68 6.57 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.732 1.621 . . . . 0.0 111.559 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -87.96 -23.36 23.88 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.051 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.665 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.4 OUTLIER -166.65 96.09 0.54 Allowed 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.309 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -67.69 18.51 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.563 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.665 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -103.63 -9.77 18.93 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.215 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -137.78 144.73 41.73 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.786 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.31 -152.27 5.67 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.308 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.612 ' NH1' ' OE2' ' A' ' 56' ' ' GLU . 4.1 ptt180 -162.42 152.03 15.94 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.925 -1.11 . . . . 0.0 111.469 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.646 HD12 HG21 ' A' ' 53' ' ' VAL . 33.5 mm -92.75 121.21 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.625 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 1.4 p -126.98 6.95 6.6 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.701 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.866 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.19 111.7 0.72 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.068 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.515 ' C ' ' CD ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -102.57 159.9 15.04 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.972 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.422 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 3.2 tptt . . . . . 0 N--CA 1.484 1.231 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.396 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.737 0.304 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mm -98.08 104.22 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.46 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -73.35 112.64 9.6 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.988 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mt -137.13 136.15 38.02 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.352 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.406 ' O ' HD23 ' A' ' 26' ' ' LEU . 28.5 tt0 -91.47 140.96 29.25 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.515 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.52 -166.98 11.02 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.038 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.544 ' N ' HG13 ' A' ' 24' ' ' VAL . 51.2 m -137.44 128.77 28.02 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.517 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.71 130.44 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.485 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.1 t -120.89 -32.42 3.98 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.13 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.22 155.5 46.03 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.573 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.13 126.68 39.51 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.958 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.59 144.26 31.5 Favored Pre-proline 0 N--CA 1.494 1.749 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.354 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 3.3 Cg_endo -64.92 164.41 24.79 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 121.539 1.492 . . . . 0.0 111.57 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.484 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 0.9 OUTLIER 76.2 34.12 0.53 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.257 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.82 61.1 2.51 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.289 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.596 ' SD ' ' CE1' ' A' ' 35' ' ' HIS . 5.2 ptm -162.52 174.78 12.2 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.597 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.764 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.25 161.5 30.79 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.696 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -84.6 138.55 32.65 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.551 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.544 HG13 ' N ' ' A' ' 12' ' ' THR . 2.0 t -127.34 131.65 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.186 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -97.13 123.65 40.95 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.95 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' GLY . 42.0 mt -74.25 155.93 37.75 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.402 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 28' ' ' ASN . 12.3 pt-20 -47.26 -40.25 16.21 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.944 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.521 ' HB3' ' ND1' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -67.53 -16.62 64.29 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.456 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 26' ' ' LEU . . . 108.89 -1.77 31.78 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.333 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.521 ' ND1' ' HB3' ' A' ' 28' ' ' ASN . 60.5 m80 -75.58 138.28 41.35 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.564 -1.254 . . . . 0.0 111.567 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.44 138.0 38.1 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.313 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.48 ' C ' HD12 ' A' ' 33' ' ' LEU . 22.0 mt -146.65 154.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.963 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 33' ' ' LEU . 7.1 mp -90.9 133.69 35.05 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.352 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.441 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 1.1 p -133.77 144.71 49.21 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.013 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.596 ' CE1' ' SD ' ' A' ' 21' ' ' MET . 13.6 m-70 -108.56 178.23 4.55 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.875 HG23 HD21 ' A' ' 40' ' ' LEU . 49.5 mt -112.25 156.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.782 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.435 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 4.6 m -107.03 155.72 19.52 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.519 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.26 -6.45 87.75 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.751 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -74.35 -59.12 2.87 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.068 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.875 HD21 HG23 ' A' ' 36' ' ' ILE . 1.9 pp -54.24 -20.55 7.16 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.539 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -70.98 -49.2 47.9 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.409 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.47 ' C ' ' H ' ' A' ' 44' ' ' PHE . 8.8 ttm -55.58 -34.99 65.29 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.585 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.1 13.12 0.33 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.47 ' H ' ' C ' ' A' ' 42' ' ' MET . 0.1 OUTLIER 56.69 34.78 25.14 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.614 -0.835 . . . . 0.0 111.296 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.634 HG22 ' N ' ' A' ' 46' ' ' ARG . 28.8 mm -98.21 170.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.251 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.634 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -149.18 154.07 38.6 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.594 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 47' ' ' ILE . 29.4 mt -132.21 144.37 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.712 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.2 mt -132.48 171.46 13.74 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.495 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 152.36 44.31 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.224 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.17 -13.96 30.09 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.229 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 0.9 OUTLIER -80.57 135.61 36.11 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.576 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.493 ' C ' HG13 ' A' ' 53' ' ' VAL . 56.9 mttt -75.24 150.19 38.66 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.029 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.765 HG21 HD11 ' A' ' 67' ' ' ILE . 29.1 m -151.93 166.29 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.94 -1.104 . . . . 0.0 112.429 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.533 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -96.6 121.11 38.07 Favored 'General case' 0 C--O 1.203 -1.382 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.714 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -104.63 123.31 58.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.345 -0.942 . . . . 0.0 113.07 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -101.1 106.4 17.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.747 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.0 mt -81.14 147.31 30.12 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.675 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 p -98.16 138.08 20.87 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.485 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.4 -9.71 21.2 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.735 1.623 . . . . 0.0 112.074 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -90.53 -22.44 21.31 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.405 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.653 ' C ' ' H ' ' A' ' 63' ' ' THR . 15.5 m-20 -153.53 89.29 1.33 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.375 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mt -69.12 20.42 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.474 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.653 ' H ' ' C ' ' A' ' 61' ' ' ASP . 59.0 m -108.7 -9.84 15.22 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.513 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -138.46 148.26 44.18 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.58 -161.92 8.97 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.526 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 8.3 ptt180 -156.48 131.35 9.02 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.61 -1.236 . . . . 0.0 111.93 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.765 HD11 HG21 ' A' ' 53' ' ' VAL . 66.3 mt -95.44 129.21 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.59 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -127.97 7.32 6.09 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.49 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.781 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -168.2 111.87 0.61 Allowed 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.75 -1.18 . . . . 0.0 112.209 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -73.45 151.93 40.93 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.483 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 tttt . . . . . 0 N--CA 1.488 1.435 0 C-N-CA 118.916 -1.113 . . . . 0.0 110.927 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.531 HG12 ' HD3' ' A' ' 59' ' ' PRO . 2.6 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.585 0.231 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.646 ' HB ' HD12 ' A' ' 57' ' ' LEU . 51.7 mt -95.95 101.94 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.258 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.7 114.12 9.46 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 55' ' ' VAL . 7.4 mt -131.0 150.99 51.88 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.456 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -97.75 144.26 27.55 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.908 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.54 -175.48 23.36 Favored Glycine 0 N--CA 1.483 1.767 0 C-N-CA 118.885 -1.626 . . . . 0.0 110.335 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.23 131.21 45.42 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.205 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.432 ' CG1' ' HA ' ' A' ' 49' ' ' GLU . 87.4 t -63.52 116.18 3.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 118.434 -1.306 . . . . 0.0 110.187 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 p -95.46 -37.52 10.88 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.749 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -146.19 151.88 38.33 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 118.558 -1.257 . . . . 0.0 111.792 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.443 ' HB2' ' CD ' ' A' ' 49' ' ' GLU . . . -100.92 130.57 46.94 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.494 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.6 mt -121.91 151.07 57.35 Favored Pre-proline 0 N--CA 1.488 1.469 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 20' ' ' ALA . 1.9 Cg_endo -61.13 -156.5 0.02 OUTLIER 'Trans proline' 0 C--O 1.204 -1.182 0 C-N-CA 121.452 1.435 . . . . 0.0 111.007 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.63 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 25.4 m120 46.8 12.72 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.87 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 71.09 42.94 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.914 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.4 170.48 15.94 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.252 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.677 ' N ' ' CD2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.73 165.84 29.75 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.443 -0.903 . . . . 0.0 112.216 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -97.06 136.89 36.97 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.887 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.1 t -129.68 143.56 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.163 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -102.88 118.87 37.77 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.197 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.944 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.2 mp -74.19 168.88 18.72 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.793 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.62 -19.42 65.22 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.022 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -68.44 -16.24 63.83 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.445 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.44 -10.85 50.51 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -91.31 177.55 6.21 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.168 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -132.8 140.19 47.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.904 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.761 HG22 ' N ' ' A' ' 33' ' ' LEU . 8.4 mm -134.58 173.27 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.386 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.761 ' N ' HG22 ' A' ' 32' ' ' ILE . 20.2 mt -90.59 145.35 24.93 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.568 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.436 ' SG ' HG13 ' A' ' 55' ' ' VAL . 90.8 m -134.91 152.26 51.59 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.188 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.52 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 33.2 t-80 -128.0 147.51 50.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.156 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.617 HG22 ' N ' ' A' ' 37' ' ' SER . 28.3 mt -86.83 166.84 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.492 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.617 ' N ' HG22 ' A' ' 36' ' ' ILE . 6.4 p -154.07 159.12 41.39 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.354 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.31 -4.9 0.09 OUTLIER Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.489 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.579 ' H ' ' C ' ' A' ' 37' ' ' SER . 0.7 OUTLIER -62.46 -61.17 2.62 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.472 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.574 HD21 ' HA ' ' A' ' 68' ' ' THR . 10.2 mt -51.56 -21.51 2.57 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.441 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.405 ' N ' ' C ' ' A' ' 39' ' ' LYS . 2.3 mmm180 -83.44 -25.79 30.9 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.333 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' LYS . 13.7 ttp -89.79 -21.39 22.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.262 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -93.23 3.87 54.94 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.788 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 52.06 66.49 1.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.725 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.621 ' CG2' ' N ' ' A' ' 46' ' ' ARG . 26.5 mt -146.22 165.58 8.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.105 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.621 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 50.3 ttm-85 -133.21 140.85 47.76 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.398 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.506 HD12 HD13 ' A' ' 40' ' ' LEU . 58.9 mt -132.44 149.04 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.263 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.839 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.9 pt? -142.97 -176.82 5.05 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.72 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 23.3 mt-10 -75.42 152.24 38.01 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.259 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.51 -14.07 37.55 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.074 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.15 143.37 26.75 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.859 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.484 ' C ' HG13 ' A' ' 53' ' ' VAL . 2.9 tttt -75.63 154.33 36.69 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.711 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.752 HG21 ' CD1' ' A' ' 67' ' ' ILE . 31.6 m -154.8 171.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.482 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.555 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -103.36 123.92 47.72 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.436 HG13 ' SG ' ' A' ' 34' ' ' CYS . 3.1 t -103.36 134.21 45.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.648 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.81 111.63 22.92 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.118 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.646 HD12 ' HB ' ' A' ' 7' ' ' ILE . 8.8 mt -77.8 121.58 24.27 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.672 -1.211 . . . . 0.0 108.981 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 60' ' ' TYR . 1.5 m -80.49 130.04 66.55 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.941 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.531 ' HD3' HG12 ' A' ' 6' ' ' VAL . 2.5 Cg_endo -61.05 -1.25 1.59 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.339 1.359 . . . . 0.0 110.646 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 58' ' ' SER . 5.7 m-30 -84.6 -21.56 30.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.608 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.4 t0 -169.82 100.64 0.31 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.046 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mt -69.25 19.31 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.876 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.608 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.1 p -102.71 -12.19 17.84 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.264 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.477 ' HG2' ' N ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -148.93 144.57 26.92 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.923 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.477 ' N ' ' HG2' ' A' ' 64' ' ' ARG . . . -120.7 -156.57 9.89 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.46 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 9.1 ptm180 -157.41 147.03 20.28 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.502 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.752 ' CD1' HG21 ' A' ' 53' ' ' VAL . 1.9 mm -94.04 118.02 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.212 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.624 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 72.2 p -127.17 7.79 6.57 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.24 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.846 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -173.66 118.49 0.28 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 118.621 -1.232 . . . . 0.0 112.403 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -68.68 161.77 27.49 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.881 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.2 tttp . . . . . 0 C--N 1.302 -1.474 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.581 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.59 HG22 ' H ' ' A' ' 7' ' ' ILE . 4.7 p . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.59 ' H ' HG22 ' A' ' 6' ' ' VAL . 24.5 mm -104.02 101.78 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.561 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 4.9 pt-20 -103.71 118.83 37.63 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.9 mt -132.25 161.25 33.92 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.431 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -87.96 135.37 33.44 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.798 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.83 154.6 26.04 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -104.9 127.87 52.9 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.856 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 22' ' ' PHE . 19.4 t -59.01 127.03 17.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 118.67 -1.212 . . . . 0.0 110.552 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.35 -39.48 8.38 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.526 -0.87 . . . . 0.0 113.013 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.09 136.27 17.57 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.231 -1.388 . . . . 0.0 112.17 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.89 113.55 21.04 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.58 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 21' ' ' MET . 64.4 mt -100.11 150.07 36.57 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.107 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 3.3 Cg_exo -56.78 160.23 12.52 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.219 1.28 . . . . 0.0 111.478 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.9 t-20 76.85 28.04 0.7 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.641 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.484 ' O ' ' CD2' ' A' ' 35' ' ' HIS . . . 55.42 61.94 2.66 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.544 -0.863 . . . . 0.0 111.928 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.503 ' HG3' ' N ' ' A' ' 22' ' ' PHE . 4.6 ttt -153.59 150.81 29.04 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.503 ' N ' ' HG3' ' A' ' 21' ' ' MET . 0.0 OUTLIER -145.38 164.85 30.21 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.298 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -99.84 113.98 26.87 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.389 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.522 HG11 HG21 ' A' ' 55' ' ' VAL . 70.8 t -94.2 150.35 4.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.125 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -121.47 111.15 16.92 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.428 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.03 ' H ' HD12 ' A' ' 26' ' ' LEU . 3.6 mp -71.25 162.88 28.71 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.139 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.65 -18.07 64.61 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.588 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.05 -16.44 63.46 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.807 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.93 -5.86 43.07 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -102.99 178.71 4.48 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.929 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 5.4 pm0 -138.71 158.72 43.71 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.994 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.701 HG22 ' N ' ' A' ' 33' ' ' LEU . 81.8 mt -141.76 167.6 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.732 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.701 ' N ' HG22 ' A' ' 32' ' ' ILE . 3.6 mp -91.51 138.14 31.81 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.238 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.44 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 4.8 m -141.84 133.16 26.5 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.647 ' CG ' ' N ' ' A' ' 36' ' ' ILE . 51.9 t-80 -107.49 176.85 5.02 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.713 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.651 ' CG2' ' N ' ' A' ' 37' ' ' SER . 26.0 mt -103.92 167.1 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.256 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.9 ' OG ' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -123.32 110.13 14.79 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.96 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.63 -26.02 0.12 Allowed Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.821 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -69.74 -56.35 7.41 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.942 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -51.32 -21.78 2.42 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.779 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' NH2' HG21 ' A' ' 36' ' ' ILE . 5.1 ttm-85 -68.46 -47.36 67.34 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.195 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.424 ' C ' ' H ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -52.78 -31.85 40.66 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.489 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.642 ' C ' ' CD2' ' A' ' 44' ' ' PHE . 2.5 t-20 -79.33 19.48 0.59 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.474 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.642 ' CD2' ' C ' ' A' ' 43' ' ' ASN . 6.6 p90 38.88 87.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.714 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.4 mt -140.92 88.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.77 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HG3' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -80.33 128.25 33.33 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.175 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -132.63 128.57 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.669 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' GLU . 83.1 mt -108.26 150.82 26.79 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.823 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 48' ' ' LEU . 1.7 tm-20 -38.48 151.44 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.771 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.74 -11.95 50.28 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.241 -1.457 . . . . 0.0 109.861 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -82.09 133.9 35.3 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.696 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.477 ' C ' HG13 ' A' ' 53' ' ' VAL . 56.5 mttp -77.83 143.68 37.66 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.078 -1.049 . . . . 0.0 111.221 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.689 ' CG2' HD12 ' A' ' 67' ' ' ILE . 35.1 m -149.87 169.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.745 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 41.2 m-20 -91.74 124.66 36.04 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.522 HG21 HG11 ' A' ' 24' ' ' VAL . 40.0 t -103.65 119.17 51.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.679 -0.808 . . . . 0.0 112.529 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.421 ' CG ' HG21 ' A' ' 6' ' ' VAL . 79.4 tt0 -91.78 113.28 25.5 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.963 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.428 ' CD2' HD13 ' A' ' 32' ' ' ILE . 10.2 mt -101.65 148.77 24.86 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.238 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 m -83.12 121.21 77.03 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.688 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -59.95 -16.45 38.76 Favored 'Trans proline' 0 C--O 1.217 -0.563 0 C-N-CA 121.254 1.302 . . . . 0.0 111.846 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -106.2 -10.88 16.25 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.485 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.587 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -138.75 77.44 1.62 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.884 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.0 mt -74.29 27.77 0.08 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.091 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.587 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.9 OUTLIER -102.4 -29.69 11.48 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.976 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -139.29 160.51 39.65 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.047 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.17 -157.41 7.18 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.41 140.06 5.95 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.249 -1.38 . . . . 0.0 112.357 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.689 HD12 ' CG2' ' A' ' 53' ' ' VAL . 39.0 mm -92.32 108.62 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.727 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.9 HG22 ' OG ' ' A' ' 37' ' ' SER . 21.5 p -128.84 8.1 5.7 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.837 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.827 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -164.47 120.39 1.52 Allowed 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 118.087 -1.445 . . . . 0.0 112.782 -179.684 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.36 152.18 36.4 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.66 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.3 tptt . . . . . 0 C--N 1.303 -1.454 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.419 -179.857 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG22 ' H ' ' A' ' 7' ' ' ILE . 3.6 p . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 62' ' ' LEU . 3.2 mt -113.85 100.62 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.842 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.24 125.01 41.52 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.735 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.3 mt -142.34 151.89 42.38 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.555 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 25.5 mp0 -86.33 138.95 31.42 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.159 -1.017 . . . . 0.0 109.971 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.12 -177.07 15.96 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 119.127 -1.511 . . . . 0.0 109.564 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.51 ' C ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -128.81 124.33 35.13 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.446 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 50' ' ' GLY . 11.3 t -59.97 132.99 25.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.0 p -110.46 -29.69 7.98 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.864 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -149.14 157.45 43.39 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.738 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.74 126.09 54.85 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.7 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.3 mt -119.74 150.33 50.18 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.22 171.7 2.99 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.293 1.329 . . . . 0.0 111.276 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 68.99 31.15 4.26 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.668 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 41' ' ' ARG . . . 55.3 52.44 11.46 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.585 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 mmm -141.02 142.24 34.25 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.874 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -143.58 157.69 44.23 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.245 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -96.66 129.2 44.1 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.219 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.51 HG13 ' C ' ' A' ' 12' ' ' THR . 14.1 t -121.42 150.47 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.528 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -126.57 128.58 47.05 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.953 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.706 HD12 HD11 ' A' ' 32' ' ' ILE . 12.4 mt -85.41 142.75 29.04 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.101 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -49.7 -26.75 4.03 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.943 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -63.8 -17.05 62.7 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.291 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.92 -0.59 38.72 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.526 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -93.23 145.2 24.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.187 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.86 141.53 37.94 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.179 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.706 HD11 HD12 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -139.85 146.78 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.943 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 6.3 mp -93.09 125.26 37.59 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.63 ' SG ' HG13 ' A' ' 55' ' ' VAL . 73.2 m -118.52 155.62 30.54 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.149 -1.02 . . . . 0.0 112.451 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -118.26 155.79 29.96 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.733 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.578 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 37.7 mt -95.04 149.84 4.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.789 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.515 ' O ' HG22 ' A' ' 36' ' ' ILE . 73.1 m -88.32 -172.76 3.91 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.007 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.88 -21.4 63.48 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.578 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.615 ' CG ' ' N ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -72.26 -55.91 6.4 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.489 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.615 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 2.4 mp -54.82 -21.69 12.05 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.445 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -72.2 -40.2 68.02 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.534 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.1 mmm -72.15 -31.46 65.98 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.759 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -74.0 -34.07 64.05 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.294 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.0 t80 40.12 61.63 1.47 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.818 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.676 HG22 ' H ' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -86.78 -165.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.158 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.676 ' H ' HG22 ' A' ' 45' ' ' ILE . 12.7 ptt85 -119.46 74.36 1.0 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 48' ' ' LEU . 4.6 mm -98.08 144.24 11.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.402 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 47' ' ' ILE . 4.4 mp -126.78 152.55 46.76 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.726 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 48' ' ' LEU . 2.9 pp20? -40.27 152.44 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.194 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 97.63 -15.05 62.54 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.26 131.91 39.55 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.262 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.479 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -77.62 146.46 36.15 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.296 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.534 ' HB ' HG23 ' A' ' 67' ' ' ILE . 35.8 m -152.45 171.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.972 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.591 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 2.0 m-80 -97.99 117.8 33.14 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.63 HG13 ' SG ' ' A' ' 34' ' ' CYS . 13.9 t -104.68 126.74 59.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.665 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.91 117.14 34.37 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.648 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.524 ' CD2' HG21 ' A' ' 32' ' ' ILE . 3.9 mt -99.27 149.16 23.4 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.907 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.36 136.13 30.35 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -59.54 -10.87 12.32 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.556 1.504 . . . . 0.0 111.715 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CD2' ' OD2' ' A' ' 61' ' ' ASP . 8.5 t80 -101.95 -14.45 17.19 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.608 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.627 ' C ' ' H ' ' A' ' 63' ' ' THR . 57.2 m-20 -144.19 79.8 1.63 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.564 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.534 ' CD2' HD12 ' A' ' 7' ' ' ILE . 5.0 mt -71.06 20.28 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.292 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.627 ' H ' ' C ' ' A' ' 61' ' ' ASP . 10.6 p -118.63 -9.68 10.19 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.298 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.501 HH21 ' HB2' ' A' ' 64' ' ' ARG . 37.3 mtp-105 -133.7 143.95 48.83 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.075 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.85 -153.48 6.25 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.597 -1.287 . . . . 0.0 109.897 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -162.68 147.5 11.95 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.504 -1.279 . . . . 0.0 112.134 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.534 HG23 ' HB ' ' A' ' 53' ' ' VAL . 20.5 mm -93.55 110.35 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.027 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.619 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 3.3 p -118.17 6.83 12.03 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.84 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -166.9 110.41 0.72 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 118.673 -1.211 . . . . 0.0 111.331 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.8 ptt-85 -76.27 136.89 39.64 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.435 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.904 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.666 HG12 ' HD3' ' A' ' 59' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.6 0.238 . . . . 0.0 110.613 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.1 100.26 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 119.167 -1.013 . . . . 0.0 109.556 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.02 112.31 20.5 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.654 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 9' ' ' LEU . 23.8 mt -137.58 149.69 46.88 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.467 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.78 144.39 25.76 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.894 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA3' HD23 ' A' ' 26' ' ' LEU . . . -145.46 -155.0 6.31 Favored Glycine 0 N--CA 1.481 1.681 0 C-N-CA 119.149 -1.501 . . . . 0.0 109.766 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 50' ' ' GLY . 31.1 m -145.24 130.62 18.68 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.026 -1.07 . . . . 0.0 111.138 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.423 ' HA ' HG22 ' A' ' 24' ' ' VAL . 11.4 t -59.6 123.12 11.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.145 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -100.4 -30.31 11.91 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.73 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -150.3 155.03 38.91 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.821 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.98 123.57 48.86 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.501 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.2 mt -121.98 151.16 57.73 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.179 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.92 -178.8 0.34 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.269 1.313 . . . . 0.0 111.544 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.608 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.6 OUTLIER 69.41 14.94 8.44 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.134 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 68.28 43.82 1.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.072 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtm -144.73 152.47 40.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.774 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -144.85 165.88 26.86 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.876 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -95.58 124.3 39.54 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.387 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 13' ' ' VAL . 78.4 t -118.52 141.25 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.956 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -118.76 113.59 21.38 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.793 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.544 HD23 ' HA3' ' A' ' 11' ' ' GLY . 26.1 mt -67.38 137.75 56.2 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.494 -0.883 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.45 -12.29 0.06 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.522 -1.271 . . . . 0.0 109.179 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.54 ' N ' ' C ' ' A' ' 26' ' ' LEU . 17.7 m120 -72.5 -17.23 61.77 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.41 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.42 0.39 35.01 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.96 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -101.22 136.3 41.29 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.969 -1.093 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.623 ' C ' HD12 ' A' ' 32' ' ' ILE . 8.1 pt-20 -109.27 132.09 54.45 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.301 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 32' ' ' ILE . 4.7 mp -141.37 165.55 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.043 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.636 ' N ' HG22 ' A' ' 32' ' ' ILE . 7.0 mp -89.28 134.32 34.1 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.329 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.519 ' CB ' HD13 ' A' ' 67' ' ' ILE . 80.0 m -128.55 148.33 50.76 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.276 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.469 ' ND1' ' O ' ' A' ' 36' ' ' ILE . 48.9 t-80 -114.81 154.97 27.62 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.273 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.65 HG23 HD21 ' A' ' 40' ' ' LEU . 51.5 mt -90.75 153.32 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.087 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 6.0 m -82.6 126.51 32.39 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.931 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.4 -12.19 0.89 Allowed Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.453 -1.356 . . . . 0.0 111.315 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -80.7 -63.01 1.5 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.257 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.65 HD21 HG23 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -59.03 -18.61 36.15 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.38 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -71.64 -40.51 69.67 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.89 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.546 ' C ' ' H ' ' A' ' 44' ' ' PHE . 7.6 mmt -61.72 -35.82 79.17 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -58.92 -0.3 0.11 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.247 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.546 ' H ' ' C ' ' A' ' 42' ' ' MET . 4.8 t80 55.21 45.11 26.53 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.309 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 46' ' ' ARG . 6.2 mm -98.55 157.49 3.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.096 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.46 ' N ' HG22 ' A' ' 45' ' ' ILE . 3.3 mtp180 -150.03 99.14 2.79 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.818 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.542 HD11 ' CG ' ' A' ' 51' ' ' ASP . 5.1 tt -87.42 149.13 4.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.576 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.904 ' N ' HD12 ' A' ' 48' ' ' LEU . 3.5 mp -83.75 135.35 34.58 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.25 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 49' ' ' GLU . 4.8 mm-40 -44.66 153.26 0.17 Allowed 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.891 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . 92.4 -15.19 62.86 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.253 -1.451 . . . . 0.0 109.628 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.542 ' CG ' HD11 ' A' ' 47' ' ' ILE . 10.2 t70 -72.79 152.95 41.32 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.046 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.472 ' C ' HG13 ' A' ' 53' ' ' VAL . 2.0 mptm? -83.98 146.65 27.88 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.745 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.473 HG21 HG12 ' A' ' 67' ' ' ILE . 24.6 m -150.34 164.62 3.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.386 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.578 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -91.83 121.52 33.52 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.507 HG13 ' SG ' ' A' ' 34' ' ' CYS . 2.3 t -105.08 123.84 59.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.517 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.13 113.32 26.47 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.31 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.43 132.75 33.89 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.956 -1.098 . . . . 0.0 110.741 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 t -85.64 121.49 73.35 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.393 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.666 ' HD3' HG12 ' A' ' 6' ' ' VAL . 3.8 Cg_exo -61.98 -9.66 15.17 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 121.074 1.183 . . . . 0.0 110.942 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -94.27 -16.94 23.14 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.615 ' C ' ' H ' ' A' ' 63' ' ' THR . 13.8 m-20 -142.99 82.33 1.76 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.942 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.9 mt -71.21 24.09 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.768 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.615 ' H ' ' C ' ' A' ' 61' ' ' ASP . 42.0 m -122.91 -7.33 8.42 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.439 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -140.17 152.05 45.73 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.449 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 66' ' ' ARG . . . -137.56 -167.44 11.06 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.676 -1.77 . . . . 0.0 108.676 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.414 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 18.1 mtt85 -155.98 131.32 9.47 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.709 -1.597 . . . . 0.0 112.899 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 67' ' ' ILE . 1.4 mp -93.32 111.89 25.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.519 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.473 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 14.3 p -126.75 7.28 6.78 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.487 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.811 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -159.57 112.11 2.15 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.665 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -74.15 141.75 45.53 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.625 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.308 -1.197 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.067 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -178.31 71.0 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -97.95 116.23 29.75 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.644 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -172.56 129.44 0.54 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.104 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.29 -165.88 1.03 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.603 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.445 HG21 ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -144.92 175.18 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.018 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.1 mm -107.69 101.9 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.285 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -81.59 115.29 20.8 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.155 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 55' ' ' VAL . 20.2 mt -132.5 164.15 27.24 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.591 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.72 146.14 25.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.12 154.77 25.76 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.002 -1.571 . . . . 0.0 109.662 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -104.98 124.72 50.01 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 51' ' ' ASP . 5.2 t -61.13 113.84 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.16 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -88.12 -31.05 19.39 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.648 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -154.4 158.1 39.51 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.463 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.595 ' H ' ' CD ' ' A' ' 15' ' ' GLU . . . -124.48 124.36 42.13 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.733 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -120.43 162.59 33.38 Favored Pre-proline 0 N--CA 1.487 1.381 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.28 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 5.9 Cg_exo -55.98 179.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.67 1.58 . . . . 0.0 111.508 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.1 t-20 74.93 17.2 2.8 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.081 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.0 50.86 9.58 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.798 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.416 ' C ' HD12 ' A' ' 17' ' ' LEU . 25.8 mtt -142.77 171.64 13.77 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.715 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.726 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.44 166.32 29.45 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.479 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -100.04 143.56 30.1 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.25 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.699 HG23 ' SG ' ' A' ' 34' ' ' CYS . 19.1 t -132.62 137.42 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.326 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 25' ' ' LYS . 8.0 ptmm? -111.42 126.93 55.47 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.393 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.694 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.5 mp -87.45 153.21 21.61 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.799 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.725 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -57.67 -17.55 15.51 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.772 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -69.23 -14.73 63.13 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.693 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.68 -11.67 53.55 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.677 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -87.78 175.48 7.83 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.015 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.612 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -137.43 149.29 46.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.316 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 33' ' ' LEU . 50.7 mt -142.86 154.06 17.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.453 ' N ' ' CG2' ' A' ' 32' ' ' ILE . 10.0 mt -86.25 147.47 26.07 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.211 -0.995 . . . . 0.0 109.231 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -139.34 147.71 41.91 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.854 -1.139 . . . . 0.0 111.393 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -119.04 155.55 31.26 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.286 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.754 HG23 HD21 ' A' ' 40' ' ' LEU . 46.8 mt -84.01 145.93 7.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.445 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 68' ' ' THR . 45.9 m -96.57 169.61 9.77 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.03 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.34 -14.09 80.79 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.335 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -75.58 -62.76 1.47 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.582 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.754 HD21 HG23 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -58.05 -19.69 33.48 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.616 -1.234 . . . . 0.0 109.086 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -42.92 70.45 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.034 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.483 ' SD ' ' O ' ' A' ' 42' ' ' MET . 4.4 tmm? -60.42 -33.68 72.85 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.696 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' HB3' HD11 ' A' ' 45' ' ' ILE . 36.5 m-20 -64.42 -17.7 64.03 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 118.769 -1.172 . . . . 0.0 109.873 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.419 ' C ' HD12 ' A' ' 45' ' ' ILE . 6.4 t80 67.7 73.67 0.31 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.067 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.635 ' CG2' ' N ' ' A' ' 46' ' ' ARG . 2.0 mp -117.85 165.86 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.337 0.589 . . . . 0.0 111.781 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.635 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 24.1 ttt180 -144.85 74.52 1.41 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.069 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 tt -77.19 149.6 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.119 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 49' ' ' GLU . 12.1 mt -120.4 139.57 52.61 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.072 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' LEU . 1.8 pm0 -38.21 148.07 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.007 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.16 -4.57 58.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.9 m-20 -98.37 139.58 33.92 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.088 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' C ' HG13 ' A' ' 53' ' ' VAL . 57.7 mttt -75.5 144.09 42.18 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.773 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.524 ' CG2' HD12 ' A' ' 67' ' ' ILE . 14.5 m -149.9 167.35 2.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.686 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.582 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -93.42 127.52 39.09 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 24' ' ' VAL . 2.9 t -104.15 129.56 56.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.438 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.445 ' OE1' HG21 ' A' ' 6' ' ' VAL . 36.5 tt0 -106.11 110.47 22.74 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.359 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.1 mt -88.01 143.17 27.24 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.065 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 60' ' ' TYR . 25.4 p -98.79 132.98 22.8 Favored Pre-proline 0 N--CA 1.492 1.658 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.118 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.4 -1.3 1.34 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.445 1.43 . . . . 0.0 111.442 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 58' ' ' SER . 5.6 t80 -81.13 -21.68 39.63 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.674 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.0 p30 179.88 105.78 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.908 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt -66.6 20.7 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.608 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.674 ' H ' ' C ' ' A' ' 61' ' ' ASP . 76.1 m -98.19 -14.4 20.38 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.044 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.423 ' NH2' ' OD1' ' A' ' 61' ' ' ASP . 17.2 mtp180 -138.83 146.61 41.47 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.197 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.57 -151.75 5.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.67 143.28 4.74 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.175 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.524 HD12 ' CG2' ' A' ' 53' ' ' VAL . 19.3 mm -93.15 119.05 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.592 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 7.2 p -126.62 7.38 6.88 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.685 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.85 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.16 111.87 0.73 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.378 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.5 ptt85 -111.36 146.28 37.4 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.255 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -44.01 154.39 0.11 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.92 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 116.347 -1.787 . . . . 0.0 110.978 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mmm . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.932 0.396 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.24 -27.02 61.68 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.948 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -42.57 -34.92 0.95 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.955 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -149.34 50.36 0.96 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.672 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -40.19 140.0 0.65 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.672 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 p -173.15 164.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.669 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.5 mt -97.73 101.38 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.222 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -94.55 108.38 20.34 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 9' ' ' LEU . 10.8 mt -132.64 148.94 52.36 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.067 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.84 144.1 27.17 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.66 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.47 179.82 25.94 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 119.069 -1.539 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.4 m -124.16 131.05 53.5 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.445 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.457 HG23 ' H ' ' A' ' 13' ' ' VAL . 1.9 t -59.73 119.08 3.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 118.576 -1.249 . . . . 0.0 110.591 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' LYS . 5.7 t -88.88 -32.24 17.85 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.165 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -151.1 156.32 40.78 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.694 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.84 107.38 18.1 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.627 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.3 mt -99.79 144.52 28.5 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.099 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.9 Cg_endo -61.01 166.68 10.15 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.255 1.304 . . . . 0.0 111.037 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 6.4 t-20 76.96 29.76 0.59 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.652 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.82 57.77 4.5 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.531 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.766 ' SD ' ' NE2' ' A' ' 35' ' ' HIS . 15.8 mtm -152.6 159.42 43.24 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.897 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.696 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -159.45 165.34 33.31 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.668 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 14' ' ' SER . 27.4 ttpt -103.29 114.3 28.47 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.657 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -98.51 146.98 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.303 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -124.2 114.4 19.57 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.746 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.539 ' C ' ' N ' ' A' ' 28' ' ' ASN . 10.6 mt -69.58 147.07 51.22 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.659 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.643 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -49.31 -11.36 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.959 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.643 ' N ' ' CD ' ' A' ' 27' ' ' GLU . 36.6 t30 -78.84 -17.79 55.08 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.7 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.69 -2.18 42.13 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.804 -1.189 . . . . 0.0 112.294 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -94.29 137.56 33.31 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.069 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -91.53 141.26 28.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.491 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.415 ' C ' HD12 ' A' ' 33' ' ' LEU . 7.5 mm -137.93 144.53 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.248 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 33' ' ' LEU . 5.2 mp -85.85 134.41 33.91 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.14 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.0 m -139.57 151.35 45.99 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.399 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.766 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 18.3 m80 -115.55 161.82 18.09 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.654 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.532 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 27.9 mt -92.59 146.06 6.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.66 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.439 ' O ' HG22 ' A' ' 36' ' ' ILE . 3.2 m -92.47 -178.34 4.88 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.21 -8.61 87.44 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.854 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -75.12 -62.18 1.64 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.48 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.526 HD13 HG23 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -53.69 -20.68 5.74 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.188 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -73.52 -39.19 64.97 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.308 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.61 -28.62 67.08 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.397 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -77.55 -16.28 58.75 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.618 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.2 t80 47.66 80.94 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.551 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 45' ' ' ILE . 33.5 mt -144.86 113.21 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.019 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -60.27 126.1 26.18 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.688 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 mm -95.12 148.28 5.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.551 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 48' ' ' LEU . 14.3 tp -125.08 135.45 52.71 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.083 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.21 152.34 0.59 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.932 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.02 -16.4 59.62 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.247 -1.454 . . . . 0.0 109.667 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.91 162.21 29.79 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.425 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.73 141.4 36.54 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.377 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.436 ' CG2' HG13 ' A' ' 67' ' ' ILE . 5.3 m -148.57 162.49 5.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.583 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 2.0 m-20 -92.46 124.09 36.25 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.23 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.57 142.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.644 -0.823 . . . . 0.0 112.254 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -122.84 108.64 13.23 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.405 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.1 mt -84.42 132.29 34.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.391 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.7 p -91.01 139.33 25.81 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 119.024 -1.07 . . . . 0.0 112.152 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.32 -4.9 8.73 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.518 1.479 . . . . 0.0 111.403 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -89.15 -22.82 22.64 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.724 -0.79 . . . . 0.0 108.98 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.644 ' C ' ' H ' ' A' ' 63' ' ' THR . 4.1 m-20 -151.34 89.31 1.49 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mt -69.89 23.06 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.417 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.644 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.1 m -119.53 -8.59 9.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.169 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.25 150.43 39.28 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.236 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.8 -152.57 6.42 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -166.36 143.76 5.2 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.146 -1.422 . . . . 0.0 112.166 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 67' ' ' ILE . 1.3 mp -92.34 121.7 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.22 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.57 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 70.2 p -124.7 7.08 8.16 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.076 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.863 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.67 111.02 0.65 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.646 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.36 162.91 28.4 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.52 133.2 1.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.114 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.419 ' H ' ' HG2' ' A' ' 72' ' ' LYS . 13.8 pttp . . . . . 0 C--N 1.307 -1.269 0 CA-C-O 116.268 -1.825 . . . . 0.0 110.76 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.456 ' HG3' ' N ' ' A' ' 2' ' ' ALA . 8.0 ptp . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.902 0.382 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' N ' ' HG3' ' A' ' 1' ' ' MET . . . -79.03 106.22 10.92 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.381 -0.927 . . . . 0.0 111.202 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 5' ' ' ASP . 35.1 tttp 54.22 -93.93 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.72 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -44.94 95.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 3' ' ' LYS . 6.2 m-20 -98.43 90.61 4.84 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.853 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.49 164.21 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.866 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 mt -94.46 102.44 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.575 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 1.9 mm-40 -80.38 117.04 20.79 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.156 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.2 mt -128.95 150.73 50.26 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.222 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -88.18 142.64 27.6 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.393 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.7 165.61 31.59 Favored Glycine 0 N--CA 1.485 1.941 0 C-N-CA 119.172 -1.489 . . . . 0.0 110.221 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.439 ' C ' HG13 ' A' ' 24' ' ' VAL . 33.7 m -113.7 125.79 54.51 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.739 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.99 112.06 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 118.624 -1.23 . . . . 0.0 110.546 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -90.36 -32.75 16.33 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.429 -0.908 . . . . 0.0 112.141 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -152.56 137.85 17.51 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.389 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.37 117.12 32.07 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.376 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -106.86 155.22 39.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.618 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.54 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 3.7 Cg_exo -56.54 -164.3 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.879 0 C-N-CA 121.334 1.356 . . . . 0.0 112.126 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 18' ' ' PRO . 8.0 p30 46.63 31.34 1.35 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.062 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' A' ' 36' ' ' ILE . . . 52.07 58.08 5.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.981 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.51 ' SD ' ' OD1' ' A' ' 19' ' ' ASN . 37.0 mtp -149.85 137.59 20.11 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.714 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -130.71 163.22 27.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.424 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -103.84 108.88 20.39 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.521 ' CG2' ' SG ' ' A' ' 34' ' ' CYS . 36.6 t -94.93 152.48 3.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.375 -0.93 . . . . 0.0 112.01 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -120.74 110.91 16.94 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.825 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.692 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.1 mp -65.45 178.6 0.92 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.545 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -77.23 -23.69 51.32 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.649 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.446 HD22 ' CB ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -66.12 -15.82 63.43 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.494 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.36 -8.23 35.13 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.068 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -95.76 176.8 6.0 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.676 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -138.34 160.46 39.43 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.82 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 33' ' ' LEU . 76.7 mt -143.53 161.67 16.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.1 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.679 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 3.9 mp -86.37 131.51 34.19 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.549 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 8.2 m -132.99 135.28 45.38 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.658 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 2.4 t60 -102.31 173.68 6.26 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.509 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.658 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 10.7 mt -91.3 165.91 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.998 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.644 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -128.2 160.77 31.04 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.946 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.97 -20.01 66.18 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.341 -1.409 . . . . 0.0 111.594 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.42 ' C ' ' N ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -67.81 -62.27 1.49 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.342 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -52.83 -20.25 3.12 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.808 -1.157 . . . . 0.0 109.643 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.437 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.35 -42.81 68.03 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.406 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.476 ' C ' ' H ' ' A' ' 44' ' ' PHE . 1.4 ptm -72.4 -22.32 61.14 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.298 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.472 ' N ' ' HG3' ' A' ' 42' ' ' MET . 7.2 m120 -67.09 6.51 0.52 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.801 -1.16 . . . . 0.0 110.646 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 42' ' ' MET . 0.8 OUTLIER 48.19 82.32 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.876 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 mm -142.46 147.06 21.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.088 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.78 75.13 1.51 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.572 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.452 HG21 ' CB ' ' A' ' 51' ' ' ASP . 42.8 mt -105.79 149.59 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.771 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.3 mt -110.72 165.8 11.54 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.517 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -40.41 153.26 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.47 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.26 -12.18 65.25 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.588 -1.292 . . . . 0.0 109.873 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.452 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -92.6 152.63 19.48 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.74 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 66.1 mttt -78.41 147.43 34.04 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.629 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.464 HG13 ' C ' ' A' ' 52' ' ' LYS . 33.9 m -149.58 162.44 4.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.643 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.516 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -95.2 123.04 38.49 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.453 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 9' ' ' LEU . 61.1 t -104.35 127.5 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.625 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.65 113.69 26.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.946 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.406 ' CD2' HD13 ' A' ' 32' ' ' ILE . 23.8 mt -88.48 147.26 24.75 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.752 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.05 135.2 33.65 Favored Pre-proline 0 N--CA 1.492 1.648 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.18 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -65.1 -4.93 9.92 Favored 'Trans proline' 0 C--O 1.217 -0.548 0 C-N-CA 121.625 1.55 . . . . 0.0 112.068 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.78 -22.05 14.98 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.083 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.617 ' C ' ' H ' ' A' ' 63' ' ' THR . 33.0 t0 -155.23 91.64 1.36 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.55 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.33 19.83 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.464 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.617 ' H ' ' C ' ' A' ' 61' ' ' ASP . 53.2 m -99.92 -13.33 19.19 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.011 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -137.67 147.31 44.76 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.13 -159.33 7.89 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.455 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 5.8 ptp180 -154.71 143.88 21.12 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.842 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.2 mm -93.26 122.05 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.296 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.635 ' OG1' ' NE1' ' A' ' 69' ' ' TRP . 5.0 p -126.47 6.4 6.93 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.012 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.859 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -158.4 157.72 32.84 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.315 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -154.32 88.72 1.24 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.063 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.23 131.66 9.46 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.655 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.4 tttt . . . . . 0 C--N 1.305 -1.336 0 CA-C-O 116.397 -1.763 . . . . 0.0 110.877 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.4 mpp? . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 60.78 170.32 0.09 Allowed 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.757 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.76 22.19 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.714 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 16.6 pttp -161.94 -155.84 0.4 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.651 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 2.1 t0 72.13 -179.07 0.21 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.201 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 58' ' ' SER . 11.9 m -82.66 151.65 4.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.214 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 mm -95.61 106.72 18.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.415 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.53 112.55 13.18 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.194 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' A' ' 9' ' ' LEU . 25.0 mt -134.0 164.95 26.17 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.611 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -90.01 143.84 26.43 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.8 148.32 18.8 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.413 HG21 ' NZ ' ' A' ' 25' ' ' LYS . 20.1 m -104.27 132.13 50.85 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 51' ' ' ASP . 4.2 t -63.36 117.66 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.619 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.09 -29.46 13.61 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.319 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -150.09 121.9 8.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.122 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.46 105.34 17.69 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.034 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.42 149.03 36.61 Favored Pre-proline 0 C--N 1.307 -1.259 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.799 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 2.3 Cg_endo -58.72 167.21 5.51 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.308 1.339 . . . . 0.0 111.229 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 4.6 t-20 75.79 29.94 0.8 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.573 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.16 61.37 3.07 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.822 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 ttm -155.23 136.51 13.99 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.61 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -136.28 165.69 25.19 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.809 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -105.08 109.01 20.83 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.365 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.694 HG11 HG21 ' A' ' 55' ' ' VAL . 69.8 t -96.35 143.96 11.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.201 -1.0 . . . . 0.0 112.079 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 14.8 pttm -110.95 126.87 55.21 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.968 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.527 HD11 ' CD1' ' A' ' 32' ' ' ILE . 4.8 mp -83.77 175.46 9.64 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.183 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -73.91 -26.93 60.78 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.775 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.85 -16.86 64.22 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.81 -11.77 35.0 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.365 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -83.72 174.98 10.01 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.284 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -133.3 151.78 51.9 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.651 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.527 ' CD1' HD11 ' A' ' 26' ' ' LEU . 65.8 mt -141.28 155.33 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.914 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.872 ' H ' HD12 ' A' ' 33' ' ' LEU . 2.2 mp -88.04 134.41 33.75 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.522 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.57 ' SG ' HG13 ' A' ' 55' ' ' VAL . 61.6 m -132.96 139.1 47.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.957 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.435 ' H ' ' HA ' ' A' ' 66' ' ' ARG . 1.7 t-80 -107.96 172.35 6.88 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.815 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.651 HG22 ' N ' ' A' ' 37' ' ' SER . 25.0 mt -98.61 167.42 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.818 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.651 ' N ' HG22 ' A' ' 36' ' ' ILE . 35.1 m -130.93 117.74 19.67 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.817 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.49 -15.34 0.05 OUTLIER Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.82 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 37' ' ' SER . 30.7 mtmt -72.42 -61.54 1.76 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.196 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 36' ' ' ILE . 1.1 pp -53.15 -21.36 4.88 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.96 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.468 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 1.9 ttt-85 -72.78 -39.72 66.52 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.52 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 42' ' ' MET . 6.9 tpp -63.72 -27.4 69.18 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.725 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -78.93 5.39 11.7 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 54.23 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.223 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.57 114.07 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -59.34 137.15 58.09 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.607 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 mm -102.52 149.78 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.39 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -164.26 134.95 4.26 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.501 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.441 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 2.2 pp20? -63.42 152.24 38.79 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.223 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.59 -8.31 28.1 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 118.873 -1.632 . . . . 0.0 109.695 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 13' ' ' VAL . 56.5 t0 -72.53 133.1 44.61 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.284 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' C ' HG13 ' A' ' 53' ' ' VAL . 77.8 mttt -76.1 141.76 41.89 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.332 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.693 ' CG2' HD12 ' A' ' 67' ' ' ILE . 16.6 m -148.48 168.79 3.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.681 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.597 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -91.42 120.26 32.11 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.538 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.694 HG21 HG11 ' A' ' 24' ' ' VAL . 26.3 t -104.76 116.66 48.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.634 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.17 120.13 33.98 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.412 ' CD2' HD13 ' A' ' 32' ' ' ILE . 12.7 mt -92.8 159.43 15.4 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.406 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.454 ' HA ' HG12 ' A' ' 6' ' ' VAL . 67.0 m -94.85 141.08 22.83 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.599 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -69.68 -21.88 33.25 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.825 1.683 . . . . 0.0 112.055 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -88.24 -26.39 22.37 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.403 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.61 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -148.04 88.21 1.65 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.12 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mt -71.76 20.61 0.06 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.278 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.61 ' H ' ' C ' ' A' ' 61' ' ' ASP . 7.1 p -98.43 -12.32 21.49 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -138.02 150.68 47.18 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.678 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.36 -153.28 5.85 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.435 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 4.8 ptt180 -165.48 147.13 7.41 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.664 -1.215 . . . . 0.0 111.595 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.693 HD12 ' CG2' ' A' ' 53' ' ' VAL . 25.2 mm -92.72 117.3 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.969 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.63 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 32.6 p -127.95 7.97 6.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.963 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.824 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -169.98 127.72 0.88 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.28 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.474 ' HD2' ' N ' ' A' ' 71' ' ' LYS . 8.7 tmm_? -72.3 162.08 29.97 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.515 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.474 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 9.2 tttt -43.28 135.2 3.49 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.416 -0.913 . . . . 0.0 111.334 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.3 tptm . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 116.304 -1.807 . . . . 0.0 110.634 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.896 0.379 . . . . 0.0 110.05 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.06 83.02 0.11 Allowed 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.859 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -165.91 94.78 0.58 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.76 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.524 ' C ' ' H ' ' A' ' 6' ' ' VAL . 8.1 tttt -148.62 -140.31 0.1 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.014 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.451 ' H ' ' HG2' ' A' ' 4' ' ' LYS . 31.2 t70 -48.52 -10.97 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.309 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.713 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -176.36 176.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.602 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.713 HD12 ' C ' ' A' ' 6' ' ' VAL . 1.8 mp -116.76 110.19 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.246 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -100.52 127.12 46.98 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.092 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' VAL . 35.2 mt -144.44 160.24 41.4 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.646 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -88.0 143.73 26.93 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.19 168.77 30.2 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.117 -1.516 . . . . 0.0 109.804 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.5 m -123.87 130.03 51.95 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.475 ' HA ' HG22 ' A' ' 24' ' ' VAL . 3.0 t -67.72 133.07 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.734 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 t -113.24 -26.92 8.18 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.326 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -153.15 158.2 41.45 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.108 -1.437 . . . . 0.0 112.223 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' H ' ' CD ' ' A' ' 15' ' ' GLU . . . -99.15 113.99 26.51 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.577 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.4 mt -104.66 146.94 33.6 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 119.739 -0.785 . . . . 0.0 111.008 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.517 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 3.1 Cg_endo -65.0 170.49 10.27 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 121.296 1.331 . . . . 0.0 111.433 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.517 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER 75.07 28.62 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.154 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.483 ' O ' ' CE1' ' A' ' 35' ' ' HIS . . . 58.89 61.99 2.01 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.347 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 19' ' ' ASN . 8.6 ptm -165.29 170.38 14.8 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.607 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -155.41 165.34 36.92 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.837 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -88.88 132.46 34.67 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.768 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.475 HG22 ' HA ' ' A' ' 13' ' ' VAL . 2.3 t -125.93 143.39 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.575 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -122.81 124.75 44.02 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.97 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.71 172.73 10.92 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.93 -41.64 62.19 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.823 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.521 ' HB3' ' CE1' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -71.63 -14.82 62.17 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.411 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.02 -0.78 44.47 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.969 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.521 ' CE1' ' HB3' ' A' ' 28' ' ' ASN . 71.7 m80 -55.34 104.88 0.14 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.835 -1.146 . . . . 0.0 111.224 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -76.19 124.28 27.21 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.431 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.486 ' C ' HD12 ' A' ' 33' ' ' LEU . 23.3 mt -137.42 152.6 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.318 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 33' ' ' LEU . 6.3 mp -90.45 132.79 35.44 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.356 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.428 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 8.8 p -132.03 134.64 45.78 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.889 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.587 ' ND1' ' N ' ' A' ' 36' ' ' ILE . 54.3 t-80 -103.68 176.23 5.22 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.941 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.587 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 22.1 mt -99.74 161.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.005 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.559 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 4.0 p -121.72 -169.49 1.88 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.389 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.32 -5.32 89.81 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.418 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -71.95 -63.41 1.14 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.769 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.586 HD13 HG23 ' A' ' 36' ' ' ILE . 1.7 mp -54.81 -21.42 11.16 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.874 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -35.16 66.91 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.601 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.8 ttp -74.66 -31.98 62.1 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.783 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.645 ' C ' ' CD1' ' A' ' 44' ' ' PHE . 2.7 t-20 -93.96 0.76 56.25 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.819 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.645 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 18.6 p90 31.01 72.55 0.06 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.1 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 46' ' ' ARG . 43.7 mt -102.69 166.5 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.823 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.611 ' N ' HG22 ' A' ' 45' ' ' ILE . 6.1 ptt180 -144.31 79.63 1.62 Allowed 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.634 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.431 HG21 ' CB ' ' A' ' 51' ' ' ASP . 5.2 mm -104.22 150.7 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.61 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 mp -99.04 156.78 16.75 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.556 -0.858 . . . . 0.0 112.359 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.686 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 6.4 mp0 -41.38 153.71 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.685 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.25 -4.62 60.54 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.004 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.431 ' CB ' HG21 ' A' ' 47' ' ' ILE . 23.8 t0 -90.82 142.27 27.94 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.591 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' C ' HG13 ' A' ' 53' ' ' VAL . 6.5 mtpm? -81.93 145.57 30.24 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.543 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.583 ' CG2' HD12 ' A' ' 67' ' ' ILE . 17.5 m -148.64 166.56 4.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.42 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.595 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 1.9 m-20 -92.17 123.83 35.81 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.835 -1.146 . . . . 0.0 108.124 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 9' ' ' LEU . 56.8 t -104.32 126.49 59.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.783 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -99.83 114.54 27.79 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.637 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.73 145.27 24.72 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.134 -1.027 . . . . 0.0 111.024 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 60' ' ' TYR . 4.5 p -86.93 128.1 57.26 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.079 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.88 -1.64 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.348 1.365 . . . . 0.0 111.378 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 58' ' ' SER . 78.6 m-85 -109.05 -16.84 14.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.881 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.61 ' C ' ' H ' ' A' ' 63' ' ' THR . 13.0 m-20 -145.11 84.0 1.7 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt -71.7 23.25 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.61 ' H ' ' C ' ' A' ' 61' ' ' ASP . 6.7 m -116.37 -5.73 11.78 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.622 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 65' ' ' GLY . 1.7 tmt_? -148.68 144.88 27.42 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.728 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.473 ' N ' ' HG2' ' A' ' 64' ' ' ARG . . . -138.28 -150.75 5.69 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.463 HH11 ' HG2' ' A' ' 66' ' ' ARG . 10.5 ptt-85 -165.59 141.45 5.19 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.855 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.583 HD12 ' CG2' ' A' ' 53' ' ' VAL . 20.2 mm -87.44 117.87 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 119.846 -0.741 . . . . 0.0 109.802 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.633 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 25.6 p -125.44 6.88 7.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.863 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -169.92 110.74 0.43 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.231 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.538 ' CG ' ' N ' ' A' ' 71' ' ' LYS . 22.6 ttp85 -68.5 161.56 27.54 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.654 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.538 ' N ' ' CG ' ' A' ' 70' ' ' ARG . 23.2 tttp -87.41 134.23 33.62 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 116.336 -1.792 . . . . 0.0 110.825 -179.924 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mtp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.78 -16.89 15.82 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.127 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HG3' ' N ' ' A' ' 4' ' ' LYS . 1.2 tppt? -167.49 142.37 3.84 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.767 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.414 ' N ' ' HG3' ' A' ' 3' ' ' LYS . 22.2 tttt -154.77 111.06 3.22 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.897 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.561 ' OD2' ' N ' ' A' ' 5' ' ' ASP . 6.8 p-10 -94.83 172.88 7.89 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.112 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.569 HG12 ' HD3' ' A' ' 59' ' ' PRO . 4.0 m -82.03 -180.0 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.117 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 7' ' ' ILE . 11.7 mt -127.12 103.06 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.38 115.14 11.27 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.446 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 mt -141.88 143.18 33.2 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -86.25 141.49 29.25 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.476 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.08 149.65 21.68 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.228 -1.463 . . . . 0.0 109.873 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.46 ' C ' HG13 ' A' ' 24' ' ' VAL . 98.8 m -93.91 130.01 40.14 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.459 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 51' ' ' ASP . 3.8 t -59.99 127.12 18.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.277 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -99.47 -32.45 11.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.943 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -160.38 157.78 28.42 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.614 -1.234 . . . . 0.0 111.818 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.63 118.7 35.94 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.785 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.8 mt -106.2 147.73 35.37 Favored Pre-proline 0 N--CA 1.491 1.582 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.399 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.74 171.18 4.9 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.611 1.54 . . . . 0.0 111.929 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.6 OUTLIER 67.58 28.95 7.32 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.805 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 59.59 60.55 2.22 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.168 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.774 ' SD ' ' CD2' ' A' ' 35' ' ' HIS . 46.7 mtm -152.4 164.51 37.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.334 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.54 165.18 31.29 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.722 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' HG2' ' CG ' ' A' ' 31' ' ' GLU . 14.3 ttmt -99.04 137.18 37.93 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.224 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.46 HG13 ' C ' ' A' ' 12' ' ' THR . 46.9 t -130.93 145.13 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.64 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.459 ' HZ3' ' HG3' ' A' ' 25' ' ' LYS . 9.0 mtmm -111.49 120.76 43.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.563 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.919 ' H ' HD12 ' A' ' 26' ' ' LEU . 3.9 mp -74.41 168.31 19.95 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.03 -29.59 70.39 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.0 -11.05 16.31 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.641 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.29 -11.52 65.36 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.735 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -78.38 167.69 20.95 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.524 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.408 ' CG ' ' HG2' ' A' ' 23' ' ' LYS . 24.1 tt0 -127.42 142.69 51.35 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.155 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.558 HG22 ' N ' ' A' ' 33' ' ' LEU . 77.0 mt -143.69 160.91 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.246 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.558 ' N ' HG22 ' A' ' 32' ' ' ILE . 6.1 mp -90.35 141.8 28.36 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.151 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.4 ' SG ' HG13 ' A' ' 55' ' ' VAL . 4.7 m -138.7 139.81 38.54 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.384 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.774 ' CD2' ' SD ' ' A' ' 21' ' ' MET . 4.3 m80 -104.15 168.81 8.87 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.321 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.527 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 57.8 mt -92.78 152.09 3.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.772 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.42 ' O ' HG22 ' A' ' 36' ' ' ILE . 3.5 m -104.08 -166.69 1.28 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.63 -16.82 74.67 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.468 -1.348 . . . . 0.0 111.252 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.486 ' C ' ' N ' ' A' ' 41' ' ' ARG . 30.0 mttp -70.89 -63.22 1.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.658 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.653 ' H ' HD12 ' A' ' 40' ' ' LEU . 4.5 mp -52.84 -20.27 3.14 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.679 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.486 ' N ' ' C ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.91 -36.95 62.18 Favored 'General case' 0 C--N 1.271 -2.848 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.898 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 39' ' ' LYS . 92.3 mtp -90.32 -21.53 21.99 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.637 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.503 ' ND2' HG13 ' A' ' 45' ' ' ILE . 12.9 t30 -83.5 -37.76 22.67 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.316 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.9 t80 42.76 54.72 4.54 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.687 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.503 HG13 ' ND2' ' A' ' 43' ' ' ASN . 5.6 mm -96.35 159.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.216 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 46' ' ' ARG . 18.2 mmm180 -62.15 137.58 58.28 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.258 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.431 ' HA ' ' NH2' ' A' ' 70' ' ' ARG . 3.3 mt -133.19 140.27 47.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.889 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.8 mt -143.77 135.33 26.11 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.289 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -43.93 152.09 0.18 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.92 -15.11 63.56 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.731 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 13' ' ' VAL . 8.7 m-20 -76.11 146.8 39.05 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.356 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -88.23 143.55 26.97 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.702 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.503 ' CG2' HD12 ' A' ' 67' ' ' ILE . 18.5 m -146.03 169.15 6.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.671 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.527 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 0.4 OUTLIER -96.57 117.93 32.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.107 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.705 HG22 HD11 ' A' ' 67' ' ' ILE . 10.4 t -105.25 117.3 50.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.197 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -94.07 118.61 31.77 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.008 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.3 mt -88.49 139.81 30.11 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.913 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.0 m -95.01 132.56 27.89 Favored Pre-proline 0 N--CA 1.49 1.538 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.356 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.569 ' HD3' HG12 ' A' ' 6' ' ' VAL . 2.0 Cg_endo -66.96 -2.81 8.51 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.297 1.332 . . . . 0.0 110.967 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -92.11 -22.83 19.67 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.659 ' C ' ' H ' ' A' ' 63' ' ' THR . 5.5 m-20 -150.83 87.26 1.41 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.199 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mt -66.87 18.81 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.677 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.659 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.3 p -113.33 -8.88 13.45 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.43 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.434 ' NH1' ' NE2' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -140.71 151.59 44.64 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.467 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.71 -153.17 6.1 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -163.72 135.88 5.02 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.195 -1.402 . . . . 0.0 112.474 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 55' ' ' VAL . 47.8 mm -92.82 123.09 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.429 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.602 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -125.1 7.09 7.89 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.544 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.817 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -168.89 166.1 11.42 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.785 -1.166 . . . . 0.0 111.483 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 47' ' ' ILE . 2.4 ttm180 -144.04 125.87 15.22 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.171 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -44.25 158.2 0.05 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.509 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 116.348 -1.787 . . . . 0.0 110.916 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.914 0.388 . . . . 0.0 109.995 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.01 150.99 29.76 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.722 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -73.64 151.54 40.78 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.891 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 4' ' ' LYS . 10.2 mmtm -90.33 105.63 17.95 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.824 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -134.54 -134.89 0.16 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.024 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG12 ' HD3' ' A' ' 59' ' ' PRO . 2.0 m -73.09 165.73 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.083 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.5 mt -114.6 100.93 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.109 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -78.87 114.59 17.93 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.398 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 9' ' ' LEU . 12.2 mt -134.32 153.37 51.92 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.383 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.49 142.1 28.61 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.704 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.03 -178.4 18.08 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.416 ' N ' HG13 ' A' ' 24' ' ' VAL . 13.7 m -137.86 125.8 22.68 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.476 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.412 ' HA ' HG22 ' A' ' 24' ' ' VAL . 6.1 t -59.79 123.94 13.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.527 -1.269 . . . . 0.0 110.534 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -105.51 -29.3 10.27 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.984 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -156.99 149.11 22.91 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.879 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.28 131.67 35.96 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -122.29 152.74 61.24 Favored Pre-proline 0 N--CA 1.492 1.626 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.571 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.29 -176.44 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.031 1.154 . . . . 0.0 110.888 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 3.2 m-20 55.52 40.93 31.23 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.51 49.65 13.3 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.848 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.483 ' HG3' ' CE1' ' A' ' 35' ' ' HIS . 28.9 mtp -140.82 168.41 19.85 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.819 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.0 165.94 29.05 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.917 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -95.3 128.58 42.25 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.109 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.416 HG13 ' N ' ' A' ' 12' ' ' THR . 39.0 t -117.65 140.23 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.647 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -105.72 122.69 46.59 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.141 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.775 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.1 mp -76.79 171.99 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.26 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -71.25 -14.5 62.25 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.444 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -75.52 -16.79 60.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.067 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.29 -15.25 33.0 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 119.767 -1.206 . . . . 0.0 111.419 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -89.5 179.24 6.1 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.115 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -137.68 149.9 46.9 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.268 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.741 HG22 ' N ' ' A' ' 33' ' ' LEU . 11.2 mm -136.99 174.73 11.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.231 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.741 ' N ' HG22 ' A' ' 32' ' ' ILE . 6.8 mp -97.01 136.5 37.49 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.577 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.535 ' SG ' HG13 ' A' ' 55' ' ' VAL . 86.1 m -132.73 152.96 51.62 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.654 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.483 ' CE1' ' HG3' ' A' ' 21' ' ' MET . 1.9 t60 -118.92 152.7 35.83 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.257 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.608 HG23 HD21 ' A' ' 40' ' ' LEU . 28.0 mt -93.99 146.68 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.995 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.5 m -97.22 136.28 37.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.37 -11.28 39.77 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.185 -1.483 . . . . 0.0 110.496 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.446 ' C ' ' N ' ' A' ' 41' ' ' ARG . 6.8 tttm -70.88 -62.22 1.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.26 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -52.72 -20.21 2.99 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.55 -1.26 . . . . 0.0 108.893 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.446 ' N ' ' C ' ' A' ' 39' ' ' LYS . 3.7 ttt180 -63.99 -53.21 53.66 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.635 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 tpp -65.5 -25.35 67.43 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.895 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -65.14 -4.48 5.03 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.739 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 t80 52.28 87.81 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.571 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.6 mt -140.29 141.88 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.722 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.407 ' H ' ' HG2' ' A' ' 46' ' ' ARG . 15.1 ptt180 -74.53 134.55 42.2 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.797 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.432 HD11 HD11 ' A' ' 40' ' ' LEU . 37.9 mt -131.18 147.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.342 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.847 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.8 pt? -159.59 148.91 18.14 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.657 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 19.3 pt-20 -63.34 152.07 39.0 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.416 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.97 -13.15 60.05 Favored Glycine 0 N--CA 1.485 1.9 0 C-N-CA 119.445 -1.36 . . . . 0.0 110.198 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.641 ' CG ' ' HE ' ' A' ' 70' ' ' ARG . 9.5 t70 -80.12 162.16 24.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.655 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.492 ' C ' HG13 ' A' ' 53' ' ' VAL . 5.9 mtpm? -91.06 152.14 20.75 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.751 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.587 HG21 HG12 ' A' ' 67' ' ' ILE . 22.3 m -154.62 167.73 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.455 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.532 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -93.72 122.41 36.15 Favored 'General case' 0 C--O 1.203 -1.351 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.27 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.535 HG13 ' SG ' ' A' ' 34' ' ' CYS . 4.1 t -104.59 121.14 56.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.419 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.85 121.2 41.65 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.606 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 mt -95.14 141.87 28.26 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.212 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.5 m -86.03 128.81 56.48 Favored Pre-proline 0 N--CA 1.493 1.677 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.592 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.653 ' HD3' HG12 ' A' ' 6' ' ' VAL . 2.2 Cg_endo -66.32 -13.38 39.65 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 121.306 1.337 . . . . 0.0 110.898 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -101.32 -10.41 20.31 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.628 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -147.1 72.45 1.26 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.771 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -70.59 23.35 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.641 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.628 ' H ' ' C ' ' A' ' 61' ' ' ASP . 9.1 m -105.5 -21.16 13.27 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.458 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -140.66 159.6 41.84 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.776 -0.77 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.18 -159.96 8.44 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.45 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 6.8 ptt180 -166.91 139.36 3.51 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 117.957 -1.497 . . . . 0.0 112.164 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.587 HG12 HG21 ' A' ' 53' ' ' VAL . 1.8 mp -93.29 126.34 45.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.563 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.469 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 4.8 p -126.77 7.04 6.74 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.888 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.843 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -166.45 142.69 4.77 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.589 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.641 ' HE ' ' CG ' ' A' ' 51' ' ' ASP . 11.0 ttt-85 -124.11 128.15 48.87 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.947 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' ARG . 16.3 mmtt -41.57 111.83 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.847 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 116.426 -1.75 . . . . 0.0 110.832 179.927 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.663 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.897 0.38 . . . . 0.0 110.102 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 71.68 -22.98 0.19 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 1' ' ' MET . 8.4 mmtp 51.92 87.44 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.885 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.535 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 12.5 tptm -77.59 -144.2 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.049 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.535 ' H ' ' CG ' ' A' ' 4' ' ' LYS . 12.3 t70 -102.58 116.68 33.1 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -88.07 164.5 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.669 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.4 mm -100.0 107.83 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -76.09 118.41 18.81 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.431 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.6 138.17 37.64 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 10' ' ' GLU . 12.3 mp0 -88.47 140.65 29.25 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.66 172.24 28.88 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.089 -1.529 . . . . 0.0 110.201 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 m -115.67 129.68 56.58 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.791 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 24' ' ' VAL . 14.9 t -59.67 127.72 19.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.749 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 23' ' ' LYS . 37.1 t -93.98 -40.11 10.29 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.664 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -156.65 158.24 36.64 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.634 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.56 123.75 44.12 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.5 mt -119.29 149.51 47.54 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.461 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 2.3 Cg_endo -59.01 -179.89 0.18 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.289 1.326 . . . . 0.0 111.104 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 6.0 t30 73.58 18.62 3.5 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.61 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 61.66 42.95 10.33 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.575 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.8 mtp -142.3 174.75 10.33 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.827 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.651 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.52 166.19 27.44 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.372 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' SER . 46.2 tttm -99.14 130.68 45.47 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.55 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 13' ' ' VAL . 95.2 t -119.85 150.46 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.336 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -124.18 112.14 16.73 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.412 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.683 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.7 mp -70.11 138.27 51.83 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.053 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.89 -15.5 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.276 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.543 ' N ' ' C ' ' A' ' 26' ' ' LEU . 18.0 m120 -65.09 -16.27 63.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.243 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.92 -11.21 52.58 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.906 -1.14 . . . . 0.0 111.354 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -98.04 172.02 7.88 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.524 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -125.49 157.94 35.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.59 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 33' ' ' LEU . 34.0 mt -152.01 156.89 5.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.171 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.539 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 7.4 mp -93.45 136.94 33.23 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.228 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' ' CG1' ' A' ' 55' ' ' VAL . 82.8 m -132.78 151.22 52.05 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.289 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -118.65 160.18 22.28 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.0 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.515 HG23 HD13 ' A' ' 40' ' ' LEU . 5.7 mt -91.49 140.67 15.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.324 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.44 ' O ' HG22 ' A' ' 36' ' ' ILE . 2.8 m -85.72 -171.56 3.66 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.011 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.13 -6.85 89.11 Favored Glycine 0 N--CA 1.487 2.039 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.208 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.68 -62.04 1.72 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.246 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.515 HD13 HG23 ' A' ' 36' ' ' ILE . 1.5 mp -56.29 -20.76 20.2 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.021 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -74.88 -38.16 61.97 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.327 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.6 tpp -71.6 -29.32 64.56 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.11 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.416 ' CB ' HD11 ' A' ' 45' ' ' ILE . 7.9 m-20 -77.04 -38.74 52.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.345 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.26 77.79 0.32 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.223 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.731 HG22 ' H ' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -124.68 -150.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.768 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.731 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -149.57 98.23 2.74 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.638 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.544 ' C ' HD12 ' A' ' 48' ' ' LEU . 4.2 mp -92.69 121.89 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.832 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.2 mp -96.19 136.89 36.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.942 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -42.46 152.66 0.09 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.248 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.24 -14.41 64.48 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -81.38 143.56 32.08 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.483 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' C ' HG13 ' A' ' 53' ' ' VAL . 37.3 mtmt -80.41 149.99 29.95 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.732 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.479 HG13 ' C ' ' A' ' 52' ' ' LYS . 26.9 m -152.06 168.4 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.798 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.552 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.9 OUTLIER -101.97 117.86 35.71 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.506 ' CG1' ' SG ' ' A' ' 34' ' ' CYS . 24.3 t -104.39 123.98 58.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.436 -0.906 . . . . 0.0 113.182 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -95.55 114.31 26.06 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.99 147.63 24.19 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.577 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 m -91.97 132.51 32.52 Favored Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.056 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.94 -18.56 64.25 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 121.426 1.417 . . . . 0.0 111.712 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.09 -11.45 24.38 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.397 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.0 t70 -142.32 78.53 1.63 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.096 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -71.7 23.93 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.413 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.614 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -115.54 -23.82 8.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.08 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.01 151.73 48.19 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.622 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 35' ' ' HIS . . . -144.05 -159.36 7.98 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -166.65 146.16 5.67 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.12 -1.432 . . . . 0.0 112.584 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.598 HD12 ' N ' ' A' ' 67' ' ' ILE . 1.8 mp -93.44 126.19 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.796 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.628 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 7.7 p -126.49 6.71 6.93 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.478 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.796 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -171.73 110.47 0.29 Allowed 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.102 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 162.22 28.77 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.379 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HG3' ' H ' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -130.16 158.31 40.05 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.14 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.468 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 46.6 tttm . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 116.332 -1.794 . . . . 0.0 110.73 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.587 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mmt . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.849 0.357 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.19 24.33 0.73 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 mttm 46.5 67.72 0.73 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.788 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.52 ' CG ' ' N ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -148.94 172.91 13.95 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.975 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.52 ' N ' ' CG ' ' A' ' 4' ' ' LYS . 7.8 p-10 38.5 -147.8 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.516 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.631 HG22 ' H ' ' A' ' 7' ' ' ILE . 3.9 p -113.14 174.58 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.06 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.631 ' H ' HG22 ' A' ' 6' ' ' VAL . 4.5 mp -103.94 146.66 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.27 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -122.46 127.85 50.13 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.454 HD12 ' CD1' ' A' ' 57' ' ' LEU . 6.4 mt -144.56 156.02 43.94 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.262 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.519 ' OE2' ' NZ ' ' A' ' 71' ' ' LYS . 39.4 mt-10 -90.56 141.87 28.33 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.609 -0.836 . . . . 0.0 111.25 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.11 158.88 27.91 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.544 ' C ' HG13 ' A' ' 24' ' ' VAL . 29.1 m -102.49 132.84 48.28 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.482 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.9 t -68.51 127.13 29.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 118.727 -1.189 . . . . 0.0 110.656 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -98.04 -39.0 9.14 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.588 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -153.56 145.15 23.29 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.092 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.74 110.58 22.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mt -100.14 145.7 30.67 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.15 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.3 Cg_endo -61.92 172.42 3.9 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.242 1.295 . . . . 0.0 111.459 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER 76.0 13.79 2.67 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.767 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 72.49 50.15 0.19 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.032 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.466 ' HB3' ' HE2' ' A' ' 21' ' ' MET . 9.5 mtp -144.18 140.62 29.44 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.114 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.761 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 3.5 m-85 -133.19 166.0 23.47 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.224 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 14' ' ' SER . 78.1 tttt -112.63 111.93 23.09 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.7 HG21 ' SG ' ' A' ' 34' ' ' CYS . 16.7 t -107.38 152.11 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 119.472 -0.891 . . . . 0.0 112.774 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.78 117.24 22.26 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.592 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.464 ' C ' ' N ' ' A' ' 28' ' ' ASN . 2.9 mp -77.0 136.48 38.71 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.855 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -45.91 -19.01 0.05 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.578 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.464 ' N ' ' C ' ' A' ' 26' ' ' LEU . 12.6 m-20 -69.32 -15.9 63.43 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.865 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.04 -12.57 34.31 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.022 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -84.17 163.81 19.53 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.505 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -131.76 144.49 50.99 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.16 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.503 HD13 ' CD2' ' A' ' 57' ' ' LEU . 68.0 mt -145.59 148.87 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.575 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 6.1 mp -84.88 125.15 32.4 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.159 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.7 ' SG ' HG21 ' A' ' 24' ' ' VAL . 59.4 m -116.53 134.24 55.08 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.39 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.458 ' N ' ' HA ' ' A' ' 66' ' ' ARG . 23.3 m170 -97.79 173.54 7.05 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.451 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.761 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 12.9 mt -100.64 147.15 8.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.796 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -94.46 161.51 14.19 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.084 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.34 -34.67 25.39 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.267 -1.445 . . . . 0.0 111.28 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -65.07 -53.21 49.15 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.056 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -51.88 -22.4 3.76 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.447 -1.301 . . . . 0.0 110.502 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.52 ' HE ' ' HA ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.06 -42.1 63.43 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 118.043 -1.463 . . . . 0.0 107.739 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.5 tpp -54.17 -29.25 44.9 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.389 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.65 ' C ' ' CD2' ' A' ' 44' ' ' PHE . 60.3 m-80 -93.25 2.84 56.45 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.65 ' CD2' ' C ' ' A' ' 43' ' ' ASN . 2.8 p90 40.8 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.0 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mm -119.9 102.59 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.578 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -70.09 115.8 9.72 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.2 mt -108.55 110.25 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.589 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mt -97.11 135.57 38.89 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.04 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 1.4 pm0 -46.27 152.38 0.43 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.941 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.61 60.58 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.147 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -91.96 156.37 17.49 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.321 -0.951 . . . . 0.0 110.769 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.51 143.66 27.62 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.547 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.453 ' CG2' HD12 ' A' ' 67' ' ' ILE . 12.3 m -146.57 161.27 9.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.571 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.9 OUTLIER -91.75 120.89 32.89 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.915 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG13 ' SG ' ' A' ' 34' ' ' CYS . 93.5 t -104.11 121.11 55.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.211 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -90.57 123.02 33.89 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.466 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.503 ' CD2' HD13 ' A' ' 32' ' ' ILE . 6.1 mt -97.3 140.12 32.24 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.771 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 60' ' ' TYR . 4.7 p -92.84 129.69 39.12 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.538 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -57.85 -2.46 0.78 Allowed 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 121.271 1.314 . . . . 0.0 111.668 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 58' ' ' SER . 27.3 t80 -100.32 -13.07 18.96 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.637 ' C ' ' H ' ' A' ' 63' ' ' THR . 26.6 m-20 -149.59 87.28 1.49 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.544 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 62' ' ' LEU . 2.0 mp -70.66 23.69 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.46 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.637 ' H ' ' C ' ' A' ' 61' ' ' ASP . 39.5 m -135.77 3.49 2.98 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.282 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -141.31 135.08 30.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.082 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.13 -147.78 4.97 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.465 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.458 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 11.9 ptp180 -165.89 151.46 8.91 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.302 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.453 HD12 ' CG2' ' A' ' 53' ' ' VAL . 17.3 mm -93.37 122.36 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.94 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.62 ' C ' ' CG ' ' A' ' 69' ' ' TRP . 0.2 OUTLIER -127.6 7.59 6.31 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.944 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.913 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -176.55 111.45 0.09 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.432 -1.307 . . . . 0.0 111.844 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -76.28 126.82 31.68 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.604 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.519 ' NZ ' ' OE2' ' A' ' 10' ' ' GLU . 12.5 tptt -45.31 143.79 1.62 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.962 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.801 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 mmt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.58 91.45 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.198 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -172.06 -90.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.9 mtmt 61.42 101.54 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.013 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.41 114.98 28.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.142 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.445 HG21 ' OE2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -148.74 173.64 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.38 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.2 mm -101.78 101.81 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.892 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -83.2 119.36 24.45 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.566 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 9' ' ' LEU . 13.0 mt -133.87 157.29 46.34 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.454 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -92.87 144.24 25.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.23 162.9 30.82 Favored Glycine 0 N--CA 1.483 1.813 0 C-N-CA 118.943 -1.599 . . . . 0.0 109.939 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 m -113.49 130.73 56.27 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.074 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.483 ' HA ' HG22 ' A' ' 24' ' ' VAL . 25.0 t -65.14 116.65 4.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 118.533 -1.267 . . . . 0.0 111.096 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.0 m -97.81 -33.45 11.26 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.752 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -141.73 157.87 44.51 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.67 117.02 24.8 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.083 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' MET . 22.7 mt -98.12 147.77 33.55 Favored Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.036 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.7 Cg_endo -60.38 152.23 68.7 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.417 1.411 . . . . 0.0 111.517 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER 79.56 46.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.137 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.43 58.07 5.81 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.596 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 17' ' ' LEU . 21.1 mtm -144.46 142.4 30.25 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.335 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.655 ' N ' ' CD2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -153.02 166.02 33.75 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.612 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -106.7 142.06 36.95 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.286 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 13' ' ' VAL . 14.0 t -133.31 132.62 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.831 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 25' ' ' LYS . 2.0 pttm -99.84 129.47 45.94 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.038 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.547 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.5 mp -86.13 177.1 7.65 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.043 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -73.34 -31.2 63.83 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.501 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -62.78 -10.79 14.22 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.486 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.41 -10.2 63.08 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.05 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.475 ' O ' HD12 ' A' ' 26' ' ' LEU . 64.1 m80 -84.98 156.77 21.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.471 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -116.17 148.55 40.25 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.599 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.697 HD13 HD21 ' A' ' 57' ' ' LEU . 78.5 mt -141.09 149.68 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 33' ' ' LEU . 5.3 mp -81.53 154.74 26.1 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.667 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.427 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . 39.9 m -145.54 154.31 42.05 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.449 -1.301 . . . . 0.0 111.546 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.441 ' H ' ' HA ' ' A' ' 66' ' ' ARG . 1.9 t60 -127.76 143.88 51.11 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.386 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.592 HG23 HD21 ' A' ' 40' ' ' LEU . 5.5 mt -70.5 135.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.085 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.91 165.43 12.67 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.923 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.88 -7.26 88.77 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -74.69 -62.71 1.44 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.592 HD21 HG23 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -55.25 -20.62 11.52 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.708 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.448 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -71.57 -41.66 68.74 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.12 -1.032 . . . . 0.0 108.861 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.7 mmt -61.54 -27.08 68.36 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.181 -1.007 . . . . 0.0 109.337 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -69.33 -1.63 8.72 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.318 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.569 ' O ' ' CG ' ' A' ' 44' ' ' PHE . 11.3 t80 57.63 54.62 6.21 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.095 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.786 HG22 ' N ' ' A' ' 46' ' ' ARG . 62.1 mt -152.88 172.3 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.162 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.786 ' N ' HG22 ' A' ' 45' ' ' ILE . 5.5 ptp85 -139.85 163.56 32.32 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.906 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 47' ' ' ILE . 2.3 mp -109.41 148.95 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.058 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.2 mt -127.78 136.94 52.18 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.977 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 15.6 mt-10 -40.18 152.47 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.855 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.61 -9.38 59.16 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.432 -1.365 . . . . 0.0 110.36 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -93.03 135.66 33.99 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.581 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.631 ' CD ' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -75.51 149.01 38.52 Favored 'General case' 0 CA--C 1.486 -1.511 0 C-N-CA 118.764 -1.174 . . . . 0.0 110.577 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.646 HG21 HD12 ' A' ' 67' ' ' ILE . 11.4 m -151.93 165.86 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.738 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.542 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -98.22 125.18 43.17 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.447 HG21 HG11 ' A' ' 24' ' ' VAL . 94.0 t -102.88 128.13 56.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.86 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.612 ' OE2' ' NH1' ' A' ' 66' ' ' ARG . 6.1 tt0 -100.33 110.28 22.5 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.395 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.697 HD21 HD13 ' A' ' 32' ' ' ILE . 17.0 mt -89.55 148.92 23.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.599 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.2 p -99.61 142.04 23.89 Favored Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 119.364 -0.934 . . . . 0.0 112.087 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.21 -3.68 6.57 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.732 1.621 . . . . 0.0 111.559 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -87.96 -23.36 23.88 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.051 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.665 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.4 OUTLIER -166.65 96.09 0.54 Allowed 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.309 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -67.69 18.51 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.563 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.665 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -103.63 -9.77 18.93 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.215 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -137.78 144.73 41.73 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.786 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.31 -152.27 5.67 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.308 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.612 ' NH1' ' OE2' ' A' ' 56' ' ' GLU . 4.1 ptt180 -162.42 152.03 15.94 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.925 -1.11 . . . . 0.0 111.469 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.646 HD12 HG21 ' A' ' 53' ' ' VAL . 33.5 mm -92.75 121.21 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.625 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 1.4 p -126.98 6.95 6.6 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.701 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.866 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.19 111.7 0.72 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.068 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.515 ' C ' ' CD ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -102.57 159.9 15.04 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.972 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.422 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 3.2 tptt -135.77 142.35 44.93 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.396 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 116.28 -1.819 . . . . 0.0 110.874 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mmm . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.869 0.366 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.42 -36.08 17.93 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.576 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -89.57 -78.72 0.35 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.632 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.75 -176.05 5.04 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.02 109.7 17.87 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.612 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.85 163.61 3.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mm -98.08 104.22 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.46 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -73.35 112.64 9.6 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.988 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mt -137.13 136.15 38.02 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.352 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.406 ' O ' HD23 ' A' ' 26' ' ' LEU . 28.5 tt0 -91.47 140.96 29.25 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.515 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.52 -166.98 11.02 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.038 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.544 ' N ' HG13 ' A' ' 24' ' ' VAL . 51.2 m -137.44 128.77 28.02 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.517 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.71 130.44 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.485 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.1 t -120.89 -32.42 3.98 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.13 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.22 155.5 46.03 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.573 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.13 126.68 39.51 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.958 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.59 144.26 31.5 Favored Pre-proline 0 N--CA 1.494 1.749 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.354 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 3.3 Cg_endo -64.92 164.41 24.79 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 121.539 1.492 . . . . 0.0 111.57 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.484 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 0.9 OUTLIER 76.2 34.12 0.53 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.257 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.82 61.1 2.51 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.289 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.596 ' SD ' ' CE1' ' A' ' 35' ' ' HIS . 5.2 ptm -162.52 174.78 12.2 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.597 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.764 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.25 161.5 30.79 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.696 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -84.6 138.55 32.65 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.551 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.544 HG13 ' N ' ' A' ' 12' ' ' THR . 2.0 t -127.34 131.65 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.186 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -97.13 123.65 40.95 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.95 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' GLY . 42.0 mt -74.25 155.93 37.75 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.402 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 28' ' ' ASN . 12.3 pt-20 -47.26 -40.25 16.21 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.944 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.521 ' HB3' ' ND1' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -67.53 -16.62 64.29 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.456 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 26' ' ' LEU . . . 108.89 -1.77 31.78 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.333 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.521 ' ND1' ' HB3' ' A' ' 28' ' ' ASN . 60.5 m80 -75.58 138.28 41.35 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.564 -1.254 . . . . 0.0 111.567 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.44 138.0 38.1 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.313 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.48 ' C ' HD12 ' A' ' 33' ' ' LEU . 22.0 mt -146.65 154.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.963 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 33' ' ' LEU . 7.1 mp -90.9 133.69 35.05 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.352 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.441 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 1.1 p -133.77 144.71 49.21 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.013 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.596 ' CE1' ' SD ' ' A' ' 21' ' ' MET . 13.6 m-70 -108.56 178.23 4.55 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.875 HG23 HD21 ' A' ' 40' ' ' LEU . 49.5 mt -112.25 156.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.782 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.435 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 4.6 m -107.03 155.72 19.52 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.519 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.26 -6.45 87.75 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.751 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -74.35 -59.12 2.87 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.068 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.875 HD21 HG23 ' A' ' 36' ' ' ILE . 1.9 pp -54.24 -20.55 7.16 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.539 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -70.98 -49.2 47.9 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.409 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.47 ' C ' ' H ' ' A' ' 44' ' ' PHE . 8.8 ttm -55.58 -34.99 65.29 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.585 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.1 13.12 0.33 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.47 ' H ' ' C ' ' A' ' 42' ' ' MET . 0.1 OUTLIER 56.69 34.78 25.14 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.614 -0.835 . . . . 0.0 111.296 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.634 HG22 ' N ' ' A' ' 46' ' ' ARG . 28.8 mm -98.21 170.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.251 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.634 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -149.18 154.07 38.6 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.594 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 47' ' ' ILE . 29.4 mt -132.21 144.37 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.712 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.2 mt -132.48 171.46 13.74 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.495 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 152.36 44.31 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.224 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.17 -13.96 30.09 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.229 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 0.9 OUTLIER -80.57 135.61 36.11 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.576 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.493 ' C ' HG13 ' A' ' 53' ' ' VAL . 56.9 mttt -75.24 150.19 38.66 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.029 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.765 HG21 HD11 ' A' ' 67' ' ' ILE . 29.1 m -151.93 166.29 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.94 -1.104 . . . . 0.0 112.429 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.533 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -96.6 121.11 38.07 Favored 'General case' 0 C--O 1.203 -1.382 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.714 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -104.63 123.31 58.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.345 -0.942 . . . . 0.0 113.07 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -101.1 106.4 17.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.747 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.0 mt -81.14 147.31 30.12 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.675 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 p -98.16 138.08 20.87 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.485 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.4 -9.71 21.2 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.735 1.623 . . . . 0.0 112.074 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -90.53 -22.44 21.31 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.405 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.653 ' C ' ' H ' ' A' ' 63' ' ' THR . 15.5 m-20 -153.53 89.29 1.33 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.375 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mt -69.12 20.42 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.474 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.653 ' H ' ' C ' ' A' ' 61' ' ' ASP . 59.0 m -108.7 -9.84 15.22 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.513 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -138.46 148.26 44.18 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.58 -161.92 8.97 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.526 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 8.3 ptt180 -156.48 131.35 9.02 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.61 -1.236 . . . . 0.0 111.93 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.765 HD11 HG21 ' A' ' 53' ' ' VAL . 66.3 mt -95.44 129.21 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.59 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -127.97 7.32 6.09 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.49 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.781 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -168.2 111.87 0.61 Allowed 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.75 -1.18 . . . . 0.0 112.209 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -73.45 151.93 40.93 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.483 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -44.1 111.61 0.31 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.916 -1.113 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.809 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 mmt . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.869 0.366 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.18 173.81 11.96 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -90.24 -179.36 5.62 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.835 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -136.86 71.92 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.507 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -111.57 18.04 19.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.518 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.531 HG12 ' HD3' ' A' ' 59' ' ' PRO . 2.6 m -92.77 141.31 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.583 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.646 ' HB ' HD12 ' A' ' 57' ' ' LEU . 51.7 mt -95.95 101.94 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.258 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.7 114.12 9.46 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 55' ' ' VAL . 7.4 mt -131.0 150.99 51.88 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.456 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -97.75 144.26 27.55 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.908 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.54 -175.48 23.36 Favored Glycine 0 N--CA 1.483 1.767 0 C-N-CA 118.885 -1.626 . . . . 0.0 110.335 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.23 131.21 45.42 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.205 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.432 ' CG1' ' HA ' ' A' ' 49' ' ' GLU . 87.4 t -63.52 116.18 3.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 118.434 -1.306 . . . . 0.0 110.187 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 p -95.46 -37.52 10.88 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.749 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -146.19 151.88 38.33 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 118.558 -1.257 . . . . 0.0 111.792 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.443 ' HB2' ' CD ' ' A' ' 49' ' ' GLU . . . -100.92 130.57 46.94 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.494 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.6 mt -121.91 151.07 57.35 Favored Pre-proline 0 N--CA 1.488 1.469 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 20' ' ' ALA . 1.9 Cg_endo -61.13 -156.5 0.02 OUTLIER 'Trans proline' 0 C--O 1.204 -1.182 0 C-N-CA 121.452 1.435 . . . . 0.0 111.007 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.63 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 25.4 m120 46.8 12.72 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.87 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 71.09 42.94 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.914 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.4 170.48 15.94 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.252 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.677 ' N ' ' CD2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.73 165.84 29.75 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.443 -0.903 . . . . 0.0 112.216 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -97.06 136.89 36.97 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.887 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.1 t -129.68 143.56 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.163 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -102.88 118.87 37.77 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.197 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.944 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.2 mp -74.19 168.88 18.72 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.793 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.62 -19.42 65.22 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.022 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -68.44 -16.24 63.83 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.445 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.44 -10.85 50.51 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -91.31 177.55 6.21 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.168 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -132.8 140.19 47.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.904 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.761 HG22 ' N ' ' A' ' 33' ' ' LEU . 8.4 mm -134.58 173.27 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.386 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.761 ' N ' HG22 ' A' ' 32' ' ' ILE . 20.2 mt -90.59 145.35 24.93 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.568 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.436 ' SG ' HG13 ' A' ' 55' ' ' VAL . 90.8 m -134.91 152.26 51.59 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.188 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.52 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 33.2 t-80 -128.0 147.51 50.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.156 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.617 HG22 ' N ' ' A' ' 37' ' ' SER . 28.3 mt -86.83 166.84 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.492 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.617 ' N ' HG22 ' A' ' 36' ' ' ILE . 6.4 p -154.07 159.12 41.39 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.354 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.31 -4.9 0.09 OUTLIER Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.489 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.579 ' H ' ' C ' ' A' ' 37' ' ' SER . 0.7 OUTLIER -62.46 -61.17 2.62 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.472 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.574 HD21 ' HA ' ' A' ' 68' ' ' THR . 10.2 mt -51.56 -21.51 2.57 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.441 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.405 ' N ' ' C ' ' A' ' 39' ' ' LYS . 2.3 mmm180 -83.44 -25.79 30.9 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.333 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' LYS . 13.7 ttp -89.79 -21.39 22.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.262 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -93.23 3.87 54.94 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.788 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 52.06 66.49 1.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.725 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.621 ' CG2' ' N ' ' A' ' 46' ' ' ARG . 26.5 mt -146.22 165.58 8.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.105 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.621 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 50.3 ttm-85 -133.21 140.85 47.76 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.398 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.506 HD12 HD13 ' A' ' 40' ' ' LEU . 58.9 mt -132.44 149.04 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.263 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.839 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.9 pt? -142.97 -176.82 5.05 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.72 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 23.3 mt-10 -75.42 152.24 38.01 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.259 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.51 -14.07 37.55 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.074 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.15 143.37 26.75 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.859 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.484 ' C ' HG13 ' A' ' 53' ' ' VAL . 2.9 tttt -75.63 154.33 36.69 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.711 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.752 HG21 ' CD1' ' A' ' 67' ' ' ILE . 31.6 m -154.8 171.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.482 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.555 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -103.36 123.92 47.72 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG13 ' SG ' ' A' ' 34' ' ' CYS . 3.1 t -103.36 134.21 45.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.648 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.81 111.63 22.92 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.118 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.646 HD12 ' HB ' ' A' ' 7' ' ' ILE . 8.8 mt -77.8 121.58 24.27 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.672 -1.211 . . . . 0.0 108.981 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 60' ' ' TYR . 1.5 m -80.49 130.04 66.55 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.941 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.531 ' HD3' HG12 ' A' ' 6' ' ' VAL . 2.5 Cg_endo -61.05 -1.25 1.59 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.339 1.359 . . . . 0.0 110.646 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 58' ' ' SER . 5.7 m-30 -84.6 -21.56 30.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.608 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.4 t0 -169.82 100.64 0.31 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.046 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mt -69.25 19.31 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.876 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.608 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.1 p -102.71 -12.19 17.84 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.264 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.477 ' HG2' ' N ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -148.93 144.57 26.92 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.923 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.477 ' N ' ' HG2' ' A' ' 64' ' ' ARG . . . -120.7 -156.57 9.89 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.46 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 9.1 ptm180 -157.41 147.03 20.28 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.502 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.752 ' CD1' HG21 ' A' ' 53' ' ' VAL . 1.9 mm -94.04 118.02 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.212 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.624 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 72.2 p -127.17 7.79 6.57 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.24 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.846 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -173.66 118.49 0.28 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 118.621 -1.232 . . . . 0.0 112.403 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -68.68 161.77 27.49 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.881 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.447 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 12.2 tttp -45.68 157.1 0.11 Allowed 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.581 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 71' ' ' LYS . 7.5 ttmt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.779 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.823 0.344 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.27 75.65 0.39 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 4' ' ' LYS . 2.4 tppp? -91.85 147.69 22.78 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 3' ' ' LYS . 10.7 mttp 51.08 85.99 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.857 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.71 145.72 0.42 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.428 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.59 HG22 ' H ' ' A' ' 7' ' ' ILE . 4.7 p -77.46 174.02 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.032 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.59 ' H ' HG22 ' A' ' 6' ' ' VAL . 24.5 mm -104.02 101.78 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.561 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 4.9 pt-20 -103.71 118.83 37.63 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.9 mt -132.25 161.25 33.92 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.431 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -87.96 135.37 33.44 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.798 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.83 154.6 26.04 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -104.9 127.87 52.9 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.856 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 22' ' ' PHE . 19.4 t -59.01 127.03 17.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 118.67 -1.212 . . . . 0.0 110.552 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.35 -39.48 8.38 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.526 -0.87 . . . . 0.0 113.013 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.09 136.27 17.57 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.231 -1.388 . . . . 0.0 112.17 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.89 113.55 21.04 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.58 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 21' ' ' MET . 64.4 mt -100.11 150.07 36.57 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.107 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 3.3 Cg_exo -56.78 160.23 12.52 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.219 1.28 . . . . 0.0 111.478 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.9 t-20 76.85 28.04 0.7 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.641 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.484 ' O ' ' CD2' ' A' ' 35' ' ' HIS . . . 55.42 61.94 2.66 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.544 -0.863 . . . . 0.0 111.928 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.503 ' HG3' ' N ' ' A' ' 22' ' ' PHE . 4.6 ttt -153.59 150.81 29.04 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.503 ' N ' ' HG3' ' A' ' 21' ' ' MET . 0.0 OUTLIER -145.38 164.85 30.21 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.298 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -99.84 113.98 26.87 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.389 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.522 HG11 HG21 ' A' ' 55' ' ' VAL . 70.8 t -94.2 150.35 4.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.125 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -121.47 111.15 16.92 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.428 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.03 ' H ' HD12 ' A' ' 26' ' ' LEU . 3.6 mp -71.25 162.88 28.71 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.139 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.65 -18.07 64.61 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.588 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.05 -16.44 63.46 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.807 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.93 -5.86 43.07 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -102.99 178.71 4.48 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.929 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 5.4 pm0 -138.71 158.72 43.71 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.994 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.701 HG22 ' N ' ' A' ' 33' ' ' LEU . 81.8 mt -141.76 167.6 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.732 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.701 ' N ' HG22 ' A' ' 32' ' ' ILE . 3.6 mp -91.51 138.14 31.81 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.238 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.44 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 4.8 m -141.84 133.16 26.5 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.647 ' CG ' ' N ' ' A' ' 36' ' ' ILE . 51.9 t-80 -107.49 176.85 5.02 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.713 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.651 ' CG2' ' N ' ' A' ' 37' ' ' SER . 26.0 mt -103.92 167.1 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.256 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.9 ' OG ' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -123.32 110.13 14.79 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.96 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.63 -26.02 0.12 Allowed Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.821 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -69.74 -56.35 7.41 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.942 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -51.32 -21.78 2.42 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.779 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' NH2' HG21 ' A' ' 36' ' ' ILE . 5.1 ttm-85 -68.46 -47.36 67.34 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.195 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.424 ' C ' ' H ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -52.78 -31.85 40.66 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.489 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.642 ' C ' ' CD2' ' A' ' 44' ' ' PHE . 2.5 t-20 -79.33 19.48 0.59 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.474 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.642 ' CD2' ' C ' ' A' ' 43' ' ' ASN . 6.6 p90 38.88 87.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.714 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.4 mt -140.92 88.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.77 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HG3' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -80.33 128.25 33.33 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.175 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -132.63 128.57 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.669 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' GLU . 83.1 mt -108.26 150.82 26.79 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.823 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 48' ' ' LEU . 1.7 tm-20 -38.48 151.44 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.771 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.74 -11.95 50.28 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.241 -1.457 . . . . 0.0 109.861 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -82.09 133.9 35.3 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.696 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.477 ' C ' HG13 ' A' ' 53' ' ' VAL . 56.5 mttp -77.83 143.68 37.66 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.078 -1.049 . . . . 0.0 111.221 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.689 ' CG2' HD12 ' A' ' 67' ' ' ILE . 35.1 m -149.87 169.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.745 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 41.2 m-20 -91.74 124.66 36.04 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG21 HG11 ' A' ' 24' ' ' VAL . 40.0 t -103.65 119.17 51.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.679 -0.808 . . . . 0.0 112.529 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.421 ' CG ' HG21 ' A' ' 6' ' ' VAL . 79.4 tt0 -91.78 113.28 25.5 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.963 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.428 ' CD2' HD13 ' A' ' 32' ' ' ILE . 10.2 mt -101.65 148.77 24.86 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.238 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 m -83.12 121.21 77.03 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.688 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -59.95 -16.45 38.76 Favored 'Trans proline' 0 C--O 1.217 -0.563 0 C-N-CA 121.254 1.302 . . . . 0.0 111.846 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -106.2 -10.88 16.25 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.485 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.587 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -138.75 77.44 1.62 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.884 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.0 mt -74.29 27.77 0.08 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.091 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.587 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.9 OUTLIER -102.4 -29.69 11.48 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.976 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -139.29 160.51 39.65 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.047 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.17 -157.41 7.18 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.41 140.06 5.95 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.249 -1.38 . . . . 0.0 112.357 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.689 HD12 ' CG2' ' A' ' 53' ' ' VAL . 39.0 mm -92.32 108.62 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.727 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.9 HG22 ' OG ' ' A' ' 37' ' ' SER . 21.5 p -128.84 8.1 5.7 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.837 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.827 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -164.47 120.39 1.52 Allowed 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 118.087 -1.445 . . . . 0.0 112.782 -179.684 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.36 152.18 36.4 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.66 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -79.79 148.19 31.52 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.419 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tttp . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.098 179.949 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 tmm? . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.7 -14.45 48.37 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.552 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -92.96 37.99 1.03 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.83 78.25 1.58 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.77 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 5' ' ' ASP . 6.0 p30 -153.4 21.94 0.55 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.281 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG22 ' H ' ' A' ' 7' ' ' ILE . 3.6 p -173.14 168.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.136 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 62' ' ' LEU . 3.2 mt -113.85 100.62 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.842 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.24 125.01 41.52 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.735 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.3 mt -142.34 151.89 42.38 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.555 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 25.5 mp0 -86.33 138.95 31.42 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.159 -1.017 . . . . 0.0 109.971 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.12 -177.07 15.96 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 119.127 -1.511 . . . . 0.0 109.564 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.51 ' C ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -128.81 124.33 35.13 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.446 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 50' ' ' GLY . 11.3 t -59.97 132.99 25.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.0 p -110.46 -29.69 7.98 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.864 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -149.14 157.45 43.39 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.738 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.74 126.09 54.85 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.7 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.3 mt -119.74 150.33 50.18 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.22 171.7 2.99 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.293 1.329 . . . . 0.0 111.276 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 68.99 31.15 4.26 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.668 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 41' ' ' ARG . . . 55.3 52.44 11.46 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.585 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 mmm -141.02 142.24 34.25 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.874 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -143.58 157.69 44.23 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.245 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -96.66 129.2 44.1 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.219 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.51 HG13 ' C ' ' A' ' 12' ' ' THR . 14.1 t -121.42 150.47 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.528 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -126.57 128.58 47.05 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.953 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.706 HD12 HD11 ' A' ' 32' ' ' ILE . 12.4 mt -85.41 142.75 29.04 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.101 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -49.7 -26.75 4.03 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.943 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -63.8 -17.05 62.7 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.291 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.92 -0.59 38.72 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.526 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -93.23 145.2 24.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.187 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.86 141.53 37.94 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.179 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.706 HD11 HD12 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -139.85 146.78 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.943 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 6.3 mp -93.09 125.26 37.59 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.63 ' SG ' HG13 ' A' ' 55' ' ' VAL . 73.2 m -118.52 155.62 30.54 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.149 -1.02 . . . . 0.0 112.451 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -118.26 155.79 29.96 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.733 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.578 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 37.7 mt -95.04 149.84 4.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.789 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.515 ' O ' HG22 ' A' ' 36' ' ' ILE . 73.1 m -88.32 -172.76 3.91 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.007 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.88 -21.4 63.48 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.578 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.615 ' CG ' ' N ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -72.26 -55.91 6.4 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.489 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.615 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 2.4 mp -54.82 -21.69 12.05 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.445 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -72.2 -40.2 68.02 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.534 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.1 mmm -72.15 -31.46 65.98 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.759 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -74.0 -34.07 64.05 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.294 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.0 t80 40.12 61.63 1.47 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.818 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.676 HG22 ' H ' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -86.78 -165.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.158 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.676 ' H ' HG22 ' A' ' 45' ' ' ILE . 12.7 ptt85 -119.46 74.36 1.0 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 48' ' ' LEU . 4.6 mm -98.08 144.24 11.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.402 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 47' ' ' ILE . 4.4 mp -126.78 152.55 46.76 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.726 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 48' ' ' LEU . 2.9 pp20? -40.27 152.44 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.194 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 97.63 -15.05 62.54 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.26 131.91 39.55 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.262 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -77.62 146.46 36.15 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.296 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.534 ' HB ' HG23 ' A' ' 67' ' ' ILE . 35.8 m -152.45 171.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.972 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.591 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 2.0 m-80 -97.99 117.8 33.14 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.63 HG13 ' SG ' ' A' ' 34' ' ' CYS . 13.9 t -104.68 126.74 59.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.665 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.91 117.14 34.37 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.648 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.524 ' CD2' HG21 ' A' ' 32' ' ' ILE . 3.9 mt -99.27 149.16 23.4 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.907 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.36 136.13 30.35 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -59.54 -10.87 12.32 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.556 1.504 . . . . 0.0 111.715 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CD2' ' OD2' ' A' ' 61' ' ' ASP . 8.5 t80 -101.95 -14.45 17.19 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.608 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.627 ' C ' ' H ' ' A' ' 63' ' ' THR . 57.2 m-20 -144.19 79.8 1.63 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.564 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.534 ' CD2' HD12 ' A' ' 7' ' ' ILE . 5.0 mt -71.06 20.28 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.292 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.627 ' H ' ' C ' ' A' ' 61' ' ' ASP . 10.6 p -118.63 -9.68 10.19 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.298 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.501 HH21 ' HB2' ' A' ' 64' ' ' ARG . 37.3 mtp-105 -133.7 143.95 48.83 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.075 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.85 -153.48 6.25 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.597 -1.287 . . . . 0.0 109.897 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -162.68 147.5 11.95 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.504 -1.279 . . . . 0.0 112.134 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.534 HG23 ' HB ' ' A' ' 53' ' ' VAL . 20.5 mm -93.55 110.35 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.027 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.619 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 3.3 p -118.17 6.83 12.03 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.84 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -166.9 110.41 0.72 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 118.673 -1.211 . . . . 0.0 111.331 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.8 ptt-85 -76.27 136.89 39.64 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.435 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.63 145.85 11.18 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.904 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.7 pttm . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.918 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.19 16.65 1.9 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.955 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp 57.32 174.8 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.646 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 6.8 mttp 47.16 -159.02 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.869 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 1.2 t0 73.01 -144.61 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.167 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.666 HG12 ' HD3' ' A' ' 59' ' ' PRO . 0.7 OUTLIER -74.27 157.18 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.613 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.1 100.26 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 119.167 -1.013 . . . . 0.0 109.556 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.02 112.31 20.5 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.654 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 9' ' ' LEU . 23.8 mt -137.58 149.69 46.88 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.467 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.78 144.39 25.76 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.894 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA3' HD23 ' A' ' 26' ' ' LEU . . . -145.46 -155.0 6.31 Favored Glycine 0 N--CA 1.481 1.681 0 C-N-CA 119.149 -1.501 . . . . 0.0 109.766 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 50' ' ' GLY . 31.1 m -145.24 130.62 18.68 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.026 -1.07 . . . . 0.0 111.138 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.423 ' HA ' HG22 ' A' ' 24' ' ' VAL . 11.4 t -59.6 123.12 11.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.145 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -100.4 -30.31 11.91 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.73 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -150.3 155.03 38.91 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.821 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.98 123.57 48.86 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.501 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.2 mt -121.98 151.16 57.73 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.179 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.92 -178.8 0.34 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.269 1.313 . . . . 0.0 111.544 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.608 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.6 OUTLIER 69.41 14.94 8.44 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.134 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 68.28 43.82 1.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.072 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtm -144.73 152.47 40.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.774 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -144.85 165.88 26.86 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.876 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -95.58 124.3 39.54 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.387 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 13' ' ' VAL . 78.4 t -118.52 141.25 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.956 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -118.76 113.59 21.38 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.793 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.544 HD23 ' HA3' ' A' ' 11' ' ' GLY . 26.1 mt -67.38 137.75 56.2 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.494 -0.883 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.45 -12.29 0.06 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.522 -1.271 . . . . 0.0 109.179 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.54 ' N ' ' C ' ' A' ' 26' ' ' LEU . 17.7 m120 -72.5 -17.23 61.77 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.41 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.42 0.39 35.01 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.96 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -101.22 136.3 41.29 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.969 -1.093 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.623 ' C ' HD12 ' A' ' 32' ' ' ILE . 8.1 pt-20 -109.27 132.09 54.45 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.301 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 32' ' ' ILE . 4.7 mp -141.37 165.55 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.043 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.636 ' N ' HG22 ' A' ' 32' ' ' ILE . 7.0 mp -89.28 134.32 34.1 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.329 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.519 ' CB ' HD13 ' A' ' 67' ' ' ILE . 80.0 m -128.55 148.33 50.76 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.276 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.469 ' ND1' ' O ' ' A' ' 36' ' ' ILE . 48.9 t-80 -114.81 154.97 27.62 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.273 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.65 HG23 HD21 ' A' ' 40' ' ' LEU . 51.5 mt -90.75 153.32 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.087 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 6.0 m -82.6 126.51 32.39 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.931 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.4 -12.19 0.89 Allowed Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.453 -1.356 . . . . 0.0 111.315 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -80.7 -63.01 1.5 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.257 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.65 HD21 HG23 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -59.03 -18.61 36.15 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.38 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -71.64 -40.51 69.67 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.89 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.546 ' C ' ' H ' ' A' ' 44' ' ' PHE . 7.6 mmt -61.72 -35.82 79.17 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -58.92 -0.3 0.11 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.247 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.546 ' H ' ' C ' ' A' ' 42' ' ' MET . 4.8 t80 55.21 45.11 26.53 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.309 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 46' ' ' ARG . 6.2 mm -98.55 157.49 3.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.096 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' N ' HG22 ' A' ' 45' ' ' ILE . 3.3 mtp180 -150.03 99.14 2.79 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.818 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.542 HD11 ' CG ' ' A' ' 51' ' ' ASP . 5.1 tt -87.42 149.13 4.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.576 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.904 ' N ' HD12 ' A' ' 48' ' ' LEU . 3.5 mp -83.75 135.35 34.58 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.25 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 49' ' ' GLU . 4.8 mm-40 -44.66 153.26 0.17 Allowed 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.891 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . 92.4 -15.19 62.86 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.253 -1.451 . . . . 0.0 109.628 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.542 ' CG ' HD11 ' A' ' 47' ' ' ILE . 10.2 t70 -72.79 152.95 41.32 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.046 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.472 ' C ' HG13 ' A' ' 53' ' ' VAL . 2.0 mptm? -83.98 146.65 27.88 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.745 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.473 HG21 HG12 ' A' ' 67' ' ' ILE . 24.6 m -150.34 164.62 3.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.386 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.578 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -91.83 121.52 33.52 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.507 HG13 ' SG ' ' A' ' 34' ' ' CYS . 2.3 t -105.08 123.84 59.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.517 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.13 113.32 26.47 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.31 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.43 132.75 33.89 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.956 -1.098 . . . . 0.0 110.741 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 t -85.64 121.49 73.35 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.393 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.666 ' HD3' HG12 ' A' ' 6' ' ' VAL . 3.8 Cg_exo -61.98 -9.66 15.17 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 121.074 1.183 . . . . 0.0 110.942 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -94.27 -16.94 23.14 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.615 ' C ' ' H ' ' A' ' 63' ' ' THR . 13.8 m-20 -142.99 82.33 1.76 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.942 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.9 mt -71.21 24.09 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.768 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.615 ' H ' ' C ' ' A' ' 61' ' ' ASP . 42.0 m -122.91 -7.33 8.42 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.439 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -140.17 152.05 45.73 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.449 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 66' ' ' ARG . . . -137.56 -167.44 11.06 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.676 -1.77 . . . . 0.0 108.676 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.414 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 18.1 mtt85 -155.98 131.32 9.47 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.709 -1.597 . . . . 0.0 112.899 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 67' ' ' ILE . 1.4 mp -93.32 111.89 25.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.519 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.473 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 14.3 p -126.75 7.28 6.78 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.487 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.811 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -159.57 112.11 2.15 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.665 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -74.15 141.75 45.53 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.625 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -87.38 164.35 16.27 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.067 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 71' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.248 0 CA-C-O 116.304 -1.807 . . . . 0.0 110.578 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.445 HG21 ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.636 0.255 . . . . 0.0 111.018 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.1 mm -107.69 101.9 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.285 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -81.59 115.29 20.8 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.155 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 55' ' ' VAL . 20.2 mt -132.5 164.15 27.24 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.591 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.72 146.14 25.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.12 154.77 25.76 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.002 -1.571 . . . . 0.0 109.662 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -104.98 124.72 50.01 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 51' ' ' ASP . 5.2 t -61.13 113.84 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.16 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -88.12 -31.05 19.39 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.648 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -154.4 158.1 39.51 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.463 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.595 ' H ' ' CD ' ' A' ' 15' ' ' GLU . . . -124.48 124.36 42.13 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.733 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -120.43 162.59 33.38 Favored Pre-proline 0 N--CA 1.487 1.381 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.28 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 5.9 Cg_exo -55.98 179.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.67 1.58 . . . . 0.0 111.508 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.1 t-20 74.93 17.2 2.8 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.081 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.0 50.86 9.58 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.798 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.416 ' C ' HD12 ' A' ' 17' ' ' LEU . 25.8 mtt -142.77 171.64 13.77 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.715 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.726 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.44 166.32 29.45 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.479 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -100.04 143.56 30.1 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.25 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.699 HG23 ' SG ' ' A' ' 34' ' ' CYS . 19.1 t -132.62 137.42 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.326 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 25' ' ' LYS . 8.0 ptmm? -111.42 126.93 55.47 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.393 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.694 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.5 mp -87.45 153.21 21.61 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.799 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.725 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -57.67 -17.55 15.51 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.772 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -69.23 -14.73 63.13 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.693 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.68 -11.67 53.55 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.677 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -87.78 175.48 7.83 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.015 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.612 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -137.43 149.29 46.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.316 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 33' ' ' LEU . 50.7 mt -142.86 154.06 17.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.453 ' N ' ' CG2' ' A' ' 32' ' ' ILE . 10.0 mt -86.25 147.47 26.07 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.211 -0.995 . . . . 0.0 109.231 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -139.34 147.71 41.91 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.854 -1.139 . . . . 0.0 111.393 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 22.4 t-80 -119.04 155.55 31.26 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.286 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.754 HG23 HD21 ' A' ' 40' ' ' LEU . 46.8 mt -84.01 145.93 7.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.445 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 68' ' ' THR . 45.9 m -96.57 169.61 9.77 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.03 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.34 -14.09 80.79 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.335 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -75.58 -62.76 1.47 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.582 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.754 HD21 HG23 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -58.05 -19.69 33.48 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.616 -1.234 . . . . 0.0 109.086 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -42.92 70.45 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.034 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.483 ' O ' ' SD ' ' A' ' 42' ' ' MET . 4.4 tmm? -60.42 -33.68 72.85 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.696 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' HB3' HD11 ' A' ' 45' ' ' ILE . 36.5 m-20 -64.42 -17.7 64.03 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 118.769 -1.172 . . . . 0.0 109.873 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.419 ' C ' HD12 ' A' ' 45' ' ' ILE . 6.4 t80 67.7 73.67 0.31 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.067 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.635 ' CG2' ' N ' ' A' ' 46' ' ' ARG . 2.0 mp -117.85 165.86 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.337 0.589 . . . . 0.0 111.781 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.635 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 24.1 ttt180 -144.85 74.52 1.41 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.069 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 tt -77.19 149.6 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.119 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 49' ' ' GLU . 12.1 mt -120.4 139.57 52.61 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.072 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' LEU . 1.8 pm0 -38.21 148.07 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.007 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.16 -4.57 58.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.9 m-20 -98.37 139.58 33.92 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.088 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' C ' HG13 ' A' ' 53' ' ' VAL . 57.7 mttt -75.5 144.09 42.18 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.773 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.524 ' CG2' HD12 ' A' ' 67' ' ' ILE . 14.5 m -149.9 167.35 2.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.686 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.582 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -93.42 127.52 39.09 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 24' ' ' VAL . 2.9 t -104.15 129.56 56.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.438 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.445 ' OE1' HG21 ' A' ' 6' ' ' VAL . 36.5 tt0 -106.11 110.47 22.74 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.359 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.1 mt -88.01 143.17 27.24 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.065 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 60' ' ' TYR . 25.4 p -98.79 132.98 22.8 Favored Pre-proline 0 N--CA 1.492 1.658 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.118 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.4 -1.3 1.34 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.445 1.43 . . . . 0.0 111.442 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 58' ' ' SER . 5.6 t80 -81.13 -21.68 39.63 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.674 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.0 p30 179.88 105.78 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.908 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt -66.6 20.7 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.608 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.674 ' H ' ' C ' ' A' ' 61' ' ' ASP . 76.1 m -98.19 -14.4 20.38 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.044 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.423 ' NH2' ' OD1' ' A' ' 61' ' ' ASP . 17.2 mtp180 -138.83 146.61 41.47 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.197 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.57 -151.75 5.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.67 143.28 4.74 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.175 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.524 HD12 ' CG2' ' A' ' 53' ' ' VAL . 19.3 mm -93.15 119.05 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.592 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 7.2 p -126.62 7.38 6.88 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.685 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.85 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.16 111.87 0.73 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.378 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.5 ptt85 -111.36 146.28 37.4 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.255 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? . . . . . 0 C--N 1.302 -1.483 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.92 -179.959 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.5 mt -97.73 101.38 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.222 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -94.55 108.38 20.34 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 9' ' ' LEU . 10.8 mt -132.64 148.94 52.36 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.067 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.84 144.1 27.17 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.66 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.47 179.82 25.94 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 119.069 -1.539 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.4 m -124.16 131.05 53.5 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.445 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.457 HG23 ' H ' ' A' ' 13' ' ' VAL . 1.9 t -59.73 119.08 3.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 118.576 -1.249 . . . . 0.0 110.591 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' LYS . 5.7 t -88.88 -32.24 17.85 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.165 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -151.1 156.32 40.78 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.694 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.84 107.38 18.1 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.627 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.3 mt -99.79 144.52 28.5 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.099 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.9 Cg_endo -61.01 166.68 10.15 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.255 1.304 . . . . 0.0 111.037 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER 76.96 29.76 0.59 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.652 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.82 57.77 4.5 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.531 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.766 ' SD ' ' NE2' ' A' ' 35' ' ' HIS . 15.8 mtm -152.6 159.42 43.24 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.897 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.696 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -159.45 165.34 33.31 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.668 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 14' ' ' SER . 27.4 ttpt -103.29 114.3 28.47 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.657 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -98.51 146.98 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.303 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -124.2 114.4 19.57 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.746 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.539 ' C ' ' N ' ' A' ' 28' ' ' ASN . 10.6 mt -69.58 147.07 51.22 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.659 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.643 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -49.31 -11.36 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.959 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.643 ' N ' ' CD ' ' A' ' 27' ' ' GLU . 36.6 t30 -78.84 -17.79 55.08 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.7 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.69 -2.18 42.13 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.804 -1.189 . . . . 0.0 112.294 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -94.29 137.56 33.31 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.069 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -91.53 141.26 28.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.491 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.415 ' C ' HD12 ' A' ' 33' ' ' LEU . 7.5 mm -137.93 144.53 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.248 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.796 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.2 mp -85.85 134.41 33.91 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.14 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.0 m -139.57 151.35 45.99 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.399 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.766 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 18.3 m80 -115.55 161.82 18.09 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.654 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.532 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 27.9 mt -92.59 146.06 6.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.66 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.439 ' O ' HG22 ' A' ' 36' ' ' ILE . 3.2 m -92.47 -178.34 4.88 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.21 -8.61 87.44 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.854 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -75.12 -62.18 1.64 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.48 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.526 HD13 HG23 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -53.69 -20.68 5.74 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.188 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -73.52 -39.19 64.97 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.308 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.61 -28.62 67.08 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.397 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -77.55 -16.28 58.75 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.618 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.2 t80 47.66 80.94 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.551 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 45' ' ' ILE . 33.5 mt -144.86 113.21 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.019 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -60.27 126.1 26.18 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.688 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 mm -95.12 148.28 5.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.551 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 48' ' ' LEU . 14.3 tp -125.08 135.45 52.71 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.083 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.21 152.34 0.59 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.932 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.02 -16.4 59.62 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.247 -1.454 . . . . 0.0 109.667 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.91 162.21 29.79 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.425 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.73 141.4 36.54 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.377 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.436 ' CG2' HG13 ' A' ' 67' ' ' ILE . 5.3 m -148.57 162.49 5.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.583 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 2.0 m-20 -92.46 124.09 36.25 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.23 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.57 142.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.644 -0.823 . . . . 0.0 112.254 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -122.84 108.64 13.23 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.405 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.1 mt -84.42 132.29 34.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.391 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.7 p -91.01 139.33 25.81 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 119.024 -1.07 . . . . 0.0 112.152 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.32 -4.9 8.73 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.518 1.479 . . . . 0.0 111.403 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -89.15 -22.82 22.64 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.724 -0.79 . . . . 0.0 108.98 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.644 ' C ' ' H ' ' A' ' 63' ' ' THR . 4.1 m-20 -151.34 89.31 1.49 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mt -69.89 23.06 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.417 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.644 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.1 m -119.53 -8.59 9.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.169 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.25 150.43 39.28 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.236 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.8 -152.57 6.42 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -166.36 143.76 5.2 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.146 -1.422 . . . . 0.0 112.166 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 67' ' ' ILE . 1.3 mp -92.34 121.7 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.22 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.57 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 70.2 p -124.7 7.08 8.16 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.076 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.863 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.67 111.02 0.65 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.646 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.36 162.91 28.4 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.114 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.928 0.394 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 mt -94.46 102.44 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.575 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 1.9 mm-40 -80.38 117.04 20.79 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.156 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.2 mt -128.95 150.73 50.26 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.222 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -88.18 142.64 27.6 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.393 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.7 165.61 31.59 Favored Glycine 0 N--CA 1.485 1.941 0 C-N-CA 119.172 -1.489 . . . . 0.0 110.221 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.439 ' C ' HG13 ' A' ' 24' ' ' VAL . 33.7 m -113.7 125.79 54.51 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.739 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.99 112.06 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 118.624 -1.23 . . . . 0.0 110.546 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -90.36 -32.75 16.33 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.429 -0.908 . . . . 0.0 112.141 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -152.56 137.85 17.51 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.389 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.37 117.12 32.07 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.376 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -106.86 155.22 39.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.618 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.54 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 3.7 Cg_exo -56.54 -164.3 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.879 0 C-N-CA 121.334 1.356 . . . . 0.0 112.126 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 18' ' ' PRO . 8.0 p30 46.63 31.34 1.35 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.062 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' A' ' 36' ' ' ILE . . . 52.07 58.08 5.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.981 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.51 ' SD ' ' OD1' ' A' ' 19' ' ' ASN . 37.0 mtp -149.85 137.59 20.11 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.714 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -130.71 163.22 27.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.424 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -103.84 108.88 20.39 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.521 ' CG2' ' SG ' ' A' ' 34' ' ' CYS . 36.6 t -94.93 152.48 3.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.375 -0.93 . . . . 0.0 112.01 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -120.74 110.91 16.94 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.825 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.692 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.1 mp -65.45 178.6 0.92 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.545 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -77.23 -23.69 51.32 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.649 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.857 HD22 ' H ' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -66.12 -15.82 63.43 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.494 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.36 -8.23 35.13 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.068 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.857 ' H ' HD22 ' A' ' 28' ' ' ASN . 22.3 m80 -95.76 176.8 6.0 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.676 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -138.34 160.46 39.43 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.82 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 33' ' ' LEU . 76.7 mt -143.53 161.67 16.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.1 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.679 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 3.9 mp -86.37 131.51 34.19 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.549 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 8.2 m -132.99 135.28 45.38 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.658 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 2.4 t60 -102.31 173.68 6.26 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.509 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.658 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 10.7 mt -91.3 165.91 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.998 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.644 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -128.2 160.77 31.04 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.946 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.97 -20.01 66.18 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.341 -1.409 . . . . 0.0 111.594 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.42 ' C ' ' N ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -67.81 -62.27 1.49 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.342 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -52.83 -20.25 3.12 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.808 -1.157 . . . . 0.0 109.643 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.437 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.35 -42.81 68.03 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.406 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.476 ' C ' ' H ' ' A' ' 44' ' ' PHE . 1.4 ptm -72.4 -22.32 61.14 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.298 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.472 ' N ' ' HG3' ' A' ' 42' ' ' MET . 7.2 m120 -67.09 6.51 0.52 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.801 -1.16 . . . . 0.0 110.646 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 42' ' ' MET . 0.8 OUTLIER 48.19 82.32 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.876 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 mm -142.46 147.06 21.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.088 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.78 75.13 1.51 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.572 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.452 HG21 ' CB ' ' A' ' 51' ' ' ASP . 42.8 mt -105.79 149.59 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.771 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.3 mt -110.72 165.8 11.54 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.517 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -40.41 153.26 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.47 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.26 -12.18 65.25 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.588 -1.292 . . . . 0.0 109.873 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.452 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -92.6 152.63 19.48 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.74 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 66.1 mttt -78.41 147.43 34.04 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.629 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.464 HG13 ' C ' ' A' ' 52' ' ' LYS . 33.9 m -149.58 162.44 4.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.643 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.516 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -95.2 123.04 38.49 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.453 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 9' ' ' LEU . 61.1 t -104.35 127.5 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.625 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.65 113.69 26.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.946 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.406 ' CD2' HD13 ' A' ' 32' ' ' ILE . 23.8 mt -88.48 147.26 24.75 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.752 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.05 135.2 33.65 Favored Pre-proline 0 N--CA 1.492 1.648 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.18 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -65.1 -4.93 9.92 Favored 'Trans proline' 0 C--O 1.217 -0.548 0 C-N-CA 121.625 1.55 . . . . 0.0 112.068 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.78 -22.05 14.98 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.083 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.617 ' C ' ' H ' ' A' ' 63' ' ' THR . 33.0 t0 -155.23 91.64 1.36 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.55 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.33 19.83 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.464 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.617 ' H ' ' C ' ' A' ' 61' ' ' ASP . 53.2 m -99.92 -13.33 19.19 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.011 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -137.67 147.31 44.76 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.13 -159.33 7.89 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.455 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 5.8 ptp180 -154.71 143.88 21.12 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.842 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.2 mm -93.26 122.05 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.296 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.635 ' OG1' ' NE1' ' A' ' 69' ' ' TRP . 5.0 p -126.47 6.4 6.93 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.012 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.859 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -158.4 157.72 32.84 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.315 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -154.32 88.72 1.24 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.063 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.309 -1.175 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.655 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 58' ' ' SER . 11.9 m . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.926 0.393 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 mm -95.61 106.72 18.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.415 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.53 112.55 13.18 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.194 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 9' ' ' LEU . 25.0 mt -134.0 164.95 26.17 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.611 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -90.01 143.84 26.43 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.8 148.32 18.8 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.413 HG21 ' NZ ' ' A' ' 25' ' ' LYS . 20.1 m -104.27 132.13 50.85 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 51' ' ' ASP . 4.2 t -63.36 117.66 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.619 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.09 -29.46 13.61 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.319 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -150.09 121.9 8.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.122 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.46 105.34 17.69 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.034 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.42 149.03 36.61 Favored Pre-proline 0 C--N 1.307 -1.259 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.799 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 2.3 Cg_endo -58.72 167.21 5.51 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.308 1.339 . . . . 0.0 111.229 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 75.79 29.94 0.8 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.573 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.546 ' O ' ' CD2' ' A' ' 35' ' ' HIS . . . 54.16 61.37 3.07 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.822 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 ttm -155.23 136.51 13.99 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.61 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -136.28 165.69 25.19 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.809 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -105.08 109.01 20.83 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.365 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.694 HG11 HG21 ' A' ' 55' ' ' VAL . 69.8 t -96.35 143.96 11.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.201 -1.0 . . . . 0.0 112.079 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 25' ' ' LYS . 14.8 pttm -110.95 126.87 55.21 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.968 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.527 HD11 ' CD1' ' A' ' 32' ' ' ILE . 4.8 mp -83.77 175.46 9.64 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.183 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -73.91 -26.93 60.78 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.775 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.85 -16.86 64.22 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.81 -11.77 35.0 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.365 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -83.72 174.98 10.01 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.284 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -133.3 151.78 51.9 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.651 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.527 ' CD1' HD11 ' A' ' 26' ' ' LEU . 65.8 mt -141.28 155.33 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.914 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.872 ' H ' HD12 ' A' ' 33' ' ' LEU . 2.2 mp -88.04 134.41 33.75 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.522 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.57 ' SG ' HG13 ' A' ' 55' ' ' VAL . 61.6 m -132.96 139.1 47.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.957 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -107.96 172.35 6.88 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.815 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.651 HG22 ' N ' ' A' ' 37' ' ' SER . 25.0 mt -98.61 167.42 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.818 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.651 ' N ' HG22 ' A' ' 36' ' ' ILE . 35.1 m -130.93 117.74 19.67 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.817 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.49 -15.34 0.05 OUTLIER Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.82 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 37' ' ' SER . 30.7 mtmt -72.42 -61.54 1.76 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.196 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.493 ' HA ' HD22 ' A' ' 43' ' ' ASN . 1.1 pp -53.15 -21.36 4.88 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.96 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.468 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 1.9 ttt-85 -72.78 -39.72 66.52 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.52 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.421 ' O ' ' SD ' ' A' ' 42' ' ' MET . 6.9 tpp -63.72 -27.4 69.18 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.725 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.493 HD22 ' HA ' ' A' ' 40' ' ' LEU . 83.2 m-20 -78.93 5.39 11.7 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.877 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 54.23 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.223 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.57 114.07 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -59.34 137.15 58.09 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.607 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 mm -102.52 149.78 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.39 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -164.26 134.95 4.26 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.501 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.441 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 2.2 pp20? -63.42 152.24 38.79 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.223 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.59 -8.31 28.1 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 118.873 -1.632 . . . . 0.0 109.695 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 13' ' ' VAL . 56.5 t0 -72.53 133.1 44.61 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.284 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' C ' HG13 ' A' ' 53' ' ' VAL . 77.8 mttt -76.1 141.76 41.89 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.332 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.693 ' CG2' HD12 ' A' ' 67' ' ' ILE . 16.6 m -148.48 168.79 3.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.681 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.597 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -91.42 120.26 32.11 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.538 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.694 HG21 HG11 ' A' ' 24' ' ' VAL . 26.3 t -104.76 116.66 48.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.634 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.17 120.13 33.98 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.412 ' CD2' HD13 ' A' ' 32' ' ' ILE . 12.7 mt -92.8 159.43 15.4 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.406 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.454 ' HA ' HG12 ' A' ' 6' ' ' VAL . 67.0 m -94.85 141.08 22.83 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.599 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -69.68 -21.88 33.25 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.825 1.683 . . . . 0.0 112.055 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -88.24 -26.39 22.37 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.403 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.61 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -148.04 88.21 1.65 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.12 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mt -71.76 20.61 0.06 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.278 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.61 ' H ' ' C ' ' A' ' 61' ' ' ASP . 7.1 p -98.43 -12.32 21.49 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -138.02 150.68 47.18 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.678 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.36 -153.28 5.85 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.435 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 4.8 ptt180 -165.48 147.13 7.41 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.664 -1.215 . . . . 0.0 111.595 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.693 HD12 ' CG2' ' A' ' 53' ' ' VAL . 25.2 mm -92.72 117.3 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.969 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.63 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 32.6 p -127.95 7.97 6.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.963 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.824 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -169.98 127.72 0.88 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.28 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.474 ' HD2' ' N ' ' A' ' 71' ' ' LYS . 8.7 tmm_? -72.3 162.08 29.97 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.515 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.474 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 9.2 tttt . . . . . 0 N--CA 1.488 1.45 0 C-N-CA 119.416 -0.913 . . . . 0.0 111.334 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.713 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.41 0.148 . . . . 0.0 110.602 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.713 HD12 ' C ' ' A' ' 6' ' ' VAL . 1.8 mp -116.76 110.19 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.246 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -100.52 127.12 46.98 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.092 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' VAL . 35.2 mt -144.44 160.24 41.4 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.646 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -88.0 143.73 26.93 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.19 168.77 30.2 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.117 -1.516 . . . . 0.0 109.804 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.5 m -123.87 130.03 51.95 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.475 ' HA ' HG22 ' A' ' 24' ' ' VAL . 3.0 t -67.72 133.07 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.734 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 t -113.24 -26.92 8.18 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.326 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -153.15 158.2 41.45 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.108 -1.437 . . . . 0.0 112.223 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' H ' ' CD ' ' A' ' 15' ' ' GLU . . . -99.15 113.99 26.51 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.577 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.4 mt -104.66 146.94 33.6 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 119.739 -0.785 . . . . 0.0 111.008 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.517 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 3.1 Cg_endo -65.0 170.49 10.27 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 121.296 1.331 . . . . 0.0 111.433 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.517 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER 75.07 28.62 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.154 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.483 ' O ' ' CE1' ' A' ' 35' ' ' HIS . . . 58.89 61.99 2.01 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.347 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 19' ' ' ASN . 8.6 ptm -165.29 170.38 14.8 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.607 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -155.41 165.34 36.92 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.837 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -88.88 132.46 34.67 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.768 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.475 HG22 ' HA ' ' A' ' 13' ' ' VAL . 2.3 t -125.93 143.39 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.575 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -122.81 124.75 44.02 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.97 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.71 172.73 10.92 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.93 -41.64 62.19 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.823 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.521 ' HB3' ' CE1' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -71.63 -14.82 62.17 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.411 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.02 -0.78 44.47 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.969 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.521 ' CE1' ' HB3' ' A' ' 28' ' ' ASN . 71.7 m80 -55.34 104.88 0.14 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.835 -1.146 . . . . 0.0 111.224 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -76.19 124.28 27.21 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.431 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.486 ' C ' HD12 ' A' ' 33' ' ' LEU . 23.3 mt -137.42 152.6 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.318 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.709 ' N ' HD12 ' A' ' 33' ' ' LEU . 6.3 mp -90.45 132.79 35.44 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.356 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.428 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 8.8 p -132.03 134.64 45.78 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.889 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.587 ' ND1' ' N ' ' A' ' 36' ' ' ILE . 54.3 t-80 -103.68 176.23 5.22 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.941 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.587 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 22.1 mt -99.74 161.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.005 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.559 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 4.0 p -121.72 -169.49 1.88 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.389 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.32 -5.32 89.81 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.418 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -71.95 -63.41 1.14 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.769 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.586 HD13 HG23 ' A' ' 36' ' ' ILE . 1.7 mp -54.81 -21.42 11.16 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.874 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -35.16 66.91 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.601 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.8 ttp -74.66 -31.98 62.1 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.783 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.645 ' C ' ' CD1' ' A' ' 44' ' ' PHE . 2.7 t-20 -93.96 0.76 56.25 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.819 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.645 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 18.6 p90 31.01 72.55 0.06 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.1 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 46' ' ' ARG . 43.7 mt -102.69 166.5 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.823 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.611 ' N ' HG22 ' A' ' 45' ' ' ILE . 6.1 ptt180 -144.31 79.63 1.62 Allowed 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.634 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.431 HG21 ' CB ' ' A' ' 51' ' ' ASP . 5.2 mm -104.22 150.7 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.61 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 mp -99.04 156.78 16.75 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.556 -0.858 . . . . 0.0 112.359 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.686 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 6.4 mp0 -41.38 153.71 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.685 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.25 -4.62 60.54 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.004 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.431 ' CB ' HG21 ' A' ' 47' ' ' ILE . 23.8 t0 -90.82 142.27 27.94 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.591 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.438 ' C ' HG13 ' A' ' 53' ' ' VAL . 6.5 mtpm? -81.93 145.57 30.24 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.543 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.583 ' CG2' HD12 ' A' ' 67' ' ' ILE . 17.5 m -148.64 166.56 4.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.42 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.595 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 1.9 m-20 -92.17 123.83 35.81 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.835 -1.146 . . . . 0.0 108.124 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 9' ' ' LEU . 56.8 t -104.32 126.49 59.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.783 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -99.83 114.54 27.79 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.637 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.73 145.27 24.72 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.134 -1.027 . . . . 0.0 111.024 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 60' ' ' TYR . 4.5 p -86.93 128.1 57.26 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.079 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.88 -1.64 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.348 1.365 . . . . 0.0 111.378 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 58' ' ' SER . 78.6 m-85 -109.05 -16.84 14.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.881 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.61 ' C ' ' H ' ' A' ' 63' ' ' THR . 13.0 m-20 -145.11 84.0 1.7 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt -71.7 23.25 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.61 ' H ' ' C ' ' A' ' 61' ' ' ASP . 6.7 m -116.37 -5.73 11.78 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.622 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 65' ' ' GLY . 1.7 tmt_? -148.68 144.88 27.42 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.728 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.473 ' N ' ' HG2' ' A' ' 64' ' ' ARG . . . -138.28 -150.75 5.69 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.463 ' HG2' HH11 ' A' ' 66' ' ' ARG . 10.5 ptt-85 -165.59 141.45 5.19 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.855 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.583 HD12 ' CG2' ' A' ' 53' ' ' VAL . 20.2 mm -87.44 117.87 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 119.846 -0.741 . . . . 0.0 109.802 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.633 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 25.6 p -125.44 6.88 7.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.863 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -169.92 110.74 0.43 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.231 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.538 ' CG ' ' N ' ' A' ' 71' ' ' LYS . 22.6 ttp85 -68.5 161.56 27.54 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.654 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.538 ' N ' ' CG ' ' A' ' 70' ' ' ARG . 23.2 tttp . . . . . 0 C--N 1.307 -1.252 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.569 HG12 ' HD3' ' A' ' 59' ' ' PRO . 4.0 m . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.892 0.377 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 7' ' ' ILE . 11.7 mt -127.12 103.06 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.38 115.14 11.27 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.446 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 mt -141.88 143.18 33.2 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -86.25 141.49 29.25 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.476 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.08 149.65 21.68 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.228 -1.463 . . . . 0.0 109.873 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.46 ' C ' HG13 ' A' ' 24' ' ' VAL . 98.8 m -93.91 130.01 40.14 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.459 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 51' ' ' ASP . 3.8 t -59.99 127.12 18.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.277 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -99.47 -32.45 11.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.943 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -160.38 157.78 28.42 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.614 -1.234 . . . . 0.0 111.818 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.63 118.7 35.94 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.785 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.8 mt -106.2 147.73 35.37 Favored Pre-proline 0 N--CA 1.491 1.582 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.399 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.74 171.18 4.9 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.611 1.54 . . . . 0.0 111.929 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.6 OUTLIER 67.58 28.95 7.32 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.805 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 59.59 60.55 2.22 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.168 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.774 ' SD ' ' CD2' ' A' ' 35' ' ' HIS . 46.7 mtm -152.4 164.51 37.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.334 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.581 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.54 165.18 31.29 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.722 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' HG2' ' CG ' ' A' ' 31' ' ' GLU . 14.3 ttmt -99.04 137.18 37.93 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.224 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.46 HG13 ' C ' ' A' ' 12' ' ' THR . 46.9 t -130.93 145.13 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.64 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.459 ' HZ3' ' HG3' ' A' ' 25' ' ' LYS . 9.0 mtmm -111.49 120.76 43.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.563 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.919 ' H ' HD12 ' A' ' 26' ' ' LEU . 3.9 mp -74.41 168.31 19.95 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.03 -29.59 70.39 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -63.0 -11.05 16.31 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.641 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.29 -11.52 65.36 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.735 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -78.38 167.69 20.95 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.524 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.408 ' CG ' ' HG2' ' A' ' 23' ' ' LYS . 24.1 tt0 -127.42 142.69 51.35 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.155 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.558 HG22 ' N ' ' A' ' 33' ' ' LEU . 77.0 mt -143.69 160.91 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.246 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.558 ' N ' HG22 ' A' ' 32' ' ' ILE . 6.1 mp -90.35 141.8 28.36 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.151 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.4 ' SG ' HG13 ' A' ' 55' ' ' VAL . 4.7 m -138.7 139.81 38.54 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.384 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.774 ' CD2' ' SD ' ' A' ' 21' ' ' MET . 4.3 m80 -104.15 168.81 8.87 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.321 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.527 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 57.8 mt -92.78 152.09 3.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.772 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.42 ' O ' HG22 ' A' ' 36' ' ' ILE . 3.5 m -104.08 -166.69 1.28 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.63 -16.82 74.67 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.468 -1.348 . . . . 0.0 111.252 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.486 ' C ' ' N ' ' A' ' 41' ' ' ARG . 30.0 mttp -70.89 -63.22 1.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.658 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.653 ' H ' HD12 ' A' ' 40' ' ' LEU . 4.5 mp -52.84 -20.27 3.14 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.679 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.486 ' N ' ' C ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.91 -36.95 62.18 Favored 'General case' 0 C--N 1.271 -2.848 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.898 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 39' ' ' LYS . 92.3 mtp -90.32 -21.53 21.99 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.637 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.503 ' ND2' HG13 ' A' ' 45' ' ' ILE . 12.9 t30 -83.5 -37.76 22.67 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.316 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.9 t80 42.76 54.72 4.54 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.687 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.503 HG13 ' ND2' ' A' ' 43' ' ' ASN . 5.6 mm -96.35 159.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.216 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 46' ' ' ARG . 18.2 mmm180 -62.15 137.58 58.28 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.258 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.431 ' HA ' ' NH2' ' A' ' 70' ' ' ARG . 3.3 mt -133.19 140.27 47.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.889 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.8 mt -143.77 135.33 26.11 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.289 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -43.93 152.09 0.18 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.92 -15.11 63.56 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.731 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 13' ' ' VAL . 8.7 m-20 -76.11 146.8 39.05 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.356 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -88.23 143.55 26.97 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.702 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.503 ' CG2' HD12 ' A' ' 67' ' ' ILE . 18.5 m -146.03 169.15 6.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.671 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.527 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 0.4 OUTLIER -96.57 117.93 32.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.107 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.705 HG22 HD11 ' A' ' 67' ' ' ILE . 10.4 t -105.25 117.3 50.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.197 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -94.07 118.61 31.77 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.008 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.3 mt -88.49 139.81 30.11 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.913 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.0 m -95.01 132.56 27.89 Favored Pre-proline 0 N--CA 1.49 1.538 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.356 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.569 ' HD3' HG12 ' A' ' 6' ' ' VAL . 2.0 Cg_endo -66.96 -2.81 8.51 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.297 1.332 . . . . 0.0 110.967 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -92.11 -22.83 19.67 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.659 ' C ' ' H ' ' A' ' 63' ' ' THR . 5.5 m-20 -150.83 87.26 1.41 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.199 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mt -66.87 18.81 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.677 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.659 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.3 p -113.33 -8.88 13.45 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.43 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.434 ' NH1' ' NE2' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -140.71 151.59 44.64 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.467 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.71 -153.17 6.1 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -163.72 135.88 5.02 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.195 -1.402 . . . . 0.0 112.474 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 55' ' ' VAL . 47.8 mm -92.82 123.09 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.429 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.602 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -125.1 7.09 7.89 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.544 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.817 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -168.89 166.1 11.42 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.785 -1.166 . . . . 0.0 111.483 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 47' ' ' ILE . 2.4 ttm180 -144.04 125.87 15.22 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.171 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt . . . . . 0 N--CA 1.488 1.452 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.509 -179.912 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG12 ' HD3' ' A' ' 59' ' ' PRO . 2.0 m . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.709 0.29 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.5 mt -114.6 100.93 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.109 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -78.87 114.59 17.93 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.398 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 9' ' ' LEU . 12.2 mt -134.32 153.37 51.92 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.383 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.49 142.1 28.61 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.704 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.03 -178.4 18.08 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.416 ' N ' HG13 ' A' ' 24' ' ' VAL . 13.7 m -137.86 125.8 22.68 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.476 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.412 ' HA ' HG22 ' A' ' 24' ' ' VAL . 6.1 t -59.79 123.94 13.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.527 -1.269 . . . . 0.0 110.534 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -105.51 -29.3 10.27 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.984 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -156.99 149.11 22.91 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.879 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.28 131.67 35.96 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -122.29 152.74 61.24 Favored Pre-proline 0 N--CA 1.492 1.626 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.571 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.29 -176.44 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.031 1.154 . . . . 0.0 110.888 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 3.2 m-20 55.52 40.93 31.23 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.51 49.65 13.3 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.848 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.483 ' HG3' ' CE1' ' A' ' 35' ' ' HIS . 28.9 mtp -140.82 168.41 19.85 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.819 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.0 165.94 29.05 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.917 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -95.3 128.58 42.25 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.109 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.416 HG13 ' N ' ' A' ' 12' ' ' THR . 39.0 t -117.65 140.23 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.647 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -105.72 122.69 46.59 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.141 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.775 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.1 mp -76.79 171.99 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.26 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -71.25 -14.5 62.25 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.444 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -75.52 -16.79 60.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.067 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.29 -15.25 33.0 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 119.767 -1.206 . . . . 0.0 111.419 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -89.5 179.24 6.1 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.115 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -137.68 149.9 46.9 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.268 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.741 HG22 ' N ' ' A' ' 33' ' ' LEU . 11.2 mm -136.99 174.73 11.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.231 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.741 ' N ' HG22 ' A' ' 32' ' ' ILE . 6.8 mp -97.01 136.5 37.49 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.577 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.535 ' SG ' HG13 ' A' ' 55' ' ' VAL . 86.1 m -132.73 152.96 51.62 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.654 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.483 ' CE1' ' HG3' ' A' ' 21' ' ' MET . 1.9 t60 -118.92 152.7 35.83 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.257 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.608 HG23 HD21 ' A' ' 40' ' ' LEU . 28.0 mt -93.99 146.68 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.995 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.5 m -97.22 136.28 37.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.37 -11.28 39.77 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.185 -1.483 . . . . 0.0 110.496 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.446 ' C ' ' N ' ' A' ' 41' ' ' ARG . 6.8 tttm -70.88 -62.22 1.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.26 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -52.72 -20.21 2.99 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.55 -1.26 . . . . 0.0 108.893 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.446 ' N ' ' C ' ' A' ' 39' ' ' LYS . 3.7 ttt180 -63.99 -53.21 53.66 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.635 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 tpp -65.5 -25.35 67.43 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.895 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -65.14 -4.48 5.03 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.739 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 t80 52.28 87.81 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.571 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.6 mt -140.29 141.88 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.722 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.407 ' H ' ' HG2' ' A' ' 46' ' ' ARG . 15.1 ptt180 -74.53 134.55 42.2 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.797 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.432 HD11 HD11 ' A' ' 40' ' ' LEU . 37.9 mt -131.18 147.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.342 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.847 HD23 ' N ' ' A' ' 48' ' ' LEU . 1.8 pt? -159.59 148.91 18.14 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.657 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 19.3 pt-20 -63.34 152.07 39.0 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.416 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.97 -13.15 60.05 Favored Glycine 0 N--CA 1.485 1.9 0 C-N-CA 119.445 -1.36 . . . . 0.0 110.198 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.641 ' CG ' ' HE ' ' A' ' 70' ' ' ARG . 9.5 t70 -80.12 162.16 24.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.655 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.492 ' C ' HG13 ' A' ' 53' ' ' VAL . 5.9 mtpm? -91.06 152.14 20.75 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.751 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.587 HG21 HG12 ' A' ' 67' ' ' ILE . 22.3 m -154.62 167.73 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.455 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.532 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -93.72 122.41 36.15 Favored 'General case' 0 C--O 1.203 -1.351 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.27 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.535 HG13 ' SG ' ' A' ' 34' ' ' CYS . 4.1 t -104.59 121.14 56.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.419 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.85 121.2 41.65 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.606 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 mt -95.14 141.87 28.26 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.212 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.5 m -86.03 128.81 56.48 Favored Pre-proline 0 N--CA 1.493 1.677 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.592 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.653 ' HD3' HG12 ' A' ' 6' ' ' VAL . 2.2 Cg_endo -66.32 -13.38 39.65 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 121.306 1.337 . . . . 0.0 110.898 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -101.32 -10.41 20.31 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.628 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -147.1 72.45 1.26 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.771 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -70.59 23.35 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.641 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.628 ' H ' ' C ' ' A' ' 61' ' ' ASP . 9.1 m -105.5 -21.16 13.27 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.458 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -140.66 159.6 41.84 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.776 -0.77 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.18 -159.96 8.44 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.45 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 6.8 ptt180 -166.91 139.36 3.51 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 117.957 -1.497 . . . . 0.0 112.164 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.587 HG12 HG21 ' A' ' 53' ' ' VAL . 1.8 mp -93.29 126.34 45.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.563 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.469 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 4.8 p -126.77 7.04 6.74 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.888 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.843 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -166.45 142.69 4.77 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.589 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.641 ' HE ' ' CG ' ' A' ' 51' ' ' ASP . 11.0 ttt-85 -124.11 128.15 48.87 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.947 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' ARG . 16.3 mmtt . . . . . 0 N--CA 1.488 1.459 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.847 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.561 0.219 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.4 mm -100.0 107.83 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -76.09 118.41 18.81 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.431 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.6 138.17 37.64 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.509 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 12.3 mp0 -88.47 140.65 29.25 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.66 172.24 28.88 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.089 -1.529 . . . . 0.0 110.201 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 m -115.67 129.68 56.58 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.791 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 24' ' ' VAL . 14.9 t -59.67 127.72 19.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.749 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 23' ' ' LYS . 37.1 t -93.98 -40.11 10.29 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.664 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -156.65 158.24 36.64 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.634 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.56 123.75 44.12 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.5 mt -119.29 149.51 47.54 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.461 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 2.3 Cg_endo -59.01 -179.89 0.18 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.289 1.326 . . . . 0.0 111.104 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 6.0 t30 73.58 18.62 3.5 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.61 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 61.66 42.95 10.33 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.575 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.8 mtp -142.3 174.75 10.33 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.827 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.651 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.52 166.19 27.44 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.372 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' SER . 46.2 tttm -99.14 130.68 45.47 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.55 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 13' ' ' VAL . 95.2 t -119.85 150.46 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.336 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -124.18 112.14 16.73 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.412 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.683 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.7 mp -70.11 138.27 51.83 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.053 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.89 -15.5 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.276 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.543 ' N ' ' C ' ' A' ' 26' ' ' LEU . 18.0 m120 -65.09 -16.27 63.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.243 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.92 -11.21 52.58 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.906 -1.14 . . . . 0.0 111.354 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -98.04 172.02 7.88 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.524 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -125.49 157.94 35.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.59 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 33' ' ' LEU . 34.0 mt -152.01 156.89 5.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.171 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 7.4 mp -93.45 136.94 33.23 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.228 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' ' CG1' ' A' ' 55' ' ' VAL . 82.8 m -132.78 151.22 52.05 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.289 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -118.65 160.18 22.28 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.0 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.515 HG23 HD13 ' A' ' 40' ' ' LEU . 5.7 mt -91.49 140.67 15.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.324 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.44 ' O ' HG22 ' A' ' 36' ' ' ILE . 2.8 m -85.72 -171.56 3.66 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.011 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.13 -6.85 89.11 Favored Glycine 0 N--CA 1.487 2.039 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.208 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.68 -62.04 1.72 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.246 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.515 HD13 HG23 ' A' ' 36' ' ' ILE . 1.5 mp -56.29 -20.76 20.2 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.021 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -74.88 -38.16 61.97 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.327 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.6 tpp -71.6 -29.32 64.56 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.11 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.483 HD22 ' N ' ' A' ' 43' ' ' ASN . 1.0 OUTLIER -77.04 -38.74 52.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.345 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.26 77.79 0.32 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.223 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.731 HG22 ' H ' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -124.68 -150.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.768 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.731 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -149.57 98.23 2.74 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.638 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.544 ' C ' HD12 ' A' ' 48' ' ' LEU . 4.2 mp -92.69 121.89 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.832 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.2 mp -96.19 136.89 36.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.942 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -42.46 152.66 0.09 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.248 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.24 -14.41 64.48 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -81.38 143.56 32.08 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.483 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.479 ' C ' HG13 ' A' ' 53' ' ' VAL . 37.3 mtmt -80.41 149.99 29.95 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.732 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.479 HG13 ' C ' ' A' ' 52' ' ' LYS . 26.9 m -152.06 168.4 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.798 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.552 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -101.97 117.86 35.71 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.506 ' CG1' ' SG ' ' A' ' 34' ' ' CYS . 24.3 t -104.39 123.98 58.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.436 -0.906 . . . . 0.0 113.182 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -95.55 114.31 26.06 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.99 147.63 24.19 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.577 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 m -91.97 132.51 32.52 Favored Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.056 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.94 -18.56 64.25 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 121.426 1.417 . . . . 0.0 111.712 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.09 -11.45 24.38 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.397 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.0 t70 -142.32 78.53 1.63 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.096 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -71.7 23.93 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.413 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.614 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -115.54 -23.82 8.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.08 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.01 151.73 48.19 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.622 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 35' ' ' HIS . . . -144.05 -159.36 7.98 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -166.65 146.16 5.67 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.12 -1.432 . . . . 0.0 112.584 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.598 ' N ' HD12 ' A' ' 67' ' ' ILE . 1.8 mp -93.44 126.19 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.796 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.628 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 7.7 p -126.49 6.71 6.93 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.478 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.796 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -171.73 110.47 0.29 Allowed 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.102 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 162.22 28.77 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.379 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.631 HG22 ' H ' ' A' ' 7' ' ' ILE . 3.9 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 120.74 0.305 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.631 ' H ' HG22 ' A' ' 6' ' ' VAL . 4.5 mp -103.94 146.66 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.27 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -122.46 127.85 50.13 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.454 HD12 ' CD1' ' A' ' 57' ' ' LEU . 6.4 mt -144.56 156.02 43.94 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.262 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.519 ' OE2' ' NZ ' ' A' ' 71' ' ' LYS . 39.4 mt-10 -90.56 141.87 28.33 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.609 -0.836 . . . . 0.0 111.25 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.11 158.88 27.91 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.544 ' C ' HG13 ' A' ' 24' ' ' VAL . 29.1 m -102.49 132.84 48.28 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.482 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.9 t -68.51 127.13 29.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 118.727 -1.189 . . . . 0.0 110.656 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -98.04 -39.0 9.14 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.588 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -153.56 145.15 23.29 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.092 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.74 110.58 22.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mt -100.14 145.7 30.67 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.15 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.3 Cg_endo -61.92 172.42 3.9 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.242 1.295 . . . . 0.0 111.459 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER 76.0 13.79 2.67 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.767 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 72.49 50.15 0.19 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.032 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.466 ' HE2' ' HB3' ' A' ' 21' ' ' MET . 9.5 mtp -144.18 140.62 29.44 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.114 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.761 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 3.5 m-85 -133.19 166.0 23.47 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.224 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 14' ' ' SER . 78.1 tttt -112.63 111.93 23.09 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.7 HG21 ' SG ' ' A' ' 34' ' ' CYS . 16.7 t -107.38 152.11 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 119.472 -0.891 . . . . 0.0 112.774 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.78 117.24 22.26 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.592 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.464 ' C ' ' N ' ' A' ' 28' ' ' ASN . 2.9 mp -77.0 136.48 38.71 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.855 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -45.91 -19.01 0.05 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.578 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.464 ' N ' ' C ' ' A' ' 26' ' ' LEU . 12.6 m-20 -69.32 -15.9 63.43 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.865 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.04 -12.57 34.31 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.022 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -84.17 163.81 19.53 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.505 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -131.76 144.49 50.99 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.16 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.503 HD13 ' CD2' ' A' ' 57' ' ' LEU . 68.0 mt -145.59 148.87 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.575 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.569 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 6.1 mp -84.88 125.15 32.4 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.159 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.7 ' SG ' HG21 ' A' ' 24' ' ' VAL . 59.4 m -116.53 134.24 55.08 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.39 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.458 ' N ' ' HA ' ' A' ' 66' ' ' ARG . 23.3 m170 -97.79 173.54 7.05 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.451 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.761 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 12.9 mt -100.64 147.15 8.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.796 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -94.46 161.51 14.19 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.084 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.34 -34.67 25.39 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.267 -1.445 . . . . 0.0 111.28 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -65.07 -53.21 49.15 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.056 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -51.88 -22.4 3.76 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.447 -1.301 . . . . 0.0 110.502 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.52 ' HA ' ' HE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.06 -42.1 63.43 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 118.043 -1.463 . . . . 0.0 107.739 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.5 tpp -54.17 -29.25 44.9 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.389 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.65 ' C ' ' CD2' ' A' ' 44' ' ' PHE . 60.3 m-80 -93.25 2.84 56.45 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.65 ' CD2' ' C ' ' A' ' 43' ' ' ASN . 2.8 p90 40.8 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.0 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mm -119.9 102.59 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.578 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -70.09 115.8 9.72 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.2 mt -108.55 110.25 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.589 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mt -97.11 135.57 38.89 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.04 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.4 pm0 -46.27 152.38 0.43 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.941 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.61 60.58 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.147 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -91.96 156.37 17.49 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.321 -0.951 . . . . 0.0 110.769 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.51 143.66 27.62 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.547 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.453 ' CG2' HD12 ' A' ' 67' ' ' ILE . 12.3 m -146.57 161.27 9.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.571 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.9 OUTLIER -91.75 120.89 32.89 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.915 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG13 ' SG ' ' A' ' 34' ' ' CYS . 93.5 t -104.11 121.11 55.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.211 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -90.57 123.02 33.89 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.466 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.503 ' CD2' HD13 ' A' ' 32' ' ' ILE . 6.1 mt -97.3 140.12 32.24 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.771 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 60' ' ' TYR . 4.7 p -92.84 129.69 39.12 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.538 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -57.85 -2.46 0.78 Allowed 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 121.271 1.314 . . . . 0.0 111.668 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 58' ' ' SER . 27.3 t80 -100.32 -13.07 18.96 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.637 ' C ' ' H ' ' A' ' 63' ' ' THR . 26.6 m-20 -149.59 87.28 1.49 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.544 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 62' ' ' LEU . 2.0 mp -70.66 23.69 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.46 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.637 ' H ' ' C ' ' A' ' 61' ' ' ASP . 39.5 m -135.77 3.49 2.98 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.282 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -141.31 135.08 30.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.082 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.13 -147.78 4.97 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.465 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.458 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 11.9 ptp180 -165.89 151.46 8.91 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.302 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.453 HD12 ' CG2' ' A' ' 53' ' ' VAL . 17.3 mm -93.37 122.36 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.94 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.62 ' C ' ' CG ' ' A' ' 69' ' ' TRP . 0.2 OUTLIER -127.6 7.59 6.31 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.944 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.913 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -176.55 111.45 0.09 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.432 -1.307 . . . . 0.0 111.844 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -76.28 126.82 31.68 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.604 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.519 ' NZ ' ' OE2' ' A' ' 10' ' ' GLU . 12.5 tptt . . . . . 0 C--N 1.303 -1.434 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.962 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.445 HG21 ' OE2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.885 0.374 . . . . 0.0 111.38 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.2 mm -101.78 101.81 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.892 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -83.2 119.36 24.45 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.566 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 9' ' ' LEU . 13.0 mt -133.87 157.29 46.34 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.454 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -92.87 144.24 25.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.23 162.9 30.82 Favored Glycine 0 N--CA 1.483 1.813 0 C-N-CA 118.943 -1.599 . . . . 0.0 109.939 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 m -113.49 130.73 56.27 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.074 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.483 ' HA ' HG22 ' A' ' 24' ' ' VAL . 25.0 t -65.14 116.65 4.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 118.533 -1.267 . . . . 0.0 111.096 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.0 m -97.81 -33.45 11.26 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.752 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -141.73 157.87 44.51 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.67 117.02 24.8 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.083 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' MET . 22.7 mt -98.12 147.77 33.55 Favored Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.036 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.7 Cg_endo -60.38 152.23 68.7 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.417 1.411 . . . . 0.0 111.517 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER 79.56 46.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.137 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.43 58.07 5.81 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.596 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 17' ' ' LEU . 21.1 mtm -144.46 142.4 30.25 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.335 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.655 ' CD2' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -153.02 166.02 33.75 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.612 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -106.7 142.06 36.95 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.286 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 13' ' ' VAL . 14.0 t -133.31 132.62 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.831 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.439 ' O ' ' CG ' ' A' ' 25' ' ' LYS . 2.0 pttm -99.84 129.47 45.94 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.038 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.547 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.5 mp -86.13 177.1 7.65 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.043 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -73.34 -31.2 63.83 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.501 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -62.78 -10.79 14.22 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.486 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.41 -10.2 63.08 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.05 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.475 ' O ' HD12 ' A' ' 26' ' ' LEU . 64.1 m80 -84.98 156.77 21.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.471 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -116.17 148.55 40.25 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.599 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.697 HD13 HD21 ' A' ' 57' ' ' LEU . 78.5 mt -141.09 149.68 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.712 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.3 mp -81.53 154.74 26.1 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.667 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.427 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . 39.9 m -145.54 154.31 42.05 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.449 -1.301 . . . . 0.0 111.546 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.441 ' H ' ' HA ' ' A' ' 66' ' ' ARG . 1.9 t60 -127.76 143.88 51.11 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.386 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.592 HG23 HD21 ' A' ' 40' ' ' LEU . 5.5 mt -70.5 135.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.085 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.91 165.43 12.67 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.923 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.88 -7.26 88.77 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -74.69 -62.71 1.44 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.592 HD21 HG23 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -55.25 -20.62 11.52 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.708 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.448 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -71.57 -41.66 68.74 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.12 -1.032 . . . . 0.0 108.861 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.7 mmt -61.54 -27.08 68.36 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.181 -1.007 . . . . 0.0 109.337 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.447 ' N ' HD22 ' A' ' 43' ' ' ASN . 3.3 m120 -69.33 -1.63 8.72 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.318 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.569 ' O ' ' CG ' ' A' ' 44' ' ' PHE . 11.3 t80 57.63 54.62 6.21 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.095 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.786 HG22 ' N ' ' A' ' 46' ' ' ARG . 62.1 mt -152.88 172.3 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.162 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.786 ' N ' HG22 ' A' ' 45' ' ' ILE . 5.5 ptp85 -139.85 163.56 32.32 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.906 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 47' ' ' ILE . 2.3 mp -109.41 148.95 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.058 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.2 mt -127.78 136.94 52.18 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.977 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 15.6 mt-10 -40.18 152.47 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.855 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.61 -9.38 59.16 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.432 -1.365 . . . . 0.0 110.36 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -93.03 135.66 33.99 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.581 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.631 ' CD ' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -75.51 149.01 38.52 Favored 'General case' 0 CA--C 1.486 -1.511 0 C-N-CA 118.764 -1.174 . . . . 0.0 110.577 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.646 HG21 HD12 ' A' ' 67' ' ' ILE . 11.4 m -151.93 165.86 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.738 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.542 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -98.22 125.18 43.17 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.447 HG21 HG11 ' A' ' 24' ' ' VAL . 94.0 t -102.88 128.13 56.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.86 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.612 ' OE2' ' NH1' ' A' ' 66' ' ' ARG . 6.1 tt0 -100.33 110.28 22.5 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.395 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.697 HD21 HD13 ' A' ' 32' ' ' ILE . 17.0 mt -89.55 148.92 23.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.599 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.2 p -99.61 142.04 23.89 Favored Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 119.364 -0.934 . . . . 0.0 112.087 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.21 -3.68 6.57 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.732 1.621 . . . . 0.0 111.559 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -87.96 -23.36 23.88 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.051 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.665 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.4 OUTLIER -166.65 96.09 0.54 Allowed 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.309 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -67.69 18.51 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.563 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.665 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -103.63 -9.77 18.93 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.215 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -137.78 144.73 41.73 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.786 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.31 -152.27 5.67 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.308 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.612 ' NH1' ' OE2' ' A' ' 56' ' ' GLU . 4.1 ptt180 -162.42 152.03 15.94 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.925 -1.11 . . . . 0.0 111.469 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.646 HD12 HG21 ' A' ' 53' ' ' VAL . 33.5 mm -92.75 121.21 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.625 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 1.4 p -126.98 6.95 6.6 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.701 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.866 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.19 111.7 0.72 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.068 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.515 ' CD ' ' C ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -102.57 159.9 15.04 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.972 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.422 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 3.2 tptt . . . . . 0 N--CA 1.484 1.231 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.396 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.737 0.304 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mm -98.08 104.22 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.46 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -73.35 112.64 9.6 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.988 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mt -137.13 136.15 38.02 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.352 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.406 ' O ' HD23 ' A' ' 26' ' ' LEU . 28.5 tt0 -91.47 140.96 29.25 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.515 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.52 -166.98 11.02 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.038 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.544 ' N ' HG13 ' A' ' 24' ' ' VAL . 51.2 m -137.44 128.77 28.02 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.517 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.71 130.44 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.485 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.1 t -120.89 -32.42 3.98 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.13 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.22 155.5 46.03 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.573 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.13 126.68 39.51 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.958 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.59 144.26 31.5 Favored Pre-proline 0 N--CA 1.494 1.749 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.354 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 3.3 Cg_endo -64.92 164.41 24.79 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 121.539 1.492 . . . . 0.0 111.57 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.484 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 0.9 OUTLIER 76.2 34.12 0.53 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.257 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.82 61.1 2.51 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.289 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.596 ' SD ' ' CE1' ' A' ' 35' ' ' HIS . 5.2 ptm -162.52 174.78 12.2 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.597 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.764 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.25 161.5 30.79 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.696 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -84.6 138.55 32.65 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.551 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.544 HG13 ' N ' ' A' ' 12' ' ' THR . 2.0 t -127.34 131.65 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.186 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -97.13 123.65 40.95 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.95 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' GLY . 42.0 mt -74.25 155.93 37.75 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.402 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 28' ' ' ASN . 12.3 pt-20 -47.26 -40.25 16.21 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.944 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.521 ' HB3' ' ND1' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -67.53 -16.62 64.29 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.456 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 26' ' ' LEU . . . 108.89 -1.77 31.78 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.333 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.521 ' ND1' ' HB3' ' A' ' 28' ' ' ASN . 60.5 m80 -75.58 138.28 41.35 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.564 -1.254 . . . . 0.0 111.567 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.44 138.0 38.1 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.313 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.48 ' C ' HD12 ' A' ' 33' ' ' LEU . 22.0 mt -146.65 154.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.963 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.734 ' N ' HD12 ' A' ' 33' ' ' LEU . 7.1 mp -90.9 133.69 35.05 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.352 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.441 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 1.1 p -133.77 144.71 49.21 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.013 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.596 ' CE1' ' SD ' ' A' ' 21' ' ' MET . 13.6 m-70 -108.56 178.23 4.55 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.875 HG23 HD21 ' A' ' 40' ' ' LEU . 49.5 mt -112.25 156.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.782 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.435 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 4.6 m -107.03 155.72 19.52 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.519 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.26 -6.45 87.75 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.751 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -74.35 -59.12 2.87 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.068 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.875 HD21 HG23 ' A' ' 36' ' ' ILE . 1.9 pp -54.24 -20.55 7.16 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.539 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -70.98 -49.2 47.9 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.409 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.47 ' C ' ' H ' ' A' ' 44' ' ' PHE . 8.8 ttm -55.58 -34.99 65.29 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.585 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.1 13.12 0.33 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.47 ' H ' ' C ' ' A' ' 42' ' ' MET . 0.1 OUTLIER 56.69 34.78 25.14 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.614 -0.835 . . . . 0.0 111.296 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.634 HG22 ' N ' ' A' ' 46' ' ' ARG . 28.8 mm -98.21 170.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.251 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.634 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -149.18 154.07 38.6 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.594 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 47' ' ' ILE . 29.4 mt -132.21 144.37 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.712 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.2 mt -132.48 171.46 13.74 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.495 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 152.36 44.31 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.224 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.17 -13.96 30.09 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.229 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 0.9 OUTLIER -80.57 135.61 36.11 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.576 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.493 ' C ' HG13 ' A' ' 53' ' ' VAL . 56.9 mttt -75.24 150.19 38.66 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.029 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.765 HG21 HD11 ' A' ' 67' ' ' ILE . 29.1 m -151.93 166.29 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.94 -1.104 . . . . 0.0 112.429 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.533 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -96.6 121.11 38.07 Favored 'General case' 0 C--O 1.203 -1.382 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.714 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -104.63 123.31 58.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.345 -0.942 . . . . 0.0 113.07 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -101.1 106.4 17.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.747 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.0 mt -81.14 147.31 30.12 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.675 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 p -98.16 138.08 20.87 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.485 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.4 -9.71 21.2 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.735 1.623 . . . . 0.0 112.074 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -90.53 -22.44 21.31 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.405 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.653 ' C ' ' H ' ' A' ' 63' ' ' THR . 15.5 m-20 -153.53 89.29 1.33 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.375 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mt -69.12 20.42 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.474 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.653 ' H ' ' C ' ' A' ' 61' ' ' ASP . 59.0 m -108.7 -9.84 15.22 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.513 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -138.46 148.26 44.18 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.58 -161.92 8.97 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.526 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 8.3 ptt180 -156.48 131.35 9.02 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.61 -1.236 . . . . 0.0 111.93 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.765 HD11 HG21 ' A' ' 53' ' ' VAL . 66.3 mt -95.44 129.21 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.59 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -127.97 7.32 6.09 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.49 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.781 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -168.2 111.87 0.61 Allowed 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.75 -1.18 . . . . 0.0 112.209 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -73.45 151.93 40.93 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.483 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 tttt . . . . . 0 N--CA 1.488 1.435 0 C-N-CA 118.916 -1.113 . . . . 0.0 110.927 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.531 HG12 ' HD3' ' A' ' 59' ' ' PRO . 2.6 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.585 0.231 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.646 ' HB ' HD12 ' A' ' 57' ' ' LEU . 51.7 mt -95.95 101.94 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.258 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.7 114.12 9.46 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 55' ' ' VAL . 7.4 mt -131.0 150.99 51.88 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.456 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -97.75 144.26 27.55 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.908 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.54 -175.48 23.36 Favored Glycine 0 N--CA 1.483 1.767 0 C-N-CA 118.885 -1.626 . . . . 0.0 110.335 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.23 131.21 45.42 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.205 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.432 ' CG1' ' HA ' ' A' ' 49' ' ' GLU . 87.4 t -63.52 116.18 3.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 118.434 -1.306 . . . . 0.0 110.187 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 p -95.46 -37.52 10.88 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.749 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -146.19 151.88 38.33 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 118.558 -1.257 . . . . 0.0 111.792 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.443 ' HB2' ' CD ' ' A' ' 49' ' ' GLU . . . -100.92 130.57 46.94 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.494 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.6 mt -121.91 151.07 57.35 Favored Pre-proline 0 N--CA 1.488 1.469 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 20' ' ' ALA . 1.9 Cg_endo -61.13 -156.5 0.02 OUTLIER 'Trans proline' 0 C--O 1.204 -1.182 0 C-N-CA 121.452 1.435 . . . . 0.0 111.007 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.63 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 25.4 m120 46.8 12.72 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.87 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 71.09 42.94 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.914 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.4 170.48 15.94 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.252 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.677 ' CD2' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.73 165.84 29.75 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.443 -0.903 . . . . 0.0 112.216 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -97.06 136.89 36.97 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.887 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.1 t -129.68 143.56 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.163 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -102.88 118.87 37.77 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.197 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.944 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.2 mp -74.19 168.88 18.72 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.793 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.62 -19.42 65.22 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.022 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -68.44 -16.24 63.83 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.445 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.44 -10.85 50.51 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -91.31 177.55 6.21 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.168 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -132.8 140.19 47.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.904 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.761 HG22 ' N ' ' A' ' 33' ' ' LEU . 8.4 mm -134.58 173.27 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.386 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.761 ' N ' HG22 ' A' ' 32' ' ' ILE . 20.2 mt -90.59 145.35 24.93 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.568 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.436 ' SG ' HG13 ' A' ' 55' ' ' VAL . 90.8 m -134.91 152.26 51.59 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.188 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.52 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 33.2 t-80 -128.0 147.51 50.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.156 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.617 HG22 ' N ' ' A' ' 37' ' ' SER . 28.3 mt -86.83 166.84 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.492 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.617 ' N ' HG22 ' A' ' 36' ' ' ILE . 6.4 p -154.07 159.12 41.39 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.354 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.31 -4.9 0.09 OUTLIER Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.489 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.579 ' H ' ' C ' ' A' ' 37' ' ' SER . 0.7 OUTLIER -62.46 -61.17 2.62 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.472 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.574 HD21 ' HA ' ' A' ' 68' ' ' THR . 10.2 mt -51.56 -21.51 2.57 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.441 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.405 ' N ' ' C ' ' A' ' 39' ' ' LYS . 2.3 mmm180 -83.44 -25.79 30.9 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.333 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' LYS . 13.7 ttp -89.79 -21.39 22.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.262 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.413 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -93.23 3.87 54.94 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.788 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 52.06 66.49 1.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.725 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.621 ' CG2' ' N ' ' A' ' 46' ' ' ARG . 26.5 mt -146.22 165.58 8.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.105 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.621 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 50.3 ttm-85 -133.21 140.85 47.76 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.398 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.506 HD12 HD13 ' A' ' 40' ' ' LEU . 58.9 mt -132.44 149.04 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.263 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.839 HD23 ' N ' ' A' ' 48' ' ' LEU . 1.9 pt? -142.97 -176.82 5.05 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.72 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 23.3 mt-10 -75.42 152.24 38.01 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.259 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.51 -14.07 37.55 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.074 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.15 143.37 26.75 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.859 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.484 ' C ' HG13 ' A' ' 53' ' ' VAL . 2.9 tttt -75.63 154.33 36.69 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.711 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.752 HG21 ' CD1' ' A' ' 67' ' ' ILE . 31.6 m -154.8 171.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.482 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.555 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -103.36 123.92 47.72 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.436 HG13 ' SG ' ' A' ' 34' ' ' CYS . 3.1 t -103.36 134.21 45.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.648 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.81 111.63 22.92 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.118 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.646 HD12 ' HB ' ' A' ' 7' ' ' ILE . 8.8 mt -77.8 121.58 24.27 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.672 -1.211 . . . . 0.0 108.981 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 60' ' ' TYR . 1.5 m -80.49 130.04 66.55 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.941 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.531 ' HD3' HG12 ' A' ' 6' ' ' VAL . 2.5 Cg_endo -61.05 -1.25 1.59 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.339 1.359 . . . . 0.0 110.646 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 58' ' ' SER . 5.7 m-30 -84.6 -21.56 30.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.608 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.4 t0 -169.82 100.64 0.31 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.046 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mt -69.25 19.31 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.876 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.608 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.1 p -102.71 -12.19 17.84 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.264 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.477 ' HG2' ' N ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -148.93 144.57 26.92 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.923 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.477 ' N ' ' HG2' ' A' ' 64' ' ' ARG . . . -120.7 -156.57 9.89 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.46 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 9.1 ptm180 -157.41 147.03 20.28 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.502 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.752 ' CD1' HG21 ' A' ' 53' ' ' VAL . 1.9 mm -94.04 118.02 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.212 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.624 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 72.2 p -127.17 7.79 6.57 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.24 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.846 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -173.66 118.49 0.28 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 118.621 -1.232 . . . . 0.0 112.403 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -68.68 161.77 27.49 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.881 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.2 tttp . . . . . 0 C--N 1.302 -1.474 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.581 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.59 HG22 ' H ' ' A' ' 7' ' ' ILE . 4.7 p . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.59 ' H ' HG22 ' A' ' 6' ' ' VAL . 24.5 mm -104.02 101.78 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.561 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 4.9 pt-20 -103.71 118.83 37.63 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.9 mt -132.25 161.25 33.92 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.431 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -87.96 135.37 33.44 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.798 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.83 154.6 26.04 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -104.9 127.87 52.9 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.856 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 22' ' ' PHE . 19.4 t -59.01 127.03 17.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 118.67 -1.212 . . . . 0.0 110.552 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.35 -39.48 8.38 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.526 -0.87 . . . . 0.0 113.013 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.09 136.27 17.57 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.231 -1.388 . . . . 0.0 112.17 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.89 113.55 21.04 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.58 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 21' ' ' MET . 64.4 mt -100.11 150.07 36.57 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.107 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 3.3 Cg_exo -56.78 160.23 12.52 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.219 1.28 . . . . 0.0 111.478 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.9 t-20 76.85 28.04 0.7 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.641 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.484 ' O ' ' CD2' ' A' ' 35' ' ' HIS . . . 55.42 61.94 2.66 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.544 -0.863 . . . . 0.0 111.928 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.503 ' HG3' ' N ' ' A' ' 22' ' ' PHE . 4.6 ttt -153.59 150.81 29.04 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.503 ' N ' ' HG3' ' A' ' 21' ' ' MET . 0.0 OUTLIER -145.38 164.85 30.21 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.298 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -99.84 113.98 26.87 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.389 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.522 HG11 HG21 ' A' ' 55' ' ' VAL . 70.8 t -94.2 150.35 4.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.125 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -121.47 111.15 16.92 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.428 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.03 ' H ' HD12 ' A' ' 26' ' ' LEU . 3.6 mp -71.25 162.88 28.71 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.139 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.65 -18.07 64.61 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.588 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.803 ' H ' HD22 ' A' ' 28' ' ' ASN . 0.4 OUTLIER -65.05 -16.44 63.46 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.807 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.93 -5.86 43.07 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -102.99 178.71 4.48 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.929 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 5.4 pm0 -138.71 158.72 43.71 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.994 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.701 HG22 ' N ' ' A' ' 33' ' ' LEU . 81.8 mt -141.76 167.6 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.732 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.701 ' N ' HG22 ' A' ' 32' ' ' ILE . 3.6 mp -91.51 138.14 31.81 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.238 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.44 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 4.8 m -141.84 133.16 26.5 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.647 ' CG ' ' N ' ' A' ' 36' ' ' ILE . 51.9 t-80 -107.49 176.85 5.02 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.713 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.651 ' CG2' ' N ' ' A' ' 37' ' ' SER . 26.0 mt -103.92 167.1 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.256 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.9 ' OG ' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -123.32 110.13 14.79 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.96 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.63 -26.02 0.12 Allowed Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.821 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -69.74 -56.35 7.41 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.942 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -51.32 -21.78 2.42 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.779 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' NH2' HG21 ' A' ' 36' ' ' ILE . 5.1 ttm-85 -68.46 -47.36 67.34 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.195 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.424 ' C ' ' H ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -52.78 -31.85 40.66 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.489 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.642 ' C ' ' CD2' ' A' ' 44' ' ' PHE . 32.3 t30 -79.33 19.48 0.59 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.474 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.642 ' CD2' ' C ' ' A' ' 43' ' ' ASN . 6.6 p90 38.88 87.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.714 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.542 HD11 HD22 ' A' ' 43' ' ' ASN . 6.4 mt -140.92 88.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.77 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HG3' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -80.33 128.25 33.33 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.175 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -132.63 128.57 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.669 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' GLU . 83.1 mt -108.26 150.82 26.79 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.823 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 48' ' ' LEU . 1.7 tm-20 -38.48 151.44 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.771 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.74 -11.95 50.28 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.241 -1.457 . . . . 0.0 109.861 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -82.09 133.9 35.3 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.696 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.477 ' C ' HG13 ' A' ' 53' ' ' VAL . 56.5 mttp -77.83 143.68 37.66 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.078 -1.049 . . . . 0.0 111.221 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.689 ' CG2' HD12 ' A' ' 67' ' ' ILE . 35.1 m -149.87 169.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.745 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 41.2 m-20 -91.74 124.66 36.04 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.522 HG21 HG11 ' A' ' 24' ' ' VAL . 40.0 t -103.65 119.17 51.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.679 -0.808 . . . . 0.0 112.529 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.421 ' CG ' HG21 ' A' ' 6' ' ' VAL . 79.4 tt0 -91.78 113.28 25.5 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.963 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.428 ' CD2' HD13 ' A' ' 32' ' ' ILE . 10.2 mt -101.65 148.77 24.86 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.238 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 m -83.12 121.21 77.03 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.688 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -59.95 -16.45 38.76 Favored 'Trans proline' 0 C--O 1.217 -0.563 0 C-N-CA 121.254 1.302 . . . . 0.0 111.846 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -106.2 -10.88 16.25 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.485 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.587 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -138.75 77.44 1.62 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.884 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.0 mt -74.29 27.77 0.08 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.091 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.587 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.9 OUTLIER -102.4 -29.69 11.48 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.976 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -139.29 160.51 39.65 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.047 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.17 -157.41 7.18 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.41 140.06 5.95 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.249 -1.38 . . . . 0.0 112.357 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.689 HD12 ' CG2' ' A' ' 53' ' ' VAL . 39.0 mm -92.32 108.62 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.727 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.9 HG22 ' OG ' ' A' ' 37' ' ' SER . 21.5 p -128.84 8.1 5.7 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.837 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.827 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -164.47 120.39 1.52 Allowed 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 118.087 -1.445 . . . . 0.0 112.782 -179.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.36 152.18 36.4 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.66 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.3 tptt . . . . . 0 C--N 1.303 -1.454 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.419 -179.857 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG22 ' H ' ' A' ' 7' ' ' ILE . 3.6 p . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 62' ' ' LEU . 3.2 mt -113.85 100.62 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.842 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.24 125.01 41.52 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.735 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.3 mt -142.34 151.89 42.38 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.555 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 25.5 mp0 -86.33 138.95 31.42 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.159 -1.017 . . . . 0.0 109.971 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.12 -177.07 15.96 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 119.127 -1.511 . . . . 0.0 109.564 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.51 ' C ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -128.81 124.33 35.13 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.446 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 50' ' ' GLY . 11.3 t -59.97 132.99 25.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.0 p -110.46 -29.69 7.98 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.864 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -149.14 157.45 43.39 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.738 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.74 126.09 54.85 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.7 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.3 mt -119.74 150.33 50.18 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.22 171.7 2.99 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.293 1.329 . . . . 0.0 111.276 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 68.99 31.15 4.26 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.668 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 41' ' ' ARG . . . 55.3 52.44 11.46 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.585 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 mmm -141.02 142.24 34.25 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.874 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -143.58 157.69 44.23 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.245 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -96.66 129.2 44.1 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.219 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.51 HG13 ' C ' ' A' ' 12' ' ' THR . 14.1 t -121.42 150.47 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.528 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -126.57 128.58 47.05 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.953 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.706 HD12 HD11 ' A' ' 32' ' ' ILE . 12.4 mt -85.41 142.75 29.04 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.101 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -49.7 -26.75 4.03 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.943 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -63.8 -17.05 62.7 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.291 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.92 -0.59 38.72 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.526 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -93.23 145.2 24.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.187 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.86 141.53 37.94 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.179 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.706 HD11 HD12 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -139.85 146.78 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.943 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 6.3 mp -93.09 125.26 37.59 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.63 ' SG ' HG13 ' A' ' 55' ' ' VAL . 73.2 m -118.52 155.62 30.54 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.149 -1.02 . . . . 0.0 112.451 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -118.26 155.79 29.96 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.733 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.578 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 37.7 mt -95.04 149.84 4.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.789 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.515 ' O ' HG22 ' A' ' 36' ' ' ILE . 73.1 m -88.32 -172.76 3.91 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.007 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.88 -21.4 63.48 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.578 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.615 ' CG ' ' N ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -72.26 -55.91 6.4 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.489 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.615 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 2.4 mp -54.82 -21.69 12.05 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.445 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -72.2 -40.2 68.02 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.534 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.1 mmm -72.15 -31.46 65.98 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.759 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -74.0 -34.07 64.05 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.294 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.0 t80 40.12 61.63 1.47 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.818 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.676 HG22 ' H ' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -86.78 -165.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.158 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.676 ' H ' HG22 ' A' ' 45' ' ' ILE . 12.7 ptt85 -119.46 74.36 1.0 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 48' ' ' LEU . 4.6 mm -98.08 144.24 11.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.402 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 47' ' ' ILE . 4.4 mp -126.78 152.55 46.76 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.726 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 48' ' ' LEU . 2.9 pp20? -40.27 152.44 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.194 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 97.63 -15.05 62.54 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.26 131.91 39.55 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.262 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.479 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -77.62 146.46 36.15 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.296 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.534 ' HB ' HG23 ' A' ' 67' ' ' ILE . 35.8 m -152.45 171.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.972 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.591 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 2.0 m-80 -97.99 117.8 33.14 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.63 HG13 ' SG ' ' A' ' 34' ' ' CYS . 13.9 t -104.68 126.74 59.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.665 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.91 117.14 34.37 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.648 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.524 ' CD2' HG21 ' A' ' 32' ' ' ILE . 3.9 mt -99.27 149.16 23.4 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.907 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.36 136.13 30.35 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -59.54 -10.87 12.32 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.556 1.504 . . . . 0.0 111.715 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CD2' ' OD2' ' A' ' 61' ' ' ASP . 8.5 t80 -101.95 -14.45 17.19 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.608 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.627 ' C ' ' H ' ' A' ' 63' ' ' THR . 57.2 m-20 -144.19 79.8 1.63 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.564 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.534 ' CD2' HD12 ' A' ' 7' ' ' ILE . 5.0 mt -71.06 20.28 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.292 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.627 ' H ' ' C ' ' A' ' 61' ' ' ASP . 10.6 p -118.63 -9.68 10.19 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.298 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.501 ' HB2' HH21 ' A' ' 64' ' ' ARG . 37.3 mtp-105 -133.7 143.95 48.83 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.075 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.85 -153.48 6.25 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.597 -1.287 . . . . 0.0 109.897 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -162.68 147.5 11.95 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.504 -1.279 . . . . 0.0 112.134 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.534 HG23 ' HB ' ' A' ' 53' ' ' VAL . 20.5 mm -93.55 110.35 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.027 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.619 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 3.3 p -118.17 6.83 12.03 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.84 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -166.9 110.41 0.72 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 118.673 -1.211 . . . . 0.0 111.331 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.8 ptt-85 -76.27 136.89 39.64 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.435 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.904 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.666 HG12 ' HD3' ' A' ' 59' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.6 0.238 . . . . 0.0 110.613 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.1 100.26 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 119.167 -1.013 . . . . 0.0 109.556 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.02 112.31 20.5 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.654 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 9' ' ' LEU . 23.8 mt -137.58 149.69 46.88 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.467 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.78 144.39 25.76 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.894 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA3' HD23 ' A' ' 26' ' ' LEU . . . -145.46 -155.0 6.31 Favored Glycine 0 N--CA 1.481 1.681 0 C-N-CA 119.149 -1.501 . . . . 0.0 109.766 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 50' ' ' GLY . 31.1 m -145.24 130.62 18.68 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.026 -1.07 . . . . 0.0 111.138 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.423 ' HA ' HG22 ' A' ' 24' ' ' VAL . 11.4 t -59.6 123.12 11.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.145 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -100.4 -30.31 11.91 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.73 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -150.3 155.03 38.91 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.821 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.98 123.57 48.86 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.501 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.2 mt -121.98 151.16 57.73 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.179 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.92 -178.8 0.34 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.269 1.313 . . . . 0.0 111.544 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.608 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.6 OUTLIER 69.41 14.94 8.44 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.134 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 68.28 43.82 1.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.072 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtm -144.73 152.47 40.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.774 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -144.85 165.88 26.86 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.876 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -95.58 124.3 39.54 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.387 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 13' ' ' VAL . 78.4 t -118.52 141.25 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.956 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -118.76 113.59 21.38 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.793 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.544 HD23 ' HA3' ' A' ' 11' ' ' GLY . 26.1 mt -67.38 137.75 56.2 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.494 -0.883 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.45 -12.29 0.06 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.522 -1.271 . . . . 0.0 109.179 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.54 ' N ' ' C ' ' A' ' 26' ' ' LEU . 39.1 m-80 -72.5 -17.23 61.77 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.41 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.42 0.39 35.01 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.96 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -101.22 136.3 41.29 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.969 -1.093 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.623 ' C ' HD12 ' A' ' 32' ' ' ILE . 8.1 pt-20 -109.27 132.09 54.45 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.301 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 32' ' ' ILE . 4.7 mp -141.37 165.55 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.043 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.636 ' N ' HG22 ' A' ' 32' ' ' ILE . 7.0 mp -89.28 134.32 34.1 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.329 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.519 ' CB ' HD13 ' A' ' 67' ' ' ILE . 80.0 m -128.55 148.33 50.76 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.276 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.469 ' ND1' ' O ' ' A' ' 36' ' ' ILE . 48.9 t-80 -114.81 154.97 27.62 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.273 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.65 HG23 HD21 ' A' ' 40' ' ' LEU . 51.5 mt -90.75 153.32 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.087 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 6.0 m -82.6 126.51 32.39 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.931 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.4 -12.19 0.89 Allowed Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.453 -1.356 . . . . 0.0 111.315 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -80.7 -63.01 1.5 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.257 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.65 HD21 HG23 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -59.03 -18.61 36.15 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.38 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -71.64 -40.51 69.67 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.89 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.546 ' C ' ' H ' ' A' ' 44' ' ' PHE . 7.6 mmt -61.72 -35.82 79.17 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -58.92 -0.3 0.11 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.247 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.546 ' H ' ' C ' ' A' ' 42' ' ' MET . 4.8 t80 55.21 45.11 26.53 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.309 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 46' ' ' ARG . 6.2 mm -98.55 157.49 3.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.096 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.46 ' N ' HG22 ' A' ' 45' ' ' ILE . 3.3 mtp180 -150.03 99.14 2.79 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.818 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.542 HD11 ' CG ' ' A' ' 51' ' ' ASP . 5.1 tt -87.42 149.13 4.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.576 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.904 ' N ' HD12 ' A' ' 48' ' ' LEU . 3.5 mp -83.75 135.35 34.58 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.25 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 49' ' ' GLU . 4.8 mm-40 -44.66 153.26 0.17 Allowed 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.891 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . 92.4 -15.19 62.86 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.253 -1.451 . . . . 0.0 109.628 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.542 ' CG ' HD11 ' A' ' 47' ' ' ILE . 10.2 t70 -72.79 152.95 41.32 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.046 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.472 ' C ' HG13 ' A' ' 53' ' ' VAL . 2.0 mptm? -83.98 146.65 27.88 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.745 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.473 HG21 HG12 ' A' ' 67' ' ' ILE . 24.6 m -150.34 164.62 3.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.386 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.578 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -91.83 121.52 33.52 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.507 HG13 ' SG ' ' A' ' 34' ' ' CYS . 2.3 t -105.08 123.84 59.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.517 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.13 113.32 26.47 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.31 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.43 132.75 33.89 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.956 -1.098 . . . . 0.0 110.741 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 t -85.64 121.49 73.35 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.393 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.666 ' HD3' HG12 ' A' ' 6' ' ' VAL . 3.8 Cg_exo -61.98 -9.66 15.17 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 121.074 1.183 . . . . 0.0 110.942 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -94.27 -16.94 23.14 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.615 ' C ' ' H ' ' A' ' 63' ' ' THR . 13.8 m-20 -142.99 82.33 1.76 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.942 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.9 mt -71.21 24.09 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.768 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.615 ' H ' ' C ' ' A' ' 61' ' ' ASP . 42.0 m -122.91 -7.33 8.42 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.439 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -140.17 152.05 45.73 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.449 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 66' ' ' ARG . . . -137.56 -167.44 11.06 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.676 -1.77 . . . . 0.0 108.676 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.414 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 18.1 mtt85 -155.98 131.32 9.47 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.709 -1.597 . . . . 0.0 112.899 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 67' ' ' ILE . 1.4 mp -93.32 111.89 25.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.519 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.473 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 14.3 p -126.75 7.28 6.78 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.487 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.811 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -159.57 112.11 2.15 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.665 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -74.15 141.75 45.53 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.625 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.308 -1.197 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.067 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -178.31 71.0 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -97.95 116.23 29.75 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.644 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -172.56 129.44 0.54 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.104 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.29 -165.88 1.03 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.603 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.445 HG21 ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -144.92 175.18 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.018 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.1 mm -107.69 101.9 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.285 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -81.59 115.29 20.8 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.155 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 55' ' ' VAL . 20.2 mt -132.5 164.15 27.24 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.591 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.72 146.14 25.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.12 154.77 25.76 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.002 -1.571 . . . . 0.0 109.662 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -104.98 124.72 50.01 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 51' ' ' ASP . 5.2 t -61.13 113.84 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.16 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -88.12 -31.05 19.39 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.648 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -154.4 158.1 39.51 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.463 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.595 ' H ' ' CD ' ' A' ' 15' ' ' GLU . . . -124.48 124.36 42.13 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.733 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -120.43 162.59 33.38 Favored Pre-proline 0 N--CA 1.487 1.381 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.28 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 5.9 Cg_exo -55.98 179.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.67 1.58 . . . . 0.0 111.508 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.1 t-20 74.93 17.2 2.8 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.081 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.0 50.86 9.58 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.798 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.416 ' C ' HD12 ' A' ' 17' ' ' LEU . 25.8 mtt -142.77 171.64 13.77 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.715 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.726 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.44 166.32 29.45 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.479 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -100.04 143.56 30.1 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.25 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.699 HG23 ' SG ' ' A' ' 34' ' ' CYS . 19.1 t -132.62 137.42 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.326 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 25' ' ' LYS . 8.0 ptmm? -111.42 126.93 55.47 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.393 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.694 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.5 mp -87.45 153.21 21.61 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.799 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.725 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -57.67 -17.55 15.51 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.772 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -69.23 -14.73 63.13 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.693 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.68 -11.67 53.55 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.677 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -87.78 175.48 7.83 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.015 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.612 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -137.43 149.29 46.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.316 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 33' ' ' LEU . 50.7 mt -142.86 154.06 17.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.453 ' N ' ' CG2' ' A' ' 32' ' ' ILE . 10.0 mt -86.25 147.47 26.07 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.211 -0.995 . . . . 0.0 109.231 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -139.34 147.71 41.91 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.854 -1.139 . . . . 0.0 111.393 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 22.4 t-80 -119.04 155.55 31.26 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.286 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.754 HG23 HD21 ' A' ' 40' ' ' LEU . 46.8 mt -84.01 145.93 7.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.445 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 68' ' ' THR . 45.9 m -96.57 169.61 9.77 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.03 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.34 -14.09 80.79 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.335 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -75.58 -62.76 1.47 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.582 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.754 HD21 HG23 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -58.05 -19.69 33.48 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.616 -1.234 . . . . 0.0 109.086 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -42.92 70.45 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.034 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.483 ' O ' ' SD ' ' A' ' 42' ' ' MET . 4.4 tmm? -60.42 -33.68 72.85 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.696 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' HB3' HD11 ' A' ' 45' ' ' ILE . 36.5 m-20 -64.42 -17.7 64.03 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 118.769 -1.172 . . . . 0.0 109.873 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.419 ' C ' HD12 ' A' ' 45' ' ' ILE . 6.4 t80 67.7 73.67 0.31 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.067 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.635 ' CG2' ' N ' ' A' ' 46' ' ' ARG . 2.0 mp -117.85 165.86 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.337 0.589 . . . . 0.0 111.781 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.635 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 24.1 ttt180 -144.85 74.52 1.41 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.069 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 tt -77.19 149.6 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.119 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 49' ' ' GLU . 12.1 mt -120.4 139.57 52.61 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.072 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' LEU . 1.8 pm0 -38.21 148.07 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.007 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.16 -4.57 58.79 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.9 m-20 -98.37 139.58 33.92 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.088 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' C ' HG13 ' A' ' 53' ' ' VAL . 57.7 mttt -75.5 144.09 42.18 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.773 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.524 ' CG2' HD12 ' A' ' 67' ' ' ILE . 14.5 m -149.9 167.35 2.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.686 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.582 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -93.42 127.52 39.09 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 24' ' ' VAL . 2.9 t -104.15 129.56 56.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.438 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.445 ' OE1' HG21 ' A' ' 6' ' ' VAL . 36.5 tt0 -106.11 110.47 22.74 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.359 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.1 mt -88.01 143.17 27.24 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.065 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 60' ' ' TYR . 25.4 p -98.79 132.98 22.8 Favored Pre-proline 0 N--CA 1.492 1.658 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.118 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.4 -1.3 1.34 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.445 1.43 . . . . 0.0 111.442 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 58' ' ' SER . 5.6 t80 -81.13 -21.68 39.63 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.674 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.0 p30 179.88 105.78 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.908 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt -66.6 20.7 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.608 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.674 ' H ' ' C ' ' A' ' 61' ' ' ASP . 76.1 m -98.19 -14.4 20.38 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.044 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.423 ' NH2' ' OD1' ' A' ' 61' ' ' ASP . 17.2 mtp180 -138.83 146.61 41.47 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.197 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.57 -151.75 5.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.67 143.28 4.74 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.175 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.524 HD12 ' CG2' ' A' ' 53' ' ' VAL . 19.3 mm -93.15 119.05 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.592 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 7.2 p -126.62 7.38 6.88 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.685 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.85 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.16 111.87 0.73 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.378 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.5 ptt85 -111.36 146.28 37.4 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.255 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -44.01 154.39 0.11 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.92 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 116.347 -1.787 . . . . 0.0 110.978 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mmm . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.932 0.396 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.24 -27.02 61.68 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.948 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -42.57 -34.92 0.95 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.955 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -149.34 50.36 0.96 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.672 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -40.19 140.0 0.65 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.672 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 p -173.15 164.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.669 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.5 mt -97.73 101.38 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.222 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -94.55 108.38 20.34 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 9' ' ' LEU . 10.8 mt -132.64 148.94 52.36 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.067 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.84 144.1 27.17 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.66 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.47 179.82 25.94 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 119.069 -1.539 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.4 m -124.16 131.05 53.5 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.445 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.457 HG23 ' H ' ' A' ' 13' ' ' VAL . 1.9 t -59.73 119.08 3.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 118.576 -1.249 . . . . 0.0 110.591 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' LYS . 5.7 t -88.88 -32.24 17.85 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.165 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -151.1 156.32 40.78 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.694 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.84 107.38 18.1 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.627 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.3 mt -99.79 144.52 28.5 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.099 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.9 Cg_endo -61.01 166.68 10.15 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.255 1.304 . . . . 0.0 111.037 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER 76.96 29.76 0.59 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.652 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.82 57.77 4.5 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.531 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.766 ' SD ' ' NE2' ' A' ' 35' ' ' HIS . 15.8 mtm -152.6 159.42 43.24 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.897 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.696 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -159.45 165.34 33.31 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.668 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 14' ' ' SER . 27.4 ttpt -103.29 114.3 28.47 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.657 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -98.51 146.98 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.303 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -124.2 114.4 19.57 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.746 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.539 ' C ' ' N ' ' A' ' 28' ' ' ASN . 10.6 mt -69.58 147.07 51.22 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.659 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.643 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -49.31 -11.36 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.959 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.643 ' N ' ' CD ' ' A' ' 27' ' ' GLU . 36.6 t30 -78.84 -17.79 55.08 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.7 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.69 -2.18 42.13 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.804 -1.189 . . . . 0.0 112.294 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -94.29 137.56 33.31 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.069 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -91.53 141.26 28.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.491 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.415 ' C ' HD12 ' A' ' 33' ' ' LEU . 7.5 mm -137.93 144.53 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.248 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.796 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.2 mp -85.85 134.41 33.91 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.14 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.0 m -139.57 151.35 45.99 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.399 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.766 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 18.3 m80 -115.55 161.82 18.09 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.654 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.532 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 27.9 mt -92.59 146.06 6.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.66 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.439 ' O ' HG22 ' A' ' 36' ' ' ILE . 3.2 m -92.47 -178.34 4.88 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.21 -8.61 87.44 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.854 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -75.12 -62.18 1.64 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.48 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.526 HD13 HG23 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -53.69 -20.68 5.74 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.188 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -73.52 -39.19 64.97 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.308 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.61 -28.62 67.08 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.397 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -77.55 -16.28 58.75 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.618 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.2 t80 47.66 80.94 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.551 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 45' ' ' ILE . 33.5 mt -144.86 113.21 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.019 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -60.27 126.1 26.18 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.688 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.7 mm -95.12 148.28 5.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.551 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 48' ' ' LEU . 14.3 tp -125.08 135.45 52.71 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.083 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.21 152.34 0.59 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.932 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.02 -16.4 59.62 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.247 -1.454 . . . . 0.0 109.667 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.91 162.21 29.79 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.425 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.73 141.4 36.54 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.377 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.436 ' CG2' HG13 ' A' ' 67' ' ' ILE . 5.3 m -148.57 162.49 5.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.583 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 2.0 m-20 -92.46 124.09 36.25 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.23 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.57 142.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.644 -0.823 . . . . 0.0 112.254 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -122.84 108.64 13.23 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.405 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.1 mt -84.42 132.29 34.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.391 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.7 p -91.01 139.33 25.81 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 119.024 -1.07 . . . . 0.0 112.152 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.32 -4.9 8.73 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.518 1.479 . . . . 0.0 111.403 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -89.15 -22.82 22.64 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.724 -0.79 . . . . 0.0 108.98 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.644 ' C ' ' H ' ' A' ' 63' ' ' THR . 4.1 m-20 -151.34 89.31 1.49 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mt -69.89 23.06 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.417 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.644 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.1 m -119.53 -8.59 9.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.169 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.25 150.43 39.28 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.236 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.8 -152.57 6.42 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -166.36 143.76 5.2 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.146 -1.422 . . . . 0.0 112.166 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 67' ' ' ILE . 1.3 mp -92.34 121.7 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.22 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.57 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 70.2 p -124.7 7.08 8.16 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.076 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.863 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.67 111.02 0.65 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.646 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.36 162.91 28.4 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.52 133.2 1.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.114 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.419 ' HG2' ' H ' ' A' ' 72' ' ' LYS . 13.8 pttp . . . . . 0 C--N 1.307 -1.269 0 CA-C-O 116.268 -1.825 . . . . 0.0 110.76 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.456 ' HG3' ' N ' ' A' ' 2' ' ' ALA . 8.0 ptp . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.902 0.382 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' N ' ' HG3' ' A' ' 1' ' ' MET . . . -79.03 106.22 10.92 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.381 -0.927 . . . . 0.0 111.202 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 5' ' ' ASP . 35.1 tttp 54.22 -93.93 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.72 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -44.94 95.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 3' ' ' LYS . 6.2 m-20 -98.43 90.61 4.84 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.853 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.49 164.21 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.866 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 mt -94.46 102.44 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.575 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 1.9 mm-40 -80.38 117.04 20.79 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.156 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.2 mt -128.95 150.73 50.26 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.222 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -88.18 142.64 27.6 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.393 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.7 165.61 31.59 Favored Glycine 0 N--CA 1.485 1.941 0 C-N-CA 119.172 -1.489 . . . . 0.0 110.221 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.439 ' C ' HG13 ' A' ' 24' ' ' VAL . 33.7 m -113.7 125.79 54.51 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.739 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.99 112.06 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 118.624 -1.23 . . . . 0.0 110.546 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -90.36 -32.75 16.33 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.429 -0.908 . . . . 0.0 112.141 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -152.56 137.85 17.51 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.389 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.37 117.12 32.07 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.376 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -106.86 155.22 39.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.618 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.54 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 3.7 Cg_exo -56.54 -164.3 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.879 0 C-N-CA 121.334 1.356 . . . . 0.0 112.126 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 18' ' ' PRO . 8.0 p30 46.63 31.34 1.35 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.062 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' A' ' 36' ' ' ILE . . . 52.07 58.08 5.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.981 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.51 ' SD ' ' OD1' ' A' ' 19' ' ' ASN . 37.0 mtp -149.85 137.59 20.11 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.714 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -130.71 163.22 27.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.424 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -103.84 108.88 20.39 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.521 ' CG2' ' SG ' ' A' ' 34' ' ' CYS . 36.6 t -94.93 152.48 3.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.375 -0.93 . . . . 0.0 112.01 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -120.74 110.91 16.94 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.825 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.692 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.1 mp -65.45 178.6 0.92 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.545 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -77.23 -23.69 51.32 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.649 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.857 HD22 ' H ' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -66.12 -15.82 63.43 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.494 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.36 -8.23 35.13 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.068 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.857 ' H ' HD22 ' A' ' 28' ' ' ASN . 22.3 m80 -95.76 176.8 6.0 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.676 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -138.34 160.46 39.43 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.82 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 33' ' ' LEU . 76.7 mt -143.53 161.67 16.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.1 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.679 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 3.9 mp -86.37 131.51 34.19 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.549 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 8.2 m -132.99 135.28 45.38 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.658 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 2.4 t60 -102.31 173.68 6.26 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.509 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.658 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 10.7 mt -91.3 165.91 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.998 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.644 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -128.2 160.77 31.04 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.946 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.97 -20.01 66.18 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.341 -1.409 . . . . 0.0 111.594 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.42 ' C ' ' N ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -67.81 -62.27 1.49 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.342 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -52.83 -20.25 3.12 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.808 -1.157 . . . . 0.0 109.643 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.437 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.35 -42.81 68.03 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.406 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.476 ' C ' ' H ' ' A' ' 44' ' ' PHE . 1.4 ptm -72.4 -22.32 61.14 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.298 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.472 ' N ' ' HG3' ' A' ' 42' ' ' MET . 7.2 m120 -67.09 6.51 0.52 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.801 -1.16 . . . . 0.0 110.646 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 42' ' ' MET . 0.8 OUTLIER 48.19 82.32 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.876 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 mm -142.46 147.06 21.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.088 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.78 75.13 1.51 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.572 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.452 HG21 ' CB ' ' A' ' 51' ' ' ASP . 42.8 mt -105.79 149.59 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.771 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.3 mt -110.72 165.8 11.54 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.517 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -40.41 153.26 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.47 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.26 -12.18 65.25 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.588 -1.292 . . . . 0.0 109.873 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.452 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -92.6 152.63 19.48 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.74 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 66.1 mttt -78.41 147.43 34.04 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.629 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.464 HG13 ' C ' ' A' ' 52' ' ' LYS . 33.9 m -149.58 162.44 4.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.643 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.516 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -95.2 123.04 38.49 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.453 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 9' ' ' LEU . 61.1 t -104.35 127.5 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.625 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.65 113.69 26.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.946 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.406 ' CD2' HD13 ' A' ' 32' ' ' ILE . 23.8 mt -88.48 147.26 24.75 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.752 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.05 135.2 33.65 Favored Pre-proline 0 N--CA 1.492 1.648 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.18 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -65.1 -4.93 9.92 Favored 'Trans proline' 0 C--O 1.217 -0.548 0 C-N-CA 121.625 1.55 . . . . 0.0 112.068 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.78 -22.05 14.98 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.083 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.617 ' C ' ' H ' ' A' ' 63' ' ' THR . 33.0 t0 -155.23 91.64 1.36 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.55 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.33 19.83 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.464 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.617 ' H ' ' C ' ' A' ' 61' ' ' ASP . 53.2 m -99.92 -13.33 19.19 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.011 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -137.67 147.31 44.76 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.13 -159.33 7.89 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.455 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 5.8 ptp180 -154.71 143.88 21.12 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.842 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.2 mm -93.26 122.05 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.296 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.635 ' OG1' ' NE1' ' A' ' 69' ' ' TRP . 5.0 p -126.47 6.4 6.93 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.012 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.859 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -158.4 157.72 32.84 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.315 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -154.32 88.72 1.24 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.063 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.23 131.66 9.46 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.655 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.4 tttt . . . . . 0 C--N 1.305 -1.336 0 CA-C-O 116.397 -1.763 . . . . 0.0 110.877 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.4 mpp? . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 60.78 170.32 0.09 Allowed 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.757 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.76 22.19 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.714 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 16.6 pttp -161.94 -155.84 0.4 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.651 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 2.1 t0 72.13 -179.07 0.21 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.201 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 58' ' ' SER . 11.9 m -82.66 151.65 4.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.214 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 mm -95.61 106.72 18.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.415 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.53 112.55 13.18 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.194 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 9' ' ' LEU . 25.0 mt -134.0 164.95 26.17 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.611 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -90.01 143.84 26.43 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.8 148.32 18.8 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.413 HG21 ' NZ ' ' A' ' 25' ' ' LYS . 20.1 m -104.27 132.13 50.85 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 51' ' ' ASP . 4.2 t -63.36 117.66 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.619 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.09 -29.46 13.61 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.319 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -150.09 121.9 8.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.122 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.46 105.34 17.69 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.034 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.42 149.03 36.61 Favored Pre-proline 0 C--N 1.307 -1.259 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.799 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 2.3 Cg_endo -58.72 167.21 5.51 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.308 1.339 . . . . 0.0 111.229 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 75.79 29.94 0.8 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.573 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.546 ' O ' ' CD2' ' A' ' 35' ' ' HIS . . . 54.16 61.37 3.07 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.822 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 ttm -155.23 136.51 13.99 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.61 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -136.28 165.69 25.19 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.809 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -105.08 109.01 20.83 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.365 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.694 HG11 HG21 ' A' ' 55' ' ' VAL . 69.8 t -96.35 143.96 11.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.201 -1.0 . . . . 0.0 112.079 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 25' ' ' LYS . 14.8 pttm -110.95 126.87 55.21 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.968 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.527 HD11 ' CD1' ' A' ' 32' ' ' ILE . 4.8 mp -83.77 175.46 9.64 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.183 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -73.91 -26.93 60.78 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.775 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.85 -16.86 64.22 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.81 -11.77 35.0 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.365 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -83.72 174.98 10.01 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.284 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -133.3 151.78 51.9 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.651 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.527 ' CD1' HD11 ' A' ' 26' ' ' LEU . 65.8 mt -141.28 155.33 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.914 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.872 ' H ' HD12 ' A' ' 33' ' ' LEU . 2.2 mp -88.04 134.41 33.75 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.193 -1.003 . . . . 0.0 109.522 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.57 ' SG ' HG13 ' A' ' 55' ' ' VAL . 61.6 m -132.96 139.1 47.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.957 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -107.96 172.35 6.88 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.815 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.651 HG22 ' N ' ' A' ' 37' ' ' SER . 25.0 mt -98.61 167.42 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.818 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.651 ' N ' HG22 ' A' ' 36' ' ' ILE . 35.1 m -130.93 117.74 19.67 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.817 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.49 -15.34 0.05 OUTLIER Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.82 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 37' ' ' SER . 30.7 mtmt -72.42 -61.54 1.76 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.196 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.493 ' HA ' HD22 ' A' ' 43' ' ' ASN . 1.1 pp -53.15 -21.36 4.88 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.96 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.468 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 1.9 ttt-85 -72.78 -39.72 66.52 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.52 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.421 ' O ' ' SD ' ' A' ' 42' ' ' MET . 6.9 tpp -63.72 -27.4 69.18 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.725 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.493 HD22 ' HA ' ' A' ' 40' ' ' LEU . 83.2 m-20 -78.93 5.39 11.7 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.877 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 54.23 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.223 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.57 114.07 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -59.34 137.15 58.09 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.607 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 mm -102.52 149.78 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.39 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -164.26 134.95 4.26 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.501 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.441 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 2.2 pp20? -63.42 152.24 38.79 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.223 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.59 -8.31 28.1 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 118.873 -1.632 . . . . 0.0 109.695 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 13' ' ' VAL . 56.5 t0 -72.53 133.1 44.61 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.284 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' C ' HG13 ' A' ' 53' ' ' VAL . 77.8 mttt -76.1 141.76 41.89 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.332 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.693 ' CG2' HD12 ' A' ' 67' ' ' ILE . 16.6 m -148.48 168.79 3.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.681 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.597 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -91.42 120.26 32.11 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.538 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.694 HG21 HG11 ' A' ' 24' ' ' VAL . 26.3 t -104.76 116.66 48.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.634 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.17 120.13 33.98 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.412 ' CD2' HD13 ' A' ' 32' ' ' ILE . 12.7 mt -92.8 159.43 15.4 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.406 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.454 ' HA ' HG12 ' A' ' 6' ' ' VAL . 67.0 m -94.85 141.08 22.83 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.599 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -69.68 -21.88 33.25 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.825 1.683 . . . . 0.0 112.055 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -88.24 -26.39 22.37 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.403 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.61 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -148.04 88.21 1.65 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.12 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mt -71.76 20.61 0.06 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.278 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.61 ' H ' ' C ' ' A' ' 61' ' ' ASP . 7.1 p -98.43 -12.32 21.49 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -138.02 150.68 47.18 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.678 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.36 -153.28 5.85 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.435 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 4.8 ptt180 -165.48 147.13 7.41 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.664 -1.215 . . . . 0.0 111.595 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.693 HD12 ' CG2' ' A' ' 53' ' ' VAL . 25.2 mm -92.72 117.3 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.969 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.63 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 32.6 p -127.95 7.97 6.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.963 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.824 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -169.98 127.72 0.88 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.28 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.474 ' HD2' ' N ' ' A' ' 71' ' ' LYS . 8.7 tmm_? -72.3 162.08 29.97 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.515 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.474 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 9.2 tttt -43.28 135.2 3.49 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.416 -0.913 . . . . 0.0 111.334 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.3 tptm . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 116.304 -1.807 . . . . 0.0 110.634 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.896 0.379 . . . . 0.0 110.05 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.06 83.02 0.11 Allowed 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.859 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -165.91 94.78 0.58 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.76 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.524 ' C ' ' H ' ' A' ' 6' ' ' VAL . 8.1 tttt -148.62 -140.31 0.1 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.014 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.451 ' H ' ' HG2' ' A' ' 4' ' ' LYS . 31.2 t70 -48.52 -10.97 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.309 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.713 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -176.36 176.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.602 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.713 HD12 ' C ' ' A' ' 6' ' ' VAL . 1.8 mp -116.76 110.19 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.246 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -100.52 127.12 46.98 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.092 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' VAL . 35.2 mt -144.44 160.24 41.4 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.646 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -88.0 143.73 26.93 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.19 168.77 30.2 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.117 -1.516 . . . . 0.0 109.804 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.5 m -123.87 130.03 51.95 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.475 ' HA ' HG22 ' A' ' 24' ' ' VAL . 3.0 t -67.72 133.07 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.734 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 t -113.24 -26.92 8.18 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.326 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -153.15 158.2 41.45 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.108 -1.437 . . . . 0.0 112.223 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' H ' ' CD ' ' A' ' 15' ' ' GLU . . . -99.15 113.99 26.51 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.577 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.4 mt -104.66 146.94 33.6 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 119.739 -0.785 . . . . 0.0 111.008 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.517 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 3.1 Cg_endo -65.0 170.49 10.27 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 121.296 1.331 . . . . 0.0 111.433 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.517 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER 75.07 28.62 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.154 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.483 ' O ' ' CE1' ' A' ' 35' ' ' HIS . . . 58.89 61.99 2.01 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.347 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 19' ' ' ASN . 8.6 ptm -165.29 170.38 14.8 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.607 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -155.41 165.34 36.92 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.837 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -88.88 132.46 34.67 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.768 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.475 HG22 ' HA ' ' A' ' 13' ' ' VAL . 2.3 t -125.93 143.39 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.575 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -122.81 124.75 44.02 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.97 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.71 172.73 10.92 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.93 -41.64 62.19 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.823 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.521 ' HB3' ' CE1' ' A' ' 30' ' ' HIS . 0.1 OUTLIER -71.63 -14.82 62.17 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.411 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.02 -0.78 44.47 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.969 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.521 ' CE1' ' HB3' ' A' ' 28' ' ' ASN . 71.7 m80 -55.34 104.88 0.14 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.835 -1.146 . . . . 0.0 111.224 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -76.19 124.28 27.21 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.431 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.486 ' C ' HD12 ' A' ' 33' ' ' LEU . 23.3 mt -137.42 152.6 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.318 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.709 ' N ' HD12 ' A' ' 33' ' ' LEU . 6.3 mp -90.45 132.79 35.44 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.356 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.428 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 8.8 p -132.03 134.64 45.78 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.889 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.587 ' ND1' ' N ' ' A' ' 36' ' ' ILE . 54.3 t-80 -103.68 176.23 5.22 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.941 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.587 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 22.1 mt -99.74 161.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.005 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.559 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 4.0 p -121.72 -169.49 1.88 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.389 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.32 -5.32 89.81 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.418 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -71.95 -63.41 1.14 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.769 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.586 HD13 HG23 ' A' ' 36' ' ' ILE . 1.7 mp -54.81 -21.42 11.16 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.874 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -35.16 66.91 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.601 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.8 ttp -74.66 -31.98 62.1 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.783 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.645 ' C ' ' CD1' ' A' ' 44' ' ' PHE . 2.7 t-20 -93.96 0.76 56.25 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.819 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.645 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 18.6 p90 31.01 72.55 0.06 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.1 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 46' ' ' ARG . 43.7 mt -102.69 166.5 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.823 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.611 ' N ' HG22 ' A' ' 45' ' ' ILE . 6.1 ptt180 -144.31 79.63 1.62 Allowed 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.634 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.431 HG21 ' CB ' ' A' ' 51' ' ' ASP . 5.2 mm -104.22 150.7 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.61 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 mp -99.04 156.78 16.75 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.556 -0.858 . . . . 0.0 112.359 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.686 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 6.4 mp0 -41.38 153.71 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.685 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.25 -4.62 60.54 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.004 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.431 ' CB ' HG21 ' A' ' 47' ' ' ILE . 23.8 t0 -90.82 142.27 27.94 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.591 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' C ' HG13 ' A' ' 53' ' ' VAL . 6.5 mtpm? -81.93 145.57 30.24 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.543 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.583 ' CG2' HD12 ' A' ' 67' ' ' ILE . 17.5 m -148.64 166.56 4.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.42 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.595 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 1.9 m-20 -92.17 123.83 35.81 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.835 -1.146 . . . . 0.0 108.124 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 9' ' ' LEU . 56.8 t -104.32 126.49 59.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.783 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -99.83 114.54 27.79 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.637 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.73 145.27 24.72 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.134 -1.027 . . . . 0.0 111.024 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 60' ' ' TYR . 4.5 p -86.93 128.1 57.26 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.079 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.88 -1.64 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.348 1.365 . . . . 0.0 111.378 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 58' ' ' SER . 78.6 m-85 -109.05 -16.84 14.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.881 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.61 ' C ' ' H ' ' A' ' 63' ' ' THR . 13.0 m-20 -145.11 84.0 1.7 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt -71.7 23.25 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.61 ' H ' ' C ' ' A' ' 61' ' ' ASP . 6.7 m -116.37 -5.73 11.78 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.622 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 65' ' ' GLY . 1.7 tmt_? -148.68 144.88 27.42 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.728 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.473 ' N ' ' HG2' ' A' ' 64' ' ' ARG . . . -138.28 -150.75 5.69 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.463 ' HG2' HH11 ' A' ' 66' ' ' ARG . 10.5 ptt-85 -165.59 141.45 5.19 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.855 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.583 HD12 ' CG2' ' A' ' 53' ' ' VAL . 20.2 mm -87.44 117.87 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 119.846 -0.741 . . . . 0.0 109.802 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.633 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 25.6 p -125.44 6.88 7.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.863 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -169.92 110.74 0.43 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.231 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.538 ' CG ' ' N ' ' A' ' 71' ' ' LYS . 22.6 ttp85 -68.5 161.56 27.54 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.654 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.538 ' N ' ' CG ' ' A' ' 70' ' ' ARG . 23.2 tttp -87.41 134.23 33.62 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 116.336 -1.792 . . . . 0.0 110.825 -179.924 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mtp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.78 -16.89 15.82 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.127 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HG3' ' N ' ' A' ' 4' ' ' LYS . 1.2 tppt? -167.49 142.37 3.84 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.767 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.414 ' N ' ' HG3' ' A' ' 3' ' ' LYS . 22.2 tttt -154.77 111.06 3.22 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.897 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.561 ' OD2' ' N ' ' A' ' 5' ' ' ASP . 6.8 p-10 -94.83 172.88 7.89 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.112 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.569 HG12 ' HD3' ' A' ' 59' ' ' PRO . 4.0 m -82.03 -180.0 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.117 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 7' ' ' ILE . 11.7 mt -127.12 103.06 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.38 115.14 11.27 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.446 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 mt -141.88 143.18 33.2 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -86.25 141.49 29.25 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.476 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.08 149.65 21.68 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.228 -1.463 . . . . 0.0 109.873 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.46 ' C ' HG13 ' A' ' 24' ' ' VAL . 98.8 m -93.91 130.01 40.14 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.459 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 51' ' ' ASP . 3.8 t -59.99 127.12 18.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.277 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -99.47 -32.45 11.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.943 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -160.38 157.78 28.42 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.614 -1.234 . . . . 0.0 111.818 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.63 118.7 35.94 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.785 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.8 mt -106.2 147.73 35.37 Favored Pre-proline 0 N--CA 1.491 1.582 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.399 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.74 171.18 4.9 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.611 1.54 . . . . 0.0 111.929 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.6 OUTLIER 67.58 28.95 7.32 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.805 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 59.59 60.55 2.22 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.168 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.774 ' SD ' ' CD2' ' A' ' 35' ' ' HIS . 46.7 mtm -152.4 164.51 37.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.334 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.581 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.54 165.18 31.29 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.722 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' HG2' ' CG ' ' A' ' 31' ' ' GLU . 14.3 ttmt -99.04 137.18 37.93 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.224 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.46 HG13 ' C ' ' A' ' 12' ' ' THR . 46.9 t -130.93 145.13 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.64 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.459 ' HZ3' ' HG3' ' A' ' 25' ' ' LYS . 9.0 mtmm -111.49 120.76 43.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.563 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.919 ' H ' HD12 ' A' ' 26' ' ' LEU . 3.9 mp -74.41 168.31 19.95 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.866 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.03 -29.59 70.39 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -63.0 -11.05 16.31 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.641 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.29 -11.52 65.36 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.735 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -78.38 167.69 20.95 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.524 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.408 ' CG ' ' HG2' ' A' ' 23' ' ' LYS . 24.1 tt0 -127.42 142.69 51.35 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.155 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.558 HG22 ' N ' ' A' ' 33' ' ' LEU . 77.0 mt -143.69 160.91 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.246 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.558 ' N ' HG22 ' A' ' 32' ' ' ILE . 6.1 mp -90.35 141.8 28.36 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.151 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.4 ' SG ' HG13 ' A' ' 55' ' ' VAL . 4.7 m -138.7 139.81 38.54 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.384 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.774 ' CD2' ' SD ' ' A' ' 21' ' ' MET . 4.3 m80 -104.15 168.81 8.87 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.321 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.527 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 57.8 mt -92.78 152.09 3.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.772 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.42 ' O ' HG22 ' A' ' 36' ' ' ILE . 3.5 m -104.08 -166.69 1.28 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.63 -16.82 74.67 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.468 -1.348 . . . . 0.0 111.252 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.486 ' C ' ' N ' ' A' ' 41' ' ' ARG . 30.0 mttp -70.89 -63.22 1.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.658 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.653 ' H ' HD12 ' A' ' 40' ' ' LEU . 4.5 mp -52.84 -20.27 3.14 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.679 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.486 ' N ' ' C ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.91 -36.95 62.18 Favored 'General case' 0 C--N 1.271 -2.848 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.898 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 39' ' ' LYS . 92.3 mtp -90.32 -21.53 21.99 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.637 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.503 ' ND2' HG13 ' A' ' 45' ' ' ILE . 12.9 t30 -83.5 -37.76 22.67 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.316 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.9 t80 42.76 54.72 4.54 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.687 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.503 HG13 ' ND2' ' A' ' 43' ' ' ASN . 5.6 mm -96.35 159.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.216 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 46' ' ' ARG . 18.2 mmm180 -62.15 137.58 58.28 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.258 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.431 ' HA ' ' NH2' ' A' ' 70' ' ' ARG . 3.3 mt -133.19 140.27 47.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.889 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.8 mt -143.77 135.33 26.11 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.289 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -43.93 152.09 0.18 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.92 -15.11 63.56 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.731 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 13' ' ' VAL . 8.7 m-20 -76.11 146.8 39.05 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.356 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -88.23 143.55 26.97 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.702 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.503 ' CG2' HD12 ' A' ' 67' ' ' ILE . 18.5 m -146.03 169.15 6.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.671 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.527 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 0.4 OUTLIER -96.57 117.93 32.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.107 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.705 HG22 HD11 ' A' ' 67' ' ' ILE . 10.4 t -105.25 117.3 50.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.197 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -94.07 118.61 31.77 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.008 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.3 mt -88.49 139.81 30.11 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.913 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.0 m -95.01 132.56 27.89 Favored Pre-proline 0 N--CA 1.49 1.538 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.356 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.569 ' HD3' HG12 ' A' ' 6' ' ' VAL . 2.0 Cg_endo -66.96 -2.81 8.51 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.297 1.332 . . . . 0.0 110.967 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -92.11 -22.83 19.67 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.659 ' C ' ' H ' ' A' ' 63' ' ' THR . 5.5 m-20 -150.83 87.26 1.41 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.199 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mt -66.87 18.81 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.677 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.659 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.3 p -113.33 -8.88 13.45 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.43 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.434 ' NH1' ' NE2' ' A' ' 35' ' ' HIS . 0.9 OUTLIER -140.71 151.59 44.64 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.467 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.71 -153.17 6.1 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -163.72 135.88 5.02 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.195 -1.402 . . . . 0.0 112.474 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 55' ' ' VAL . 47.8 mm -92.82 123.09 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.429 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.602 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -125.1 7.09 7.89 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.544 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.817 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -168.89 166.1 11.42 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.785 -1.166 . . . . 0.0 111.483 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 47' ' ' ILE . 2.4 ttm180 -144.04 125.87 15.22 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.171 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -44.25 158.2 0.05 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.509 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 116.348 -1.787 . . . . 0.0 110.916 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.914 0.388 . . . . 0.0 109.995 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.01 150.99 29.76 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.722 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -73.64 151.54 40.78 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.891 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HD3' ' N ' ' A' ' 4' ' ' LYS . 10.2 mmtm -90.33 105.63 17.95 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.824 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -134.54 -134.89 0.16 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.024 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG12 ' HD3' ' A' ' 59' ' ' PRO . 2.0 m -73.09 165.73 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.083 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.5 mt -114.6 100.93 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.109 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -78.87 114.59 17.93 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.398 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 9' ' ' LEU . 12.2 mt -134.32 153.37 51.92 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.383 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.49 142.1 28.61 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.704 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.03 -178.4 18.08 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.416 ' N ' HG13 ' A' ' 24' ' ' VAL . 13.7 m -137.86 125.8 22.68 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.476 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.412 ' HA ' HG22 ' A' ' 24' ' ' VAL . 6.1 t -59.79 123.94 13.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.527 -1.269 . . . . 0.0 110.534 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -105.51 -29.3 10.27 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.984 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -156.99 149.11 22.91 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.879 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.28 131.67 35.96 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -122.29 152.74 61.24 Favored Pre-proline 0 N--CA 1.492 1.626 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.571 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.29 -176.44 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.031 1.154 . . . . 0.0 110.888 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 3.2 m-20 55.52 40.93 31.23 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.51 49.65 13.3 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.848 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.483 ' HG3' ' CE1' ' A' ' 35' ' ' HIS . 28.9 mtp -140.82 168.41 19.85 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.819 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.0 165.94 29.05 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.917 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -95.3 128.58 42.25 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.109 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.416 HG13 ' N ' ' A' ' 12' ' ' THR . 39.0 t -117.65 140.23 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.647 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -105.72 122.69 46.59 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.141 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.775 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.1 mp -76.79 171.99 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.26 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -71.25 -14.5 62.25 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.444 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -75.52 -16.79 60.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.067 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.29 -15.25 33.0 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 119.767 -1.206 . . . . 0.0 111.419 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -89.5 179.24 6.1 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.115 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -137.68 149.9 46.9 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.268 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.741 HG22 ' N ' ' A' ' 33' ' ' LEU . 11.2 mm -136.99 174.73 11.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.231 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.741 ' N ' HG22 ' A' ' 32' ' ' ILE . 6.8 mp -97.01 136.5 37.49 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.577 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.535 ' SG ' HG13 ' A' ' 55' ' ' VAL . 86.1 m -132.73 152.96 51.62 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.654 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.483 ' CE1' ' HG3' ' A' ' 21' ' ' MET . 1.9 t60 -118.92 152.7 35.83 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.257 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.608 HG23 HD21 ' A' ' 40' ' ' LEU . 28.0 mt -93.99 146.68 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.995 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.5 m -97.22 136.28 37.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.37 -11.28 39.77 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.185 -1.483 . . . . 0.0 110.496 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.446 ' C ' ' N ' ' A' ' 41' ' ' ARG . 6.8 tttm -70.88 -62.22 1.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.26 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -52.72 -20.21 2.99 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.55 -1.26 . . . . 0.0 108.893 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.446 ' N ' ' C ' ' A' ' 39' ' ' LYS . 3.7 ttt180 -63.99 -53.21 53.66 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.635 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 tpp -65.5 -25.35 67.43 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.895 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -65.14 -4.48 5.03 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.739 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 t80 52.28 87.81 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.571 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.6 mt -140.29 141.88 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.722 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.407 ' H ' ' HG2' ' A' ' 46' ' ' ARG . 15.1 ptt180 -74.53 134.55 42.2 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.797 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.432 HD11 HD11 ' A' ' 40' ' ' LEU . 37.9 mt -131.18 147.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.342 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.847 HD23 ' N ' ' A' ' 48' ' ' LEU . 1.8 pt? -159.59 148.91 18.14 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.657 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 19.3 pt-20 -63.34 152.07 39.0 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.416 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.97 -13.15 60.05 Favored Glycine 0 N--CA 1.485 1.9 0 C-N-CA 119.445 -1.36 . . . . 0.0 110.198 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.641 ' CG ' ' HE ' ' A' ' 70' ' ' ARG . 9.5 t70 -80.12 162.16 24.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.655 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.492 ' C ' HG13 ' A' ' 53' ' ' VAL . 5.9 mtpm? -91.06 152.14 20.75 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.751 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.587 HG21 HG12 ' A' ' 67' ' ' ILE . 22.3 m -154.62 167.73 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.455 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.532 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -93.72 122.41 36.15 Favored 'General case' 0 C--O 1.203 -1.351 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.27 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.535 HG13 ' SG ' ' A' ' 34' ' ' CYS . 4.1 t -104.59 121.14 56.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.419 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.85 121.2 41.65 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.606 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 mt -95.14 141.87 28.26 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.212 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.5 m -86.03 128.81 56.48 Favored Pre-proline 0 N--CA 1.493 1.677 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.592 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.653 ' HD3' HG12 ' A' ' 6' ' ' VAL . 2.2 Cg_endo -66.32 -13.38 39.65 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 121.306 1.337 . . . . 0.0 110.898 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -101.32 -10.41 20.31 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.628 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -147.1 72.45 1.26 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.771 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -70.59 23.35 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.641 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.628 ' H ' ' C ' ' A' ' 61' ' ' ASP . 9.1 m -105.5 -21.16 13.27 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.458 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -140.66 159.6 41.84 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.776 -0.77 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.18 -159.96 8.44 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.45 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 6.8 ptt180 -166.91 139.36 3.51 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 117.957 -1.497 . . . . 0.0 112.164 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.587 HG12 HG21 ' A' ' 53' ' ' VAL . 1.8 mp -93.29 126.34 45.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.563 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.469 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 4.8 p -126.77 7.04 6.74 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.888 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.843 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -166.45 142.69 4.77 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.589 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.641 ' HE ' ' CG ' ' A' ' 51' ' ' ASP . 11.0 ttt-85 -124.11 128.15 48.87 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.947 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' ARG . 16.3 mmtt -41.57 111.83 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.847 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 116.426 -1.75 . . . . 0.0 110.832 179.927 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.663 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.897 0.38 . . . . 0.0 110.102 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 71.68 -22.98 0.19 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 1' ' ' MET . 8.4 mmtp 51.92 87.44 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.885 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.535 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 12.5 tptm -77.59 -144.2 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.049 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.535 ' H ' ' CG ' ' A' ' 4' ' ' LYS . 12.3 t70 -102.58 116.68 33.1 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -88.07 164.5 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.669 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.4 mm -100.0 107.83 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -76.09 118.41 18.81 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.431 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.6 138.17 37.64 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.509 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 12.3 mp0 -88.47 140.65 29.25 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.66 172.24 28.88 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.089 -1.529 . . . . 0.0 110.201 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 m -115.67 129.68 56.58 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.791 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 24' ' ' VAL . 14.9 t -59.67 127.72 19.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.749 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 23' ' ' LYS . 37.1 t -93.98 -40.11 10.29 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.664 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -156.65 158.24 36.64 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.634 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.56 123.75 44.12 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.5 mt -119.29 149.51 47.54 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.461 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 2.3 Cg_endo -59.01 -179.89 0.18 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.289 1.326 . . . . 0.0 111.104 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 6.0 t30 73.58 18.62 3.5 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.61 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 61.66 42.95 10.33 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.575 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.8 mtp -142.3 174.75 10.33 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.827 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.651 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.52 166.19 27.44 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.372 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' SER . 46.2 tttm -99.14 130.68 45.47 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.55 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 13' ' ' VAL . 95.2 t -119.85 150.46 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.336 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -124.18 112.14 16.73 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.412 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.683 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.7 mp -70.11 138.27 51.83 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.053 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.89 -15.5 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.276 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.543 ' N ' ' C ' ' A' ' 26' ' ' LEU . 18.0 m120 -65.09 -16.27 63.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.243 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.92 -11.21 52.58 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.906 -1.14 . . . . 0.0 111.354 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -98.04 172.02 7.88 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.524 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -125.49 157.94 35.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.59 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 33' ' ' LEU . 34.0 mt -152.01 156.89 5.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.171 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 7.4 mp -93.45 136.94 33.23 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.228 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' ' CG1' ' A' ' 55' ' ' VAL . 82.8 m -132.78 151.22 52.05 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.289 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -118.65 160.18 22.28 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.0 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.515 HG23 HD13 ' A' ' 40' ' ' LEU . 5.7 mt -91.49 140.67 15.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.324 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.44 ' O ' HG22 ' A' ' 36' ' ' ILE . 2.8 m -85.72 -171.56 3.66 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.011 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.13 -6.85 89.11 Favored Glycine 0 N--CA 1.487 2.039 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.208 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.68 -62.04 1.72 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.246 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.515 HD13 HG23 ' A' ' 36' ' ' ILE . 1.5 mp -56.29 -20.76 20.2 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.021 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -74.88 -38.16 61.97 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.327 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.6 tpp -71.6 -29.32 64.56 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.11 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.483 HD22 ' N ' ' A' ' 43' ' ' ASN . 1.0 OUTLIER -77.04 -38.74 52.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.345 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.26 77.79 0.32 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.223 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.731 HG22 ' H ' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -124.68 -150.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.768 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.731 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -149.57 98.23 2.74 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.638 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.544 ' C ' HD12 ' A' ' 48' ' ' LEU . 4.2 mp -92.69 121.89 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.832 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.2 mp -96.19 136.89 36.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.942 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -42.46 152.66 0.09 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.248 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.24 -14.41 64.48 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -81.38 143.56 32.08 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.483 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' C ' HG13 ' A' ' 53' ' ' VAL . 37.3 mtmt -80.41 149.99 29.95 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.732 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.479 HG13 ' C ' ' A' ' 52' ' ' LYS . 26.9 m -152.06 168.4 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.798 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.552 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -101.97 117.86 35.71 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.506 ' CG1' ' SG ' ' A' ' 34' ' ' CYS . 24.3 t -104.39 123.98 58.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.436 -0.906 . . . . 0.0 113.182 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -95.55 114.31 26.06 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.99 147.63 24.19 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.577 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 m -91.97 132.51 32.52 Favored Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.056 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.94 -18.56 64.25 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 121.426 1.417 . . . . 0.0 111.712 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.09 -11.45 24.38 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.397 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.0 t70 -142.32 78.53 1.63 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.096 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -71.7 23.93 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.413 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.614 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -115.54 -23.82 8.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.08 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.01 151.73 48.19 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.622 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 35' ' ' HIS . . . -144.05 -159.36 7.98 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -166.65 146.16 5.67 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.12 -1.432 . . . . 0.0 112.584 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.598 ' N ' HD12 ' A' ' 67' ' ' ILE . 1.8 mp -93.44 126.19 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.796 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.628 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 7.7 p -126.49 6.71 6.93 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.478 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.796 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -171.73 110.47 0.29 Allowed 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.102 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 162.22 28.77 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.379 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HG3' ' H ' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -130.16 158.31 40.05 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.14 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.468 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 46.6 tttm . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 116.332 -1.794 . . . . 0.0 110.73 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.587 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mmt . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.849 0.357 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.19 24.33 0.73 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 mttm 46.5 67.72 0.73 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.788 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.52 ' CG ' ' N ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -148.94 172.91 13.95 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.261 -0.975 . . . . 0.0 110.975 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.52 ' N ' ' CG ' ' A' ' 4' ' ' LYS . 7.8 p-10 38.5 -147.8 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.516 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.631 HG22 ' H ' ' A' ' 7' ' ' ILE . 3.9 p -113.14 174.58 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.06 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.631 ' H ' HG22 ' A' ' 6' ' ' VAL . 4.5 mp -103.94 146.66 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.27 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -122.46 127.85 50.13 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.853 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.454 HD12 ' CD1' ' A' ' 57' ' ' LEU . 6.4 mt -144.56 156.02 43.94 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.262 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.519 ' OE2' ' NZ ' ' A' ' 71' ' ' LYS . 39.4 mt-10 -90.56 141.87 28.33 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.609 -0.836 . . . . 0.0 111.25 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.11 158.88 27.91 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.544 ' C ' HG13 ' A' ' 24' ' ' VAL . 29.1 m -102.49 132.84 48.28 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.482 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.9 t -68.51 127.13 29.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 118.727 -1.189 . . . . 0.0 110.656 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -98.04 -39.0 9.14 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.588 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -153.56 145.15 23.29 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.092 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.74 110.58 22.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mt -100.14 145.7 30.67 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.15 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.3 Cg_endo -61.92 172.42 3.9 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 121.242 1.295 . . . . 0.0 111.459 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER 76.0 13.79 2.67 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.767 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 72.49 50.15 0.19 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.032 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.466 ' HE2' ' HB3' ' A' ' 21' ' ' MET . 9.5 mtp -144.18 140.62 29.44 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.114 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.761 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 3.5 m-85 -133.19 166.0 23.47 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.224 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 14' ' ' SER . 78.1 tttt -112.63 111.93 23.09 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.7 HG21 ' SG ' ' A' ' 34' ' ' CYS . 16.7 t -107.38 152.11 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 119.472 -0.891 . . . . 0.0 112.774 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.78 117.24 22.26 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.592 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.464 ' C ' ' N ' ' A' ' 28' ' ' ASN . 2.9 mp -77.0 136.48 38.71 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.855 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -45.91 -19.01 0.05 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.578 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.464 ' N ' ' C ' ' A' ' 26' ' ' LEU . 12.6 m-20 -69.32 -15.9 63.43 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.865 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.04 -12.57 34.31 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.022 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -84.17 163.81 19.53 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.505 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -131.76 144.49 50.99 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.16 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.503 HD13 ' CD2' ' A' ' 57' ' ' LEU . 68.0 mt -145.59 148.87 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.575 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.569 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 6.1 mp -84.88 125.15 32.4 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.159 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.7 ' SG ' HG21 ' A' ' 24' ' ' VAL . 59.4 m -116.53 134.24 55.08 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.39 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.458 ' N ' ' HA ' ' A' ' 66' ' ' ARG . 23.3 m170 -97.79 173.54 7.05 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.451 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.761 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 12.9 mt -100.64 147.15 8.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.796 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -94.46 161.51 14.19 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.084 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.34 -34.67 25.39 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.267 -1.445 . . . . 0.0 111.28 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -65.07 -53.21 49.15 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.056 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -51.88 -22.4 3.76 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 118.447 -1.301 . . . . 0.0 110.502 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.52 ' HA ' ' HE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.06 -42.1 63.43 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 118.043 -1.463 . . . . 0.0 107.739 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.5 tpp -54.17 -29.25 44.9 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.389 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.65 ' C ' ' CD2' ' A' ' 44' ' ' PHE . 60.3 m-80 -93.25 2.84 56.45 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.65 ' CD2' ' C ' ' A' ' 43' ' ' ASN . 2.8 p90 40.8 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.0 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mm -119.9 102.59 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.578 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -70.09 115.8 9.72 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.2 mt -108.55 110.25 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.589 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mt -97.11 135.57 38.89 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.04 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.4 pm0 -46.27 152.38 0.43 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.941 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.61 60.58 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.147 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -91.96 156.37 17.49 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.321 -0.951 . . . . 0.0 110.769 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.51 143.66 27.62 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.547 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.453 ' CG2' HD12 ' A' ' 67' ' ' ILE . 12.3 m -146.57 161.27 9.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.571 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.9 OUTLIER -91.75 120.89 32.89 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.915 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG13 ' SG ' ' A' ' 34' ' ' CYS . 93.5 t -104.11 121.11 55.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.211 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -90.57 123.02 33.89 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.466 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.503 ' CD2' HD13 ' A' ' 32' ' ' ILE . 6.1 mt -97.3 140.12 32.24 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.771 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 60' ' ' TYR . 4.7 p -92.84 129.69 39.12 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.538 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -57.85 -2.46 0.78 Allowed 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 121.271 1.314 . . . . 0.0 111.668 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 58' ' ' SER . 27.3 t80 -100.32 -13.07 18.96 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.637 ' C ' ' H ' ' A' ' 63' ' ' THR . 26.6 m-20 -149.59 87.28 1.49 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.544 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 62' ' ' LEU . 2.0 mp -70.66 23.69 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.46 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.637 ' H ' ' C ' ' A' ' 61' ' ' ASP . 39.5 m -135.77 3.49 2.98 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.282 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -141.31 135.08 30.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.082 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.13 -147.78 4.97 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.465 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.458 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 11.9 ptp180 -165.89 151.46 8.91 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.302 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.453 HD12 ' CG2' ' A' ' 53' ' ' VAL . 17.3 mm -93.37 122.36 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.94 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.62 ' C ' ' CG ' ' A' ' 69' ' ' TRP . 0.2 OUTLIER -127.6 7.59 6.31 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.944 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.913 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -176.55 111.45 0.09 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.432 -1.307 . . . . 0.0 111.844 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -76.28 126.82 31.68 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.604 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.519 ' NZ ' ' OE2' ' A' ' 10' ' ' GLU . 12.5 tptt -45.31 143.79 1.62 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.962 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.801 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 mmt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.58 91.45 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.198 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -172.06 -90.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.9 mtmt 61.42 101.54 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.013 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.41 114.98 28.97 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.142 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.445 HG21 ' OE2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -148.74 173.64 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.38 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.2 mm -101.78 101.81 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.892 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -83.2 119.36 24.45 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.566 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 9' ' ' LEU . 13.0 mt -133.87 157.29 46.34 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.454 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -92.87 144.24 25.47 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.23 162.9 30.82 Favored Glycine 0 N--CA 1.483 1.813 0 C-N-CA 118.943 -1.599 . . . . 0.0 109.939 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 m -113.49 130.73 56.27 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.074 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.483 ' HA ' HG22 ' A' ' 24' ' ' VAL . 25.0 t -65.14 116.65 4.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 118.533 -1.267 . . . . 0.0 111.096 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.0 m -97.81 -33.45 11.26 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.752 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -141.73 157.87 44.51 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.67 117.02 24.8 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.083 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' MET . 22.7 mt -98.12 147.77 33.55 Favored Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.036 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 1.7 Cg_endo -60.38 152.23 68.7 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.417 1.411 . . . . 0.0 111.517 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER 79.56 46.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.137 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.43 58.07 5.81 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.596 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 17' ' ' LEU . 21.1 mtm -144.46 142.4 30.25 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.335 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.655 ' CD2' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -153.02 166.02 33.75 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.612 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -106.7 142.06 36.95 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.286 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 13' ' ' VAL . 14.0 t -133.31 132.62 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.831 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' O ' ' CG ' ' A' ' 25' ' ' LYS . 2.0 pttm -99.84 129.47 45.94 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.038 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.547 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.5 mp -86.13 177.1 7.65 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.043 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -73.34 -31.2 63.83 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.501 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -62.78 -10.79 14.22 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.486 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.41 -10.2 63.08 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.05 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.475 ' O ' HD12 ' A' ' 26' ' ' LEU . 64.1 m80 -84.98 156.77 21.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.471 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -116.17 148.55 40.25 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.599 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.697 HD13 HD21 ' A' ' 57' ' ' LEU . 78.5 mt -141.09 149.68 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.712 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.3 mp -81.53 154.74 26.1 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.667 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.427 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . 39.9 m -145.54 154.31 42.05 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.449 -1.301 . . . . 0.0 111.546 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.441 ' H ' ' HA ' ' A' ' 66' ' ' ARG . 1.9 t60 -127.76 143.88 51.11 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.386 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.592 HG23 HD21 ' A' ' 40' ' ' LEU . 5.5 mt -70.5 135.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.085 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.91 165.43 12.67 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.923 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.88 -7.26 88.77 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -74.69 -62.71 1.44 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.592 HD21 HG23 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -55.25 -20.62 11.52 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.708 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.448 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -71.57 -41.66 68.74 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.12 -1.032 . . . . 0.0 108.861 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.7 mmt -61.54 -27.08 68.36 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.181 -1.007 . . . . 0.0 109.337 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.447 ' N ' HD22 ' A' ' 43' ' ' ASN . 3.3 m120 -69.33 -1.63 8.72 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.318 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.569 ' O ' ' CG ' ' A' ' 44' ' ' PHE . 11.3 t80 57.63 54.62 6.21 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.095 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.786 HG22 ' N ' ' A' ' 46' ' ' ARG . 62.1 mt -152.88 172.3 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.162 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.786 ' N ' HG22 ' A' ' 45' ' ' ILE . 5.5 ptp85 -139.85 163.56 32.32 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.906 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 47' ' ' ILE . 2.3 mp -109.41 148.95 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.058 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.2 mt -127.78 136.94 52.18 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.977 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 15.6 mt-10 -40.18 152.47 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.855 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.61 -9.38 59.16 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.432 -1.365 . . . . 0.0 110.36 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -93.03 135.66 33.99 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.581 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.631 ' CD ' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -75.51 149.01 38.52 Favored 'General case' 0 CA--C 1.486 -1.511 0 C-N-CA 118.764 -1.174 . . . . 0.0 110.577 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.646 HG21 HD12 ' A' ' 67' ' ' ILE . 11.4 m -151.93 165.86 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.738 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.542 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -98.22 125.18 43.17 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.447 HG21 HG11 ' A' ' 24' ' ' VAL . 94.0 t -102.88 128.13 56.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.86 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.612 ' OE2' ' NH1' ' A' ' 66' ' ' ARG . 6.1 tt0 -100.33 110.28 22.5 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.395 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.697 HD21 HD13 ' A' ' 32' ' ' ILE . 17.0 mt -89.55 148.92 23.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.599 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.2 p -99.61 142.04 23.89 Favored Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 119.364 -0.934 . . . . 0.0 112.087 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.21 -3.68 6.57 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.732 1.621 . . . . 0.0 111.559 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -87.96 -23.36 23.88 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.051 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.665 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.4 OUTLIER -166.65 96.09 0.54 Allowed 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.309 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -67.69 18.51 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.563 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.665 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -103.63 -9.77 18.93 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.215 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -137.78 144.73 41.73 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.786 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.31 -152.27 5.67 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.308 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.612 ' NH1' ' OE2' ' A' ' 56' ' ' GLU . 4.1 ptt180 -162.42 152.03 15.94 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.925 -1.11 . . . . 0.0 111.469 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.646 HD12 HG21 ' A' ' 53' ' ' VAL . 33.5 mm -92.75 121.21 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.625 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 1.4 p -126.98 6.95 6.6 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.701 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.866 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -167.19 111.7 0.72 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.068 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.515 ' CD ' ' C ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -102.57 159.9 15.04 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.972 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.422 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 3.2 tptt -135.77 142.35 44.93 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.396 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 116.28 -1.819 . . . . 0.0 110.874 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mmm . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.869 0.366 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.42 -36.08 17.93 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.576 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -89.57 -78.72 0.35 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.632 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.75 -176.05 5.04 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.02 109.7 17.87 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.612 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.85 163.61 3.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mm -98.08 104.22 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.46 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -73.35 112.64 9.6 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.988 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mt -137.13 136.15 38.02 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.352 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.406 ' O ' HD23 ' A' ' 26' ' ' LEU . 28.5 tt0 -91.47 140.96 29.25 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.515 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.52 -166.98 11.02 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.038 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.544 ' N ' HG13 ' A' ' 24' ' ' VAL . 51.2 m -137.44 128.77 28.02 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.517 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.71 130.44 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.485 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.1 t -120.89 -32.42 3.98 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.13 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.22 155.5 46.03 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.573 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.13 126.68 39.51 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.958 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.59 144.26 31.5 Favored Pre-proline 0 N--CA 1.494 1.749 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.354 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 3.3 Cg_endo -64.92 164.41 24.79 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 121.539 1.492 . . . . 0.0 111.57 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.484 ' HB3' ' SD ' ' A' ' 21' ' ' MET . 0.9 OUTLIER 76.2 34.12 0.53 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.257 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.82 61.1 2.51 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.289 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.596 ' SD ' ' CE1' ' A' ' 35' ' ' HIS . 5.2 ptm -162.52 174.78 12.2 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.597 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.764 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.25 161.5 30.79 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.696 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -84.6 138.55 32.65 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.551 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.544 HG13 ' N ' ' A' ' 12' ' ' THR . 2.0 t -127.34 131.65 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.186 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -97.13 123.65 40.95 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.95 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' GLY . 42.0 mt -74.25 155.93 37.75 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.402 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 28' ' ' ASN . 12.3 pt-20 -47.26 -40.25 16.21 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.944 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.521 ' HB3' ' ND1' ' A' ' 30' ' ' HIS . 0.2 OUTLIER -67.53 -16.62 64.29 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.456 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 26' ' ' LEU . . . 108.89 -1.77 31.78 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.333 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.521 ' ND1' ' HB3' ' A' ' 28' ' ' ASN . 60.5 m80 -75.58 138.28 41.35 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.564 -1.254 . . . . 0.0 111.567 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.44 138.0 38.1 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.313 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.48 ' C ' HD12 ' A' ' 33' ' ' LEU . 22.0 mt -146.65 154.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.963 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.734 ' N ' HD12 ' A' ' 33' ' ' LEU . 7.1 mp -90.9 133.69 35.05 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.352 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.441 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 1.1 p -133.77 144.71 49.21 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.013 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.596 ' CE1' ' SD ' ' A' ' 21' ' ' MET . 13.6 m-70 -108.56 178.23 4.55 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.875 HG23 HD21 ' A' ' 40' ' ' LEU . 49.5 mt -112.25 156.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.782 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.435 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 4.6 m -107.03 155.72 19.52 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.519 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.26 -6.45 87.75 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.751 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -74.35 -59.12 2.87 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.068 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.875 HD21 HG23 ' A' ' 36' ' ' ILE . 1.9 pp -54.24 -20.55 7.16 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.539 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -70.98 -49.2 47.9 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.409 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.47 ' C ' ' H ' ' A' ' 44' ' ' PHE . 8.8 ttm -55.58 -34.99 65.29 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.585 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.1 13.12 0.33 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.47 ' H ' ' C ' ' A' ' 42' ' ' MET . 0.1 OUTLIER 56.69 34.78 25.14 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.614 -0.835 . . . . 0.0 111.296 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.634 HG22 ' N ' ' A' ' 46' ' ' ARG . 28.8 mm -98.21 170.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.251 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.634 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -149.18 154.07 38.6 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.594 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 47' ' ' ILE . 29.4 mt -132.21 144.37 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.712 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.2 mt -132.48 171.46 13.74 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.495 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 152.36 44.31 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.224 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.17 -13.96 30.09 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.229 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 51' ' ' ASP . 0.9 OUTLIER -80.57 135.61 36.11 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.576 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.493 ' C ' HG13 ' A' ' 53' ' ' VAL . 56.9 mttt -75.24 150.19 38.66 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.029 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.765 HG21 HD11 ' A' ' 67' ' ' ILE . 29.1 m -151.93 166.29 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.94 -1.104 . . . . 0.0 112.429 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.533 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -96.6 121.11 38.07 Favored 'General case' 0 C--O 1.203 -1.382 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.714 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -104.63 123.31 58.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.345 -0.942 . . . . 0.0 113.07 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -101.1 106.4 17.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.747 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.0 mt -81.14 147.31 30.12 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.675 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 p -98.16 138.08 20.87 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.485 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.4 -9.71 21.2 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.735 1.623 . . . . 0.0 112.074 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -90.53 -22.44 21.31 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.405 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.653 ' C ' ' H ' ' A' ' 63' ' ' THR . 15.5 m-20 -153.53 89.29 1.33 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.375 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mt -69.12 20.42 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.474 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.653 ' H ' ' C ' ' A' ' 61' ' ' ASP . 59.0 m -108.7 -9.84 15.22 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.513 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -138.46 148.26 44.18 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.58 -161.92 8.97 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.526 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 8.3 ptt180 -156.48 131.35 9.02 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.61 -1.236 . . . . 0.0 111.93 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.765 HD11 HG21 ' A' ' 53' ' ' VAL . 66.3 mt -95.44 129.21 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.59 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -127.97 7.32 6.09 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.49 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.781 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -168.2 111.87 0.61 Allowed 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.75 -1.18 . . . . 0.0 112.209 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -73.45 151.93 40.93 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.483 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -44.1 111.61 0.31 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.916 -1.113 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.809 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 mmt . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.869 0.366 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.18 173.81 11.96 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -90.24 -179.36 5.62 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.835 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -136.86 71.92 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.507 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -111.57 18.04 19.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.518 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.531 HG12 ' HD3' ' A' ' 59' ' ' PRO . 2.6 m -92.77 141.31 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.583 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.646 ' HB ' HD12 ' A' ' 57' ' ' LEU . 51.7 mt -95.95 101.94 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.258 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.7 114.12 9.46 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 55' ' ' VAL . 7.4 mt -131.0 150.99 51.88 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.456 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -97.75 144.26 27.55 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.908 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.54 -175.48 23.36 Favored Glycine 0 N--CA 1.483 1.767 0 C-N-CA 118.885 -1.626 . . . . 0.0 110.335 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.23 131.21 45.42 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.205 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.432 ' CG1' ' HA ' ' A' ' 49' ' ' GLU . 87.4 t -63.52 116.18 3.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 118.434 -1.306 . . . . 0.0 110.187 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 p -95.46 -37.52 10.88 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.749 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -146.19 151.88 38.33 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 118.558 -1.257 . . . . 0.0 111.792 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.443 ' HB2' ' CD ' ' A' ' 49' ' ' GLU . . . -100.92 130.57 46.94 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.494 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.6 mt -121.91 151.07 57.35 Favored Pre-proline 0 N--CA 1.488 1.469 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 20' ' ' ALA . 1.9 Cg_endo -61.13 -156.5 0.02 OUTLIER 'Trans proline' 0 C--O 1.204 -1.182 0 C-N-CA 121.452 1.435 . . . . 0.0 111.007 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.63 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 25.4 m120 46.8 12.72 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.87 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 71.09 42.94 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.914 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.4 170.48 15.94 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.252 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.677 ' CD2' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.73 165.84 29.75 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.443 -0.903 . . . . 0.0 112.216 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -97.06 136.89 36.97 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.887 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.1 t -129.68 143.56 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.163 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -102.88 118.87 37.77 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.197 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.944 ' H ' HD12 ' A' ' 26' ' ' LEU . 4.2 mp -74.19 168.88 18.72 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.793 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.62 -19.42 65.22 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.022 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -68.44 -16.24 63.83 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.445 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.44 -10.85 50.51 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -91.31 177.55 6.21 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.168 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -132.8 140.19 47.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.904 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.761 HG22 ' N ' ' A' ' 33' ' ' LEU . 8.4 mm -134.58 173.27 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.386 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.761 ' N ' HG22 ' A' ' 32' ' ' ILE . 20.2 mt -90.59 145.35 24.93 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.568 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.436 ' SG ' HG13 ' A' ' 55' ' ' VAL . 90.8 m -134.91 152.26 51.59 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.188 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.52 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 33.2 t-80 -128.0 147.51 50.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.156 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.617 HG22 ' N ' ' A' ' 37' ' ' SER . 28.3 mt -86.83 166.84 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.492 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.617 ' N ' HG22 ' A' ' 36' ' ' ILE . 6.4 p -154.07 159.12 41.39 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.354 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.31 -4.9 0.09 OUTLIER Glycine 0 N--CA 1.487 2.047 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.489 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.579 ' H ' ' C ' ' A' ' 37' ' ' SER . 0.7 OUTLIER -62.46 -61.17 2.62 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.472 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.574 HD21 ' HA ' ' A' ' 68' ' ' THR . 10.2 mt -51.56 -21.51 2.57 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.441 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.405 ' N ' ' C ' ' A' ' 39' ' ' LYS . 2.3 mmm180 -83.44 -25.79 30.9 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.333 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' LYS . 13.7 ttp -89.79 -21.39 22.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.262 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.413 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -93.23 3.87 54.94 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.788 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 52.06 66.49 1.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.725 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.621 ' CG2' ' N ' ' A' ' 46' ' ' ARG . 26.5 mt -146.22 165.58 8.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.105 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.621 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 50.3 ttm-85 -133.21 140.85 47.76 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.398 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.506 HD12 HD13 ' A' ' 40' ' ' LEU . 58.9 mt -132.44 149.04 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.263 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.839 HD23 ' N ' ' A' ' 48' ' ' LEU . 1.9 pt? -142.97 -176.82 5.05 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.72 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 23.3 mt-10 -75.42 152.24 38.01 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.259 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.51 -14.07 37.55 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.074 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.15 143.37 26.75 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.859 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.484 ' C ' HG13 ' A' ' 53' ' ' VAL . 2.9 tttt -75.63 154.33 36.69 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.711 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.752 HG21 ' CD1' ' A' ' 67' ' ' ILE . 31.6 m -154.8 171.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.482 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.555 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -103.36 123.92 47.72 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG13 ' SG ' ' A' ' 34' ' ' CYS . 3.1 t -103.36 134.21 45.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.648 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.81 111.63 22.92 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.118 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.646 HD12 ' HB ' ' A' ' 7' ' ' ILE . 8.8 mt -77.8 121.58 24.27 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.672 -1.211 . . . . 0.0 108.981 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 60' ' ' TYR . 1.5 m -80.49 130.04 66.55 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.941 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.531 ' HD3' HG12 ' A' ' 6' ' ' VAL . 2.5 Cg_endo -61.05 -1.25 1.59 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.339 1.359 . . . . 0.0 110.646 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 58' ' ' SER . 5.7 m-30 -84.6 -21.56 30.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.608 ' C ' ' H ' ' A' ' 63' ' ' THR . 2.4 t0 -169.82 100.64 0.31 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.046 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mt -69.25 19.31 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.876 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.608 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.1 p -102.71 -12.19 17.84 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.264 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.477 ' HG2' ' N ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -148.93 144.57 26.92 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.923 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.477 ' N ' ' HG2' ' A' ' 64' ' ' ARG . . . -120.7 -156.57 9.89 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.46 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 9.1 ptm180 -157.41 147.03 20.28 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.502 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.752 ' CD1' HG21 ' A' ' 53' ' ' VAL . 1.9 mm -94.04 118.02 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.212 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.624 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 72.2 p -127.17 7.79 6.57 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.24 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.846 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -173.66 118.49 0.28 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 118.621 -1.232 . . . . 0.0 112.403 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -68.68 161.77 27.49 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.881 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.447 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 12.2 tttp -45.68 157.1 0.11 Allowed 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.581 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 71' ' ' LYS . 7.5 ttmt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.779 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.823 0.344 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.27 75.65 0.39 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 4' ' ' LYS . 2.4 tppp? -91.85 147.69 22.78 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 3' ' ' LYS . 10.7 mttp 51.08 85.99 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.857 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.71 145.72 0.42 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.428 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.59 HG22 ' H ' ' A' ' 7' ' ' ILE . 4.7 p -77.46 174.02 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.032 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.59 ' H ' HG22 ' A' ' 6' ' ' VAL . 24.5 mm -104.02 101.78 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.561 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 4.9 pt-20 -103.71 118.83 37.63 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.9 mt -132.25 161.25 33.92 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.431 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -87.96 135.37 33.44 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.798 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.83 154.6 26.04 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -104.9 127.87 52.9 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.856 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 22' ' ' PHE . 19.4 t -59.01 127.03 17.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 118.67 -1.212 . . . . 0.0 110.552 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.35 -39.48 8.38 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.526 -0.87 . . . . 0.0 113.013 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.09 136.27 17.57 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.231 -1.388 . . . . 0.0 112.17 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.89 113.55 21.04 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.58 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 21' ' ' MET . 64.4 mt -100.11 150.07 36.57 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.107 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 3.3 Cg_exo -56.78 160.23 12.52 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.219 1.28 . . . . 0.0 111.478 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.9 t-20 76.85 28.04 0.7 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.641 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.484 ' O ' ' CD2' ' A' ' 35' ' ' HIS . . . 55.42 61.94 2.66 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.544 -0.863 . . . . 0.0 111.928 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.503 ' HG3' ' N ' ' A' ' 22' ' ' PHE . 4.6 ttt -153.59 150.81 29.04 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.503 ' N ' ' HG3' ' A' ' 21' ' ' MET . 0.0 OUTLIER -145.38 164.85 30.21 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.298 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -99.84 113.98 26.87 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.389 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.522 HG11 HG21 ' A' ' 55' ' ' VAL . 70.8 t -94.2 150.35 4.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.125 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -121.47 111.15 16.92 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.428 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.03 ' H ' HD12 ' A' ' 26' ' ' LEU . 3.6 mp -71.25 162.88 28.71 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.139 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.65 -18.07 64.61 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.588 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.803 ' H ' HD22 ' A' ' 28' ' ' ASN . 0.4 OUTLIER -65.05 -16.44 63.46 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.807 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.93 -5.86 43.07 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -102.99 178.71 4.48 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.929 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 5.4 pm0 -138.71 158.72 43.71 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.994 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.701 HG22 ' N ' ' A' ' 33' ' ' LEU . 81.8 mt -141.76 167.6 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.732 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.701 ' N ' HG22 ' A' ' 32' ' ' ILE . 3.6 mp -91.51 138.14 31.81 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.238 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.44 ' SG ' ' CG2' ' A' ' 24' ' ' VAL . 4.8 m -141.84 133.16 26.5 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.647 ' CG ' ' N ' ' A' ' 36' ' ' ILE . 51.9 t-80 -107.49 176.85 5.02 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.713 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.651 ' CG2' ' N ' ' A' ' 37' ' ' SER . 26.0 mt -103.92 167.1 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.256 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.9 ' OG ' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -123.32 110.13 14.79 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.96 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.63 -26.02 0.12 Allowed Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.821 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -69.74 -56.35 7.41 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.942 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -51.32 -21.78 2.42 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.779 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' NH2' HG21 ' A' ' 36' ' ' ILE . 5.1 ttm-85 -68.46 -47.36 67.34 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.195 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.424 ' C ' ' H ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -52.78 -31.85 40.66 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.489 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.642 ' C ' ' CD2' ' A' ' 44' ' ' PHE . 32.3 t30 -79.33 19.48 0.59 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.474 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.642 ' CD2' ' C ' ' A' ' 43' ' ' ASN . 6.6 p90 38.88 87.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.714 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.542 HD11 HD22 ' A' ' 43' ' ' ASN . 6.4 mt -140.92 88.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.77 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HG3' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -80.33 128.25 33.33 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.175 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -132.63 128.57 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.669 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' GLU . 83.1 mt -108.26 150.82 26.79 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.823 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 48' ' ' LEU . 1.7 tm-20 -38.48 151.44 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.771 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.74 -11.95 50.28 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.241 -1.457 . . . . 0.0 109.861 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -82.09 133.9 35.3 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.696 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.477 ' C ' HG13 ' A' ' 53' ' ' VAL . 56.5 mttp -77.83 143.68 37.66 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.078 -1.049 . . . . 0.0 111.221 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.689 ' CG2' HD12 ' A' ' 67' ' ' ILE . 35.1 m -149.87 169.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.745 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' HB2' ' CD1' ' A' ' 69' ' ' TRP . 41.2 m-20 -91.74 124.66 36.04 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG21 HG11 ' A' ' 24' ' ' VAL . 40.0 t -103.65 119.17 51.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.679 -0.808 . . . . 0.0 112.529 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.421 ' CG ' HG21 ' A' ' 6' ' ' VAL . 79.4 tt0 -91.78 113.28 25.5 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.963 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.428 ' CD2' HD13 ' A' ' 32' ' ' ILE . 10.2 mt -101.65 148.77 24.86 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.238 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 m -83.12 121.21 77.03 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.688 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -59.95 -16.45 38.76 Favored 'Trans proline' 0 C--O 1.217 -0.563 0 C-N-CA 121.254 1.302 . . . . 0.0 111.846 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -106.2 -10.88 16.25 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.485 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.587 ' C ' ' H ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -138.75 77.44 1.62 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.884 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.0 mt -74.29 27.77 0.08 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.091 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.587 ' H ' ' C ' ' A' ' 61' ' ' ASP . 0.9 OUTLIER -102.4 -29.69 11.48 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.976 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -139.29 160.51 39.65 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.047 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.17 -157.41 7.18 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.41 140.06 5.95 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.249 -1.38 . . . . 0.0 112.357 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.689 HD12 ' CG2' ' A' ' 53' ' ' VAL . 39.0 mm -92.32 108.62 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.727 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.9 HG22 ' OG ' ' A' ' 37' ' ' SER . 21.5 p -128.84 8.1 5.7 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.837 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.827 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -164.47 120.39 1.52 Allowed 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 118.087 -1.445 . . . . 0.0 112.782 -179.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.36 152.18 36.4 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.66 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -79.79 148.19 31.52 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.419 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tttp . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.098 179.949 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 tmm? . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.7 -14.45 48.37 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.552 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -92.96 37.99 1.03 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.83 78.25 1.58 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.77 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 5' ' ' ASP . 6.0 p30 -153.4 21.94 0.55 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.281 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG22 ' H ' ' A' ' 7' ' ' ILE . 3.6 p -173.14 168.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.136 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 62' ' ' LEU . 3.2 mt -113.85 100.62 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.842 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.24 125.01 41.52 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.735 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.3 mt -142.34 151.89 42.38 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.555 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 25.5 mp0 -86.33 138.95 31.42 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.159 -1.017 . . . . 0.0 109.971 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.12 -177.07 15.96 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 119.127 -1.511 . . . . 0.0 109.564 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.51 ' C ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -128.81 124.33 35.13 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.446 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 50' ' ' GLY . 11.3 t -59.97 132.99 25.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.0 p -110.46 -29.69 7.98 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.864 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -149.14 157.45 43.39 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.738 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.74 126.09 54.85 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.7 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.3 mt -119.74 150.33 50.18 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.22 171.7 2.99 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.293 1.329 . . . . 0.0 111.276 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 68.99 31.15 4.26 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.668 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 41' ' ' ARG . . . 55.3 52.44 11.46 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.585 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 mmm -141.02 142.24 34.25 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.874 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -143.58 157.69 44.23 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.245 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -96.66 129.2 44.1 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.219 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.51 HG13 ' C ' ' A' ' 12' ' ' THR . 14.1 t -121.42 150.47 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.528 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -126.57 128.58 47.05 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.953 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.706 HD12 HD11 ' A' ' 32' ' ' ILE . 12.4 mt -85.41 142.75 29.04 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.101 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -49.7 -26.75 4.03 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.943 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -63.8 -17.05 62.7 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.291 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.92 -0.59 38.72 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.526 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -93.23 145.2 24.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.187 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.86 141.53 37.94 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.179 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.706 HD11 HD12 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -139.85 146.78 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.943 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 6.3 mp -93.09 125.26 37.59 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.63 ' SG ' HG13 ' A' ' 55' ' ' VAL . 73.2 m -118.52 155.62 30.54 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.149 -1.02 . . . . 0.0 112.451 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -118.26 155.79 29.96 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.733 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.578 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 37.7 mt -95.04 149.84 4.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.789 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.515 ' O ' HG22 ' A' ' 36' ' ' ILE . 73.1 m -88.32 -172.76 3.91 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.007 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.88 -21.4 63.48 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.578 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.615 ' CG ' ' N ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -72.26 -55.91 6.4 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.489 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.615 ' N ' ' CG ' ' A' ' 39' ' ' LYS . 2.4 mp -54.82 -21.69 12.05 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.445 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -72.2 -40.2 68.02 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.534 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.1 mmm -72.15 -31.46 65.98 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.759 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -74.0 -34.07 64.05 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.294 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.0 t80 40.12 61.63 1.47 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.818 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.676 HG22 ' H ' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -86.78 -165.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.158 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.676 ' H ' HG22 ' A' ' 45' ' ' ILE . 12.7 ptt85 -119.46 74.36 1.0 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 48' ' ' LEU . 4.6 mm -98.08 144.24 11.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.402 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 47' ' ' ILE . 4.4 mp -126.78 152.55 46.76 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.726 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 48' ' ' LEU . 2.9 pp20? -40.27 152.44 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.194 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 97.63 -15.05 62.54 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.26 131.91 39.55 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.262 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -77.62 146.46 36.15 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.296 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.534 ' HB ' HG23 ' A' ' 67' ' ' ILE . 35.8 m -152.45 171.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.972 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.591 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 2.0 m-80 -97.99 117.8 33.14 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.63 HG13 ' SG ' ' A' ' 34' ' ' CYS . 13.9 t -104.68 126.74 59.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.665 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.91 117.14 34.37 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.648 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.524 ' CD2' HG21 ' A' ' 32' ' ' ILE . 3.9 mt -99.27 149.16 23.4 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.907 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.36 136.13 30.35 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -59.54 -10.87 12.32 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.556 1.504 . . . . 0.0 111.715 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.507 ' CD2' ' OD2' ' A' ' 61' ' ' ASP . 8.5 t80 -101.95 -14.45 17.19 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.608 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.627 ' C ' ' H ' ' A' ' 63' ' ' THR . 57.2 m-20 -144.19 79.8 1.63 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.564 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.534 ' CD2' HD12 ' A' ' 7' ' ' ILE . 5.0 mt -71.06 20.28 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.292 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.627 ' H ' ' C ' ' A' ' 61' ' ' ASP . 10.6 p -118.63 -9.68 10.19 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.298 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.501 ' HB2' HH21 ' A' ' 64' ' ' ARG . 37.3 mtp-105 -133.7 143.95 48.83 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.075 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.85 -153.48 6.25 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.597 -1.287 . . . . 0.0 109.897 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -162.68 147.5 11.95 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.504 -1.279 . . . . 0.0 112.134 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.534 HG23 ' HB ' ' A' ' 53' ' ' VAL . 20.5 mm -93.55 110.35 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.027 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.619 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 3.3 p -118.17 6.83 12.03 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.84 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -166.9 110.41 0.72 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 118.673 -1.211 . . . . 0.0 111.331 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.8 ptt-85 -76.27 136.89 39.64 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.435 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.63 145.85 11.18 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.904 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.7 pttm . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.918 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.19 16.65 1.9 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.955 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp 57.32 174.8 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.646 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 6.8 mttp 47.16 -159.02 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.869 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 1.2 t0 73.01 -144.61 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.167 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.666 HG12 ' HD3' ' A' ' 59' ' ' PRO . 0.7 OUTLIER -74.27 157.18 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.613 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.1 100.26 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 119.167 -1.013 . . . . 0.0 109.556 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.02 112.31 20.5 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.654 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 9' ' ' LEU . 23.8 mt -137.58 149.69 46.88 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.467 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.78 144.39 25.76 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.894 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA3' HD23 ' A' ' 26' ' ' LEU . . . -145.46 -155.0 6.31 Favored Glycine 0 N--CA 1.481 1.681 0 C-N-CA 119.149 -1.501 . . . . 0.0 109.766 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 50' ' ' GLY . 31.1 m -145.24 130.62 18.68 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.026 -1.07 . . . . 0.0 111.138 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.423 ' HA ' HG22 ' A' ' 24' ' ' VAL . 11.4 t -59.6 123.12 11.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.145 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -100.4 -30.31 11.91 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.73 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -150.3 155.03 38.91 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.821 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.98 123.57 48.86 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.501 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.2 mt -121.98 151.16 57.73 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.179 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.92 -178.8 0.34 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.269 1.313 . . . . 0.0 111.544 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.608 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.6 OUTLIER 69.41 14.94 8.44 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.134 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 19' ' ' ASN . . . 68.28 43.82 1.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.072 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.2 mtm -144.73 152.47 40.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.774 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -144.85 165.88 26.86 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.876 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -95.58 124.3 39.54 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.387 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 13' ' ' VAL . 78.4 t -118.52 141.25 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.956 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -118.76 113.59 21.38 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.793 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.544 HD23 ' HA3' ' A' ' 11' ' ' GLY . 26.1 mt -67.38 137.75 56.2 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.494 -0.883 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.45 -12.29 0.06 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.522 -1.271 . . . . 0.0 109.179 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.54 ' N ' ' C ' ' A' ' 26' ' ' LEU . 39.1 m-80 -72.5 -17.23 61.77 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.41 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.42 0.39 35.01 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.96 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -101.22 136.3 41.29 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.969 -1.093 . . . . 0.0 112.494 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.623 ' C ' HD12 ' A' ' 32' ' ' ILE . 8.1 pt-20 -109.27 132.09 54.45 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.301 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 32' ' ' ILE . 4.7 mp -141.37 165.55 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.043 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.636 ' N ' HG22 ' A' ' 32' ' ' ILE . 7.0 mp -89.28 134.32 34.1 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.329 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.519 ' CB ' HD13 ' A' ' 67' ' ' ILE . 80.0 m -128.55 148.33 50.76 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.276 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.469 ' ND1' ' O ' ' A' ' 36' ' ' ILE . 48.9 t-80 -114.81 154.97 27.62 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.273 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.65 HG23 HD21 ' A' ' 40' ' ' LEU . 51.5 mt -90.75 153.32 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.087 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 36' ' ' ILE . 6.0 m -82.6 126.51 32.39 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.931 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.4 -12.19 0.89 Allowed Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.453 -1.356 . . . . 0.0 111.315 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -80.7 -63.01 1.5 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.257 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.65 HD21 HG23 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -59.03 -18.61 36.15 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.38 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -71.64 -40.51 69.67 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.89 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.546 ' C ' ' H ' ' A' ' 44' ' ' PHE . 7.6 mmt -61.72 -35.82 79.17 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -58.92 -0.3 0.11 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.247 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.546 ' H ' ' C ' ' A' ' 42' ' ' MET . 4.8 t80 55.21 45.11 26.53 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.309 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 46' ' ' ARG . 6.2 mm -98.55 157.49 3.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.096 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' N ' HG22 ' A' ' 45' ' ' ILE . 3.3 mtp180 -150.03 99.14 2.79 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.818 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.542 HD11 ' CG ' ' A' ' 51' ' ' ASP . 5.1 tt -87.42 149.13 4.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.576 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.904 ' N ' HD12 ' A' ' 48' ' ' LEU . 3.5 mp -83.75 135.35 34.58 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.25 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 49' ' ' GLU . 4.8 mm-40 -44.66 153.26 0.17 Allowed 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.891 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . 92.4 -15.19 62.86 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.253 -1.451 . . . . 0.0 109.628 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.542 ' CG ' HD11 ' A' ' 47' ' ' ILE . 10.2 t70 -72.79 152.95 41.32 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.046 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.472 ' C ' HG13 ' A' ' 53' ' ' VAL . 2.0 mptm? -83.98 146.65 27.88 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.745 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.473 HG21 HG12 ' A' ' 67' ' ' ILE . 24.6 m -150.34 164.62 3.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.386 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.578 ' CB ' ' CD1' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -91.83 121.52 33.52 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.507 HG13 ' SG ' ' A' ' 34' ' ' CYS . 2.3 t -105.08 123.84 59.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.517 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.13 113.32 26.47 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.31 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.43 132.75 33.89 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.956 -1.098 . . . . 0.0 110.741 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 t -85.64 121.49 73.35 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.393 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.666 ' HD3' HG12 ' A' ' 6' ' ' VAL . 3.8 Cg_exo -61.98 -9.66 15.17 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 121.074 1.183 . . . . 0.0 110.942 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -94.27 -16.94 23.14 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.615 ' C ' ' H ' ' A' ' 63' ' ' THR . 13.8 m-20 -142.99 82.33 1.76 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.942 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.9 mt -71.21 24.09 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.768 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.615 ' H ' ' C ' ' A' ' 61' ' ' ASP . 42.0 m -122.91 -7.33 8.42 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.439 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -140.17 152.05 45.73 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.449 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 66' ' ' ARG . . . -137.56 -167.44 11.06 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.676 -1.77 . . . . 0.0 108.676 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.414 ' CG ' ' O ' ' A' ' 65' ' ' GLY . 18.1 mtt85 -155.98 131.32 9.47 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.709 -1.597 . . . . 0.0 112.899 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 67' ' ' ILE . 1.4 mp -93.32 111.89 25.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.519 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.473 ' OG1' ' CE2' ' A' ' 69' ' ' TRP . 14.3 p -126.75 7.28 6.78 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.487 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.811 ' CD1' ' N ' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -159.57 112.11 2.15 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.665 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -74.15 141.75 45.53 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.625 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -87.38 164.35 16.27 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.067 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 71' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.248 0 CA-C-O 116.304 -1.807 . . . . 0.0 110.578 179.985 . . . . . . . . 2 2 . 1 stop_ save_